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III Summary 
Molecular  biology  has  provided  new  opportunities  to  understand  better  the 
functioning  of  the  immune  system  and  to  exploit  this  information  for  the  construction 
of  specific  antibodies  against  a  wide  variety  of  antigens  including  the  pathogens  of 
humans  and  animals.  In  spite  of  the  economic  importance  of  cattle,  many  aspects  of 
the  immunology  of  this  animal  remain  uncharacterised  and  tools  to  understand  better 
bovine  infections  are  lacking.  This  project  has  addressed  aspects  of  both  issues. 
The  bovine  immunoglobulin  (Ig)  system  resembles  that  of  other  domesticated 
mammals  in  some  respects,  but  other  properties  (eg  the  length  of  the  third  antigen- 
binding  region  of  the  heavy  chain)  appear  unique.  The  first  area  for  investigation  in 
this  project  was  to  characterise  the  bovine  JH  locus  and  to  understand  why  Ig 
rearrangement  apparently  favours  a  single  JH  segment.  PCR  was  used  to  recover  J1; 
sequence  from  genomic  DNA,  either  from  non-lymphoid  tissues  or  lambda  vectors 
isolated  and  studied  by  other  investigators.  A  region  of  3200  bp  was  characterised 
which  included  the  DQ52  segment,  6  JH  segments  and  the  heavy  chain  enhancer.  The 
bovine  DQ52  sequence  is  longer  than  those  of  other  species  and  differs  in  sequence 
from  a  common  consensus.  For  the  most  part,  the  JH  locus  is  homologous  to  that  of  the 
sheep.  The  sixth  JH  segment  identified  appears  to  undergo  rearrangement  and  is 
expressed  in  a  minority  of  cattle  antibodies.  However,  none  of  the  segments  carried  the 
sequence  which  is  most  commonly  expressed  in  bovine  Ig.  To  identify  which  segment 
participates  in  this  process,  sequence  was  recovered  from  the  rearranged  genomic 
DNA  of  isolated  bovine  B  cells  using  PCR  with  primers  against  VH  and  JH  regions. 
This  implicated  the  rearrangement  of  the  fourth  JH  segment  in  the  formation  of  bovine 
Igs  but  as  the  sequence  differed  between  germline  and  rearranged  copies,  it  appears 
that  a  non-conventional  process  operates  in  cattle.  It  is  proposed  that  a  gene  conversion 
event  or  modified  rearrangement  process  introduces  sequence  to  form  the  fourth 
framework  region  of  bovine  Ig  which  does  not  exist  at  the  JH  locus  in  the  gern-line.  The 
mechanism  of  this  modification  requires  more  investigation. 
The  second  part  of  this  project  aimed  to  construct  a  library  of  recombinant  bovine 
Fab  antibodies  from  the  Ig  repertoire  of  'a  calf  vaccinated  against  Mannheimia 
haemolytica  (previously  named  Pasteurella  haemolytica).  Using  PCR  on  lymphoid 
cDNA,  the  bovine  VL  and  VF{  repertoires  were  recovered  with  ease  for  direct  cloning 
into  the  phage  display  vector  pComBov.  Complications  encountered  at  the  cloning 
stage  led  us  to  an  alternative  strategy,  the  cloning  of  amplicons  as  blunt  fragments  into 
IV an  intermediate  vector,  pUC18,  in  order  to  increase  the  efficiency  of  subsequent 
restriction  enzyme  digestion.  Intermediate  libraries  of  the  light  and  heavy  chain 
repertoires  were  constructed  successfully  and  the  VL  repertoire  was  then  released  for 
cloning  to  pComBov  by  digestion  with  Sstl  and  BstEII.  In  contrast,  difficulties  were 
encountered  in  recloning  heavy  chain  RsrII  /  SpeI  fragments  into  the  pComBov-VL 
library.  It  was  confirmed  that  the  heavy  chain  fragment  could  be  released  from  the 
intermediate  heavy  chain  library  and  so  the  obstacle  arose  at  ligation.  A  thorough 
investigation  of  experimental  conditions  attempted  to  find  a  solution  but  without 
success.  After  the  failure  of  indirect  cloning  of  the  heavy  chain  repertoire  into  a 
pComBov-VL  library,  attention  returned  to  a  direct  cloning  strategy  using  revised 
primers,  in  which  the  distance  between  the  restriction  sites  and  the  termini  of  heavy 
chain  amplicons  was  increased.  The  resulting  VH  amplicons  could  be  digested 
efficiently  with  RsrII  and  SpeI  but  attempts  to  clone  the  digestion  products  were 
unsuccessful  again. 
In  the  third  part  of  the  project,  recombinant  antibodies  against  the  outer  membrane 
proteins  (OMPs)  of  Mannheimia  haemolytica  were  isolated  from  the  Griffin.  1  scFv 
library.  OMPs  were  prepared  using  Sarkosyl  and  their  composition  assessed  by  SDS- 
PAGE.  The  proteins  were  coated  to  plastic  and  the  library  screened  for  binders  via  3 
rounds  of  selection.  Phage  antibodies  were  eluted  by  either  triethylamine  or  an  anti- 
OMP  serum  in  separate  selections.  Ninety  six  clones  from  each  round  of  selection 
were  screened  for  the  most  reactive  antibodies  through  monoclonal  phage  ELISA. 
Comparison  of  eighty  clones  which  reacted  best  with  OMPs  showed  that  the  affinity  of 
phage  antibodies  increased  by  progressive  reduction  in  the  target  concentration  at  the 
coated  surface  through  the  selection  process.  Reaction  was  detected  between  several  of 
the  recombinant  Igs  and  an  OMP  of  40  kDa  using  Western  blotting.  By  using  mass 
spectrometry,  this  protein  was  identified  as  Mannheimia  haemolytica  PomA. 
Overall,  the  project  identified  aspects  of  the  immunology  of  cows  that  appear  to  be 
entirely  novel,  and  applied  recombinant  antibody  technology  to  understand  better  an 
important  bacterial  pathogen  for  this  livestock  species. 
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XVII Chapter  1 
General  Introduction 1  General  Introduction 
1.1  Antibodies  as  passive  therapeutics 
The  survival  of  animals  in  a  hostile  environment  teeming  with  pathogens  has 
necessitated  the  evolution  of  complex  systems  of  immune  defence.  These  systems 
contain  molecules,  primarily  antibodies,  and  T-cell  receptors,  with  exquisite  specificities 
which  have  naturally  attracted  attention  as  potential  therapeutic  agents.  Antibodies  are 
clearly  more  straightforward  to  use  in  this  role  since  they  are  soluble  protein  molecules 
whereas  T-cell  receptors  are  of  course  cell  associated  and  require  MHC  compatibility  for 
recognition. 
Indeed  over  100  years  ago,  Emil  von  Behring  demonstrated  the  efficacy  of 
hyperimmune  horse  serum  containing  high  titres  of  antibody  to  diphtheria  in  combating 
an  outbreak  of  disease  in  humans.  However,  despite  this  early  success,  the  use  of  passive 
immunisation  through  the  20th  Century  has  been  very  limited.  This  probably  reflects  the 
great  success  of  antibiotics  in  combating  bacterial  diseases,  of  vaccines  in  the  prevention 
of  viral  diseases,  and  the  difficulties  of  obtaining  antibodies  useful  for  passive 
immunisation.  With  regard  to  the  latter  issue,  the  stimulation  of  high  titre  sera  in  animals 
is  a  relatively  trivial  matter  but  their  use  as  passive  therapeutics  in  human  patients 
inevitably  elicits  a  response  leading  to  elimination  of  the  foreign  immunoglobulin  from 
the  circulation.  This  severely  constrains  heterologous  passive  transfer  as  a  therapeutic 
strategy.  The  risks  inherent  in  human  to  human  transfer  are  sufficiently  formidable  to 
effectively  rule  out  this  option  as  an  alternative  and  hydridoma  techniques  for  the 
production  of  monoclonal  antibody  (Kohler  and  Milstein,  1975)  have  never  fulfilled 
their  potential  as  a  means  to  produce  of  human  antibody  in  vitro.  However,  the 
emergence  of  AIDS  in  the  1980s  and  of  a  spectrum  of  infections  in  a  large  pool  of 
immunocompromised  patients  has  renewed  interest  in  passive  immunisation  for  the 
treatment  of  infectious  disease.  This  has  coincided  with  a  period  of  rapid  progress  in  the 
generation  and  design  of  antibodies  for  medicine  using  recombinant  DNA  techniques. 
1.2  Antibody  engineering 
1.2.1  Ilybridomas 
Antibody  engineering  became  possible  with  the  development  of  hybridoma 
technology  by  Kohler  and  Milstein  in  1975.  In  common  with  the  generation  of 
polyclonal  antibodies,  it  requires  the  initial  immunisation  of  a  laboratory  animal  (usually 
mouse  or  rat)  to  raise  a  high  titre  of  circulating  antibodies  against  the  immunising 
i antigen.  B  lymphocytes  are  then  isolated  from  the  spleen.  Through  rearrangement  of 
immunoglobulin  genes,  each  B  lymphocyte  produces  antibodies  with  affinity  for  a  single 
antigenic  unit  or  epitope.  Monospecific  antibodies  with  this  same  specificity  cannot  be 
obtained  directly  from  isolated  B  lymphocytes  as  they  rapidly  die  in  cell  culture.  To 
overcome  this  obstacle,  Kohler  and  Milstein  fused  B  lymphocytes  with  plasmacytoma 
cells,  descendants  of  a  plasma-cell-tumour.  The  resulting  "hybridoma  cells"  possess  the 
properties  of  both  fusion  partners:  they  are  immortalised  and  produce  a  monoclonal 
antibody  as  coded  by  the  B  lymphocyte  partner. 
Monoclonal  antibody  technology  remains  one  of  the  core  technologies  of 
biotechnology,  and  thousands  of  medically  and  diagnostically  relevant  hybridomas  have 
been  developed.  A  disadvantage  of  this  method,  however,  is  the  labour-intensive 
procedure  needed  for  the  selection  of  the  desired  antibody-producing  clone  from 
thousands  of  hybridomas  that  manufacture  irrelevant  antibodies. 
In  principle  unlimited  quantities  of  a  monospecific  antibody  could  be  produced  from 
the  immortalised  cells,  but  the  technology  is  consistently  more  successful  for  production 
of  rodent  monoclonal  antbodies  than  for  human  (James  and  Bell,  1987).  Clinical  testing 
of  murine  monoclonal  antibodies  in  human  immunotherapy  also  has  generally  yielded 
disappointing  results;  murine  immunoglobulins  invariably  evoke  a  human  anti-mouse 
immune  response;  they  are  ineffective  as  cytotoxic  agents  and  in  their  ability  to  recruit 
effector  cells  or  molecules  of  the  complement  system.  This  situation  has  stimulated 
endeavours  aimed  at  the  construction  of  genetically  engineered  antibodies  with  reduced 
immunogenicity  and  improved  effector  functions  (de  Kruif  et  al.,  1996) 
1.2.2  Recombinant  antibodies 
In  recombinant  antibody  technology,  synthesis  of  the  protein  is  removed  from  a 
laboratory  animal  and  takes  place  in  bacteria  or  in  eukaryotic  cell  culture,  in  vitro. 
Expression  of  the  full-length  protein  complete  with  antigen-binding  and  effector 
domains  is  just  one  option.  Genetic  manipulation  of  the  coding  sequence  can  result  in 
expression  of  Fab  fragments  or  entirely  artificial  products  such  as  single  chain  antibodies 
(scFvs),  isolated  heavy  chain  domains  (Fvs)  or  constructs  with  dual  antigenic 
specificities  (diabodies). 
2 Why  recombinant  antibodies? 
Recombinant  antibodies  can  be  obtained  in  vitro 
In  contrast  to  all  other  methods  mentioned,  recombinant  antibodies  can  be  expressed 
in  a  bacterial  host  that  is  completely  independent  of  a  vertebrate.  This  eliminates  the 
chance  of  possible  contamination  with  contagious  pathogens,  a  risk  always  presents 
when  human  or  animal  products  are  used.  These  recombinant  antibodies  are,  of  course, 
also  monoclonal  because  they  originate  from  a  single  (bacterial)  cell.  Moreover, 
handling  bacterial  clones  is  usually  simpler and  cheaper  than  for  hybridoma  cells  in  term 
of  their  culture,  analysis  and  storage.  More  important  however  is  the  fact  that  the  power 
of  bacterial  genetics  can  be  applied  to  the  analysis  and  modification  of  the  encoded 
immunoglobulin.  Consequently,  sequencing  and  countless  modifications  are  simplified. 
Recombinant  antibodies  can  be  produced  from  many  different  host  species 
Currently,  recombinant  antibodies  can  be  produced  without  the  need  for  prior 
immunisation,  by  using  immunoglobulin  libraries  carried  in  bacteriophage  (see  below), 
thereby  reducing  laboratory  animal  experimentation.  Recombinant  antibodies  can  be 
produced  against  native  sequence  from  a  wide  range  of  species.  For  many  of  these 
animals,  hybridoma  technology  is  not  available;  where  heterohybridomas  have  been 
used,  their  stability  is  frequently  poor.  To  date,  the  recombinant  approach  has  been  most 
popular  for  the  production  of  human  and  rodent  immunoglobulins,  but  it  has  also  proved 
successful  with  rabbits,  a  range  of  domesticated  livestock  and  primates  (O'Brien  and 
Aitken  2002).  As  noted  above,  antibodies  of  native  sequence  are  specially  favoured  over 
those  from  other  animals  when  used  in  vivo  for  diagnosis  or  therapy.  They  could  be 
applied  as  passive  therapeutics  against  pathogens  or  toxins  and  are  of  proven  value  in  the 
fight  against  cancer,  due  to  their  specificity,  while  avoiding  the  immune  response  which 
would  be  triggered  by  antibodies  from  a  different  species  (Breitling  and  Dubel,  1999). 
Chimeric  antibodies 
The  first  generation  of  recombinant  monoclonal  antibodies  consisted  of  rodent- 
derived  variable  (V)  regions  fused  to  human  constant  (C)  regions.  It  is  thought  that  the 
most  immunogenic  regions  of  antibodies  are  the  conserved  C  domains  (Khazaeli  et  al., 
1994).  Because  the  antigen  binding  site  of  the  antibody  is  localised  within  the  V  regions, 
the  chimeric  molecules  retain  their  binding  affinity  for  the  antigen  and  acquire  the 
function  of  substituted  C  regions.  For  examples,  mouse::  human  IgGI  chimeric 
3 antibodies  have  been  shown  to  mediate  the  lysis  of  tumour  cells  in  the  presence  of 
human  complement  (Liu  et  al.,  1987). 
The  chimeric  antibodies  are  easily  produced  but  retain  the  mouse  variable  domains 
with  possible  consequences  for  immunogenicity.  Clinical  experience  with  rodent 
monoclonal  and  mouse::  human  chimeric  antibodies  indicates  that  for  some  antibodies  a 
strong  anti-idiotypic  reaction  is  elicited  (Jaffers  et  al.,  1986).  Therefore,  to  reduce  the 
murine  content  even  further,  procedures  have  been  developed  for  humanising  the  Fv 
regions  (Kipriyanov  and  Little,  1999). 
Humanised  antibodies 
A  large  decrease  in  the  immunogenicity  of  an  antibody  can  be  achieved  by  variable 
domain  replacement  (Boulianne  et  al.,  1984;  Morrison  et  al.,  1984;  Neuberger  et  al., 
1985)  or  by  grafting  the  complementary-determining  regions  (CDRs)  of  foreign 
antibodies  onto  human  framework  (FR)  and  C  regions  (Jones  et  al.,  1986;  Verhoeyen  et 
al.,  1988).  This  can  generate  antibodies  suitable  for  use  in  vivo  but  humanised  antibodies 
are  tedious  to  construct  and  often  yield  molecules  with  reduced  affinity  for  the  target 
antigen.  Indeed,  it  is  frequently  found  that  some  FR  residues  from  the  original  antibody 
need  to  be  preserved  in  the  humanised  molecule  if  significant  antigen-binding  affinity  is 
to  be  retained  (Queen  et  al.,  1989;  Ohtomo  et  al.,  1995).  The  following  approaches  have 
been  used  to  produce  effective  antibodies  by  CDR-grafting  (Co  and  Queen,  1991): 
a-  In  one  approach,  human  V  regions  showing  the  greatest  sequence  homology  to 
murine  V  regions  are  chosen  from  a  database  in  order  to  provide  the  human  FR.  The 
selection  of  human  FRs  can  be  either  from  human  consensus  sequences  or  from 
individual  human  antibodies  (Kolbinger  et  al.,  1993). 
b-  In  an  alternative  approach,  murine  CDRs  are  grafted  onto  a  given  human  V  region. 
If  the  humanised  antibody  has  reduced  or  no  affinity  for  the  target  antigen,  new 
constructs  are  made  that  incorporate  one  to  three  additional  mouse  residue  near  the 
CDRs,  and  so  on  until  binding  is  restored. 
c-  In  a  third  approach,  the  surface  of  the  xenogenic  antibody  is  humanised.  A 
statistical  analysis  of  unique  human  and  murine  immunoglobulin  heavy  and  light  chain 
V  regions  revealed  that  the  precise  patterns  of  exposed  residues  are  different  in  human 
and  murine  antibodies,  and  most  surface  locations  have  a  strong  preference  for  a  small 
number  of  different  residues  (Padlan,  1991;  Pedersen  et  al.,  1993).  Therefore,  it  may  be 
possible  to  reduce  the  immunogenicity  of  a  non-human  Fv,  while  preserving  its  antigen- 
4 binding  properties,  by  replacing  exposed  FR  residues  that  differ  from  those  usually  found 
in  human  antibodies  (Padlan,  1991).  This  would  humanise  the  surface  of  the  xenogenic 
antibody  while  retaining  the  interior  and  contact  residues  that  influence  antigen-binding 
and  inter-domain  contacts.  Since  protein  antigenicity  can  be  correlated  with  surface 
accessibility,  replacement  of  the  surface  residues  may  be  sufficient  to  render  the  mouse 
variable  region  "  invisible"  to  the  human  immune  system.  This  procedure  of 
humanisation  is  referred  to  as  "veneering"  since  only  the  outer  surface  of  the  antibody  is 
altered  and  the  supporting  residues  remain  unaltered.  Another  approach  to  minimise  the 
immune  response  to  foreign  antibodies  is  to  alter  the  surface  epitopes  which  may  be 
reactive  with  host  T  cells  (de-immunisation).  In  this  process,  computer  modelling  is  used 
to  identify  potential  T  cell  epitopes  on  the  antibody  fragment.  These  amino  acids  are  then 
substituted  with  less  reactive  residues  without  altering  the  conformation  of  the  antibody 
(discussed  by  Adair,  2000). 
Combinatorial  libraries 
Hybridoma  methodologies  allow  for  a  limited  sampling  of  the  immune  repertoire. 
Cloning  the  entire  repertoire  or  a  significant  proportion  of  it  in  E.  coli  would  allow  a 
much  more  extensive  survey  of  the  immune  response  and  might  be  essential  for 
screening  or  selection  for  rare  specificities.  This  approach  became  feasible  through  two 
developments.  First,  it  was  demonstrated  in  1988  that  Fvs  and  Fab  constructs  could  be 
expressed  and  functionally  assembled  in  E.  coli  (Better  et  at,  1988;  Skerra  and  Plukthun, 
1988).  In  these  experiments,  antibody  fragments  were  secreted  from  the  cytoplasm  to  the 
oxidising  environment  of  the  periplasm  of  E.  coli  guided  by  bacterial  leader  sequences. 
The  oxidising  environment  is  necessary  for  disulfide  bond  formation  and  proper  folding 
of  antibody  domains.  Second,  the  development  of  the  polymerase  chain  reaction  (PCR) 
allowed  for  the  rapid  cloning  of  antibody  genes  from  hybridomas  (Chiang  et  al.,  1989; 
Larrick  et  al.,  1989;  Orlandi  et  al.,  1989)  and  large  collections  of  variable  genes  (Huse  et 
al.,  1989;  Sastry  et  al.,  1989  Ward  et  al.,  1989). 
The  first  combinatorial  library  experiment  reported  in  1989  (Huse  et  al.,  1989) 
involved  plaque-screening  antibody  Fab  fragments  with  labelled  antigen.  In  this  case  the 
libraries  were  expressed  in  lambda  phage,  a  lytic  phage  which  upon  lysis  of  infected 
bacteria,  releases  the  periplasmically  sequestered  Fab.  In  these  experiments  a  mouse  was 
immunised  with  a  hapten  designed  to  elicit  catalytic  antibodies  and  RNA  was  prepared 
from  the  spleen.  After  reverse  transcription,  cDNAs  encoding  antibody  heavy  chains  (Fd 
5 part  of  IgGI)  and  light  chains  were  amplified  by  the  PCR  reaction  and  ligated  into 
modified  lambda  phage  vectors  to  give  libraries  of  heavy  and  light  chains.  The  two 
libraries  were  then  combined  by  digestion  of  opposite  arms  of  the  vectors  and  religation 
to  generate  a  random  combinatorial  library  containing  the  genetic  information  for  the 
production  of  Fab  fragments.  The  library  was  screened  by  transferring  Fabs  from  lambda 
plaques  on  to  nitrocellulose  filters.  The  filters  were  then  probed  with  an  '25I-labeled 
hapten  conjugate.  This  revealed  a  high  frequency  of  positives  in  the  library  (about  1  in 
5000)  which  allowed  200  monoclonal  Fab  fragments  to  be  identified  following  an 
examination  of  106  Fabs.  The  screening  of  this  library  of  a  million  clones  required  20 
filter  lifts,  a  relatively  modest  task. 
1.3  Phage  display  of  antibody  fragments 
The  screening  procedure  limits  the  size  of  the  library  that  may  be  examined  in  lambda 
phage  system.  For  example,  the  screening  of  a  library  of  5x108  antibodies  would  require 
an  examination  of  a  minimum  of  10000  filters  lifts  at  50000  plaques  per  plate. 
Furthermore,  the  screening  procedure  places  restrictions  on  the  antigens  which  are  being 
examined  in  that  the  antigen  must  be  available  in  significant  quantities  in  purified  form 
for  labelling  with  1251  or  enzymes,  and  should  not  stick  significantly  to  filters  in  the 
absence  of  antibody.  This  is  very  restrictive  if  the  interest  is  in  isolating  antibodies 
against  proteins  which  have  yet  to  be  identified  or  characterised,  found  for  example  on 
the  surface  of  a  cell  or  in  a  crude  protein  extract  such  as  a  viral  lysate. 
Selection  is  a  more  efficient  method  for  driving  the  isolation  of  positive  clones  from  a 
library  than  screening  since  virtually  no  effort  is  wasted  examining  the  majority  of 
negative  clones.  Selection  is  practised  very  effectively  by  the  immune  system  through 
the  expression  of  immunoglobulin  on  the  surface  of  B  cells.  The  selected  clones  are  then 
amplified  by  the  linkage  of  this  recognition  device  to  the  replication  of  the  genetic 
information  within  the  B  cell,  the  process  of  clonal  expansion.  It  was  therefore  logical  to 
seek  a  selection  system  in  which  recognition  and  replication  could  be  linked.  George 
Smith  (1985)  had  shown  that  peptides  could  be  expressed  on  the  surface  of  filamentous 
phage  (Ff  phage)  indicating  how  this  linkage  might  be  achieved.  The  concept  of 
selectable  phage  display  libraries  had  been  established  in  1990  with  peptide  libraries 
(Cwirla  et  al.,  1990;  Devlin  et  al.,  1990;  Scott  and  Smith,  1990).  Fragments  of  beta- 
galactosidase  had  previously  been  displayed  on  phage  (Parmley  and  Smith,  1988).  The 
concept  needed  only  be  extended  to  libraries  of  proteins.  Numerous  kind  of  proteins 
6 have  been  displayed  on  phage  including  enzymes  such  alkaline  phosphatase  (Meola  et 
al.,  1995)  and  ß-lactamase  (Soumillion  et  al.,  1994);  hormones  such  angiotensin 
(McConnell  et  al.,  1994)  and  endothelin  (McConnel  and  Hoess,  1995);  cytokines  such 
IL-3  (Gram  et  al.,  1993);  toxins  such  ricin  B  chain  (Swimmer  et  al.,  1992)  and 
Aspergillusfumigatus  ribotoxin  (Crameri  and  Suter,  1993).  This  would  allow  selection 
of  specific  antibodies  based  on  their  ability  to  bind  to  immobilised  antigen  largely 
circumventing  the  problems  associated  with  screening.  In  1990  McCafferty  showed  that 
antibody  fragments  could  be  displayed  on  the  surface  of  filamentous  phage  particles  by 
fusion  of  the  antibody  variable  genes  to  one  of  the  phage  coat  proteins.  Antigen-specific 
phage  antibodies  could  subsequently  be  enriched  by  multiple  round  of  affinity  selection, 
because  the  phage  particle  carried  the  gene  encoding  the  displayed  antibody.  This  was 
originally  reported  for  scFvs  (McCafferty  et  al.,  1990),  and  later  for  Fab  fragments 
(Chang  et  al.,  1991;  Garrard  et  al.,  1991;  Hoogenboom  et  al.,  1991)  and  other  antibody 
derivatives  such  as  diabodies  (McGuinness  et  al.,  1996)  and  has  been  extended  to  other 
display  systems. 
1.4  Filamentous  (Ff)  phage 
Ff  phage,  most  notably  F1,  fd  and  M13  (the  three  are  almost  identical)  infect  Gram- 
negative  bacteria  by  virtue  of  a  specific  interaction  between  one  end  of  the  phage  and  the 
F  pilus.  Ff  phage  are  long  and  thin  (ca.  900  x  6-10nm);  essentially  they  are  tubes  of 
protein  encapsulating  a  single-stranded  closed  circular  DNA  genome.  The  mature  Ff 
phage  comprises  five  proteins  and  a  covalently  closed  genome  of  approximately  6.4  kb. 
Approximately  2700  copies  of  the  protein  encoded  by  gene  8  (g8p  or  cpVIII)  exist. 
Minor  coat  proteins  (g3p  or  cpIII,  g6p,  g7p,  g9p)  are  present  in  about  five  copies  each. 
The  proteins  are  arranged  so  that  g3p  and  g6p  are  expressed  at  the  tail  of  the  phage,  g7p 
and  g9p  at  the  head.  g3p  is  the  phage  protein  that  makes  specific  contact  with  the 
bacterial  receptor.  Rough  genetic  mapping  has  demonstrated  that  g3p  has  two  domains, 
an  amino-terminal  domain  important  for  phage  infectivity  and  a  carboxy-terminal 
domain  important  for  closing  or  capping  the  phage  tube.  An  important  regulatory 
element,  the  intergenic  region  (IR),  is  present  in  the  genome  aside  from  reading  frames 
for  structural  and  non-structural  proteins.  The  IR  contains  a  DNA  origin  of  replication 
and  a  DNA  packaging  signal.  A  plasmid  with  an  Ff  IR,  most  commonly  F1,  is known  as 
a  phagemid.  The  IR  is  sufficient  to  allow  helper  phage-mediated  replication  and 
packaging  of  the  phagemid  into  phage  particles  as  single-stranded  closed  circular  DNA. 
7 Packaged  phagemids  can  infect  bacteria  and  are  known  as  transducing  particles.  Unlike 
lambda  phage  in  which  the  first  repertoire  cloning  experiments  were  performed,  the  Ff 
phage  are  not  assembled  in  the  cytoplasm  and  are  not  released  by  cell  lysis.  They  are 
instead  extruded  through  the  membrane  leaving  the  cell  unharmed.  Assembly  begins 
with  the  coating  of  genomic  (or  phagemid)  single-stranded  DNA  by  g5p.  This 
nucleoprotein  complex  then  migrates  to  the  inner  membrane.  Coat  proteins  then  replace 
g5p  in  a  vectorial  fashion,  g7p  and  g9p  are  first,  followed  by  polymerisation  of  g8p  on  to 
the  DNA  rod,  and  finally  g6p  and  g3p  cap  the  particle. 
G3p  and  g8p  are  exported  through  the  cytoplasmic  membrane  of  the  bacterial  host 
and  become  anchored  on  the  periplasmic  face  from  where  they  are  assembled  to  form  the 
surface  of  the  phage.  These  features  make  them  ideal  targets  for  fusion  with  antibody 
domains.  Secretion  into  the  periplasmic  space  is  a  prerequisite  for  proper  folding  and 
assembly  of  antibodies  in  all  but  specifically  engineered  E.  coll.  Phage  which  display 
antibody  fragments  can  then  be  screened  by  a  process  known  as  panning  to  isolate  those 
that  encode  the  desired  specificity  and  highest  affinity  as  described  below. 
1.5  Phage  display  vector  systems 
The  phage  genome  itself  may  serve  as  a  cloning  vehicle,  i.  e.  genes  can  be  directly 
cloned  into  the  phage  genome.  Genomic  g3p  fusion  systems  allow  the  polyvalent  display 
of  foreign  peptides.  In  these  systems  every  copy  of  the  three  to  five  copies  of  g3p  is 
fused  with  the  displayed  protein  or  peptide.  With  multivalent  display  of  antibodies  on  the 
phage  surface,  avidity  effects  minimise  the  selective  discrimination  of  clones  bearing 
antibodies  which  differ  by  two  orders  of  magnitude  in  affinity  for  a  target  antigen. 
Genomic  g3p  fusions  have  been  highly  successful  in  the  area  of  peptide  libraries  but 
have  been  superseded  for  antibody  display  by  phagemid  systems. 
Phagemid  systems  offer  an  attractive  alternative  to  cloning  directly  in  to  the  phage 
genome.  Phagemids  are  simply  plasmids  which  bear  the  IR  region  of  an  Ff  phage.  When 
propagated  in  cells  superinfected  with  a  helper  phage,  phagemids  will  be  packaged  as 
phage  particles  in  a  fashion  identical  to  the  phage  itself.  Phagemid  systems  have  two 
distinct  advantages  over  cloning  into  the  phage  genome.  First,  double-stranded  DNA  is 
easily  obtained  making  library  construction  less  tedious  and,  second,  the  valency  of  the 
displayed  protein  may  be  controlled.  Phagemid  systems  has  been  described  using  both 
g8p  and  g3p  fusions.  During  superinfection,  native  and  fused  variants  of  the  coat  protein 
are  expressed,  with  native  copies  derived  either  from  helper  phage  or  from  wild  type 
S sequences  present  on  the  phagemid.  As  phage  assembly  takes  place,  there  is  a 
competition  between  these  proteins  for  incorporation  into  the  virion. 
The  g8p  system  like  the  genomic  system  offers  multivalent  display.  The  display  of 
Fab  fragments  as  g8p  fusions  was  described  initially  by  Kang  et  al.,  (1991)  and  later  by 
Chang  et  al.,  (1991).  Sorting  of  antibodies  of  different  specificities  was  demonstrated  in 
one  case  with  a  1000-fold  enrichment  in  a  single  panning  step.  Analysis  of  the  phage 
revealed  the  presence  of  a  variable  number  of  Fab  fragments  ranging  from  1  to  24. 
Further  examination  of  this  system  demonstrated  that  the  avidity  effect  of  multiple 
copies  of  Fab  on  the  phage  surface  does  not  allow  for  the  selection  of  antibodies  of  the 
highest  affinity.  In  panning  experiments  with  human  anti-tetanus  toxoid  antibodies, 
which  differed  by  100-fold  in  affinity,  only  a  5-fold  enrichment  could  be  demonstrated 
in  a  single  selection  (Barbas  et  al.,  1991). 
In  contrast  to  g8p  fusions,  monovalent  display  is  possible  by  fusion  to  g3p.  In  the 
virion,  there  are  normally  3-5  copies  of  gap.  The  assembly  of  virus  in  bacteria  carrying  a 
phagemid-encoded  g3p  fusion  after  superinfection  with  helper  phage  leads  to 
incorporation  of  recombinant  and  the  native  forms  of  g3p  into  the  virion.  The  expression 
of  native  g3p  from  sequences  carried  on  the  helper  phage  is  necessary  for  infection  of  the 
resulting  viral  particles.  The  fusion,  generally  one  copy  per  phage  particle,  is  displayed 
in  functional  form  on  the  surface  of  the  phage  and  is  therefore  available  for  antigen 
selection.  Fusion  with  g3p  needs  to  retain  the  two  functions  carried  out  by  this  406- 
residue  protein,  infectivity  and  normal  (nonpolyphage)  morphogenesis.  These  properties 
map  roughly  to  the  first  and  second  halves  of  the  gene,  respectively.  The  N-terminal 
domain  of  g3p  binds  to  the  F'  pilus,  allowing  for  infection  of  E.  coli,  whereas  the 
membrane-bound  C-terminal  domain  (residues  P198-S406)  serves  the  morphogenic  role  of 
capping  the  trailing  end  of  the  filament  as  it  is  extruded  through  the  bacterial  membrane. 
Another  important  biological  feature  of  the  N-terminal  domain  of  g3p  is  its  role  in 
providing  immunity  to  superinfection  by  other  Ff  phage.  This  property  has  important 
consequences  in  the  design  of  phagemid  vectors  which  generate  g3p  fusions:  since 
superinfection  with  helper  phage  is  required  for  the  production  of  viral  particles, 
sequences  encoding  the  N-terminal  domain  of  g3p  must  be  deleted  from  the  phagemid 
otherwise  superinfection  will  be  prevented.  This  feature  was  incorporated  in  the  first 
vector  designed  for  Fab  display,  pComb3  (Barbas  et  al.,  1991)  and  is  also  found  in 
pDH188  (Garrard  et  al.,  1991)  and  pEXmid3  (Soderlind  et  al.,  1992),  which  are  also 
designed  for  Fab  display.  Several  g3p  phagemid  systems  designed  for  scFv  display  - 
9 pHEN  (Hoogenboom  et  al.,  1991),  pSEX  (Dubel,  1993),  pCANTAB  (Pharmacia)  - 
utilise  the  entire  g3p  as  a  fusion  partner.  In  these  systems,  additional  steps  in  the 
selection  process  are  necessary.  For  example,  glucose  must  be  added  to  shut  down 
expression  from  the  phagemid  to  allow  superinfection.  Removal  of  this  solute  by 
washing  or  dilution  relieves  catabolite  repression,  allowing  expression  for  display.  The 
key  feature  of  all  g3p-based  strategies  is  their  capacity  for  monovalent  display  -  this  has 
important  consequences  for  the  selection  of  antibodies  of  the  highest  affinity. 
1.6  Antibody  fragments  used  in  library  construction 
Two  major  types  of  antibody  fragments  may  be  chosen  for  the  construction  of  phage 
display  libraries,  Fabs  or  Fvs.  Fab  fragments,  the  natural  antigen  binding  fragments  of 
whole  antibodies,  retain  the  binding  characteristics  of  the  whole  antibody  with  the 
exception  of  avidity.  The  Fv  fragments  consisting  only  of  the  VH  and  VL  domains  are  the 
smallest  immunoglobulin  fragments  to  contain  the  whole  antigen-binding  site.  They  may 
have  greatly  reduced  binding  affinity  for  antigen  as  compared  to  the  whole  antibody 
(Bird  and  Walker,  1991).  Fvs  appear  to  have  a  lower  energy  of  interaction  between  their 
two  chains  than  Fab  fragments,  which  are  also  held  together  by  the  constant  domains 
CH1  and  CL.  Stable  association  of  the  VH  and  VL  domains  can  be  achieved  with  a  linking 
peptide  sequence  (Huston  et  at,  1988)  or  disulphide  bridges  (Glockshuber  et  at,  1990). 
In  scFvs  (single  chain  Fv  fragments),  peptide  linkers  of  about  3.5  nm  are  required  to 
span  the  distance  between  the  C-terminus  of  one  domain  and  the  N-terminus  of  the  other 
(Huston  et  al.,  1988).  Both  orientations,  VH-linker-VL  or  VL-linker-VH  can  be  used.  The 
15  amino  acid  linker  (G4S)3  originally  employed  by  Huston  et  al.  is  often  used  in  VH-VL 
scFvs.  Since  scFvs  are  only  half  the  size  of  Fabs,  they  have  lower  tissue  retention  times, 
more  rapid  blood  clearance  and  better  tumour  penetration.  They  are  also  less 
immunogenic,  and  are  amenable  to  fusion  with  other  proteins  and  peptides.  Potential 
applications  include  tissue  imaging  and  the  targeted  delivery  of  drugs,  toxins  or 
radionuclides  to  a  tumour  site  (Little  et  al.,  2000). 
Generally  Fv  fragments  by  themselves  are  unstable  because  the  VH  and  VL  domains  of 
the  heterodimer  can  dissociate  and  this  results  in  reduced  binding  affinity.  Covalent 
connection of  VH  and  VL  by  a  flexible  peptide  linker  results  in  scFv  molecules  (Bird  et 
at,  1988;  Huston  et  al.,  1988)  that  are  more  stable  than  Fvs.  Another  approach  for 
improving  Fv  stability  is  to  introduce  a  disulphide  bind  between  the  two  domains, 
forming  a  ds-Fv  (Young  et  al.,  1995).  Recombinant  antibodies,  especially  scFvs,  often 
10 fail  to  fold  properly  and  aggregate  within  the  bacterial  periplasm  or  can  be  toxic  to  the 
host  cell.  Toxicity  most  likely  occurs  because  the  export  of  these  proteins  interferes  with 
the  normal  function  of  the  secretory  machinery  of  the  cell.  Protein  misfolding  and 
aggregetion  can  be  alleviated  by  growing  the  cells  at  30  or  25  °C  (Somerville  et  al., 
1994),  by  using  tightly  regulated  promoters  (Clark  et  al.,  1997),  or  by  co-expression  of 
proteins  that  assist  folding  such  chaperones  (Hayhurst  and  Harris,  1999). 
Other  forms  of  Fvs  include  single  antibody  domains,  antigen  binding  VH  domains 
(Ward  et  al.,  1989).  However,  these  constructs  carry  a  "sticky  patch"  which  usually 
forms  interactions  with  VL  domains.  In  the  absence  of  a  light  chain  partner,  these 
residues  adversely  affect  the  solubility  and  stability  of  isolated  VH  domains  (Ward  et  al., 
1989;  Davies  and  Riechmann,  1994).  Even  smaller  antigen-binding  peptides  based  on 
one  CDR  have  been  described,  but  they  often  have  a  low  affinity  for  antigen  and  the 
tendency  to  cross  react  with  unrelated  antigens  (Adams,  1998). 
To  increase  the  avidity  of  monovalent  scFvs,  they  can  be  forced  to  form  multimers  by 
shortening  the  peptide  linker.  scFvs  are  predominantly  monomeric  (-30  kDa)  when  the 
VH  and  VL  domains  are  joined  by  polypeptide  linkers  of  more  than  12  residues  (Figure 
1.1).  A  scFv  molecule  with  a  linker  of  3  to  12  residues  cannot  fold  into  a  functional  Fv 
domain  and  instead  associates  with  a  second  scFv  molecule  to  form  a  bivalent  dimer  or 
"diabody"  (-60  kDa;  Holliger  et  al.,  1993).  Reducing  the  linker  length  still  further  to 
below  three  residues  can  result  in  the  formation  for  trimers  (tribody,  -90  kDa)  or 
tetramers  (tetrabody,  -120  kDa).  Diabodies  can  be  provided  with  extra  stability  by 
joining  the  two  dimerising  parts  with  a  peptide  linker  (Kipriyanov  et  al.,  1999).  Under 
certain  conditions,  these  four-domain  chains  dimerise  again  to  form  a  fairly  stable 
tetravalent  tandem  diabody,  which  is  particularly  interesting  for  the  production  of 
tetravalent  bispecific  molecules  (Kipriyanov  et  al.,  1999).  Diabodies  have  been  produced 
using  disulphide  bridges  (Adams  et  al.  1993),  or  by  joining  the  two  scFv  fragments  with 
a  third  polypeptide  linker  (Gruber  et  a!.,  1994).  Alternatively,  the  scFv  can  be  genetically 
fused  with  protein  dimerising  motifs  such  as  amphipathic  helices  (Pack  and  Plucktun, 
1992)  or  immunoglobulin  CH3  domains  (Hu  et  al.,  1996).  In  a  similar  fashion,  tetravalent 
scFv  have  been  produced  by  fusing  them  with  the  tetramerisation  domain  of  the  human 
transcription  factor  p53  (Rheinnecker  et  al.,  1996)  or  streptavidin  (Kipriyanov  et  al., 
1996b). 
ii F(ab')2 
Immunotoxin  or 
Immunocytokine 
Fab 
Diabody  Triabody  Tetrabody 
Fv 
scFv 
Figure  1.1  Schematic  representation  of  some  different  formats  of  antibody  fragments. 
The  f'v  fragment  (Vii  and  Vi  domains)  possess  the  binding  activity.  The  sr[Fv  corresponds 
the  Vii  linked  to  the  Vi  by  a  flexible  peptide  linker  (black  line).  Dia-,  ti-i-  and  tetrabodies 
can  he  obtained  by  using  short  linkers  (represented  by  black  tines  or  dots). 
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(Chamcs  and  Baty,  2000) 
Minibody 1.7  Cloning  strategies  for  library  construction 
Library  construction  begins  with  mRNA  that  is  used  as  a  template  for  cDNA 
synthesis.  cDNA  then  becomes  the  template  for  the  PCR.  Thorough  consideration  of  the 
end  use  of  the  antibody  fragment  should  dictate  the  strategy  to  be  taken.  Protocols  for  the 
construction  of  Fab  or  scFv  libraries  are  quite  distinct.  A  major  difference  in  the 
construction  of  scFv  libraries  is  that  there  is  no  antibody  constant  region  in  this  construct. 
This  dictates  that  multiple  J  region  primers  -  the  number  depends  on  the 
immunoglobulin  system  of  the  species  under  investigation  -  are  used  with  primers 
against  the  framework  sequences  to  recover  the  expressed  repertoire  by  PCR  from 
cDNA.  Generally,  the  cloning  of  Fabs  requires  fewer  primers.  Subsequent  rounds  of 
PCR  are  required  to  create  the  linker  regions  that  fuse  VH  and  VL  domains  and 
appropriate  restriction  sites  for  cloning  into  the  phage  display  vector. 
1.8  Sources  of  antibody  genes 
1.8.1  Genes  from  hybridoma  cell  lines 
The  direct  cloning  of  antibody  genes  from  hybridoma  cell  lines  formed  the  basis  for 
the  first  attempts  to  produce  recombinant  antibody  fragments  (Huse  et  al.,  1989;  Orlandi 
et  al.,  1989;  Songsivilai  et  al.,  1990;  Dubel  et  al.,  1994).  Even  though  hybridoma  cell 
lines  are  described  as  monoclonal,  alternative  antibody  sequences  are  continually  being 
found  (Fuchs  et  al.,  1997).  In  the  generation  of  hybridomas,  the  myeloma  fusion  partner 
is  chosen  for  its  minimal  expression  of  endogenous  antibody  genes.  Despite  this,  weakly 
expressed  pseudogenes,  or  other  immunoglobulins  can  be  amplified  through  PCR  along 
with  mutated  sequences  that  have  accumulated  during  extended  cultivation  of  the 
hybridoma.  It  is  therefore  advisable  to  use  hybridoma  cultures  that  are  freshly  subcloned 
and  tested  as  a  source  of  cDNA  for  cloning.  When  soluble  antigen  is  available,  screening 
an  immunoglobulin  library  by  phage  display  is  surely  the  method  of  choice.  The  genetic 
heterogeneity  can  be  analysed  by  sequencing  at  least  10  clones  per  region.  If  different 
sequences  appear,  all  possible  combinations  of  light  and  heavy  chains  fragments  should 
be  produced  separately  and  functionally  tested  (Breitling  and  Dubel,  1999). 
1.8.2  Genes  fragments  from  immune  libraries 
Producing  human  monoclonal  antibodies  with  conventional  hybridoma  technology  is 
very  difficult  and  targeted  immunisation  of  human  patients  is  only  possible  in  rare  cases. 
Recombinant  antibodies  offer  a  way  out  of  this  dilemma  by  the  use  of  human  antibody 
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already  developed  an  appropriate  immune  response  resulting  from  exposure  to  an 
infectious  agent,  malignancy  or  other  immunological  trigger.  An  important  area  of  use  of 
immunised  libraries  is  research  into  autoimmune  diseases.  Various  potential 
autoantibodies  could  be  identified  with  the  help  of  patient  libraries.  Patient  libraries 
therefore  offer  a  way  to  access  the  antibodies  that  are  otherwise  difficult  to  obtain. 
An  interesting  variation  in  the  production  of  human  antibodies  is  offered  by  the 
immunisation  of  SCID  (severe  combined  immune  deficiency)  mice.  These  mice  lack 
their  functional  immune  system  and  can  be  temporarily  populated  with  human  peripheral 
lymphocytes.  Antibody  responses  can  be  triggered  amongst  these  cells  by  primary 
exposure  to  antigen;  when  they  include  memory  B  lymphocytes,  it  is  possible  to 
stimulate  them  into  a  second,  strong  immune  response  with  antigen.  Specific  human 
antibody  fragments  can  then  be  isolated  from  an  antibody  library  produced  as  outlined 
above  (Duchosal  et  al.,  1992).  A  further  interesting  source  of  material  for  the 
construction  of  human  antibody  libraries  against  specific  agents  are  genetically  modified 
lines  of  mice  which  have  undergone  germline  reconstitution  with  human  lymphoid 
material  . 
In  non-human  species,  ethical  constraints  on  specific  immunisation  are  not  so 
restrictive  and  so  libraries  can  be  constructed  after  antigen  exposure  has  increased  the 
frequency  of  antigen-specific  B  cells,  and  somatic  hypermutation  has  matured  the 
affinity  of  immunoglobulins  for  the  targets  of  interest.  These  are  features  likely  to 
increase  the  likelihood  of  success  with  in  vitro  phage  selection  techniques. 
(Hoogenboom  and  Chames,  2000).  To  date,  antibody  phage  display  techniques  have 
been  applied  to  a  wide  range  of  species  including  non-human  primates,  mice,  rats, 
rabbits,  sheep,  cattle,  camels,  and  chickens  (O'Brien  and  Aitken,  2002). 
1.8.3  Genes  from  nonimmune  libraries 
In  the  early  1990s,  two  sets  of  findings  raised  the  possibility  that  specific 
immunisation  could  be  bypassed  in  the  search  for  antigen-specific  immunoglobulins. 
First,  it  was  shown  that  antibodies  against  many  different  antigens  could  be  selected 
from  a  "naive"  library  made  from  gene  pools  contributing  to  the  IgM  repertoire  of 
nonimmunised,  healthy  individuals  (Marks  et  al.,  1991).  Second,  libraries  of  germline 
segments  synthetically  diversified  by  oligonucleotide  cloning  (Hoogenboom  et  al.,  1991; 
Barbas  et  al.,  1992a)  were  shown  to  behave  in  a  similar  way  to  "naive"  antibody 
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isolation  of  antibodies  against  most  antigens,  indeed  the  diversity  carried  in  these 
resources  has  proved  sufficient  to  provide  antibodies  against  molecules  which  are 
nonimmunogenic  in  vivo,  toxic  substances  and  targets  which  are  conserved  between 
species  (reviewed  by  Winter  et  al.,  1994). 
1.8.3.1  Antibody  gene  libraries  from  nonimmunised  donors 
`Naive'  antibody  libraries  have  been  more  widely  used  than  synthetically  diversified 
resources.  The  libraries  have  been  built  from  various  lymphoid  materials,  including 
peripheral  blood,  bone  marrow,  spleen  or  tonsils.  These  libraries  have  harvested  antibody 
binding  sites  which  are  assembled  naturally  (Marks  et  al.,  1991).  To  minimise  bias  by 
the  inclusion  of  V-genes  of  immune  responses  on-going  in  the  donor,  the  B  cells  can  be 
enriched  for  IgM-IgD  surface  expression  (Hawkins  and  Winter,  1992),  or  the  variable 
heavy-chain  gene  can  be  amplified  from  IgM  mRNA  (Marks  et  al.,  1991). 
Provided  the  repertoire  captured  in  a  library  is  diverse,  larger  libraries  give  rise  both 
to  many  more  different  antibodies  against  a  given  antigen,  and  also  to  higher  affinity 
antibodies  (reviewed  in  Winter  et  al.,  1994).  As  a  consequence,  there  have  been  several 
efforts  to  establish  very  large  primary  libraries  by  brute-force  cloning  (Vaughan  et  al., 
1996;  Sheets  et  al.,  1998;  de  Haard  et  al.,  1999)  or  by  site-specific  recombination 
procedures  (Griffiths  et  al.,  1994;  Sblattero  and  Bradbury,  2000),  to  yield  collections  of 
109  to  10"  potentially  different  binding  sites.  These  library  sizes  are  close  to  the  total 
number  of  clones  that  can  be  effectively  sampled  using  in  vitro  selection,  and  larger 
libraries  are  not  expected  to  yield  much  better  antibodies.  Instead,  the  binding  sites  can 
be  fine-tuned  in  vitro  for  binding  to  the  antigen  in  a  process  that  resembles  the  in  vivo 
affinity  maturation  process. 
1.8.3.2  Synthetic  antibody  gene  libraries 
Binding-site  repertoires  with  naturally  rearranged  V-genes  are  potentially  heavily 
biased  towards  certain  sequences  and  clones,  owing  to  evolutionary  pressures  and  the 
immune  history  of  the  host.  This  will  result  in  biases  and  redundancy  in  natural  binding- 
site  libraries.  The  use  of  laboratory-assembled  variable-regions  genes  would  provide 
complete  control  over  library  composition,  allow  engineering  of  the  individual  building 
blocks,  and  a  choice  of  where  and  how  the  diversity  could  be  introduced  in  these 
repertoires.  It  was  thought  that  with  these  possibilities,  antibody  libraries  could  be  built 
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(Hoogenboom  and  Chames,  2000). 
In  the  first  synthetic  antibody  library  to  be  described  (Hoogenboom  and  Winter,  1992; 
Nissim  et  al.,  1994),  a  large  collection  of  human  germ  line  gene  segments  was  randomly 
diversified  in  CDR3  of  the  heavy  chain  by  PCR.  Later  modifications  introduced  limited 
diversity  in  CDR3 for  the  light  chain  (Griffiths  et  al.,  1994).  This  design  strategy  reflects 
the  limited  natural  germline  diversity  in  the  other  CDR  regions.  From  this  and  related 
libraries,  antibodies  to  many  different  targets  have  been  isolated  with  affinities  into  the 
nanomolar  range  (Griffiths  et  al.,  1994).  Other  synthetic  designs  have  been  described, 
varying  from  the  use  of  one  rearranged  VH  and  VL  segment  with  randomised  CDR3 
regions  (Barbas  et  al.,  1992a),  to  segments  with  completely  randomised  CDRs  (Garrard 
and  Henner,  1993;  Hayashi  et  al.,  1995;  Soderlind  et  al.,  1995).  Other  design  strategies 
have  attempted  to  extend  diversity  beyond  what  is  generated  by  the  immune  system  in 
vivo.  For  example,  diversification  of  the  heavy  chain  CDR3  might  provide  a  primary 
`signature'  for  the  antibody,  which  could  be  enhanced  by  directing  further  mutation  to 
the  natural  hot  spots  for  somatic  hypermutation  located  in  the  other  CDRs  (Pipi  et  al., 
1998).  Libraries  with  non-natural  CDR  regions  (e.  g.  mixed  between  species,  artificially 
combined  or  with  longer  or  shorter  CDR  loops  [Jirholt  et  al.,  1998])  could  well  expand 
the  structural  scope  of  the  repertoire,  or  might  be  used  to  build  up  the  antigen  combining 
site  around  the  antigen  (Lamminmaki  et  al.,  1999).  The  first  binding-site  libraries  with  a 
propensity  for  binding  to  a  chosen  antigen  or  antigenic  epitope  have  been  constructed 
(Kirkham  et  al.,  1999). 
1.9  Selection 
The  selection  step  is  a  key  feature  of  any  molecular  display  technology.  A  major 
advantage  of  this  in  vitro  procedure  is  that  we  can  choose  and  manipulate  the  procedure 
and  therefore  the  outcome  of  selection  (reviewed  in  Hoogenboom,  1997). 
Phage  systems  readily  allow  sorting  of  enormous  libraries.  This  is  a  result  of  the 
linkage  of  recognition  and  replication;  only  those  phage  that  express  at  their  surface 
antibody  capable  of  interacting  with  the  target  antigen  propagate  through  a  procedure 
known  as  panning.  Surface  display  of  antibody  on  the  phage  surface  allows  for  the 
selection  of  clones  by  panning  against  antigen  coated  onto  ELISA  wells  or 
immunotubes.  Alternatively,  the  binding  event  can  take  place  in  solution.  Antigen-bound 
phage  can  then  be  retrieved  by  incubation  with  streptavidin-coated  magnetic  beads 
15 (biotinylated  antigen)(Hawkins  et  al.,  1992;  Schier  and  Marks,  1996)  or  other  ligands 
that  capture  the  antigen  (e.  g.  antibodies).  The  phage  display  approach  is  not  limited  by  a 
requirement  for  purified  antigen  and  is  sensitive  to  rather  rare  components,  for  example, 
in  viral  lysates,  allowing  for  the  discovery  in  principle  of  biologically  active  antibodies 
to  unknown  antigens  (Burton  and  Barbas,  1994). 
Many  other  sources  of  antigen  have  been  used  for  selection,  ranging  from  whole  cells 
or  cell  lysates,  tissue  and  protein  blots,  to  bacteria  that  display  recombinant  antigens. 
When  using  such  complex  sources,  selection  of  phage  bearing  antibodies  against 
irrelevant  antigens  or  epitopes  has  to  be  reduced,  for  example,  by  specific  elution  using  a 
known  ligand  to  the  antigen.  Depletion  or  subtraction  procedures  are  also  possible  using 
an  excess  of  irrelevant  antigens,  for  example,  by  fluorescence-activated  cell  sorting  or 
sorting  with  magnetic  beads  (Siegel  et  al.,  1997;  Chang  and  Siegel,  1998). 
Despite  the  availability  of  these  elegant  selection  methods,  it  has  been  difficult  to 
isolate  high-affinity  antibodies  to  some  antigens,  including  carbohydrates  and  seven- 
transmembrane  receptors.  In  some  instances,  the  antibody  repertoire  might  have  a 
structural  limitation  in  what  antigen  type  it  can  recognise;  in  others,  the  phage  antibodies 
might  not  be  able  to  access  the  antigen  (Hoogenboom  et  al.,  1999).  Given  the  rapid 
advances  made  in  phage  display  technology  over  the  past  decade,  one  might  predict  that 
solutions  to  these  obstacles  will  emerge  in  due  course. 
1.9.1  Selection  for  function 
The  in  vitro  procedure  permits  selection  for  function  as  well  as  binding  capabilities. 
Selection  can  be  performed  under  conditions  that  mediate  the  selection  of  phage 
antibodies  with  particular  characteristics,  for  example,  under  reducing  conditions  to 
retrieve  disulfide  free  yet  stable  antibodies  (Proba  et  al.,  1998),  or  in  the  presence  of 
protease  to  select  for  successfully  folded  molecules  (Kristensen  and  Winter,  1998). 
Antibodies  might  also  be  selected  with  or  for  a  particular  functional  activity,  for  receptor 
cross-linking,  signalling,  gene  transfer  or  catalysis.  The  availability  of  the  cloned 
antibody  genes  further  offers  the  possibility  of  combining  phage  selections  (for  binding) 
with  other  selections,  such  as  a  neutralising  activity  of  the  antibody  when  expressed  in  an 
intracellular  environment  (Gargano  and  Cattaneo,  1997;  reviewed  in  Hoogenboom  et  al., 
1998). 
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Several  selection  methods  have  been  described  which  are  based  on  the  restoration  of 
phage  infectivity  using  the  antibody-antigen  reaction.  In  this  approach  only  phage 
antibodies  that  bind  to  the  antigen  would  provide  the  phage  with  the  necessary  elements 
(e.  g.  functional  g3p)  for  infectivity  (Duenas  and  Borrebaek,  1994;  Garmatikoff  et  al., 
1995).  In  selectively  infective  phage  (SIP)  technology,  the  basic  infectivity  of  the  M13 
filamentous  phage  is  destroyed  by  deleting  from  the  phage  genome  the  N  domains  of  the 
gIIl.  A  peptide  or  protein  library  is  fused  N-terminally  to  some  or  all  of  the  C  domain  of 
g3p.  The  infectivity  of  the  phage  can  now  only  be  restored  by  adding  N  domains  which 
are  absolutely  required  for  infection.  These  domains  are  themselves  fused  or  chemically 
coupled  to  a  ligand  which  binds  to  the  peptide  or  protein  displayed  on  phage.  These 
systems  require  a  very  high  affinity  interaction  between  antibody  and  antigen  to  be 
effective,  and  are  thus  not  yet  suited  for  applications  with  most  primary  phage  libraries 
(reviewed  in  Jung  et  al.,  1999).  With  an  increase  in  understanding  of  the  phage  infection 
process,  more  generally  applicable  infectivity-mediated  selection  procedures  based  on 
bacterial  antigen  display  and  phage  antibody  libraries,  might  be  developed  in  the  future 
(Borrebaeck  1998). 
1.10  Eluting 
After  vigorous  washing,  phage  bound  to  the  immobilised  target  are  enriched  for 
those,  which  display  antigen-specific  antibodies.  Elution  of  the  phage  is  most  generally 
achieved  by  acid  elution.  Alternatives  to  acid  elution  include  base  elution,  antigen 
elution,  trypsin  elution  (  Goletz  et  at.,  2002)  direct  infection  by  simple  addition  of  E. 
coli,  reductive  elution.  The  recovered  virus  are  then  amplified  and  reselected  by  further 
rounds  of  panning.  Each  step  selects  for  antigen-specific  clones  as  well  as  for  clones  of 
the  highest  affinity,  at  least  in  the  monovalent  display.  In  this  way  one  can  rapidly 
generate  a  panel  of  antigen-specific  Fabs  /  scFvs  (Burton  and  Barbas,  1994). 
1.11  Objectives 
The  aims  for  this  study  can  be  divided  into  two  parts:  to  characterise  the  bovine 
immunoglobulin  JH  locus;  to  use  the  antibody  phage  display  technique  to  generate 
recombinant  antibodies  against  Mannheimia  haemolytica,  an  important  pathogen  of 
cattle.  The  former  would  provide  information  required  to  interpret  events  during  heavy 
chain  gene  rearrangement  and  aid  the  generation  of  recombinant  antibody  fragments. 
17 The  second  part  of  study  would  help  optimise  the  construction  of  bovine  recombinant 
antibody  libraries  and  the  generation  of  antibodies  against  antigens  of  importance  in 
bovine  disease. 
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Characterisation  of  the  bovine  JH  locus 2.1  Introduction 
2.1.1  Structure  of  antibodies 
Typically  antibodies  have  a  common  core  structure  of  two  identical  light  chains  and 
two  identical  heavy  chains.  One  light  chain  is  attached  to  each  heavy  chain,  and  two 
heavy  chains  are  attached  to  each  other.  Both  the  light  chains  and  the  heavy  chains 
contain  a  series  of  repeating,  homologous  units,  each  about  110  amino  acids  residues  in 
length,  which  fold  independently  in  a  common  globular  motif,  called  an 
immunoglobulin  (Ig)  domain. 
In  humans,  there  are  more  than  lx  107,  and  perhaps  as  many  as  109  structurally 
different  antibody'  molecules  in  every  individual,  each  with  unique  amino  acid  sequence 
in  their  antigen-combining  sites.  The  extraordinary  diversity  of  structure  accounts  for  the 
extraordinary  specificity  of  antibodies  for  antigens,  because  each  amino  acid  difference 
may  produce  a  difference  in  antigen  binding.  In  theory,  such  extensive  sequence 
diversity  poses  a  structural  problem  because  the  three-dimensional  structure  of  any 
protein  is  completely  determined  by  its  amino  acid  sequence  and  certain  sequences  are 
incapable  of  folding  into  soluble,  stable  proteins.  In  the  evolution  of  antibody 
molecules,  this  problem  has  been  avoided  by  confining  the  sequence  diversity  to  three 
short  stretches  within  the  amino  terminal  Ig  domains  of  the  heavy  and  light  chains. 
These  amino  terminal  domains  are  called  variable  (V)  regions  to  distinguish  them  from 
the  more  conserved  constant  (C)  regions  of  the  remainder  of  each  chain  (Wu  and  Kabat, 
1970).  The  three  highly  divergent  stretches  within  the  V  regions  are  called  hypervariable 
regions  (Kabat  et  al.,  1977),  and  they  are  held  in  place  by  more  conserved  framework 
regions  (FRI-FR4).  In  an  intact  Ig,  the  three  hypervariable  regions  of  a  light  chain  and 
the  three  hypervariable  regions  of  a  heavy  chain  can  be  brought  together  in  three- 
dimensional  space  to  form  an  antigen-binding  surface.  Because  these  sequences  form  a 
surface  complementary  to  the  three-dimensional  surface  of  the  bound  antigen,  the 
hypervariable  regions  are  also  called  complementary-determining  regions  (CDRs). 
Proceeding  from  the  amino  terminus,  these  regions  are  called  the  CDRI,  CDR2  and 
CDR3,  respectively.  CDR3  is  the  most  variable  of  the  CDRs  and  there  are  more  genetic 
mechanisms  for  generating  sequence  diversity  in  this  region  than  in  CDRI  and  CDR2. 
V  region  folding  into  an  Ig  domain  is  mostly  determined  by  the  framework  regions 
adjacent  to  the  CDRs.  Within  the  framework  regions,  certain  amino  acid  residues  and 
certain  structural  features  are  very  conserved.  Other  portions  of  the  framework  regions 
differ  between  kappa  (K)  and  lambda  (2.  )  chains.  When  V  regions  fold  into  an  Ig  domain, 
19 the  CDRs  are  positioned  on  the  surface  as  projecting  loops.  Sequence  differences  among 
the  CDRs  of  different  antibody  molecules  result  in  unique  chemical  structures  being 
displayed  by  the  projecting  loops.  Relatively  few  residues  have  been  identified  that, 
through  their  packing,  hydrogen  bonding  or  the  ability  to  assume  unusual  conformations 
are  primarily  responsible  for  the  variation  in  three-dimensional  or  canonical  structure. 
These  variations  in  surface  structure  account  for  specificity  for  binding  to  antigens 
(Chothia  and  Lesk,  1987).  The  structure  of  immunoglobulin  molecule  has  been 
reviewed  by  Padlan  (1994). 
2.1.2  Mechanisms  of  antibody  diversification 
VJ  and  VDJ  combinatorial  association 
The  question  of  germ-line  versus  somatic  generation  of  antibody  diversity  was  long  a 
central  debate  in  immunology.  The  antibody  repertoire  is,  in  fact,  generated  during  B 
cell  development  by  DNA  rearrangements  (somatic  rearrangement)  that  combine  and 
assemble  different  segments  from  relatively  small  groups  of  sequences  at  each  Ig  locus. 
Diversity  is  further  enhanced  by  the  process  of  somatic  hypermutation  in  mature  B  cells. 
In  the  case  of  light  chains  each  variable  domain  is  encoded  in  two  separate  DNA 
segments.  The  V,  or  VA  segment  encodes  the  first  95-101  (amino  terminal)  amino  acids 
of  the  light  chains;  the  second  segment  encodes  the  remainder  of  the  variable  domain 
and  is  termed  a  joining  (J,,  or  J))  gene  segment.  The  joining  during  rearrangement  of  aV 
and  aJ  segment  creates  a  continuous  piece  of  DNA  encoding  the  whole  of  the  light 
chain  variable  region.  The  heavy  chain  variable  domains  are  encoded  in  three  gene 
segments.  In  addition  to  the  V  and  J  gene  segments  (denoted  VH  and  JH)  a  third  segment 
is  recruited  to  the  coding  unit  during  rearrangement  called  the  diversity  or  DH  gene 
segment.  The  cluster  of  D11  segments  lies  between  the  VH  and  JH  gene  segments  at  the 
heavy  chain  locus.  The  process  of  recombination  that  generates  a  complete  heavy  chain 
variable  region  occurs  in  two  stages.  In  the  first,  a  DH  segment  is  joined  to  a  JH  gene 
segment;  then  a  VH  gene  segment  rearranges  to  DJH  to  complete  a  heavy  chain  variable 
region  gene. 
In  the  light  chain,  FRl  to  FR3  (including  the  CDR1  and  CDR2)  and  the  amino 
terminus  of  CDR3  are  encoded  by  the  V  gene  segment.  The  carboxy  terminus  of  CDR3 
and  FR4  are  encoded  by  the  J  segment.  Similar  patterns  operate  in  the  heavy  chain, 
although  CDR3  largely  is  encoded  by  the  DH  gene  segment  selected  during 
20 rearrangement. 
There  are  multiple  copies  of  all  of  the  gene  segments  in  germline  DNA.  The  number 
of  functional  gene  segments  varies  between  species.  It  varies  even  between  the 
individuals  in  each  species  because  of  insertion  or  deletion  of  gene  segments  by  meiotic 
recombination,  or  because  of  mutations  that  transform  a  functional  gene  into  a 
pseudogene. 
Junctional  and  insertional  diversity 
The  variability  of  CDR1  and  CDR2  arises  mainly  from  the  sequence  heterogeneity  of 
the  multiple  germline  V  genes.  In  comparison  with  the  factors  that  diversify  CDR3,  this 
variability  is  modest.  Diversity  in  CDR3  is  based  on  the  multiplicity  of  DH  and  JH 
segments,  and  is  further  increased  by  imprecision  in  the  joining  process,  the  deletion  of 
nucleotides  from  the  ends  of  segments  during  joining,  the  addition  of  N  nucleotides  and 
use  of  all  three  reading  frames  in  the  D  segment  (Reynaud  et  al.,  1994;  Corbett  et  al. 
1997).  The  precise  positions  at  which  the  genes  for  the  V  and  J,  or  the  V,  D,  and  J, 
segments  are  fused  together  are  not  constant  and  imprecise  DNA  recombination  can  lead 
to  changes  in  amino  acids  at  these  junctions  and  shifts  in  the  reading  frame  of  the  D 
segment.  Further  diversification  can  arise  through  deletion  as  nucleases  remove  bases 
from  the  free  ends  of  the  rearranging  segments.  Furthermore,  on  the  heavy  chain,  small 
sets  of  nucleotides  may  be  inserted  at  the  V-D,  and  D-J  junctions  through  the  action  of 
terminal  transferase.  These  extra  bases  are  called  N  regions  and  are  typified  by  an 
enriched  G/C  content  (Alt  and  Baltimore,  1982;  Roth  et  al.,  1988).  They  are  rarely 
longer  than  about  15  nucleotides  (Roth  et  al.,  1988). 
Somatic  gene  conversion 
Studies  in  some  species,  most  notably  in  birds  and  rabbits,  have  revealed  that  these 
animals  use  a  mechanism  known  as  somatic  gene  conversion  to  generate  a  repertoire  of 
diverse  Ig  specificities.  In  somatic  gene  conversion,  part  of  a  donor  gene  or  genes  is 
copied  into  an  acceptor  gene,  but  only  the  acceptor  gene  is  altered.  Typically  the  donor 
sequence  is derived  from  an  Ig  pseudogene. 
It  is  now  clear  that,  in  contrast  to  mice  and  humans,  many  species  rely  on  somatic 
gene  conversion  and  somatic  hypermutation  to  generate  diversity  within  the  primary  Ig 
repertoire,  that  is,  before  antigen  stimulation.  For  example,  chickens  use  somatic  gene 
conversion  as  a  major  mechanism  to  generate  the  primary  light  chain  and  heavy  chain 
21 repertoires  (Reynaud  et  al.,  1985;  Reynaud  et  al.,  1987;  Reynaud  et  al.,  1989).  Other 
species  such  as  rabbits  (Becker  and  Knight,  1990;  Knight  et  al.,  1995;  Schiaffella  et  at, 
1999)  and  cattle  (Pamg  et  al.,  1996)  use  very  limited  V(D)J  recombination  plus  somatic 
gene  conversion  and  somatic  hypermutation  to  generate  their  primary  Ig  diversity. 
Sontatic  hyperntutation 
Mutations  that  occur  in  V  genes  of  heavy  and/or  light  chains  during  the  lifetime  of  a 
B  cell  also  increase  the  variety  of  antibodies  produced  by  the  B  cell  population. 
Generally  an  antibody  of  low  affinity  is  produced  in  the  primary  response  to  antigen.  As 
the  immune  response  matures,  especially  after  secondary  stimulation  by  antigen,  an 
increase  in  affinity  of  the  antibody  for  the  antigen  occurs,  and  a  divergence  is  found 
from  the  amino  acid  sequence  that  is  encoded  in  germline  DNA.  This  divergence  results 
from  point  mutation  in  the  recombined  V(D)J  unit,  which  results  in  changes  in 
individual  amino  acids  most  frequently  in  the  CDRs.  This  phenomenon  is  termed 
somatic  hypermutation  and  is  used  in  humans  (Griffiths  et  al.,  1984;  Berek  and  Milstein, 
1987),  mice  and  sheep  (Reynaud  et  al.,  1991b;  Reynaud  et  a1.,  1995;  Reynaud  et 
a1.,  1997)  for  V-gene  diversification.  By  increasing  the  affinity  of  interaction  between 
antibodies  and  antigens,  somatic  hypermutation  increases  the  functional  diversity  of  the 
Ig  repertoire. 
Random  assortment  of  heavy  and  light  chains 
As  both  the  heavy  and  light  chain  variable  regions  contribute  to  antibody  specificity, 
each  light  chain  in  the  Ig  repertoire  can  combine  with  many  different  heavy  chains  to 
give  numerous  different  antibody  specificities.  The  ability  to  create  many  different 
specificities  by  making  many  different  combinations  within  a  small  gene  pool  is  known 
as  combinatorial  diversity.  In  practice,  combinatorial  diversity  is  likely  to  be  less 
significant  in  Ig  diversification  than  we  might  expect  from  the  theoretical  calculations  as 
not  all  of  the  functional  V  gene  segments  are  used  at  the  same  frequency;  some  are 
common,  while  others  are  found  only  rarely  (Cook  and  Tomlinson,  1995) 
. 
Moreover, 
not  all  VH  regions  pair  successfully  with  all  VL  regions.  It  remains  most  likely  that 
imprecise  joining  of  V(D)J  gene  segments  and  somatic  hypermutation  are  of  greater 
significance  in  generating  a  diverse  Ig  repertoire. 
22 2.1.3  Rearrangement  of  V,  D  and  J  gene  segments 
Non-coding  regions  flanking  the  different  heavy  and  light  chain  V,  D,  and  J  gene 
segments  have  conserved  sequences  adjacent  to  the  points  at  which  recombination  takes 
place.  The  sequences  consist  of  a  conserved  block  of  seven  nucleotides  (heptamer) 
which  is  always  contiguous  with  the  coding  sequence,  separated  by  a  spacer  of  roughly 
12  or  23  base  pairs  from  a  second  conserved  block  of  nine  nucleotides  (nonamer).  The 
spacer  varies  in  sequence  but  its  length  is  conserved.  The  heptamer-spacer-nonamer  is 
often  called  a  recombination  signal  sequence,  RSS 
. 
Recombination  can  only  link  a  gene  segment  flanked  by  a  12mer-spaced 
recombination  signal  sequence  to  one  with  a  23mer-spaced  RSS  (the  12/23  rule  [Sakano 
et  al.,  1980]).  Thus,  for  the  heavy  chain,  a  DH  gene  segment  can  be  joined  to  a  JH  gene 
segment,  but  VH  gene  segment  cannot  be  joined  to  JH  segment  directly,  as  both  V  and  J 
gene  segments  are  flanked  by  23  base  pair  spacers  and  the  DH  gene  segments  have  12 
base  pair  spacers.  Gene  segments  that  lack  conventional  RSS  are  rendered  non- 
functional  and  these  pseudogenes  fail  to  contribute  to  the  Ig  repertoire. 
2.1.4  Human  Ig  variable  regions 
Heavy  chains 
The  functional  human  V,  D  and  J  segments  genes  that  encode  heavy  chain  variable 
regions  are  located  on  chromosome  14q32.3  (Darlington  et  al.,  1982).  The  VH  locus 
contains  approximately  95  VH  segments  (Tomlinson  et  al.,  1992,  Matsuda  et  al.,  1993; 
Cook  et  al.,  1994).  Interestingly,  8  VH  segments  and  a  cluster  of  DH5  are  located  on 
chromosome  15g11.2  and  16  VH  segments  have  been  mapped  on  chromosome  16.  pl1.2 
(Nagaoka  et  al.,  1994;  Tomlinson  et  al,.  1994).  Some  of  these  orphan  genes  are 
potentially  functional  but  there  is  no  evidence  to  date  that  they  contribute  to  the 
functional  repertoire. 
The  VH  segments  can  be  grouped  into  families  on  the  basis  of  similarity  of  DNA 
sequence  and  on  this  basis,  they  have  been  subdivided  into  seven  families  whose 
members  are  more  than  80%  homologous.  The  families  can  be  further  grouped  into 
clans,  made  up  of  families  that  are  more  similar  to  each  other  than  to  families  in  other 
clans.  Human  VH  gene  segments  fall  into  three  such  clans.  All  of  the  VH  gene  segments 
identified  from  other  species  also  fall  into  the  same  three  clans,  suggesting  that  all  may 
have  evolved  by  gene  duplication  from  three  ancestral  V  gene  segments  (Cook  and 
Tomlinson,  1995). 
23 For  the  heavy  chains  of  human,  there  are  51  functional  VH  gene  segments,  6 
functional  JH  gene  segments  (Ravetch  et  al.,  1981)  and  approximately  27  DH  gene 
segments  (Corbett  et  al.,  1997).  Thus  around  8000  different  possible  VH  regions  are 
possible  through  rearrangement  alone,  emphasising  the  importance  of  other  processes  in 
the  diversification  of  the  repertoire. 
Light  chains 
The  human  Vx  locus  is  located  on  chromosome  22g11.2  (de  la  Chapelle  et  al.,  1983) 
and  contains  37  gene  segments  of  which  approximately  30  are  functional  (Williams  et 
al.,  1996).  The  locus  also  carries  7J  segments,  4  of  them  functional,  each  with  a  slightly 
different  copy  of  Cx  gene  nearby.  A  Vx  segment  may  fuse  to  any  of  these  alternative  J, 
segments  and  the  resulting  VI/J;,  exon  can  then  be  transcribed  together  with  the  adjacent 
C,  segment  (Vasicek  and  Leder,  1990). 
The  genetic  information  needed  to  produce  K  chains  lies  within  a  single  locus  on 
chromosome  2p11.2  (Malcolm  et  al.,  1982).  This  carries  77  V,,  segments  and  55 
truncated  pseudogenes  and  relics  (Lotscher  et  al.,  1986;  Schable  and  Zachau,  1993; 
Kawasaki,  et  al.,  2001).  Of  the  Vic  segments,  46  possess  open  reading  frames,  37  genes 
rearrange  with  J,,,  31  of  these  rearranged  products  are  transcribed  and  finally  only  29 
genes  produce  functional  proteins  (Kawasaki  et  al.,  2001).  The  human  J, 
'  cluster  consists 
of  five  segments  all  of  which  are  functional  (Hieter  et  a1.,  1982). 
2.1.5  Features  of  animal  heavy  chain  variable  regions 
The  V(D)J  rearrangement  process  is  common  to  all  vertebrates  but  germline 
sequence  diversity  varies  across  species.  The  genetic  mechanisms  by  which  antibody 
diversity  is  generated  have  been  studied  extensively  in  mice  and  humans,  but  less  so  in 
other  species.  VH  gene  families  in  mice  and  humans  have  been  classified  into  three  clans 
designated  I,  II  and  III.  In  each  clan,  FR3  is  unique.  Experiments  with  mouse  VH  probes 
suggest  that  clan  III  is  the  closest  to  the  primordial  gene  from  which  the  vertebrate  Ig 
gene  arose.  Ig  genes  from  fish  have  close  similarity  to  clan  III  and,  to  a  lesser  extent,  to 
clan  II  mammalian  Ig  Vy  genes,  corroborating  this  idea.  In  contrast,  clan  I  probes  from 
mice  hybridised  only  with  members  of  Rodentia,  suggesting  this  clan  has  diverged  more 
between  species.  In  mice,  there  are  in  excess  of  100  VH  germline  genes  which  group  into 
fourteen  families. 
24 Birds  and  other  mammals  which  have  been  studied  show  less  variability  in  the  use  of 
VH  genes.  For  instance,  in  rabbits  80-90%  of  antibodies  are  derived  from  only  one  VH 
gene,  known  as  VH  1,  although  >I  00  VH  genes  are  present  in  the  genome  (Gallarda  et  al., 
1985;  Currier  et  al.,  1988;  DiPietro  and  Knight,  1990).  Two  other  VH  segments,  VHX 
and  VHY,  are  used  in  most  other  rearrangement  products  (Friedman  et  al.,  1994).  The 
primary  repertoire  arises  mainly  from  gene  conversion  in  which  the  other  VH  genes 
donate  genetic  information  to  VH1,  as  well  as  by  somatic  hypermutation  (Knight  and 
Becker,  1990;  Schiaffella  et  al.,  1999).  Preferential  utilisation  of  D  and  JH  has  also  been 
observed,  so  of  the  12  D  and  6  JH  segments  available,  D2a,  D2b,  D5  and  JH4  are  used 
most  frequently  (Friedman  et  al.,  1994;  Tunyaplin  and  Knight,  1995). 
Gene  conversion  is  also  involved  in  generating  diversity  in  the  chicken  repertoire:  the 
single  functional  VH  gene  is  diversified  by  gene  conversion  with  the  100  VH 
pseudogenes  which  lie  upstream  at  the  locus  (Reynaud  et  al.,  1989).  The  chicken  DH 
cluster  contains  16  D  segments,  with  15  of  them  being  extremely  homologous  and  1 
being  divergent  (Dx)  Dx  is  judged  to  be  poorly  functional,  since  it  has  a  low 
rearrangement  frequency.  The  high  incidence  of  D-D  junctions  observed  (25%  of  DJ 
rearrangements)  might  represent  the  major  functional  contribution  of  this  multigene 
cluster  to  a  system  in  which  diversity  will  be  generated  later  by  gene  conversions 
(Reynaud  et  al.,  1991  a;  Reynaud  et  al.,  1994). 
In  swine,  it  appears  there  are  <20  VH  genes  belonging  to  a  single  gene  family,  which 
has  identity  to  human  VHIII  (Sun  et  al.,  1994;  Butler  et  al.,  1996).  Despite  the  close 
similarity  of  their  Ig  gene  sequences  to  humans,  swine  belong  to  the  group  of  animals 
that  includes  chickens,  sheep  and  rabbits  when  classified  on  the  basis  of  B  cell 
development.  This  group,  unlike  rodents  and  humans,  have  a  single  Vii  family,  diversify 
the  antibody  repertoire  in  hindgut  follicles  early  in  life  (rather  than  bone  marrow 
throughout  life)  and  achieve  this  through  gene  conversion  (Reynaud  et  al.,  1989, 
Reynaud  et  al.,  1991  b;  Lanning  et  al.,  2000). 
The  germline  of  sheep  contains  nine  VH  segments  belonging  to  a  single  VH  family 
closely  related  to  the  human  VH4  gene  family.  Six  of  these  genes  are  potentially 
functional  and  three  are  pseudogenes  (Dufour  et  al.,  1996). 
The  presence  of  few  functional  germline  V  genes  in  chicken,  rabbit,  pig,  sheep,  and 
cattle  restricts  the  combinatorial  diversity  encoded  in  the  germline,  but  these  species 
employ  other  strategies  to  achieve  antibody  diversification.  For  example,  gene 
conversion  is  involved  in  diversification  of  the  pre-immune  antibody  repertoire  in  the 
25 bursa  of  Fabricius  of  chickens  and  in  the  appendix  of  rabbits.  In  sheep,  somatic 
hypermutation  occurs  during  B  cell  development  in  ileal  Peyer's  Patches  (Reynaud  et 
al.,  1989;  Reynaud  et  al.,  1991  b;  Lanning  et  al.,  2000). 
In  most  vertebrates  studied  to  date  including  humans,  mice,  rats,  rabbits,  sheep  and 
chickens,  JH  gene  segments  encode  the  3'  part  of  CDR3  and  the  whole  of  FR4.  In  all 
species  except  the  cartilaginous  fishes,  JH  segments  are  carried  at  a  locus  spanning  1.5  - 
2.5  kilobases  (kb)  5-8  kb  5'  to  the  Cµ1  gene.  The  sequences  of  JH  segments  and  their 
adjacent  RSS  tend  to  be  conserved,  but  the  number  of  segments  varies  between  species. 
Variability  in  the  number  of  JH  segments  may  reflect  duplication  and/or  deletion  events 
during  evolution.  The  utilisation  of  JH  segments  also  varies  according  to  the  species  and 
developmental  stage.  Generally,  all  JH  segments  are  not  used  with  same  frequency,  and 
one  or  a  few  JH  segments  are  preferentially  expressed  and  found  in  the  variable  regions 
of  heavy  chains. 
Unique  structure  of  Camel  Immunoglobulin 
The  majority  of  functional  camel  antibodies  are  homodimers  consisting  of  only  heavy 
chains,  devoid  of  light  chains  (Hamers-Casterman  et  al.,  1993).  Sequence  analysis  has 
shown  that  the  VH  part  of  these  heavy  chain  antibodies  is  very  similar  to  human  and 
mouse  VH  (Hamers-Casterman  et  al.,  1993;  Muyldermans  et  al.,  1994).  Mouse  VH 
proteins  have  been  reported  to  be  sticky  (Ward  et  al.,  1989;  Davies  and  Riechmann, 
1994)  probably  because  removal  of  the  VL  domain  exposes  a  large  hydrophobic  surface 
(Chothia  et  al.,  1985;  Stanfield  et  al.,  1993).  In  contrast,  camel  VHHs  were  found  to  have 
a  good  solubility  behaviour  presumably  due  in  part  to  several  amino  acid  substitutions  at 
this  surface  (Muyldermans  et  al.,  1994).  The  potential  antigen-binding  surface  of  the 
camel  VHH  is  increased  due  to  CDR3  sequences  that  average  14  amino  acids  in  length 
(Muyldermans  et  al.,  1994). 
2.1.6  Animal  light  chain  variable  region 
The  processes,  which  diversify  the  heavy  chain  repertoire  of  an  animal  generally  also, 
act  upon  immunoglobulin  light  chains.  Chickens  express  light  chains  of  the  ?  isotype.  A 
single  Vß,  1  gene  is  functional  and  this  is  located  1.8  kb  upstream  of  a  single  J-C  unit. 
Upstream  of  V1  lies  a  cluster  of  25  V  pseudogenes.  Most  of  these  pseudogenes  lack 
recombination  signal  sequences,  none  of  them  have  upstream  regulatory  elements,  and 
26 some  of  them  are  so  severely  truncated  that  they  only  encode  part  of  the  V  coding 
sequence.  Sequences  of  somatically  rearranged  Vl  genes  from  embryonic  and  bursal 
cells  post-hatching  show  that  diversification  of  light  chain  sequences  occurs  during 
ontogeny  by  segmental  gene  conversion  which  takes  place  at  a  frequency  of  0.05-0.1  per 
cell  generation  between  the  pseudogene  pool  and  the  unique  rearranged  functional  V 
gene  (Reynaud  et  al.,  1985;  Reynaud  et  al.,  1987). 
In  rabbits,  the  limited  VH  gene  repertoire  sits  in  contrast  with  the  diverse  set  of  VJK 
sequences  which  are  expressed.  Sehgal  et  al.  (1999)  identified  at  least  39  rabbit  germline 
V,,  genes  of  which  at  least  28  were  expressed.  As  for  VH  genes,  the  V,,  genes  are  further 
diversified  by  somatic  hypermutation  and  gene  conversion  during  clonal  expansion  of  B 
cells  (Sehgal  et  al.,  2000). 
In  sheep,  foetal  B  cells  express  12  distinct  Va,  segments  from  90-100  Vx  genes  in  the 
germline  and  6  V,,  segments  are  present.  Southern  blot  analysis  using  V,,  probes  indicated 
that  the  sheep  Igic  locus  contains  perhaps  10  V,,  genes  (Reynaud  et  al.,  1995;  Hein  and 
Dudler,  1999).  Antigen-independent  hypermutation  is  the  major  process  that  provides 
diversity  post-rearrangement  in  sheep  light  chains  (Reynaud  et  al.,  1995). 
In  common  with  many  domesticated  animals,  the  light  chain  repertoire  of  cattle  is 
dominated  by  expression  of  lambda  chains  (Butler,  1997).  Investigation  has  revealed 
that  the  bovine  light  chain  repertoire  is  dominated  by  a  single  gene  family  designated 
V,  L1  with  at  least  14  members  (Sinclair  et  al.,  1995).  Studies  of  the  bovine  light  chain 
repertoire  have  identified  FR4  sequence  which  are  closely  related  (Ivanov  et  al.,  1988; 
Jackson  et  al.,  1992;  Sinclair  et  al.,  1995;  Parng  et  al.,  1996)  suggesting  that  V, 
segments  rearrange  with  a  single  or  a  very  limited  number  of  J  segments,  although  there 
may  be  more  present  at  the  lambda  locus  (Parng  et  al.,  1994).  Cattle  are  unable  to 
establish  a  diverse  primary  antibody  repertoire  from  the  process  of  rearrangement  alone. 
Evidence  for  gene  conversion  and  /  or  somatic  hypermutation  is  being  actively  sought  in 
several  laboratories. 
2.1.7  Bovine  heavy  chain  variable  region  and  the  Jig  locus 
The  most  marked  differences  between  the  Ig  genes  of  cattle  and  humans  or  mice  are 
found  amongst  those  sequences  that  contribute  to  the  formation  of  the  antibody  variable 
region.  All  characterisations  of  the  bovine  heavy  chain  repertoire  to  date  have  concurred 
that  it  is  founded  upon  expression  of  a  single  family  of  Vii  segments  (BovHl) 
27 homologous  to  the  murine  Q52  family  (Sinclair  and  Aitken,  1995;  Berens  et  al.,  1997; 
Saini  et  al.,  1997;  Sinclair  et  al.,  1997).  BovHl  has  highest  identity  to  the  single 
expressed  sheep  family  (83%)  and  is  assigned  to  the  clan  II  cluster  of  Ig  (Sinclair  and 
Aitken,  1995;  Berens  et  al.,  1997).  There  is  evidence  that  alternative  gene  families  are 
present  in  the  germline  (Berens  et  al.,  1997;  Saini  et  al.,  1997)  but  they  do  not  appear  to 
be  expressed  for  reasons  which,  at  present,  are  not  clear.  It  has  been  estimated  that  the 
dominant  gene  family  comprises  as  few  as  15  members;  of  greater  significance  is  the 
very  low  levels  of  diversity  which  have  been  observed  amongst  these  segments  (Berens 
et  al.,  1997;  Sinclair  et  al.,  1997).  As  in  the  sheep  (Reynaud  et  al.,  1991b;  Reynaud  et 
a!.,  1994;  Reynaud  et  al.,  1997),  rearrangement  would  thus  seem  unable  to  impart 
significance  diversity  upon  the  primary  heavy  chain  repertoire,  an  inference  which  is 
supported  by  analysis  of  foetal  bovine  heavy  chain  cDNA  (Berens  et  al.,  1997). 
Many  studies  have  shown  that  bovine  immunoglobulin  heavy  chain  cDNA  possesses 
highly  conserved  FR4  sequences  with  little  or  no  mutation  (Armour  et  al.,  1994;  Sinclair 
and  Aitken,  1995;  Berens  et  al.,  1997;  Saini  et  al.,  1997;  Sinclair  et  al.,  1997)  suggesting 
that  one  JH  segment  is  preferentially  utilised  in  rearrangement.  Supported  by  the 
similarity  of  sequences  encoding  FR4,  this  property  is  shared  with  the  sheep,  in  which 
just  two  of  six  segments  at  the  JH  locus  are  functional,  one  of  which  is  predominantly 
expressed  (Dufour  and  Nau,  1997).  However,  one  striking  feature  of  the  bovine  heavy 
chain  repertoire  which  distinguishes  it  from  the  ovine  system  is  the  frequency  with 
which  CDR3  sequences  arise  encoding  an  average  of  21  (Sinclair  and  Aitken,  1995; 
Berens  et  al.,  1997;  Saini  et  al.,  1997;  Sinclair  et  al.,  1997)  and  up  to  61  amino  acids 
(aa)  (Saini  et  al.,  1999);  ovine  CDR3  segments  are  more  typical  in  their  length  (beween 
5-18  as  with  an  average  of  13  aa;  [Dufour  et  al.,  1996]).  The  basis  of  this  property 
remains  a  matter  of  speculation  (Aitken  -  et  al.,  1999)  until  such  time  as  bovine  D 
segments  can  be  isolated. 
2.1.8  Objectives 
The  objective  of  work  presented  in  this  chapter  was  to  isolate  and  characterise  the 
bovine  JH  locus.  It  was  then  my  intention  to  establish  the  evolutionary  relationship 
between  the  bovine  JH  system  and  loci  from  other  mammals  and  to  explain  if  possible 
the  dominance  of  a  single  JH  segment  in  the  bovine  heavy  chain  repertoire. 
28 2.2  Materials  and  methods 
Preliminary  data  indicated  close  homology  between  bovine  and  ovine  antibody 
cDNA  sequences  in  framework  4  (Jackson  et  al.,  1992;  Armour  et  al.,  1994;  Sinclair 
and  Aitken,  1995;  Dufour  et  al.,  1996;  Berens,  et  al.,  1997;  Dufour  and  Nau,  1997; 
Saini,  et  al.,  1997;  Sinclair  et  al.,  1997),  suggesting  that  the  JH  loci  carry  segments  of 
related  sequence.  From  this  foundation  primers  can  be  designed  to  recover  parts  of  the 
bovine  JH  locus,  basing  these  primers  on  ovine  sequence. 
The  nucleotide  sequences  of  primers  used  in  this  section  are  shown  in  Table  2.1. 
2.2.1  Ovine  JH1=  JH4  amplicons 
2.2.1.1  Amplification 
Primer  ovine  JH1  primes  upstream  of  the  first  segment  in  the  ovine  JH  locus.  It  was 
designed  from  the  sheep  JH  sequence  (Dufour  et  al.,  1996).  Primer  JH4  was  based  upon 
the  short  stretches  of  bovine  sequence  lying  about  80  base  pairs  (bp)  downstream  of  a 
JH  segment  (Aitken  and  Sinclair,  unpublished  data). 
Bovine  genomic  DNA  was  isolated  from  liver  obtained  from  a  local  slaughterhouse 
using  Wizard  DNA  Purification  Kit  (Promega).  The  tissue  was  stored  at  -80  °C  after 
collection.  Small  pieces  of  frozen  tissue  were  ground  to  a  fine  powder  in  a  mortar  and 
pestle  on  dry  ice.  Approximately  20-40  mg  of  powdered  tissue  was  transferred  to  a  1.5 
ml  eppendorf  tube  containing  600  tl  of  nuclei  lysis  solution.  The  mixture  was 
incubated  at  65  °C  for  30  min.  RNase  was  added  to  the  viscous  nuclear  lysate  to  a  final 
concentration  of  20  µg/ml  and  the  mixture  was  incubated  at  37  °C  for  15  min.  Two 
hundred  µl  of  protein  precipitation  solution  was  added  and  after  vortexing  the  mixture 
for  20  sec  and  chilling  on  ice  for  5  min,  it  was  centrifuged  at  13000  xg  for  10  min.  The 
supernatant  was  separated  from  the  white  protein  pellet  and  was  transferred  to  a  1.5  ml 
tube  containing  600  µl  of  isopropanol  at  room  temperature.  The  solution  was  inverted 
gently  until  thread-like  strands  of  DNA  became  visible.  The  tube  was  centrifuged  at 
13000  xg  for  1  min  at  room  temperature  and  the  supernatant  was  decanted.  The  DNA 
pellet  was  washed  by  adding  600  tl  of  70%  ethanol  and  inverting  the  tube.  After 
centrifuging  at  13000  xg  for  another  1  min,  the  ethanol  was  discarded  and  the  pellet 
was  air  dried.  DNA  was  then  recovered  using  100  tl  of  DNA  rehydration  solution  (10 
mM  Tris-HCI  [pH  7.4],  1mM  EDTA  [pH  8])  and  incubation  at  65  °C  for  1  hr. 
29 Table  2.1  The  nucleotide  sequences  of  primers  used  for  recovery  and  characterisation  of 
the  bovine  JH  locus*. 
Ovine  JH1 
Ovine  JH1R 
JH2A 
JH4 
JH  4F 
M13/pUC 
M13/pUC 
JH6: 
JH7 
JH8 
JH8R 
JH9 
JH1OR: 
EIR 
Lambda 
Lambda 
M13/pUC 
M13/pUC 
DQ52 
VHF 
VH1A 
Forward" 
Reverse* 
Right  Reverse 
Right  Reverse 
Forward* 
Reverse* 
GCCCACTGTGACTATGCTGACTTCC 
GGAAGTCTGCATAGTCACAGTGG 
CCTGGTCACCGTCTCCTCAGG 
GGACATATCAGAGGACCGGACAGTGATG 
CTGAGCATCACTGGTCCTCTGATGTGTCC 
GTTTTCCCAGTCACGAC 
CAGGAAACAGCTATGAC 
GGTGAGGGCTTAGGTGAG 
ATCATTGTCACTGTTTAACAACTGG 
TGGGCCGGAGGAAAGGTGG 
CCACCTTTCCTCCCGCCCAGTCAGC 
GACGGAAGCCCCTGGTCCTGCTC 
TTGCTGGCCCTGACTCCCAT 
AGACTCTCAAGTGGACATGCTTCCTGCCACC 
GTACGCATTACAGGTGATGCG 
CATATACATGGTTCTCTCCAGAGG 
GACGTTGTAAAACGACGGCCAG 
TCACACAGGAAACAGCTATGA 
RGHRYCWGTGCTAACTGG** 
CCCACTGTGGACCCTCCTCTTT 
AGTACTATAGTATACGGACCGAGCCTGGTGAAGCC 
CTCACAGACC 
*  All  primers  are  shown  5'  to  3' 
Used  for  sequencing  of  pZErO2  (1.5)  and  crude  lysate  screening  (3.4) 
*  Used  by  MBSU  for  sequencing  of  pUC18  and  pCR®4-TOPO®vector 
**  R=A  or  G,  W=A  or  T,  Y=C  or  T,  H=A  or  C  or  T 1  tg  of  bovine  genomic  DNA  was  used  as  template  to  amplify  the  JH  locus  by  using 
the  primers  Ovine  Jill  and  JH4.  PCR  was  performed  in  a  reaction  volume  of  50  Al 
with  final  concentration  of  750  µM  of  each  dNTPs  (Life  Technologies),  600  nM  of 
each  primer  in  water,  40  µg/ml  bovine  serum  albumin  and  5  MM  M902.  The  PCR 
buffer  used  for  the  reaction  (Promega,  M190)  also  provided  10  mM  Tris-HCI  (pH  9.0), 
50  mM  KCl  and  0.1%  TritonýX-100  (final  concentrations).  2.6  units  of  ExpandTM  high 
fidelity  polymerase  containing  thermostable  Taq  DNA  and  Pwo  DNA  polymerase 
(Boehringer  Mannheim)  was  used  for  amplification.  The  reaction  was  heated  to  93°C 
for  1.5  min  and  was  then  incubated for  35  temperature  cycles  of  93  °C  for  30  seconds, 
55  °C  for  I  min  and  68  °C  for  2.5-3  min  (5  cycles  for  each  +5  seconds).  A  final 
incubation  of  68  °C  for  5  min  completed  the  amplification  reaction. 
2.2.1.2  Filling  the  protruding  ends  of  amplicons 
Amplicons  were  purified  from  agarose  gels  by  the  QIAQuick®  Gel  extraction  kit 
(QIAGEN)  as  described  in  Appendix  2.  Since  the  amplicons  were  to  be  cloned  in  a 
blunt  ended  ligation  protocol,  their  termini  were  polished.  About  900  ng  of  the  1.8  kb 
amplicons  recovered  by  PCR,  were  incubated  with  5  units  of  Klenow  fragment  of 
DNA  polymerase  I  (Promega),  in  a  total  volume  of  20  µl  containing  10  µM  dNTPs  and 
30  µg/ml  bovine  serum  albumin.  Two  µl  of  Klenow  buffer  (Promega)  provided  50  mM 
Tris-HCI  (pH  7.5),  10  nM  MgSO4  and  0.1  mM  DDT  (final  concentrations).  Reactions 
were  incubated  at  37  °C  for  15  min  and  the  enzyme  was  then  inactivated  at  75  °C  for 
10  min. 
2.2.1.3  Cloning  the  polished  amplicons 
The  vector  pZErO2  (InVitrogen)  was  used  for  cloning  of  amplicons.  It  was  cut  with 
EcoRV  (Life  Technologies)  to  form  blunt  ends.  Digestion  was  done  at  37  °C  for  30 
min  and  then  the  reaction  was  heated  at  65  °C  for  5  min  to  inactivate  the  enzyme. 
The  blunt  ended  amplicons  and  50  ng  of  vector  were  ligated  in  a  ratio  of  3/1. 
Ligation  was  done  using  3  units  of  T4  DNA  ligase  (Promega)  in  a  total  volume  of  20 
µl  at  16°C  for  19  hrs.  Two  µl  of  ligase  buffer  (Promega)  provided  30  mM  Tris-HCI 
(pH  7.8),  10  mM  MgC12,10  mM  DDT  and  1  mM  ATP  for  the  reaction. 
30 2.2.1.4  Transformation  of  ligated  DNA 
Competent  E.  coif  DH5a  cells  (100  µl;  Promega)  were  thawed  on  ice  from  storage 
at  -80  °C.  Three  pl  of  ligation  reaction  was  added  and  the  mixture  was  incubated  for 
30  min  on  ice.  The  bacteria  were  then  heat  shocked  at  42  °C  for  60  seconds.  The 
transformed  cells  were  incubated  in  900  µl  SOC  media  at  37  °C  for  1  hr  and  10  and 
100  µl  of  culture  then  were  plated  on  Luria  agar  (LA)  plates  containing  35µg/ml 
Kanamycin  and  3mM  IPTG.  Plates  were  incubated  overnight. 
Of  23  colonies,  5  were  selected  for  the  isolation  of  plasmid  DNA.  Colonies  were 
inoculated  into  5  ml  Luria  broth  (LB)  and  incubated  at  37  °C  overnight.  The  cultures 
were  centrifuged  and  plasmid  DNA  isolated  from  the  bacterial  pellet  using  the 
QlAprep  spin  miniprep  kit  (QIAGEN)  (discussed  in  Appendix  2).  DNA  was  double 
digested  with  restriction  enzymes  EcoRI  and  XhoI  (Life  Technologies)  at  37  °C  for  1.5 
hrs  and  then  analysed  on  a  0.5  %  agarose  gel. 
2.2.1.5  Sequencing  of  cloned  fragment 
A  clone  (2-4)  that  carried  the  amplicon  was  sequenced  with  M13/pUC  forward  and 
reverse  primers  by  the  PNACL  DNA  sequencing  service  at  the  University  of  Leicester. 
Since  the  sequencing  data  did  not  cover  the  whole  length  of  the  fragment,  another  3 
primers  JH7,  JH8  and  JH9  were  designed.  Reactions  with  these  oligonucleotides 
completed  sequencing  of  the  insert  carried  in  2-4. 
2.2.2  JH2A-E[tR  ampilcons 
2.2.2.1  Amplification 
Since  analysis  of  the  sequences  of  Ovine  JH1-JH4  amplicon  revealed  the  location  of 
a  JH  segment  expressed  with  low  frequency  in  bovine  antibodies  (Berens  et  al.,  1997), 
more  frequently  expressed  segments  were  sought  in  flanking  regions.  To  amplify  the 
downstream  sequences,  two  primers  JH2A  and  Eli  reverse  (EµR)  were  used.  The 
former  had  been  designed  in  our  laboratory  based  on  the  sequences  of  bovine  antibody 
cDNA  (Sinclair  and  Aitken,  1995;  Sinclair  et  al.,  1997)  and  primes  the  sequence 
commonly  observed  in  FR4,  extending  towards  the  Cµ  region.  The  second  primer 
sequence,  EpR,  was  taken  from  the  ovine  immunoglobulin  heavy  chain  5'  intronic 
enhancer  sequence,  selecting  a  region  without  significant  repetition  that  was  conserved 
across  a  number  of  species  (bases  297-320;  GenBank  accession  number  Z98207) 
31 (Figure  2.1).  It  was  intended  to  anneal  to  complementary  bovine  enhancer  sequences, 
extending  towards  the  JH  region. 
PCR  was  performed  in  a  reaction  volume  of  50  pl  with  final  concentration  of  500 
tM  of  each  dNTPs  (Promega),  800  nM  of  each  primers  and  5  mM  MgCI2.  In  addition, 
reaction  buffer  provided  50  mM  KCI,  10  mM  Tris-HC1(pH  9.0)  and  0.1%  Triton®X- 
100.  Five  units  of  Taq  DNA  polymerase  (Promega)  were  used  for  amplification  with 
the  following  conditions.  The  reaction  was  heated  to  94°C  for  5  min  and  was  then 
incubated  for  35  temperature  cycles  of  94  °C  for  1  min,  55  °C  for  1  min  and  72  °C  for  3 
min,  and  then  a  final  incubation  of  72  °C  for  5  min. 
2.2.2.2  Phosphorylation  and  polishing  of  amplicons 
Dephosphorylated  Smal  cut  pUC18  (Pharmacia)  was  used  to  clone  the  900  bp 
JH2A-EµR  amplicons.  Firstly,  the  PCR  product  was  run  in  1%  agarose  gel  and  the 
desired  band  was  extracted  using  the  QIAQuick®  Gel  extraction  kit.  The  vector  was 
supplied  with  dephosphorylated  blunt  ends.  Thus  in  contrast  to  cloning  into  pZErO2 
(subheading  2.2.1.3),  amplicons  were  phosphorylated  and  polished  prior  to  the  ligation 
step.  These  modifications  were  performed  concurrently  in  a  50  µl  reaction  containing 
about  1  µg  DNA,  1mM  ATP,  35  p.  M  dNTPs,  20mM  MgC12,80  µM  Tris-HC1(pH  7.6), 
5  mM  DTT,  10  units  T4  polynucleotide  kinase  (Promega)  and  5  units  Klenow 
fragment  of  DNA  polymerase  I  (Promega).  The  reaction  was  incubated  at  37  °C  for  40 
min  and  the  enzymes  were  then  inactivated  at  75  °C  for  10  min.  The  DNA  was 
precipitated  with  sodium  acetate  and  ethanol,  dried  and  rehydrated  in  30  µl  of  distilled 
water.  To  determine  the  concentration  of  recovered  DNA,  2  µl  was  run  on  a  1% 
agarose  gel. 
2.2.2.3  Cloning  of  amplicons 
200  ng  of  each  amplicon  and  vector  were  used  in  ligation  reactions,  providing  a 
ratio  of  about  4/1  of  insert/vector.  Ligation  was  done  at  16  °C  for  18  hrs  in  a  volume  of 
20  µl  containing  10mM  DDT,  400  units  T4  DNA  ligase  (New  England  Biolabs)  and  2 
pl  of  ligase  buffer  that  provided  50  mM  Tris-HC1  (pH  7.5),  10  mm  MgC12,10  mM 
DDT,  50  µM  ATP  and  25  µg/ml  BSA. 
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w 2.2.2.4  Transformation  of  ligated  DNA 
E.  coli  XL-1  supercompetent  cells  (Stratagene)  were  thawed  on  ice  from  -80  °C  and 
mixed  with  (3-mercaptoethanol  to  a  final  concentration  of  25  mM.  After  incubation  on 
ice  for  10  min,  4  µl  of  each  ligation  reaction  was  added,  and  the  incubation  continued 
for  a  further  30  min.  The  cells  were  then  heat  shocked  at  42  °C  for  45  sec,  added  to  950 
µl  of  SOC  media  and  then  incubated  at  37  °C  with  shaking.  After  1.5  hrs  40  111  of 
culture  was  plated  on  LA  containing  100  µg/ml  ampicillin,  12  µg/ml  tetracycline,  forty 
µl  of  4%  X-gal  and  40  µl  of  25  mM  IPTG  and  incubated  at  37  °C  overnight. 
The  following  day,  six  white  colonies  were  inoculated  into  5  ml  Luria  broth  (LB) 
and  incubated  at  37  °C  overnight.  Plasmid  DNA  was  isolated  using  the  QlAprep  spin 
miniprep  kit.  Purified  DNA  was  digested  with  EcoRI  (Promega)  to  determine  the  size 
of  the  linearised  molecule,  and  also  with  two  flanking  enzymes  HindIIl  /  SstI  (Life 
Technologies)  to  check  the  insert  frequency.  Digests  were  analysed  on  1%  agarose 
gels. 
2.2.2.5  Sequencing  of  cloned  fragment 
A  clone  designated  E2  carrying  the  expected  size  of  insert  was  chosen  for 
sequencing.  The  plasmid  was  sequenced  at  the  Molecular  Biology  Support  Unit 
(MB  SU)  at  the  University  of  Glasgow  using  primers  M13/pUC  forward  and  reverse. 
2.2.3  Right  reverse-JH8R  amplicons 
2.2.3.1  Amplification 
To  amplify  the  sequences  upstream  from  the  region  recovered  with  primers  Ovine 
Jill  and  JH4,  a  phage  designated  clone  15  from  a  lambda  phage  library  of  bovine 
genomic  DNA  was  used  as  template.  This  clone  was  a  gift  from  Professor  Katherine 
Knight  (Department  of  Microbiology  and  Immunology,  Loyola  University,  Chicago). 
It  carries  about  18  kb  fragment  spanning  the  JH  locus,  the  Sµ  switch  region  and 
Cµ  exons  (Knight  et  al.,  1988).  From  the  limited  published  data,  it  was  predicted  that 
the  insert  would  carry  sufficient  sequence  upstream  from  the  JH  locus  to  include  any 
homologue  of  the  DQ52  segment  present  in  the  bovine  genome.  The  amplification  was 
performed  using  primers  right  reverse  (RR)  and  JH8  reverse  (JH8R).  The  primer  RR 
primes  sequences  on  the  right  arm of  the  lambda  phage  vector  230  bp  from  the  insert. 
Preliminary  experiments  established  that  the  genomic  DNA  carried  in  clone  15  is 
33 orientated  with  the  JH  locus  proximal  to  the  right  arm  of  the  vector.  The  JH8R  primer 
anneals  to  sequences  between  the  second  and  third  JH  segments,  revealed  from 
sequencing  of  Ovine  JH1-JH4  amplicons. 
PCR  was  done  in  a  reaction  volume  of  50  pl  with  final  concentration  of  500  µM  of 
each  dNTPs  (Promega),  400  nM  of  each  primers  and  3  mM  MgC12.  The  PCR  buffer 
(Promega)  also  provided  50  mM  KCI,  10  mM  Tris-HC1(pH  9.0),  and  0.1%  Triton®X- 
100.  Five  units  of  Taq  DNA  polymerase  (Promega)  were  used  for  amplification.  The 
reaction  was  heated  up  to  94°C  for  5  min  and  was  then  incubated  for  35  temperature 
cycles  of  94  °C  for  1  min,  55°C  for  1  min  and  72  °C  for  3  min,  and  then  a  final 
incubation  of  72  °C  for  5  min. 
2.2.3.2  Phosphorylation  and  polishing  of  amplicons 
Dephosphorylated  Smal  cut  pUC18  (Amersham  Pharmacia  Biotech)  was  used  as 
vector  for  cloning  of  the  1.2  kb  amplicons  from  this  reaction.  Protocols  for 
purification,  phosphorylation  and  polishing  of  PCR  products  are  described  in 
subheading  2.2.2.2.  The  ethanol  precipitated  DNA  was  dissolved  in  20  tl  of  distilled 
water  and  2  µ1  was  run  in  1%  agarose  gel  to  determine  the  concentration  of  recovered 
DNA. 
2.2.3.3  Cloning  of  amplicons 
'300  ng  of  amplicons  and  200  ng  of  pUC18  were  used  in  ligation  reactions  providing 
a  ratio  of  about  4/1  insert/vector.  Ligation  was  performed  at  16  °C  for  18  hrs  in  a 
volume  of  20  tl  with  reaction  conditions  described  in  subheading  2.2.2.3. 
2.2.3.4  Transformation  of  ligated  DNA 
E.  coli  Sure®2  supercompetent  cells  (Stratagene)  were  used  for  transformation. 
Bacteria  (50  µl)  were  thawed  on  ice  from  storage  at  -80  °C  and  ß-mercaptoethanol 
added  to  a  final  concentration  of  25  mM.  After  10  min  4  µl  of  each  ligation  reaction 
was  added,  incubation  on  ice  continued  for  30  min  and  cells  were  then  shocked  at  42 
°C  for  30  seconds.  SOC  medium  (950  µl)  was  added  and  after  1.5  hrs  shaking  at  37  °C, 
30  µl  of  culture  was  plated  on  LA  containing  100  µg  /  ml  ampicillin,  40  µl  of  4%  X- 
gal  and  40  µl  of  25  mM  IPTG.  Plates  were  incubated  at  37  °C  overnight. 
34 Of  the  white  colonies  observed  the  following  day,  22  were  picked  to  check  for  the 
presence  of  insert.  This  was  achieved  by  preparing  crude  lysates  by  heating  (protocol 
mentioned  in  Appendix  2:  General  Methods)  and  PCR  with  M13/pUC  forward  and 
reverse  primers.  Eight  µl  of  each  PCR  reaction  was  then  analysed  on  1%  agarose  gels 
to  identify  clones  carrying  the  insert  of  interest. 
2.2.3.5  Sequencing  of  cloned  fragment 
A  clone  designated  C15-10  with  the  desired  insert  was  chosen  for  sequencing  with 
M13/pUC  forward  and  reverse  primers.  Since  the  first  set  of  sequencing  did  not  cover 
the  insert  in  its  entirety,  a  second  round  of  sequencing  was  performed  using  primers 
Right  reverse  2  (RR2)  and  JH10  Reverse.  The  former  primes  the  right  arm  of  the 
lambda  vector  45  bp  from  the  cloning  site;  the  latter  primes  the  region  between  the  first 
and  second  bovine  JH  segments.  Sequencing  reactions  were  carried  out  in  the  MBSU, 
University  of  Glasgow. 
2.2.4  Comparison  of  unrearranged  and  rearranged  DNA  from  one  individual 
The  work  described  above  failed  to  locate  the  JH  segment  which  is  most  frequently 
rearranged  in  bovine  heavy  chain  cDNA.  In  all,  germline  genomic  DNA  was 
characterised  from  four  different  sources.  To  identify  the  JH  segment  concerned, 
attempts  were  focused  on  isolating  and  sequencing  the  JH  locus  from  tissue  in  which 
rearrangement  had  taken  place.  In  B  cells,  the  V  and  D  segments  are  fused  to  the  JH 
segment  selected  for  rearrangement,  so  the  distance  between  V  and  J  segments  is  short 
enough  to  be  amplified  by  PCR  (Figure  2.2).  By  using  primers  specific  for  the  VH 
segment  and  the  3'  terminus  of  the  JH  locus,  it  was  reasoned  that  the  rearranged 
segment  could  be  identified  from  its  sequence  and  flanking  regions. 
2.2.4.1  Recovery  of  rearranged  antibody  sequences  from  B  cell  genomic  DNA 
I  Amplification  with  VHF  and  JH4 
B  cell  genomic  DNA  from  an  adult  bull  (gifted  by  Dr.  S.  Stephens,  Institute  for 
Animal  Health,  Compton)  was  used  as  template  for  PCR  with  primers  VHF  and  JH4. 
VHF  binds  to  the  leader  sequences  in  the  5'  region  of  bovine  VH  segments  and  JH4 
binds  to  sequences  at  the  3'  terminus  of  the  JH  locus,  about  80  bp  downstream  from  the 
sixth  JH  segment.  In  principle,  the  amplicon  should  cover  the  V,  D  and  J  segment's,  its 
size  depending  upon  which  JH  segment  undergoes  rearrangement  (Figure  2.2). 
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0 Three  PCR  reactions  were  performed  using  the  conditions  described  in  subheading 
2.2.3.1  with  MgC12  concentrations  of  3.5,4  and  4.5  mM  and  using  Taq  DNA 
polymerase.  The  annealing  temperature  for  these  reactions  was  58  °C. 
II  Cloning 
PCR  products  were  run  on  1%  agarose  gels.  Analysis  showed  four  bands  with  sizes 
of  about  470,600,900  and  1500  bp.  All  bands  were  extracted  using  the  QIAQuick  Gel 
extraction  kit.  Firstly,  amplicons  of  470  and  600  bp  were  polished,  phosphorylated  and 
cloned  into  dephosphorylated  pUC18  as  described  in  subheadings  2.2.2.2  and  2.2.2.3. 
The  sequencing  of  these  amplicons  revealed  that  they  were  irrelevant.  The  amplicons 
of  900  and  1500  bp  were  cloned  into  pCR4-TOPO  vector  using  TOPO  TA  cloning  Kit 
(Invitrogen).  The  pCR4-TOPO  vector  is  a  linearised  vector  carrying  topoisomerase  I 
molecules  at  the  3'  termini.  Topoisomerase  I  increases  the  efficiency  of  cloning.  Four 
µl  of  the  extracted  DNA  (900  and  1500  bp  products),  1  µl  (10  ng)  of  vector  and  1  Id  of 
salt  solution,  containing  1.2  M  NaCl  and  0.06  M  MgC12  were  mixed  and  the  reaction 
was  incubated  on  ice  for  30  min. 
III  Transformation 
Two  µl  of  each  ligation  reaction  was  then  added  to  thawed  TOPO10  competent  cells 
and  after  30  min  incubation  on  ice,  the  cells  were  heat  shocked  at  42  °C  for  30  sec.  The 
cells  were  left  on  ice  for  2  min  before  addition  of  250  µl  of  SOC  media  and  incubation 
at  37  °C  with  shaking  for  1.5  hrs.  Fifty  µl  of  each  reaction  were  plated  on  LB  agar 
containing  100  µg/ml  ampicillin  and  the  plates  were  incubated  overnight  at  37  °C. 
The  next  day,  10  and  14  colonies  from  the  900  and  1500  bp  amplicon  cloning 
reactions  were  chosen  to  check  the  insert  frequency.  Crude  lysates  from  these  colonies 
were  prepared  as  described  in  Appendix  2.  PCR  on  crude  lysates  was  performed  with 
primers  M13F  and  M13R  to  determine  whether  an  insert  was  present. 
IV  Sequencing 
Plasmids  of  clones  carrying  900  and  1500  bp  inserts  were  isolated  (QIAGEN)  for 
sequencing.  Sequencing  was  carried  out  in  the  MBSU,  University  of  Glasgow.  The 
results  showed  that  the  900  bp  fragment  was  irrelevant  but  sequencing  of  a  clone 
designated  B12  carrying  an  insert  of  1500  bp  fragment  with  M13  forward  and  reverse 
36 primers  revealed  that  VH  and  JH  sequences  were  present.  Resequencing  with  primer 
JH6  recovered  the  entire  sequence  of  the  insert.  The  results  showed  that  the  VD  genes 
were  fused  to  JH  sequences  located  at  the  position  of  the  fourth  JH  segment.  Also,  the 
sequence  corresponding  to  framework  region  4  matched  precisely  that  which 
predominates  in  bovine  antibodies.  To  confirm  the  result,  another  8  clones  (designated 
B2,  B5,  B7,  B9,  B14,  B21,  B22  and  B25)  were  sequenced  with  primers  JH6  and/or 
M13  forward  and  reverse  primers.  The  results  showed  again  that  sequence 
corresponding  to  predominant  FR4  located  at  the  position  of  the  fourth  JH  segment, 
supporting  the  conclusion  that  the  fourth  JH  segment  undergoes  frequent 
rearrangement. 
2.2.4.2  Unrearranged  genomic  DNA 
The  results  from  B  cell  genomic  DNA  conflicted  with  the  sequence  of  the  fourth  JH 
segment  recovered  from  the  germline  of  different  individuals:  the  sequence  of  the 
rearranged  JH  segment  in  B  cell  DNA  matched  the  sequences  that  encodes  the  frequent 
expressed  FR4.  Therefore,  genomic  DNA  from  non-lymphoid  tissue  of  the  B  cell 
donor  was  subjected  to  sequencing. 
I  Preparation  of  genomic  DNA 
Genomic  DNA  was  prepared  from  peripheral  blood  lymphocytes  using  Wizard 
Genomic  DNA  Purification  Kit  (Promega).  Twenty  ml  of  heparinised  blood  from  the  B 
cell  donor  was  divided  to  two  aliquots  of  10  ml  and  each  was  treated  using  the 
following  procedures.  Thirty  ml  of  cell  lysis  solution  was  added  to  each  10  ml  aliquot 
of  blood  in  a  50  ml  centrifuge  tube  to  lyse  red  blood  cells.  The  tube  was  inverted 
gently  6  times.  The  mixture  was  incubated  at  room  temperature  for  10  min,  inverting 
every  2-3  min.  The  mixture  was  then  centrifuged  at  2000  xg  for  10  min.  The 
supernatant  was  discarded  without  the  disturbing  the  white  pellet  and  the  pellet  was 
then  resuspended  in  the  remaining  liquid  in  the  tube.  Ten  ml  of  nuclei  lysis  solution 
was  added.  Cell  lysis  was  facilitated  by  repeated  pipetting  and  incubation  at  37  °C  for 
20  min.  RNase  was  added  to  the  viscous  nuclear  lysate  to  a  final  concentration  of  20 
µg/ml  and  the  mixture  was  incubated  at  37  °C  for  15  min  . 
Three  point  three  ml  of 
protein  precipitation  solution  was  added  and  after  vortexing  the  mixture  for  20  sec,  it 
was  centrifuged  at  2000  xg  for  10  min.  The  supernatant  was  separated  from  the  dark 
brown  protein  pellet  and  was  transferred  to  a  50  ml  tube  containing  10  ml  of 
37 isopropanol  at  room  temperature.  The  solution  was  inverted  gently  until  thread-like 
strands  of  DNA  became  visible.  The  tube  was  centrifuged  at  2000  xg  for  1  min  at 
room  temperature  and  the  supernatant  was  decanted.  The  DNA  pellet  was  washed  by 
adding  10  ml  of  70%  ethanol  and  inverting  the  tube.  After  centrifuging  at  2000  xg  for 
another  1  min,  the  ethanol  was  discarded  and  the  pellet  was  air  dried.  DNA  then  was 
recovered  using  800  µl  of  DNA  rehydration  solution  and  incubation  at  65  °C  for  1  hr. 
II  Amplification 
Isolated  genomic  DNA  was  used  as  template  for  PCR  with  primers  JH8  and  JH6. 
The  primer  JH8  binds  to  sequences  between  the  second  and  third  JH  segments  and  JH6 
binds  to  sequences  downstream  of  the  fifth  JH  segment.  The  amplicon  would  thus 
include  the  fourth  JH  segment,  resolving  the  apparent  contradiction  between  the 
sequence of  this  region  in  B  cell  DNA  from  this  donor  and  previously  determined 
germline  sequences.  PCR  was  performed  with  conditions  described  in  subheading 
2.2.3.1  using  1  [ti  of  genomic  DNA,  a  final  concentration  of  3.5  mM  MgC12  and  an 
annealing  temperature  of  56  °C. 
III  Cloning  and  transformation 
PCR  products  were  run  on  an  agarose  gel  and  bands  of  about  1500  bp  were 
extracted  using  the  QIAQuick  Gel  extraction  kit.  The  protocol  for  cloning  and 
transformation  of  amplicons  into  the  pCR4-TOPO  vector  and  TOPO10  competent  cells 
is  described  in  subheading  2.2.4.1.  II. 
Plasmids  from  10  colonies  were  isolated  (QIAGEN)  and  were  digested  with  EcoRI 
to  assess  which  carried  inserts.  The  cloning  site  in  pCR4-TOPO  is  flanked  by  EcoRI 
sites. 
IV  Sequencing 
A  clone  carrying  an  insert  (designated  BG1)  was  chosen  for  sequencing. 
Sequencing  was  carried  out  in  the  MBSU,  University  of  Glasgow  using  M13  forward 
and  reverse  primers. 
38 2.3  Results 
2.3.1  Recovery  and  cloning  of  the  J11  locus 
2.3.1.1  Ovine  JH1-JH4  amplicons 
High  molecular  weight  genomic  DNA  was  recovered  from  homogenised  liver  for  use 
as  template  in  the  PCR.  In  contrast  to  some  reactions  attempted  in  the  course  of  this 
work,  the  Ovine  JH1-JH4  primer  set  reproducibly  yielded  a  1.8  kb  product  without  the 
need  for  substantial  optimisation  of  the  reaction  conditions  (Figure  2.3).  This  justified 
our  strategy  for  recovery  of  the  majority  of  the  bovine  JH  locus  with  primers  designed 
from  its  ovine  homologue  (Dufour  and  Nau,  1997). 
The  vector  pZErO2  was  chosen  for  cloning  the  Ovine  JH1-JH4  amplicon.  This  vector 
carries  the  ccdB  gene  which  is  lethal  when  expression  from  the  lac  promoter  is  induced 
with  IPTG.  It  thus  provided  high-stringency  selection  for  successful  ligation  of  PCR 
products  into  the  vector  after  digestion  with  EcoRV,  without  the  need  for  further 
modification  (e.  g.  dephosphorylation  of  the  vector).  In  later  work,  a  commercial  source 
of  Smal-digested,  dephosphorylated  pUC18  was  used,  eliminating  the  need  for  repeated 
vector  preparation  and  digestion.  After  ligation  of  the  polished  Ovine  JH1-JH4  amplicon 
with  pZErO2  and  transformation  into  E.  coli  DH5a,  23  colonies  were  obtained  from 
plating  of  100µl  of  the  transformation  mixture  onto  selective  plates  containing  IPTG. 
Plasmid  DNA  was  isolated  from  5  colonies,  and  digested  with  EcoRI  and  Xhol  since  the 
relevant  recognition  sequences  flank  the  EcoRV  site  into  which  amplicons  were  ligated. 
Plasmid  DNA  from  a  clone  designated  2-4  released  fragments  of  3  kb,  about  1.5  kb  and 
about  200  bp  whereas  other  samples  apparently  lacked  inserts  (Figure  2.4).  DNA  from 
clone  2-4  was  submitted  for  sequencing.  Later  analysis  revealed  that  the  insert  contains 
two  internal  Xhol  site  and  that  in  consequence,  digestion  with  EcoRI  and  XhoI  would  be 
expected  to  release  fragments  of  3  kb  (the  vector  backbone),  1.4  kb  and  two  fragments  of 
200  bp. 
2.3.1.2  JH2A-EµR  amplicons 
To  recover  sequence  downstream  from  the  main  Jl{  locus,  primers  JH2A  and  EpR 
were  used  in  PCR  with  liver  genomic  DNA.  The  sequence  of  primer  ERR  was  taken 
from  the  published  sequence  of  the  ovine  5'  intronic  enhancer  (GenBank  accession 
number  Z98207)  (Figure  2.1).  PCR  with  the  JH2A-EJR  primer  set  yielded  an  amplicon 
of  about  900  bp  (Figure  2.5).  This  was  phosphorylated,  polished  and  ligated  with  Smal- 
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Figure  2.3  PCR  from  bovine  gnomic  1)NA  with  primers  Ovine 
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a:  Ovine  JHI-JH4  amplicon  (c.  1.8  kh) 
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Figure  2.4  Restriction  analysis  of  clone  2-4  with  EvoIUl  /,  VIwI. 
a:  I)iuested  sample  ol'I)NA  from  clone  2--1.  Irm.  mnettts 
kb  (vector)  and  1.5  kb  (insert)  are  visible.  A  taint  insert 
fragment  of  200  bp  was  also  detected. 
M:  Ikb  ladder  (Litt'Fechnologies).  The  migration  of  markers 
of  3  kb,  1.6  kb  and  500  hp  is  indicated.  Other  lanes  on  the 
gel  contain  DNA  samples  from  non-recombinant  clones digested,  dephosphorylated  pUC18.  E.  coli  XL-1  cells  were  transformed  and  screened  on 
selective  indicator  medium  for  a  white  phenotype.  Plasmid  DNA  was  isolated  from  6 
candidate  colonies  and  digested  with  EcoRI  to  linearise  the  DNA.  Further  analysis  by 
digestion  with  HindlIl  and  SstI  showed  that  one  released  fragments  of  2.7  kb 
(corresponding  to  the  pUC18  vector)  and  another  of  the  same  size  as  the  original 
amplicon  (Figure  2.6).  This  clone,  designated  E-2,  was  sequenced. 
2.3.1.3  Right  reverse-JH8R  amplicons 
Many  attempts  were  made  to  recover  sequence  upstream  from  the  main  Jn  locus  with 
primers  designed  from  alignment  of  DQ52  segments  from  several  species.  These 
experiments  failed  to  produce  amplicons  with  bovine  genomic  DNA  from  the  liver.  To 
achieve  this  objective,  lambda  clone  15  was  obtained  from  Prof  K.  Knight.  Viral  DNA 
was  then  used  as  a  template  in  PCR  with  the  primers  Right  reverse  and  JHBR  These 
anneal  to  the  lambda  right  arm  and  within  the  JH  locus  respectively.  These  reactions  were 
successful  and  produced  an  amplicon  of  about  1.2  kb  (Figure  2.7).  The  phosphorylated, 
polished  product  was  ligated  into  Smal-digested  dephosphorylated  pUC18.  Transformed 
E.  coli  Sure2  cells  were  checked  for  a  white  phenotype  on  selective  indicator  medium. 
Candidate  white  colonies  were  screened  by  PCR,  using  crude  bacterial  lysates  and 
primers  flanking  the  Smal  site  in  the  cloning  vector.  Of  22  samples,  19  contained  inserts 
and  10  appeared  to  be  of  the  right  size  (Figure  2.8).  A  clone  designated  C15-10  was 
chosen  for  sequencing. 
2.3.2  Analysis  the  sequence  of  insert  of  clone  2-4 
The  completed  sequence  of  the  Ovine  JH1-JH4  amplicon  was  scanned  for  potential 
JH  segments,  seeking  5'  recombination  signal  sequences  (RSS),  3'  donor  splice  sites  and 
regions  homologous  to  the  ovine  J11  locus  (Dufour  and  Nau,  1997).  Six  segments  were 
identified  with  these  criteria.  The  sequence  of  these  segments  and  the  flanking  elements 
including  5'  nonamer,  spacer  and  heptamer  motifs  and  3'  donor  splice  site  are  shown  in 
Figure  2.9.  The  segments  span  about  1850  bp  with  inter-segment  regions  ranging  from 
129  -500  bp.  Nonamer  motifs  are  variable  in  sequence  as  are  the  RSS  spacers  which  vary 
in  length  from  20  to  23  bp.  Heptamers  are  better  conserved;  only  those  associated  with 
the  second  and  third  segments  depart  from  the  CACTGTG  consensus.  Segments  are 
between  45  and  51  bp  in  length  according  to  the  criteria  set  out  in  the  legend  to  Figure 
2.9.  Splice  sites  for  RNA  processing  are  present  for  all  segments  except  the  second  but 
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Figure  2.5  PCR  from  bovine  genomic  DNA  with  primers  JH2A  and  EIR. 
a:  JH2A-EiR  amplicon  (c.  720  bp) 
M:  lkb  ladder  (Promega).  The  migration  of  markers  of  I  kb  and 
750  bp  is  indicated 
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Figure  2.6  Restriction  analysis  of  clone  E-2. 
a:  JI-12A-GtR  amplicon 
b:  Sample  o1  DNA  from  clone  F-2  digested  with  EcOR! 
c:  Sample  ol'DNA  f  om  clone  F-2  digested  with  i/iadIII  /,  5.  v/I. 
M:  I  kb  ladder  (Pt-omega).  'I'hc  mieratiom  of  markers  ut'3  kb, 
2.5  kb  and  I  kb  is  indicated 
M  It  bc 1.61dß  - 
ild) 
IN 
Figure  2.7  NCR  from  lambda  clone  15  DNA  using  primers  RR  and  .  IH8R. 
a:  RR-.  IH8  amplicon  (c.  1.2  kb) 
M:  I  kb  ladder  (Cite  Technology).  The  migration  of  markers  of 
1.6  kb  and  I  kh  is  indicated 
i  kb 
iIth 
Figure  2.8  PCR  screening  of  clones  for  insertion  of  the  RR-.  II18R  amplicoIt. 
PCR  was  performed  ýý  ith  NI  1-1IA  '  and  and  reverse  primers.  0122 
clones.  19  contained  an  insert.  10  vv  ere  c.  12  Ich 
a:  Clone  with  insert  ol'the  size  sought  (clone  designated  I5-IO). 
Smaller  inserts  are  prohahly  related  to  the  degraded  amplicon  Fragment. 
M:  1  kh  ladder  (Life  I  echnulop  ).  The  migration  of  markers  of  1.5  kh 
and  I  kb  is  indicated 
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ii+ only  the  third  and  forth  segments  perfectly  match  the  conventional.  sequence 
(C/A)AGGT(G/A)AG  (Mount  1982). 
Of  the  JH  segments  identified  in  the  Ovine  JH1-JH4  amplicon,  only  the  second  would 
immediately  appear  to  be  a  pseudogene  on  the  basis  of  the  features  outlined  above. 
Assessment  of  functionality  for  the  others  can  best  be  judged  from  comparison  of  their 
coding  sequences  with  FR4  sequences  from  bovine  immunoglobulin  cDNA  (Figure 
2.10).  In  this  regard,  segments  one  and  three  to  six  have  similarity  to  the  highly- 
conserved  sequence  observed  in  FR4  (Armor  et  al.,  1994;  Sinclair  et  al.,  1995;  Berens  et 
al.,  1997;  Saini  et  al.,  1997;  Sinclair  et  al.,  1997)  but  none  are  a  perfect  match  (Figure 
2.11).  The  sixth  JH  segment  must  be  functional  since  the  deduced  amino  acid  sequence 
corresponds  exactly  to  17  amino  acids  of  a  rare  FR4  sequence  but  one  that  can  be 
detected  in  cDNA  (Berens  et  al.,  1997;  Figure  2.11).  This  segment  possesses 
conventional  5'  nonamer  and  heptamer  RSS  sequence,  GGTTTTTGT  and  CACTGTG, 
with  a  22  nucleotide  spacer.  The  segment  also  possesses  the  functional  3'  donor  splice 
sequence  AGGT  . (Mount  1982).  The  fourth  segment  is  homologous  to  the  most 
commonly  expressed  segment  at  the  ovine  locus.  There  are  7  substitutions  within  the 
segment  itself  but  control  sequences  are  almost  identical  -a  single  nucleotide 
substitution  in  the  nonamer  (bovine:  GGGTTTTGC;  ovine:  GGTTITTGC)  and  the 
bovine  spacer  is  of  the  theoretically  ideal  length  (23  bp  c.  f.  22  bp  at  the  ovine 
locus)(Figure  2.21).  However,  there  is  no  evidence  from  bovine  immunoglobulin  cDNA 
sequences  that  this  segment  is  rearranged  in  cattle. 
Overall,  the  sequence  characterised  in  clone  2-4  is  strikingly  similar  to  the 
comparable  part  of  the  ovine  JH  locus  (Figure  2.12).  There  are  limited  stretches  where 
deletion  or  insertions  have  occurred.  For  example,  sequences  are  present  in  the  ovine 
locus  at  positions  55  -  65  and  1258  -  1278  (numbering  taken  from  ovine  data)  which  are 
absent  from  the  bovine.  Similarly,  a  stretch  of  27  bases  is  present  at  position  1878  -  1904 
in  the  bovine  locus  which  do  not  appear  in  the  ovine.  BLAST  searches  with  these 
differences  failed  to  make  any  significant  matches. 
2.3.3  Analysis  the  sequence  of  clone  E-2 
By  using  primers  against  the  5'  intron  enhancer,  about  900  bp  of  additional  sequence 
was  recovered  downstream  from  the  sixth  JH  segment  (Figure  2.12).  Again,  significant 
similarity  with  the  ovine  locus  is  apparent  with  short  runs  of  species-specific  sequence 
that  lack  function  as  can  be  judged  by  BLAST  searches  (Figure  2.12).  By  comparing  the 
41 CDR'i  I 
k-FR4 
H  103 
w 
---  ---  AG-  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  --- 
--T  -C-  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  --- 
GG-  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  --- 
--T  -GA  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  --- 
--T  -GA  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  --- 
--T  TG-  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  --- 
GGG  A--  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  --- 
CCA  CA-  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  --- 
GGT  T-T  TT-  TTG  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  --- 
-G-  --T  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  --- 
A--  ---  -TT  --------------------------------- 
A--  --A  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  --- 
C-A  ---  ---  ---  ---  --T  ---  ---  --T  ---  ---  ---  ---  ---  --- 
---  ---  ---  ---  ---  ---  ---  ---  A--  ---  ---  ---  ---  ---  --- 
--T  CAT  C-A  ---  ---  --A  ---  ---  ---  ---  ---  ---  ---  ---  --- 
---  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  --T  ---  --- 
GGA  T--  ---  ---  ---  ---  ---  ---  ---  -  ---  -  --- 
---  C--  ---  C--  ---  ---  -T-  ---  ---  ---  ---  ---  ---  ---  --- 
G--  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  -A-  -G-  ---  --- 
---  T-T  --C  TA-  ---  ---  ---  ---  AC-  ---  ---  ---  ---  ---  --- 
AT-  -C-  ---  ---  ---  ---  ---  ---  ---  ---  -  --  ---  ---  ---  --- 
-C-  ---  C--  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  --- 
--T  ---  --C  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  --- 
---  ---  ACC  -----------------------T  ---  ---  ---  --- 
---  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  --- 
-T-  CA-  ---  ---  ---  ---  ---  ---  ---  ---  -  --  ---  ---  ---  --- 
---  A-  A-C  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  ---  --- 
YVDAWGQGLLVTVSS 
TAC  GTC  GAT  GCC  TGG  GGC  CAA  GGA  CTC  CTG  GTC  ACC  GTC  TCC  TCA 
b 
1st  segment 
WSQAALGCPAS 
TAT  GCT  GAC  TTC  CAT  CTC  TGG  AGC  CAG  GCT  GCC  CTG  GGC  TGC  CCT  GCC  TCA 
WSQAALGTVSS 
AT  GCA  GAC  TTC  CAT  CTC  TGG  AGC  CAG  GCT  GCC  CTG  GGC  ACC  GTC  TCC  TCA 
2nd  segment 
WGQRTPVIVSL 
TGC  TGG  GAC  TTG  GAT  CTC  TGG  GGC  CAG  CGC  ACC  CCG  GTC  ATC  GTG  TCC  TTG 
3rd  segment 
WGQRTPISASS 
GCT  TTT  GAC  TCC  TGG  GGC  CAG  CGC  ACC  CCC  ATC  TCC  GCC  TCC  TCA 
4th  segment 
WGPG  I/T  QNTVSS 
CTA  TTC  GAC  AAC  TGG  GGC  CCA  GGA  A  (T/C)C  CAA  AAC  ACC  GTC  TCC  TCA 
5th  segment 
LGSGSLGTVCS 
CAA  CTG  GCT  CAA  GCA  CTG  GGG  TCA  GGA  AGC  CTG  GGC  ACT  GTC  TGC  TCA 
6th  segment 
WGRGLRVTVSS 
TAC  TAT  GGT  ATA  GAC  GCC  TGG  GGC  CGA  GGG  CTC  AGG  GTC  ACC  GTC  TCC  TCA 
Figure  2.10  Comparison  between  the  dominant  sequence  of  bovine  Ig  framework  four  and  the 
coding  sequences  of  genomic  JH  segments. 
(a)  Aligned  sequences  of  framework  four  from  bovine  Ig  cDNA  showing  the  boundary  between 
CDR3  and  FR4  as  denoted  by  the  conserved  W  codon  at  position  103  (top  of  figure).  A  prototypical 
sequence  for  this  region  and  its  translated  sequence  is  shown  at  the  bottom  of  the  figure.  Above,  the 
figure  shows  nucleotide  variations  to  this  sequence.  Data  prepared  from  Berens  et  al.,  1997. 
(b)  The  nucleotide  and  predicted  translated  sequences  of  the  six  segments  identified  at  the  JH  locus. 
Differences  between  each  segments  and  the  dominant  expressed  sequence  at  the  nucleotide  and 
protein  level  are  indicated  with  red  letters.  Two  different  sequences  are  presented  for  the  first  JH 
segment.  These  are  variants  recovered  from  the  genomic  DNA  of  different  individuals. WR3  -1  F-FR4 
a 
b 
C 
103 
WGRGLRVTVSS 
TAC  TAT  GGT  ATA  GAC  GCC  TGG  GGC  CGA  GGG  CTC  AGG  GTC  ACC  GTC  TCC  TCA 
WGRGLRVTVSS 
GGT  ATA  GAC  GCC  TGG  GGC  CGA  GGG  CTC  AGG  GTC  ACC  GTC  TCC  TCA 
GGT  ATA  GAC  GCC  TGG  GGC  CGA  GGG  CTC  AGG  GTC  ACC  GTC  TCC  TCA 
XGQGLLVTVSS 
TAC  GTC  GAT  GCC  TGG  GGC  CAA  GGA  CTC  CTG  GTC  ACC  GTC  TCC  TAC 
Figure  2.11  Comparison  between  the  less  commonly  expressed  framework  four 
sequence  and  the  sixth  JH  segment. 
(a)  The  predicted  coding  sequence  of  the  sixth  JH  segment  showing  the  boundary 
between  CDR3  and  FR4  as  denoted  by  the  conserved  W  codon  at  position  103  (top  of 
figure).  (b)  The  nucleotide  and  protein  sequences  of  the  less  commonly  expressed 
bovine  FR4  region.  (c)  The  nucleotide  and  protein  sequences  of  the  dominant  FR4 
region.  Data  in  (b)  and  (c)  prepared  from  Berens  et  al.,  1997.  Note  the  R  codons  in  (a) 
and  (b)  and  the  identical  sequences  upstream  of  the  W  codon. Figure  2.12  Alignment  of  the  bovine  and  ovine  JH  loci.  The  ovine  JH  sequence  was  assembled  from 
NCBI  (accession  number  Z71572  bases  1-2630;  accession  number  Z98207  bases  2631-2764).  The  bovine 
JH  sequence  is  numbered  from  the  DQ52  segment  (see  Fig.  2.14).  Overall  homology  between  the  two 
sequence  is  89%.  The  location  of  six  JH  segments  (blue),  and  the  immunoglobulin  heavy  chain  5'  intronic 
enhancer  (purple)  is  indicated,  with  RSS  motifs  (red).  In  view  of  the  high  level  of  identity,  nucleotide 
differences  are  highlighted  in  the  alignment  with  vertical  lines.  Where  gaps  have  been  introduced  to 
improve  the  alignment,  this  is  indicated  with  dots. 
Ovine:  1  TCGAGGGTGG  GGGGCAAGCG  TCTTCAGGAA  GACAGACTTA  CAGCTCCCGG  GGGCTTCCTG 
III  III  111111  IIIII 
Bovine:  407  TGTCGGTTGG  GGGGCAAGTG  TCTTCAGGAA  GACAGACTTG  CAGC...... 
.....  TCCTG 
Ovine:  61  GGGGCTTCCT  GGGGACCCTG  AGTGGGTTTC  CATGCCCCCC  AGCACAGGGC  CAGCCCACTG 
Bovine:  456  GGGGCTCCCT  GGGGACCCTG  GGTGGGTTTC 
II 
CGTGCCTCCC  AGCACAGGGC  CAGCCCACTG 
Ovine:  121  TGACTATGCT  GACTTCCATC  TCTGGGACCA  GGGTGCCCTG  GTCACCGTCT  CCTCAGGAGA  lot  JB 
I  II  I  I  II  IIII  1  segment 
Bovine:  516  TGACTATGCA  GACTTCCATC  TCTGGAGCCA  GGCTGCCCTG  GGCTGCCCTG  CCTCAGGTGA 
Ovine:  181  ATCTCGTGTC  CAGTGACCAA  ATCAGGGGAC  AATGGGACTT  GGGTGGACTG  GGGATGGGAG 
Bovine:  576  ATCTGGTGTC  TAGTGTCCAA  GTCAGGGGAC 
III 
AGCAGGACTT 
I 
GGGTGGACTT  GGGATGGGAG 
Ovine:  241  TCAGGGCCAG  CAAGGAGGCA  GTGTGTGTTT  TTGTAGAAAA 
I 
GAAGCAGCAG  AATAGAAGCT 
Bovine:  636  TCAGGGCCAG  CAAGGAGGTA  GGGTGTGTTT  TTGTGGAAAA 
II  I 
GAATTAACAG 
II 
AAGAGAAGCC 
Ovine:  301  ACGCTGCTGG  GACTCGGGTC  TCTGGGGCCA  GCGCACCCCG  GTCACCGTGT  CCTTGGGCAG  2nd  JH 
I  segment 
Bovine:  696  ATGCTGCTGG  GACTTGGATC  TCTGGGGCCA  GCGCACCCCG  GTCACCGTGT  CCTTGGGGAG 
Ovine:  361  TGTCTCCCTT  GCAGTGCTGC 
II 
CTGGGCCTCG  GGCAGTTCCC  TGGG.  TCTGTG  CAG.  000ACCA 
Bovine:  756  TGTCTCCCTT  GCAGCACTGC  CTGGGCCTCG 
II 
GGCAGTTCCC  TGGGGTCCGTG 
I1 
CAGCCCCACCG 
Ovine:  421  TGCCCGGAGC  AAGGCAGGGT  CCTGGTCTAG  TGGGGTCCTG 
I  II 
CCCTTGGATC  TGCCAGAGCC 
Bovine:  818  TGCCCTGAGC  AAGGCAGGGT  CCTGGTCCAA  CGGGGTCGCG  CCCTTGGATC 
I 
TGCCGGAGCC 
Ovine:  481  CCTGGAGGTG  AGGCAGCTGA. 
I 
GCCTGAGAGG  AGGACAGGAG  CTG.  CTGGGTG  GGAGGAAACG 
Bovine:  878  CCTGGAGATA  AGCCAGCTGAG  GCCTGAGGGG  AGGACAGGAG  CTGACTGGGCG  GGAGGAAAGG 
Ovine:  541  TGG.  CAGAGCC  CGACGGGTCA  GGGTCTGTGT 
I 
GGTGAGGGCA 
I 
GGGGAGGCCC  CTGGGCCTGA 
Bovine:  940  TGGGCAGAGC.  TGACGGGGCA  GGGTCTGTGC  AGTGAGGGCA  GGGGAGGCCC  CCGGGACTGG 
Ovine:  601  CCTCCCAAGG  GTTCATGTCT  TGGGGACAGC  CGGGACGGCG  TCCTTCATCA  TTGCTTTTGA 
Bovine:  1000  CCTCCCCAGG  GTTCATGTCT  TGGGGGCAGC  CGGGACTGCG  TCCCTCAGCA  ATGCTTTTGA 
Ovine:  661  CTCCTGGGGC  CAGCGCGCCC  CGGTCACAGT  CTCCTCAGGT  GAGACGGCCC  TCTGCCCGCT  3rd  JH 
1  II  11I  I  segment 
Bovine:  1060  CTCCTGGGGC  CAGCGCACCC  CCATCTCCGC  CTCCTCAGGT  GAGACGGCTC  TCTGCCCGCT 
Ovine:  721  CGGTCCTGGG  CTGGGAAAGA  AGTCTCCAGA  GGCCCCTCGG  TCTGTGGCAG  ACCCTCTGTG 
Bovine:  1120 
I 
CCGTCCTGGG 
I 
CCGGGGAAGG  CGTCTCCAGG  GGCCCCTTGG  TCTGGGGCAG  ACCCTCCGTG 
Ovine:  781  GCCCCTGGGG 
I 
GATCTGCCTC  TGAGGCCGTT  TGCCTCTCTG  CCCTGTTGAG  GTGGTGCCTC 
Bovine:  1180  GTCCCTGGGG 
1 
GATCTGCGTC  TGAGGCCGTT  TGCCTCTCTG  CCCTGTTGAG 
I 
GTGGCGCCTC 
Ovine:  841  TGCCTGTGGA  ATGTGGCCAG  GCAGAGTGGG  CTCTGTGGAC  CTGGGGGCCT  GGCTTTGCAT 
Bovine:  1240  TGCCTGTGGA 
II 
ACGCGGCCAG  GCAGAGTGGG 
II 
CTCTGTG..  C  CTGGGGGCCT 
II 
GGCTTTGTGT Fig.  2.12  (continued) 
Ovine:  901  GGGAGCAGAG  GCCGCCAAGC  CTTGGGTTTT  TGCACAGC.  CC  TAACGGGGCC  CATGGCACTG 
Bovine:  1298  GGGGGCAGAG  GACGCCAGGC  CTTGGGGTTT  TGCACAGCCCC  TAGCGGGGCC  CATGGCACTG 
Ovine:  961  TGACTATATC  GACTACTGGG  GCCCAGGACT  CCTGGTCACC  GTCTCCTCAG  GTGAGCCCTC 
1  IIII  I 
Bovine:  1359  TGACTAT.  TC  GACAACTGGG  GCCCAGGAAT  CCAAAACACC  GTCTCCTCAG  GTGAGTCCTC 
Ovine:  1021  ACCAGCCTTC  TCTCCTCACT  CT..  CTCTGAGT  TTTGGTGCAC  TTTGGGGGAA  ATCGAGGGTG 
II  II  III 
Bovine:  1418  AACAGCCCTC  TCTCCTCACT  CTGTCTCAGGGT  TTTGGTGCAC  TTTGGGGAAA  ATCG'AGGGTG 
Ovine:  1081  TCGGGTCTAG  AGGGCCTGGG  ACGGCCAGGG  GTCTGAGACG  GGGAAGGCCC  AGGGC,  CCCAG 
iiiIIiii 
Bovine:  1480  TCGGGTCTAG  AGGGCCTGGG  GCGG.  CTGGG  ATCTGAGACA  CGGAGGACCC  AGGGGCCCAG 
Ovine:  1141  GCTTACAGCA  GCAAGGAGCA  GAGGCTCCAG  GCACCCTCTC  CTCCTGGGCT  CTGTAGCCAG 
Bovine:  1539  GCTTACAGCA  GCGAGGAGCA  GAGGCTCCAG  GCACCCTCTC  CTCCTGGGCT  CTGTAGCCAG 
Ovine:  1201  GGCCTTCTCT  GAGGGCCTCA  GCCACCCTTG  GGCTCTGGAC  TCCCAAGGTC  CCAGCTGTGC 
III 
Bovine:  1599  GGCTTTCTCT  GGGGGCCTCA  GCCACCCTTG  GGCTCTGGAC  TCCCAAGGTC  CCAGCTG... 
Ovine:  1261  TGGCCTCGTG  AGGCCACATG  TGAGGTAGTC  CGGAGGCCTC  AGCCGGCCAC  GAGCTCGTGC 
1111111111  11111111 
Bovine:  1656 
..........  ........  TG  TGAGGTGGTC  CGGAGGCCTC  AGCCGGCCAC  GAGCTCTTGC 
Ovine:  1321  TTGGGGTCCC  AGCATCACTG  TCACAGTGTA  ACGACTGGCT  CAAGCACTGG  GGCCAGGGAC 
I 
Bovine:  1698  CTGGGGTCAC  AGCATGITTG  TCACTGTGTA  ACAACTGGCT  CAAGCACTGG  GGTCAGGAAG 
Ovine:  1381  CCCGA.  CGCTG  TCTGCTCAGC  TGAGCCCTCC  CCACCCCACT  TCACTGCACC  TGGGGAGGCC 
Bovine:  1758  CCTGGGCACTG  TCTGCTCAGC  TGAGCCCTCA  CCACCCCACT  CCACTGCACC  TGGGGAGACC 
Ovine:  1441  TGGGGTGTCA  GAGATCCAGG  GGCATTCTGG  AGGTCAAGAA  AGGGAGCTGG  GGAGAGGGT 
Bovine:  1819  TGGAGCGTCA  GAGATCCAGA  GGCATTCTGG  AGGTCAAGAA  AGGGAGCTGG  GGAGAGGGT 
Ovine:  1500 
..........  ...........  .......  C 
1111111111  1111111111  1111111 
Bovine:  1878  TCTGGTAAAC  AGGCAGAGCC  AGACCTCC 
Ovine:  1501  CCGCCCCAAG  GACACTGCAA  TGTGGGTATG  AGGCGGCTCC  TCTGGCGGGT  CTGGCTGTCT 
II  I  II  II  I1 
Bovine:  1906  CTGCCCCAAG  GACACCACGA  TGTGGGTACA  AGGCGGCTCC  TTCGGTGGGT  CTGGCTGCCT 
Ovine:  1561  GACTTGAGCA  GGACCGGGGG  CTTCCGTCGC  TGTCTGGGGC  AGGTGGCTGC  TCAAGGCTGG 
II 
Bovine:  1966  CACTTGAGCA  GGACCAGGGG  CTTCCGTCAC  TTTCTGGGGC  AGGCAGCTGC  TCGAGGCTGG 
Ovine:  1621  ACTTAGGTGT  CTGTGGGTCA  CGGTCAGCTG  GTCCAGGCAG  GCACTGGTCT  GGCCTCTGGG 
IIII  II  IIII 
Bovine:  2026  ACTTAGGAGT  CTGTGGTTCA  TGGTCCGCCA  GCCCAGCCAG  GCAGTGGTCT  GGCCTCTGTG 
Ovine:  1681  GGCCAAAATG  GGACATAGTG  TCTCTGGCAC  AGTCAGGTGG  GGCGGGGCCG  GCAGAGGGCC 
Bovine:  2086  GGCCAGAATG  GG11CATAGTG  TCTCTGGCAC  AGTCAGGTGG  GGTGGGGCCA  GCAGAGGGTC 
Ovine:  1741  ACAGGCAAGC  GACTTTGACC  AGCGGCTTCC  CTGTGGTGCC  TGGAGATGGG  GTGGGGGCCC 
II  II  II 
Bovine:  2146  ACTGACAAGC  GACTTTGACC  AATGGTTTCC  CTGTGGCGCC  TGG1GATGGG  GTGGGGGCCC 
4th  JH 
segment 
5th  JH 
segment 
Ovine:  1801  AGGTGCCTCG  AGCCTTGCCA  GGCTCCCGAC  GTTTTTGTTG  GGCGAGGCTG  GAGATAATCG 
Bovine:  2206  AGGCGCCTCG  AGCCTCGTC  GGCTCCCGAG  GTTTTTCTTG  GGCGAGGCTG  GAGATA.  TCA Fig.  2.12  (continued) 
Ovine:  1861  CCACTGTGAT  TACTACGGTG  TAGATGTCTG  GGGCCGAGGA  CTCCTGGTCA  CCGTCTCCTC  6th  JH 
IIIII1  II  segment 
Bovine:  2265  CCACTGTGTT  TACTATGGTA  TAGACGCCTG  GGGCCGAGGG  CTCAGGGTCA  CCGTCTCCTC 
Ovine:  1921  AGGTAAGAGC  GGCC.  ATACAG  AGCCTTTGCT  TTCTCTCCTA  TTCGTGGGAT  TTTTCTGAGC 
Bovine:  2325  AGGTAAGAGC  AGCCCATCCAG  GGCCTTTGCT  TTATCTCAT.  TTCGTGCGAT  TTTTCTGAGC 
Ovine:  1981  ATCACTG....  GTC  CTCTGATGTG  TCCTTGTCCC  CTCCTCCCCG  GGGGGACTGG  GCAGACTGGC 
IIII  I 
Bovine:  2385  ATCACTGTCTGGTC  CTCTGATGTG  TCCTTGTCCC  CTCCTCCCCG  GGGGAACTGG  GCAGACTGGC 
Ovine:  2041  CAGGAGGG.  AC  CAGCTGCCCT  ATGCATTTCA  GAGTCTCT.  AT  CTTCTGATAG  CTTTAAAAAA 
IIII  11 
Bovine:  2449  CAGGAGGGGAC  CAGCTGCCCT  ATGCATTTCA  GAGTCTCTTAT  TTTCCGATGC  CTTTAAAAAA 
Ovine:  2101  CCAGAATCTT  GCTGGCATTC  AGAGGGGGCT  TGGGCAGGAA  GGGCCACCAG  TGGGGGAGTC 
Bovine:  2511  TCAGAATCTT  GCTGGCATTC  AGAAGGGGCT  TGGGCGGGAA  T(Y,  CCACCAG  TGGGGGAGTC 
Ovine:  2161  CCAGGCCTCC  CTTGGCAGCA  G......... 
..........  ...  GGCAACTTG  CTGTGGTCCT 
IIIIIIIII  IIIIIIIIII  III  II 
Bovine:  2571  CCAGGCCCCT  CTTGGCAGCA  GGGCAGCTTG  GGATGCGGTG  GAAGGCAACTTG  CTGCAGTCCT 
Ovine:  2201  AGCATCTGCG  GAGGAGCGTG  TCTGGATAAC  TTAGGGCCTC  AGGAGCGCCG  CCCGCAGTGG 
III  II  I 
Bovine:  2633  AGCATCTGCG  GAGGAGCGTG  TCTGGATAA.  TTAGGGCCTC  AGGAACGCTG  CCCGTGGCGG 
Ovine:  2261  G.  GCHGNGAAG  GCCCTCCTCG  GGTGAGGTTG  GCTCTGCACT  AGACTGTGTT  TAAAATTCTT 
IIII  11  I 
Bovine:  2692  GCGCAGAGiAC  GCCCCCCTCG  CGTGAGGTGT  GTTCTGCACT  AGACTGTGTT  TAAAATTCTT 
Ovine:  2321  TATTGGGCAG  GAAGAGAATT  GTCTAGGTGA  GGAC.  GACACG  CAGTGTCCCG  ACCGCGGCAA 
Bovine:  2753  TATTGGGTAG  GAAGAGAATT  GTCTAGGTGA  GGACGGACATG  CAGTGTCCCG  ATCGTGGCGA 
Ovine:  2381  Gl.  GAGGGGAG  GCTGGGGAGG  TGACGGGCGC  TGGGCTTTGT  GAGGCCACTG  TAAGAGAAAG 
I  11 
Bovine:  2814  GAGAGGGGAG  CCCGGGGAGG  TGACGGGCGC  TGGGCTTTGT  GAGGCCAGTC  TAAGAGA..  G 
Ovine:  2441  AAAAGCTGTT  CGCCAGAGGA  GGTGTGCTTG  CGAATACCAA  GACAGGGCAT  CTTCAAAGCG  Enhancer 
III 
Bovine:  2872  AAAGGCCGTT  CGCCAG?  GGA  GGTGTGCTTG  CGAACACCAA  GACAGGGCAT  CTCTGAAGCG 
Ovine:  2501  A:  TCCTGATA  GTCTG(GAAAA  TTGAAACTTT  AAAAAGAGAG  ATGTTTAAAG  TATTTTAAAT 
II  II  I 
Bovine:  2932  ATTCCTGATA  GTCTGAAAAA  TTGAAACTTT  AAAAA..  GAA  ATGTTTAAAG  TATTTTAAAT 
Ovine:  2561  TTTTATCATT  TAATTAACAA  CTGCGAATCA  TGGCTTTGGA  GAGTTGAGTA  AG.....  AGTTTGGC 
II  11111 
Bovine:  2990  TTTTATCATT  TAATTAACAA  CCGCAAATCG  TGGCTTTGGA  GAGTTGAGAC  AGGTACAAGTTTGGC 
Ovine:  2621  TGAAAAGTAC  TAACTAGGTT  CCATCGGCCC  TCGGCCCCAA  TTCAGGGCTG  TTTTGAGAAT 
Bovine:  3055  CGAAAAGTAC  TAACTAGGTT  CCATCGGCCC  TCGGCCCCAA  TTCAGGGCTG  TTTTGAGAAT 
Ovine:  2681  AATAAATTCA  GCTTATTTTT  TTAATGTAAT  TGGTGGTGCC  GAGTTAGTCA  AGATGGCCAC 
Bovine:  3115  AATAAATTCA  GCTTATTTTT  TTAATGTAAT  TGGTGGTGCC  CAGTTAGTCA  AGATGGCCAC 
Ovine:  2741  GGGCCAGACT  GACCACCTGC  AGCA  2764 
II 
Bonne:  3175  GGGCAGGACT  GACCACCTGC  AGCA  3198 ovine  and  bovine  sequences  from  the  first  base  of  ovine  JH  locus  (Dufour  and  Nau,  1997; 
accession  number  Z71572)  to  the  296th  nucleotide  of  immunoglobulin  heavy  chain 
enhancer  (accession  number  Z98207),  89%  homology  can  be  calculated.  Close  scrutiny 
failed  to  reveal  the  presence  of  further  JH  segments. 
23.4  Analysis  the  sequence  of  clone  C15-10 
Recovery  and  cloning  of  the  RR-JH8R  amplicon  from  lambda  clone  15  extended 
analysis  of  the  bovine  JH  locus  about  500  bp  upstream  of  the  first  JH  segment. 
Examination  of  the  upstream  flank  identified  the  bovine  DQ52  gene  410  bp  upstream 
from  the  first  JH  segment  (Figures  2.13  and  2.14).  As  shown  in  Figure  2.13,  the  coding 
region  consists  of  14  nucleotides,  somewhat  longer  than  in  other  species  (11  nucleotides 
in  human,  mouse,  rat  and  rabbit  and  10  in  Suncus  murinus  (Chen  et  al.,  1996)).  The 
coding  region  is  flanked  by  RSS  comprising  nonamer  and  heptamer  sequences  with  12 
nucleotide  spacers,  in  accordance  with  the  23/12  rule.  The  JH-distal  RSS  is  probably 
functional  given  its  similarity  to  consensus  sequences.  However,  the  heptamer  present  in 
the  JH-proximal  RSS  departs  significantly  from  consensus  (Figure  2.13)  and  it  is 
therefore  unlikely  that  rearrangement  between  the  bovine  DQ52  segment  and  JH 
segment(s)  takes  place  in  vivo. 
2.3.5  Consensus  sequence  of  the  bovine  Jai  locus 
By  assembling  sequence  from  the  clones  characterised,  a  consensus  for  the  bovine  JH 
locus  can  be  derived  (Figure  2.14).  This  is  based  upon  28  sequencing  reactions  with 
different  primers  on  five  different  individual  genomic  DNA  clones  (Appendix  1). 
Restriction  sites  for  the  locus  were  mapped  onto  the  sequence  using  DNAStar  software 
(Fig  2.15).  The  locus  consists  of  a  DQ52  segment  positioned  a  short  distance  upstream 
from  the  main  cluster  of  JH  segments,  as  is  typical  for  mammals.  There  are  6  JH 
segments  and  a  heavy  chain  enhancer  all  of  which  bear  close  similarity  to  equivalent 
sequences  from  the  sheep.  In  contrast  to  the  sheep,  it  is  not  immediately  apparent  from 
the  data  which  JH  segment  is  responsible  for  the  highly  conserved  FR4  sequence  found 
in  the  large  majority  of  bovine  heavy  chain  cDNAs. 
42 H 
w 
O 
A 
M 
N 
m 
U 
ro 
a N 
m 
u 
41  ý 
a 
aý 
tli 
e 
O' 
. a. tr 
a, N 
O 
O 
u 
w 
a 
v x 
U, 
m 
U 
Id a 
to 
U) 
N 
m 
a 
0 a 
O  1  1  1  I  E1 
U  Ü  i  i1  i  1 
1  1  1  1  11 
1  1  1  C9  11 
1  1  E1  1  11 
A,  1  1  E  1  1 
4  04  111  ÜaýH 
0IH  "µ' 
11  ro  E- 
H0UUIV 
a111I1i 
i  i  i  c  i  i 
U 
UU 
(9  U' 
0"ßa 
E4  E-  a 
1I1H 
HIIIIII 
Hä 
V  I  H  1  A  1  1 
CU's 
U 
1 1 
U 
1 
I 
Ü 
1 
I 
0 
1 
I 
I 
U 
0 
11 
1 
I 
1 
I 
1 
1 
1 
I 
I 
1 
1 
1 
1 
1 
I 
1 
1 
1 
0 
N  1 
ý 
1 
1 
1 
1 
I 
1 
1 
C)  1  1  1  1  1  1 
I  I  I  I  I  I  N 
H  1  1  1  1  1  1 
El 
Cý  ý7  U'  U'  C  9  U' 
1 
N 
in  Z 
a A 
,)  in  m 
Ä  ro 
0  +ý 
41 
41  x  ä 
ä  N  ä  ü 
4  °' 
2E" 
-ö 
c 
-o 
c 
.NU2 
9)  0x3N 
+'  bN 
NU  'b 
ry 
yC 
C) 
W 
cn 
N 
UcN 
7N 
CN  bQ 
OÜ 
W 
aO'  O 
b0 
N~  %' 
üN0= 
fy  U0  y 
L 
il  yL 
. 
_L 
O  fC  fd 
.c  Y 
CN  Ck> 
.ý  cd 
g 
w 
y^  ice, 
0 
O 
OOA  Cü 
tr.  C) 
C,  bQ  Yý+ 
Nl 
N0>W 
V1  #..  00 
C) 
CY  ID 
dW  O 
U  ICJ 
6)  N  ý+ 
0OM  O' 
ON0 
NN 
CNC 
r-  0  Mw.  -  le 
öý 
OýU 
tV 
0y 
-5  Z Figure  2.14  Complete  sequence  of  the  bovine  JH locus.  The  sequence  consists  of  3282 
nucleotides  and  contains  a  DQ52  segment  (green),  six  JH  segments  (blue)  with 
RSS  motifs  (red)  and  part  of  the  heavy  chain  enhancer  (purple).  These  features  are 
indicated  on  the  right  of  the  figure  and  are  highlighted  in  different  colors. 
Numbering  begins  from  the  first  nucleotide  of  the  5'  nonomer  of  the  DQ52  RSS. 
AATT  CCCCGGATCT  GTGGGCAGGG 
TTCCCAAGGG  GGTCGGTGGC  CGACCCCCCT  GGCCCTTGCT  CGCCTGCGGC  CAGCCCTAAG 
1 
;  _=17( 
7  ;.;  =.  3(.  'A"Aý;  AGA 
_,  ,A  AA:  ".  "  DQ52 
61  '  --AAAAA  CCTGAGCAAA  GTGGCCCCAG  GGAAGCCGGG  GGGGGTCTCA  CTTTGAGGGT 
121  TCCCTGTCAG  CGCACACGGG  GTCAGGTCAG  CCAGGAGCCT  GAAGGCACTG  GAAAAGAGCC 
181  ACCTGGGCTG  ACGGTGAAGG  GGCCTCCCAG  GCGGGCACGG  AGCCAGGCCC  AGCCCAGGCA 
241  AGGGGCCAGG  TCCCCAAGGC  CTGGGGTGCA  GGGAGTCCAG  GGAATTGGGG  GTTGAGGTGG 
301  AAAGCCTCGG  GAGGGGCAGG  GAGCATGTGA  CCTCATGGGA  ACAAAGCAGA  TCAGGAGACA 
361  GCAGACACTC  AAATCCCAGA  CCAGGGGCCT  GAGGCAGACA  GGTGCTTGTC  GGTTGGGGGG 
421  CAAGTGTCTT  CAGGAAGACA  GACTTGCAGC  TCCTGGGGGC  TCCCTGGGGA  CCCTGGGTGG 
481  GTTTCCGTGC  CTCCCAGCAC  AGGGCCAGCC  CACTGTGACT  ATGCAGACTT  CCATCTCTGG  lot 
segment 
541  AGCCAGGCTG  CCCTGGGCTG  CCCTGCCTCA  GGTGAATCTG  GTGTCTAGTG  TCCAAGTCAG 
601  GGGACAGCAG  GACTTGGGTG  GACTTGGGAT  GGGAGTCAGG  GCCAGCAAGG  AGGTAGGGTG 
661  TGTTTTTGTG  GAAAAGAATT  AACAGAAC,  AG  AAGCCATGCT  GCTGGGACTT  GGATCTCTGG  2nd 
segment 
721  GGCCAGCGCA  CCCCGGTCAC  CGTGTCCTTG  GGGAGTGTCT  CCCTTGCAGC  ACTGCCTGGG 
781  CCTCGGGCAG  TTCCCTGGGG  TCCGTCCAGC  CCCACCGTGC  CCTGAGCAAG  GCAGGGTCCT 
841  GGTCCAACGG  GGTCGCGCCC  TTGGATCTGC  CGGAGCCCCT  GGAGATAAGC  CAGCTGAGGC 
901  CTGAGGGGAG  GACAGGAGCT  GACTGGGCGG  GAGGAAAGGT  GGGCAGAGCT  GACCGGGGCAG 
961  GGTCTGTGCA  GTGAGGGCAG  GGGAGGCCCC  CGGGACTGGC  CTCCCCAGGG  TTCATGTCTT 
1021  GGGGGCAGCC  GGGACTGCGT  CCCTCAGCAA  TGCTTTTGAC  TCCTGGGGCC  AGCGCACCCC  3rd 
segment 
1081  CATCTCCGCC  TCCTCAGGTG  AGACGGCTCT  CTGCCCGCTC  CGTCCTGGGC  CGGGGAAGGC 
1141  GTCTCCAGGG  GCCCCTTGGT  CTGGGGCAGA  CCCTCCGTGG  TCCCTGGGGG  ATCTGCGTCT 
1201  GAGGCCGTTT  GCCTCTCTGC  CCTGTTGAGG  TGGCGCCTCT  GCCTGTGGAA  CGCGGCCAGG 
1261  CAGAGTGGGC  TCTGTGCCTG  GGGGCCTGGC  TTTGTGTGGG  GGCAGAGGAC  GCCAGGCCTT 
1321  GGGGTTTTGC  ACAGCCCCTA  GCGGGGCCCA  TGGCACTGTG  ACTATTCGAC  AACTGGGGCC  4th 
segment 
1381  CAGGAATCCA  AAACACCGTC  TCCTCAGGTG  AGTCCTCAAC  AGCCCTCTCT  CCTCACTCTG 
1441  TCTCAGGGTT  TTGGTGCACT  TTGGGGAAAA  TCGAGGGTGT  CGGGTCTAGA  GGGCCTGGGG 
1501  CGGCTGGGAT  CTGAGACACG  GAGGACCCAG  GGGCCCAGGC  TTACAGCAGC  GAGGAGCAGA 
1561  GGCTCCAGGC  ACCCTCTCCT  CCTGGGCTCT  GTAGCCAGGG  CTTTCTCTGG  GGGCCTCAGC 
1621  CACCCTTGGG  CTCTGGACTC  CCAAGGTCCC  AGCTGTGTGA  GGTGGTCCGG  AGGCCTCAGC 
1681  CGGCCACGAG  CTCTTGCCTG  GGGTCACAGC  ATCATTGTCA  CTGTGTAACA  ACTGGCTCAA  5th 
segment 
1741  GCACTGGGGT  CAGGAAGCCT  GGGCACTGTC  TGCTCAGCTG  AGCCCTCACC  ACCCCACTCC 
1801  ACTGCACCTG  GGGAGACCTG  GAGCGTCAGA  GATCCAGAGG  CATTCTGGAG  GTCAAGAAAG 
1861  GGAGCTGGGG  AGAGGGTTCT  GGTAAACAGG  CAGAGCCAGA  CCTCCCTGCC  CCAAGGACAC 
1921  CACGATGTGG  GTACAAGGCG  GCTCCTTCGG  TGGGTCTGGC  TGCCTCACTT  GAGCAGGACC 
1981  AGGGGCTTCC  GTCACTTTCT  GGGGCAGGCA  GCTGCTCGAG  GCTGG\CTTA  GGAGTCTGTG 
2041  GTTCATGGTC  CGCCAGCCCA  GCCAGGCAGT  GGTCTGGCCT  CTGTGGGCCA  GAATGGGACA Fig.  2.14  (Continued) 
2101  TAGTGTCTCT  GGCACAGTCA  GGTGGGGTGG  GGCCAGCAGA  GGGTCACTGA  CAAGCGACTT 
2161  TGACCAATGG  1TT000TGTG  GCGCCTGGAG  ATGGGGTGGG  GGCCCAGGCG  CCTCGAGCCT 
2221  CGTCAGGCTC  CCGAGGTTTT  TGTTGGGCGA  GGCTGGAGAT  ATCACCACTG  TGTTTACTAT 
2281  GGTATAGACG  CCTGGGGCCG  AGGGCTCAGG  GTCACCGTCT  CCTCAGGTAA  GAGCAGCCCA 
2341  TCCAGGGCCT  TTGCTTTATC  TCATTTCGTG  CGATTTTTCT  GAGCATCACT  GTCTGGTCCT 
2401  CTGATGTGTC  CTTGTCCCCT  CCTCCCCGGG  GGAACTGGGC  AGACTGGCCA  GGAGGGGACC 
2461  AGCTGCCCTA  TGCATTTCAG  AGTCTCTTAT  TTTCCGATGC  CTTTAAAAAA  TCAGAATCTT 
2521  GCTGGCATTC  AGAAGGGGCT  TGGGCGGGAA  TGGCCACCAG  TGGGGGAGTC  CCAGGCCCCT 
2581  CTTGGCAGCA  GGGCAGCTTG  GGATGCGGTG  GAAGGCAACT  TGCTGCAGTC  CTAGCATCTG 
2641  CGGAGGAGCG  TGTCTGGATA  ATTAGGGCCT  CAGGAACGCT  GCCCGTGGCG  GG:  GCAGAGA 
2701  ACGCCCTCCT  CGCGTGAGGT  GTGTTCTGCA  CTAGACTGTG  TTTAAAATTC  TTTATTGGGT 
2761  AGGAAGAGAA  TTGTCTAGGT  GAGGACGGAC  ATGCAGTGTC  CCGATCGTGG  CGAGAGAGGG 
2821  GAGCCCGGGG  AGGTGACGGG  CGCTGGGCTT  TGTGAGGCCA  GTCTAAGAGA  GAAAGGCCGT 
2881  TCGCCAGAGG  AGGTGTGCTT  GCGAACACCA  AGACAGGGCA  TC  TC  TGAAGC  GATTCCTGAT 
2941  AGTCTGAAAA  ATTGAAACTT  TAAAAAGAAA  TGTTTAAAGT  ATTTTAAATT  TTTATCATTT 
3001  AATTAACAAC  CGCAAATCGT  GGCTTTGGAG  AGTTGAGAC  AGGTACAAGTT  TGGCCGAAAA 
3061  GTACTAACTA  GGTTCCATCG  GCCCTCGGCC  CCAATTCAG  GGCTGTTTTGA  GAATAATAAA 
3121  TTCAGCTTAT  TTTTTTAATG  TAATTGGTGG  TGCCGAGTT  AGTCAAGATGG  CCACGGGCAG 
3181  GACTGACCAC  CTGCAGCA  3198 
6th 
segment 
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Alo  I  Bpi  I  Csp  I  Iliac  II  Psi  I  StylT  III 
Ama  I  BsaA  I  Csp45  I  hind  III  Rhc  I  StySK  I 
Aos  I  BsaF  I  Eco  VIII  Hpa  I  Rrh4273  I  StySP.  I 
Ape  I  BsaK  I  DsaV  I  Kpu  1  Rsr  II  StySQ  I 
Apu  161  Bsb  I  EciA  I  A1xa879  I  Sac  II  Swa  I 
Asc  I  BscE  I  Eco47  III  Mae  II  Sall  Tail 
Ase  I  BsiW  I  Eco52  I  Mile  I  SAP  I  Taq  II 
Asp52  I  BsmG  I  Eco72  I  1111u  I  Sdi  I  Ttm  I 
Asp511  I  BsoD  I  Eco82  I  111iu113  I  SexA  I  Vsp  I 
AtuC  I  Bsp87I  EcoA  I  Mun  I  Sri  I  Xma  I 
Avr  II  BspD  I  EcoB  Ncr  I  Sgf  I 
Bae  I  Bspll  I  EcoD  II  Nde  I  SgrA  I 
Figure  2.15  Restriction  map  of  the  bovine  JH  locus.  The  sequence  analysed  comprises  that 
presented  in  Figure  2.14. 
Top:  A  selection  of  restriction  enzymes  in  common  use  that  cut  the  sequence.  Numbering  across 
the  top  is  as  used  in  Figure  2.14.  The  numbers  to  the  right  of  the  enzyme  names  show  the  number  of 
sites  present  in  the  sequence.  The  location  of  sites  is  indicated  with  vertical  lines. 
Bottom:  A  list  of  enzymes  taken  from  a  database  of  501  endonucleases  that  do  not  cut  the 
sequence. 
Analysis  was  performed  using  DNAStar  software. 
I 
200  4?  0  600  800  1000  1200  1400  1600  1800  2000  2200  2400  2600  2800  3000 2.3.6  Sequencing  of  rearranged  antibody  genes  in  B  cell  genomic  DNA 
Rearranged  genomic  DNA  prepared  from  B  cells  and  was  used  as  a  template  to 
amplify  the  sequence  spanning  the  VH  and  JH  segments  and  sequence  downstream  of  the 
JH  locus.  Four  amplicons  of  about  470,600,900  and  1500  bp  were  obtained  from  PCR. 
Sequencing  of  clones  carrying  inserts  of  470,600  and  900  bp  showed  that  they  were 
irrelevant  with  no  meaningful  matches  identified  by  BLAST  searches  of  the  GenBank 
database.  Sequencing  of  one  clone  designated  B12  carrying  a  1500  bp  insert  was  more 
informative. 
Initial  BLAST  searches  and  close  inspection  revealed  that  the  DNA  carried  bovine  Ig 
sequence.  At  one  -terminus  of  the  insert,  the  presence  of  the  VH  intron  confirmed  that  the 
amplicon  was  derived  from  genomic  DNA  (Figure  2.16). 
Taking  the  data  in  detail  from  the  downstream  terminus  (Figure  2.17),  the  rearranged 
sequences  are  near-identical  to  the  germline  downstream  of  the  sixth  JH  segment. 
Sequence  homologous  to  the  sixth  segment  is  present  but  there  are  significant  differences 
to  the  germline.  In  particular,  aG  to  C  substitution  alters  the  W  codon  which  is  one  of 
the  most  characteristic  features  of  JH  segments.  Upstream,  further  substitutions  to  the 
coding  sequence  are  apparent  but  the  RSS  remains  intact.  Since  the  rearranged  sequences 
were  recovered  from  peripheral  B  cells,  the  loss  of  this  match  with  JH6  could  be  due  to 
antigen-driven  processes  (e.  g.  somatic  hypermutation)  but  the  consistent  occurrence  of 
substitutions  in  the  sixth  JH  segment  suggests  an  alternative  explanation  -  that  these 
sequences  are  drawn  from  a  different  genomic  location  to  the  germline  locus  described 
earlier. 
Further  substitutions  to  the  germline  can  be  detected  between  the  fifth  and  sixth  JH 
segments.  These  are  mainly  single  nucleotide  substitutions  but  a  deletion  of  20  bases 
(2123-2149)  can  also  be  seen.  Sequence  could  not  be  recovered  for  the  majority  of  the 
fifth  segment  because  of  limits  on  the  length  of  sequencing  reads  with  the  M13  primers 
but  the  matches  with  flanking  regions  are  very  strong,  showing  that  this  segment  is 
present.  Immediately  upstream  of  the  fifth  segment,  another  interesting  feature  emerges: 
an  insertion  of  21  bp  to  the  germline  sequence  (between  1655-1656).  This  shows  some 
similarities  with  the  comparable  region  of  the  ovine  JH  locus,  including  some  internal 
complementarity.  It  is  unlikely  that  a  feature  of  this  size  was  introduce  by  somatic 
hypermutation. 
Intergenic  sequences  between  the  fourth  and  fifth  JH  segments  are  present  but  the 
frequency  of  substitutions  to  the  germline  seem  to  increase  closer  to  the  fourth  segment. 
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ou Figure  2.17  Alignment  of  the  ovine  and  bovine  JH  loci  with  rearranged  sequences  recovered  from  B  cell 
genomic  DNA. 
The  numbering  and  alignment  of  the  ovine  and  bovine  loci  (black)  is  taken  from  Figure  2.12,  with 
vertical  lines  indicating  nucleotide  differences,  dots  indicting  where  gaps  have  been  introduced.  The 
green  and  red  lettering  show  the  germline  sequence  from  the  B  cell  donor  and  the  rearrange 
sequence  recovered  from  purified  B  cells  respectively.  Dashes  show  identity  with  the  bovine 
germline  sequence.  Nucleotide  differences  to  the  bovine  and  ovine  consensus  are  shown. 
Designations  to  the  left  of  the  figure  identify  the  clone  which  was  sequenced  and  the  primer  used  for 
sequencing. 
Ovine:  541  TGG.  CAGAGCC  CGACGGGTCA  GGGTCTGTGT  GGTGAGGGCA  GGGGAGGCCC  CTGGGCCTGA 
Bovine:  940  TGGGCAGAGC.  TGACGGGGCA  GGGTCTGTGC  AGTGAGGGCA  GGGGAGGCCC  CCGGGACTGG 
BG1.  M13F  >  ---------  ----------  ----------  ----------  ---------- 
Ovine:  601  CCTCCCAAGG  GTTCATGTCT  TGGGGACAGC  CGGGACGGCG  TCCTTCATCA  TTGCTTTTGA 
Bovine:  1000  CCTCCCCAGG  GTTCATGTCT  TGGGGGCAGC  CGGGACTGCG  TCCCTCAGCA  ATGCTTTTGA 
BG1.  M13F  ----------  ----------  ----------  ----------  ----------  ---------- 
Ovine:  661  CTCCTGGGGC  CAGCGCGCCC  CGGTCACAGT  CTCCTCAGGT  GAGACGGCCC  TCTGCCCGCT 
II  I 
Bovine:  1060  CTCCTGGGGC  CAGCGCACCC  CCATCTCCGC  CTCCTCAGGT  GAGACGGCTC  TCTGCCCGCT 
BG1.  M13F  ----------  ----------  --------AT  ----------  ----------  ---------- 
Ovine:  721  CGGTCCTGGG  CTGGGAAAGA  AGTCTCCAGA  GGCCCCTCGG  TCTGTGGCAG  ACCCTCTGTG 
Bovine:  1120  CCGTCCTGGG  CCGGGGAAGG  CGTCTCCAGG  GGCCCCTTGG  TCTGGGGCAG  ACCCTCCGTG 
BG1.  M13F  ----------  ----------  ----------  ----------  ----------  ---------- 
Ovine:  781  GCCCCTGGGG  GATCTGCCTC  TGAGGCCGTT  TGCCTCTCTG  CCCTGTTGAG  GTGGTGCCTC 
Bovine:  1180  GTCCCTGGGG  GATCTGCGTC  TGAGGCCGTT  TGCCTCTCTG  CCCTGTTGAG  GTGGCGCCTC 
BG1.  M13F  ----------  ----------  ----------  ----------  ----------  ---------- 
BG1.  M13R  <  ----A--  ---------- 
Ovine:  841  TGCCTGTGGA  ATGTGGCCAG  GCAGA.  GTGGG  CTCTGTGGAC  CTGGGGGCCT  GGCTTTGCAT 
Bovine:  1240  TGCCTGTGGA  ACGCGGCCAG  GCAGA.  GTGGG  CTCTGTG..  C  CTGGGGGCCT  GGCTTTGTGT 
BG1.  M13F  ----------  ----------  -----------  -----------  ----------  ---------- 
BG1.  M13R  ---T------  --------CA  --CANA-----  --T-T---..  -  ----------  ---------- 
Ovine:  901  GGGAGCAGAG  GCCGCCAAGC  CTTGGGTTTT  TGCACAGC.  CC  TAACGGGGCC  CATGGCACTG 
Bovine:  1298  GGGGGCAGAG  GACGCCAGGC  CTTGGGGTTT  TGCACAGCCCC  TAGCGGGGCC  CATGGCACTG 
BG1.  M13F  ----------  ----------  ----------  -----------  --G-------  ---------- 
BG1.  M13R  ----------  ----------  ----------  -----------  --G-------  ---------- Fig.  2.17  (continued) 
The  fourth  JH  segment 
Ovine:  961  TGACTATATC  GACTACTGGG  GCCCAGGACT  CCTGGTCACC  GTCTCCTCAG  GTGAGCCCTC 
Bovine:  1359  TGACTAT.  TC  GACAACTGGG  GCCCAGGAAT  CCAAAACACC  GTCTCCTCAG  GTGAGTCCTC 
BG1.  M13F  ----------  ----------  ----------  ----------  -------N--  ---------N 
BG1.  M13R  -------  --  ----------  ----------  ---------  ---------- 
B12.  JH6  <  -----  ---A--N-C-  -TTGGT----  --G-------  --------A- 
B12.  M13R  >  -----  ---A-A--C-  NTTGGT----  --G----T-A  --------A- 
B2.  JH6  <  -----  ---AG-N-C-  -TTGGT----  -----N----  T--------- 
B5.  JH6  <  -----  ---AG---C-  --TGGT----  -----N----  C--------- 
B14.  JH6  <  --  ---A--A-N-  -TTGGT----  -----C----  ---------- 
B21.  JH6  <  -----  ---A----C-  --TGGT----  ----------  ----A----- 
B22.  JH6  <  -----  ---A----C-  --TGGT----  ----------  ---------- 
Ovine:  1021  ACC.  AGCCT.  TC 
Bovine:  1418  AAC.  AGCCC.  TC 
BG1.  M13F  ---A-----  C-- 
BG1.  M13R  ---  -------- 
B12.  JH6  --T.  -----.  -- 
B12.  M13R  --T.  -----.  -- 
B14.  JH6  --------  N.  -T 
B2.  JH6  ---  -----  -- 
B5.  JH6  ---.  -------- 
B21.  JH6  ---  -----  -- 
B22.  JH6  ------------ 
TCTCCTCACT  CT..  CTCTGAGT 
II  I1 
TCTCCTCACT  CTGTCTCAGGGT 
----------  TN---T-A-N--- 
----------  ------------ 
----TATT--  --T-T--TCA-A 
-T--A-A-GC  G-C--C------ 
--G------C  T-N-TG------ 
--G------  C  N-C-TG------ 
----T-----  ------------ 
--------T-  --C--------- 
TTTGGTGCAC  TTTGGGGGAA  ATCGAGGGTG 
TTTGGTGCAC  TTTGGGGAAA  ATCGAGGGTG 
----------  ---T---G--  -----  A---- 
---------- 
A--TTCAACT  CC-AT--T--GA-----C---A 
---------G  ----AATTTG  --T-TAA-G- 
GAG-C-C---  ------N---  ---------- 
GAG-C-C---  ----------  ---------- 
----C----A  ---A------  -----CAA-- 
---------G  ----------  ---------- 
Ovine:  1081  TCGGGTCTAG  AGGGCCTGGG  ACGGCCAGGG  GTCTGAGACG  GGGAAGGCCC  AGGGGCCCAG 
Bovine:  1480  TCGGGTCTAG  AGGGCCTGGG  GCGG.  CTGGG  ATCTGAGACA  CGGAGGACCC  AGGGGCCCAG 
BG1.  M13F  ----------  -A--------  ----  > 
BG1.  M13R  ----------  ---  -----  ----------  ----------  ---------- 
B12.  JH6  -CTTA----A  -C-AA  -GC-C---A-  AC---------  -T---A----  ---------- 
B2.  JH6  --NAA-TG--  T-TT------  --A-C-GA--  G--A--C---  TT----  C---  -A-------- 
B5.  JH6  ---AA-TG--  T-TT------  --A-C-GA--  G--A--C---  TT----  C---  -A-------- 
B14.  JH6  GCCTGGAGTAT  TTGGGTTTTTAAAATAGTGAGGGCCCAACCCTNTAATT  T 
...........  ........... 
B21.  JH6  ---CC----  A  G---------  --ACC-G-A-  T-----A-..  GA--------  ----GT-..  G 
B22.  JH6  ------G-GA  G--C------  --A-C-G---  G-----  A---  -T---A----  G-------G- 
Ovine:  1141  GCTTACAGCA  GCAAGGAGCA  GAGGCTCCAG  GCACCCTCTC  CTCCTGGGCT  CTGTAGCCAG 
Bovine:  1539  GCTTACAGCA  GCGAGGAGCA  GAGGCTCCAG  GCACCCTCTC  CTCCTGGGCT  CTGTAGCCAG 
BG1.  Ml3R  ---------  ----  ----------  ---------- 
--------A-  C----AT---  ----------  --G-------  T--T--C-TA  A----  CTT-- 
B2.  JH6  --AAG-G---  --A--.  --G-  ---C------  A------AA-  T--T------  -C-------- 
B5.  JH6  C-AAN-G---  --A--.  --G-  ---C------  A------AA-  T--T------  -C-------- 
B14.  JH6 
...........  .........................  ........ 
TCCAT  CACCGAGGNGTAAT----  C---- 
B21.  JH6  -AC--GTA--  C---------  ----------  ---G------  T--G---A--  ---------- 
B22.  JH6  A---G--A--  CG---T--T-  --AAA-----  ----------  -------A--  ---------- Fig.  2.17  (continued) 
Ovine:  1201  GGCCTTCTCT  GAGGGCCTCA 
Bovine:  1599  GGCTTTCTCT  GGGGGCCTCA 
BG1.  M13R  --------N-  ---------- 
B12.  JH6  ----------  ----C 
B14.  JH6  -A------N-  ---------- 
B2.  JH6  C-T-------  ---------- 
B5.  JH6  C-T-------  ---------- 
B9.  JH6  -------- 
B21.  JH6  ----C-----  ---------- 
B22.  JH6  ------T---  ------... 
Ovine:  1261  TGGCCTCGTG  AGGCCACATG 
Bovine:  1656  ..........  ........  TG 
BG1.  M13R  ..........  - 
B12.  JH6  TCGCCTCATG  AGCCCACAGA 
B14.  JH6  TCGTCTCACG  AGGCTACAG- 
B2.  JH6  TGACCTCAGG  AGGCCACAG- 
B5.  JH6  TGACCTCAGG  AGGCCACAG- 
B9.  JH6  TGACCTCAGG  AGGCCACAG- 
B21.  JH6  TGGCCTCATG  AGGCCACAG- 
B22.  JH6  TGGCCTCATG  AGGCCACAG- 
Ovine:  1321  TTGGGGTCCC  AGCATCACTG 
Bovine:  1698  CTGGGGTCAC  AGCATCATTG 
BGI.  M13R  ----------  ---------- 
B12.  JH6  --------C-  -TG------- 
B14.  JH6  --------C-  --  < 
B2.  JH6  --T-----C-  < 
B5.  JH6  --T-----C-  < 
B9.  JH6  --T-----C-  < 
B21.  JH6  -------TC-  -CT---N--- 
B22.  JH6  --------CA  --TG--G-C- 
GCCACCCTTG  GGCTCTGGAC  TCCCAAGGTC  CCAGCTGTGC 
III 
GCCACCCTTG  GGCTCTGGAC  TCCCAAGGTC  CCAGCTG... 
--  -A-------  G  --G-------  -------TGC 
ATT-------  ----------  ----------  --GC--ACTT 
-TT-------  ATT----A-T  ----------  -------TAC 
-TT-------  ATT----  A-T  ----------  -------TAC 
-TT-------  ATT-N--A-T  ----------  -------TAC 
A-T-------  ----------  ----------  --G----TTC 
----  ----------  -G--------  -------TGT 
TGAGGTAGTC  CGGAGGCCTC  AGCCGGCCAC  GAGCTCGTGC 
TGAGGTGGTC  CGGAGGCCTC  AGCCGGCCAC  GAGCTCTTGC 
GA-C--G---  -----  -----  ----------  ---T  --- 
---A-G-A--  ----  -----  ----------  ---------- 
----------  -----  -----  G---------  ---------- 
----------  -----  -----  G---------  ---------- 
----------  -----  -----  G---------  ---------- 
--C---A---  -----  -----  ----------  ---------- 
---C------  -----  -----  --------G-  --C------- 
TCACAGTGTA  ACGACTGGCT  CAAGCACTGG  GGCCAGGGAC  5"  JH 
segment 
TCACTGTGTA  ACAACTGGCT  CAAGCACTGG  GGTCAGGAAG 
----------  ----------  ----------  ---------- 
----  C----  T  -GGC------  ---  < 
--  C-----  -A-------- 
----C---GT  -----C----  ----------  -- 
Ovine:  1381  CCCGA.  CGCTG  TCTGCTCAGC  TGAGCCCTCC 
Bovine:  1758  CCTGGGCACTG  TCTGCTCAGC  TGAGCCCTCA 
BG1.  M13R  -----------  --------C-  -A-------- 
B12.  M13F  ---N--- 
B21.  M13R  <  -----  C--------- 
B22.  M13R  <  ---  -T--N---CT  -N-N-----N 
Ovine:  1441  TGGGGTGTCA  GAGATCCAGG 
Bovine:  1819  TGGAGCGTCA  GAGATCCAGA 
1-'.  M13F  CA  ý:  T  ------  (-,  -G 
B21.  M13R  CAAGAT--A-  ---------G 
B22.  M13R  CA-G-T---C  N--------G 
CCACCCCACT  TCACTGCACC  TGGGGAGGCC 
CCACCCCACT  CCACTGCACC  TGGGGAGACC 
--------T-  T-.  -N----  N-CN---A----- 
-------  G.  -  T---A---G-  CA-A-A---- 
--------  T-  T--T----G-  C---A----- 
GGCATTCTGG  AGGTCAAGAA  AGGGAGCTGG  GGAGAGGGT 
GGCATTCTGG  AGGTCAAGAA  AGGGAGCTGG  GGAGAGGGT 
--------A  ----------  -----C----  -A-N---A- 
------N---  GC-----  A--  ----GA----  -N-N----- 
------T---  ----T--A--  ---A------  -A------- Fig.  2.17  (continued) 
Ovine:  1500  ..........  ...........  .......  C 
Bovine:  1878  TCTGGTAAAC  AGGCAGAGCC  AGACCTCC 
B12.  M13F  -N  ----  N-N.  --CA-N--.  -  -------- 
B21.  Mi3R  -T-.  -----.  -------  A--  ---G---- 
B22.  M13R  -T-----..  -  --N--N----  -------- 
Ovine:  1501  CCGCCCCAAG  GACACTGCAA  TGTGGGTATG  AGGCGGCTCC  TCTGGCGGGT  CTGGCTGTCT 
Bovine:  1906  CTGCCCCAAG  GACACCACGA  TGTGGGTACA  AGGCGGCTCC  TTCGGTGGGT  CTGGCTGCCT 
B12.  M13F  T---------  ---T--G-G-  -----C---G  ---T--G--T  --T--C----  ---------C 
B21.  M13R  TC-----C-C  ------G--T  N--------N  ---T------  --T--C----  ------  C--- 
B22.  M13R  TC--------  ----  G-G-G-  ---------G  ---T------  --T--C----  ---------- 
Ovine:  1561  GACTTGAGCA  GGACCGGGGG  CTTCCGTCGC  TGTCTGGGGC  AGGTGGCTGC  TCAAGGCTGG 
Bovine:  1966  CACTTGAGCA  GGACCAGGGG  CTTCCGTCAC  TTTCTGGGGC  AGGCAGCTGC  TCGAGGCTGG 
B12.  M13F  GCT-------  --------A-  --------G-  ------A---  ----G-----  ---------- 
B21.  M13R  N-G------  G  ----------  --------G-  ---N------  ----  G-A---  ---------- 
B22.  M13R  AG--------  ----------  -C------G-  ---T------  -.  --G---C-  --G-----.  - 
Ovine:  1621  ACTTAGGTGT  CTGTGGGTCA  CGGTCAGCTG  GTCCAGGCAG  GCACTGGTCT  GGCCTCTGGG 
Bovine:  2026  ACTTAGGAGT  CTGTGGTTCA  TGGTCCGCCA  GCCCAGCCAG  GCAGTGGTCT  GGCCTCTGTG 
EiM13F  ----  -----C----  CC---A---G  ------G---  ---A------  -------G- 
B21.  M13R  ----------  ----------  C----.  C--G  ------G---  ----------  . 
C------  G- 
B22.  M13R  ----------  ----------  C----A---G  ------G---  ----------  .  -------G- 
Ovine:  1681  GGCCAAAATG  GGACATAGTG  TCTCTGGCAC  AGTCAGGTGG  GGCGGGGCCG  GCAGAGGGCC 
Bovine:  2086  GGCCAGAATG  GGACATAGTG  TCTCTGGCAC  AGTCAGGTGG  GGTGGGGCCA  GCAGAGGGTC 
312.  M13F  -A--------  --------  C--  ---------G  -A--------  ..........  .......  --- 
1321.  M  3R  -A--------  -----------  -N-N-----  G  ...  ------  ..........  .......  --- 
1322.  M13R  -A--------  ---------  -G  ------  --- 
TGCGTGAC 
Ovine:  1741  ACAGGCAAGC  GACTTTGACC  AGCGGCTTCC 
II  I 
CTGTGGTGCC 
1 
TGGAGATGGG  GTGGGGGCCC 
Bovine:  2146 
II 
ACTGACAAGC  GACTTTGACC  AATGGTTTCC  CTGTGGCGCC  TGGAGATGGG  GTGGGGGCCC 
--AC-----T  ------C---  CC  -  ---------  T  ---------- 
B21.  M13R  ACGCA----T  ----------  G-C--C----  ----------  ---------C  ---------- 
B22.  M13R  --AC-----T  ----------  G-C--C----  ----------  --N------C  ---------- 
Ovine:  1801  AGGTGCCTCG  AGCCTTGCCA 
Bovine:  2206  AGGCGCCTCG  AGCCTCGTCA 
F1 
. 
M1?  r 
-_________ 
B21.  Mi3R  G---------  -----T-C-- 
B22.  M13R  G---------  -----T-C-- 
GGCTCCCGAG  GTTTTTGTTG  GGCGAGGCTG 
GGCTCCCGAG  GTTTTTGTTG  GGCGAGGCTG 
A--  ---------C  C--------- 
A--  ----------  ---------- 
A--  ---C------  ---------- 
GAGATAATCG 
GAGATA.  TCA Fig.  2.17  (continued) 
Ovine:  1861  CCACTGTGAT  TACTACGGTG  TAGATGTCTG  GGGCCGAGGA  CTCCTGGTCA  CCGTCTCCTC  6`"  Je 
1  1  11  segment 
Bovine:  2265  CCACTGTGTT  TACTATGGTA  TAGACGCCTG  GGGCCGAGGG  CTCAGGGTCA  CCGTCTCCTC 
B12.  M13F  --------A-  ------A--G  G-TTT-TT--  C---------  A---GA-----  ---------- 
￿  ',,  Fl,  ------  Al  A-  -T-'  , V;  -  C- 
Ovine:  1921  AGGTAAGAGC  GGCC.  ATACAG  AGCCTTTGCT  TTCTCTCCTA  TTCGTGGGAT  TTTTCTGAGC 
Bovine:  2325  AGGTAAGAGC  AGCCCATCCAG  GGCCTTTGCT  TTATCTCAT.  TTCGTGCGAT  TTTTCTGAGC 
B12.  M13F  ----------  G----------  ----------  G-------  ----------  --------- 
B21.  M13R  ---  G----G---  --  -------- 
B22.  M13R  ----------  G----------  ----------  T--------.  ----------  --------- 
_ 
JH4  primer 
Ovine:  1981  ATCACTG....  GTC  CTCTGATGTG  TCCTTGTCCC  CTCCTCCCCG  GGGGGACTGG  GCAGACTGGC 
IIII  I 
Bovine:  2385  ATCACTGTCCGGTC  CTCTGATGTG  TCCTTGTCCC  CTCCTCCCCG  GGGGAACTGG  GCAGACTGGC Upon  reaching  this  part  of  the  sequence,  two  features  are  readily  apparent.  Firstly,  the 
reading  frame  of  the  segment  is  altered  from  the  germline  to  that  typically  seen  in  Ig 
cDNA  encoding  framework  region  4.  The  modification  of  codons  for  (I/T),  Q  and  N 
(isoleucine,  glutamine  and  asparagine)  to  L,  L  and  V  (leucine,  leucine  and 
valine)(sequence  changes  from  A(T/C)C  CAA  AAC  to  CTC  CTG  GTC)  is  striking. 
Secondly,  the  sequence  upstream  to  the  W  codon  loses  it  match  to  the  germline  sequence 
of  the  JH  locus  and  eventually  shows  the  features  of  bovine  Ig  framework  region  3  (data 
not  shown).  This  confirms  that  the  fourth  JH  segment  has  undergone  rearrangement. 
As  shown  in  Figure  2.17,  multiple  clones  carrying  inserts  of  about  1500  bp  were 
sequenced  to  confirm  these  results.  Analysis  supported  the  conclusion  that  the  fourth  JH 
segment  undergoes  rearrangement  (Figure  2.17).  A  variety  of  sequences  can  be  seen 
downstream  from  the  rearranged  segment  showing  that  several  rearrangement  events 
have  been  captured,  but  clones  B2,  B5  and  B9  seem  to  be  identical.  These  three  clones 
carried  VHF-JH4  amplicons  of  1  kb.  Sequencing  of  additional  clones  did  not  yield  data 
of  sufficient  quality  for  presentation.  Whilst  there  are  some  deviations  in  the  nucleotide 
sequences  of  the  rearranged  JH  segment  from  that  which  predominates  in  Ig  cDNA,  the 
encoded  protein  sequences  are  remarkably  similar  (Figure  2.18). 
2.3.7  Sequencing  of  germline  DNA  from  the  B  cell  donor 
Given  the  apparent  conflict  between  the  germline  sequence  of  the  fourth  JH  segment 
and  that  present  in  B  cell  genomic  DNA,  germline  material  from  the  B  cell  donor  was 
sequenced  through  the  majority  of  the  JH  locus.  This  data  is  presented  in  Figure  2.17  as 
clone  BG1.  This  showed  a  near-perfect  match  to  the  germline  sequences  previously 
gathered  from  other  individual  animals.  This  similarity  spans  the  fourth  JH  segment  and 
the  deleted  region  equivalent  to  positions  1258-1278  in  the  ovine  sequence  (Figure  2.17). 
Hence  the  differences  observed  between  germline  and  rearranged  DNA  in  the  fourth  JH 
segment  do  not  related  to  the  genotype  of  the  individual  from  which  B  cells  were 
isolated. 
2.3.8  Phylogeny  of  the  J11  segments 
The  sequences  of  functional  JH  segments  and  JH  pseudogenes  characterised  from 
cattle  were  compared  to  segments  from  humans,  mice,  rabbits,  sheep  and  llama  using 
DNAStar  software.  Using  this  package,  phylogenic  trees  were  prepared  by  maximum 
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iL  (T7  CI7  Cm  Co  cm  Co  Pa  f-Q  k+ likelihood  analysis  (Figure  2.19)  and  percentage  identities  are  shown  in  Figure  2.20.  The 
closest  relationships  are  between  the  ovine  and  bovine  segments  as  noted  at  the  outset  of 
this  work.  For  segments  judged  to  be  non-functional,  percent  identities  range  between 
66%  (the  fifth  segment  present  at  each  locus;  bovine  ps4  and  ovine  ps4)  and  94%  (the 
second  segment  present  at  each  locus;  bovine  pst  and  ovine  ps2).  The  sixth  segment 
(bovine  JH2  and  ovine  JH2)  which  in  cattle  seems  to  contribute  infrequently  to  the  Ig 
repertoire,  are  84%  identical  at  the  nucleotide  level.  This  study  has  shown  that  the  fourth 
segment  (bovine  JH1)  undergoes  rearrangement  but  also  some  sort  of  modification  takes 
place.  In  sheep,  the  sequence  of  the  equivalent  segment  is  identical  in  the  germline  and 
in  Ig  cDNA.  The  -germline  sequence  of  this  bovine  segment  is  76%  identical  to  its  ovine 
counterpart,  but  this  rises  to  82%  after  rearrangement.  Expressed  JH  segments  tend  to 
encode  relatively  conserved  protein  sequences  and  this  is  reflected  in  a  wider  analysis  of 
the  homology  of  the  bovine  locus.  Bovine  JHl  is  very  similar  in  sequence  to  human 
segments  JH2,  JH4  and  JH5  and  rabbit  JH1  and  JH2  (>70%  identity).  Bovine  JH2 
matches  human  JH6  (86%  identity)  and  murine  JH4  (72  %).  In  several  cases, 
modification  the  germline  sequence  of  bovine  JH1  to  the  rearranged  sequence  improves 
the  level  of  identity.  For  example,  human  JH2  and  the  bovine  germline  JH1  segment  are 
69%  identical,  but  this  reaches  76%  when  taking  the  rearranged  bovine  sequence. 
Similar  trends  are  seen  when  comparing  with  rabbit  JH1  (72  to  77).  Interestingly,  in 
some  instances  the  reverse  is  true.  This  is  shown  when  comparing  the  sequences  with 
llama  JH3  (71  %  identity  falls  to  64%),  mouse  JH2  and  J114  (71  %  falling  to  64%;  67% 
to  60%)  and  rabbit  JH4  (76%  to  71%). 
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Figure  2.19  Phylogenetic  relationships  between  bovine  and  ovine  JH  segments.  Having 
confirmed  in  previous  figures  that  the  fourth  and  sixth  bovine  JH  segments  undergo 
rearrangement,  these  are  now  designated  Jill  and  JH2  respectively.  Other  segments  are 
designated  pseudogenes  (ps)  1  (the  first  segment  in  the  locus)  to  4  (the  fifth  segment). 
Ovine  segments  are  identified  using  the  same  convention  (Dufour  and  Nau,  1997). tö 
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(C/A)AGGT(G/A)  AG 
1"  ovine:  GGTTTCCAT  22  CACTGTG  CAGGAGAA 
15T  Bovine:  GGTTTCCGT  22  CACTGTG  CAGGTGAA 
2ND  OVINE:  TGTTTTTCT  22  AGCTACG  - 
2ND  BOVINE:  TGTTTTTGT  22  AGCCATG  - 
3RD  OVINE:  GGTTCATGT  23  CCTTCAT  CAGGTGAG 
3RD  BOVINE:  GGTTCATGT  23  CCCTCAG  CAGGTGAG 
4TH  OVINE:  GGTTTTTGC  22  CACTGTG  CAGGTGAG 
4TH  BOVINE:  GGGTTTTGC  23  CACTGTG  CAGGTGAG 
5TH  OVINE:  GCTCGTGCT  20  CACAGTG  CAGCTGAG 
5TH  BOVINE:  GCTCTTGCC  20  CACTGTG  CAGCTGAG 
6TH  OVINE:  GGTTTTTGT  23  CACTGTG  CAGGTAAG 
6  T"  BOVINE:  GGTTTTTGT  22  CACTGTG  CAGGTAAG 
Figure  2.21  Comparison  between  consensus  RSS  motifs  and  transcriptional  splice 
sites  and  features  of  bovine  and  ovine  JH  segments.  The  segments  are  numbered 
according  to  their  order  at  the  loci.  Deviations  from  the  consensus  sequences  are 
indicated  in  red. 2.4  Discussion 
2.4.1  Preliminary  studies 
Although  this  chapter  describes  the  isolation  of  the  bovine  JH  locus  using  PCR 
methods,  this  was  not  the  first  strategy  employed  in  the  project.  Initially,  a  cosmid 
library  of  bovine  genomic  DNA  was  screened  to  identify  clones  carrying  the  locus.  The 
library  was  made  with  the  cosmid  vector  cNEO  (Southern  and  Berg,  1982)  by  Dr  John 
Williams  and  colleagues  at  the  Roslin  Institute,  Edinburgh,  using  genomic  DNA  from 
peripheral  blood.  To  screen  the  library,  a  digoxigenin-labelled  probe  was  made  from 
clone  L2-1  which  carries  the  3'  region  of  the  bovine  JH  locus.  The  clone  was  generated 
using  adapter-ligated  fragments  of  bovine  genomic  DNA  and  PCR  with  primers 
designed  from  heavy  chain  framework  4  sequences  (Aitken  et  al.,  unpublished  data). 
The  screen  identified  several  colonies  that  hybridised  with  the  probe,  but  analysis  of  the 
bovine  genomic  inserts  was  complicated  by  the  lack  of  a  well-defined  restriction  map 
of  the  vector.  Subcloning  and  sequencing  of  restriction  fragments  did  not  yield  data 
with  homology  to  the  heavy  chain  loci  of  other  species  and  so  this  approach  was 
abandoned  in  favour  of  the  strategy  described  in  this  chapter  of  the  thesis. 
2.4.2  PCR  strategies  for  assembly  of  a  contiguous  sequence 
Following  attempts  to  screen  the  cosmid  library,  effort  focused  on  amplification  of 
the  JH  locus  directly  from  the  germline.  In  the  first  step,  the  primers  Ovine  JH1  and  JH4 
were  designed  from  the  sequence  of  the  sheep  JH  locus  and  the  limited  sequence 
available  from  clone  L2-1.  This  experiment  recovered  the  majority  of  the  bovine  JH 
locus  (about  1.85  kb). 
Since  none  of  the  JH  segments  identified  in  the  recovered  sequence  matched  the 
more  frequently  expressed  sequences  in  bovine  framework  4,  the  downstream  and 
upstream  flanks  were  sought.  To  recover  the  downstream  sequence,  primers  JH4 
forward  (JH4F)  and  Eft  reverse  (E  tR)  were  used.  Analysis  of  two  clones  carrying  the 
resultant  amplicons  revealed  irrelevant  sequences  with  the  JH4  primer  sequence  at  both 
termini.  It  was  concluded  that  this  primer  bound  to  bovine  genomic  DNA  non- 
specifically.  Hence,  the  primer  JH4F  was  replaced  with  JH2A  that  primes  in  the  6th  JH 
segment  100  bp  upstream  to  the  JH4F  binding  site.  By  using  this  primer  and  EµR, 
about  900  bp  of  sequence  was  determined.  Although  the  heavy  chain  enhancer  was 
46 recognised  in  the  terminus  distal  to  the  locus,  additional  JH  segments  were  not 
identified. 
To  recover  regions  of  the  locus  lying  upstream  to  the  Ovine  JH1-JH4  amplicon, 
different  methods  were  used. 
Using  a  primer  to  DQ52 
In  many  species,  the  D  segment  DQ52  is  located  adjacent  to  the  JH  locus  and 
contributes  to  the  heavy  chain  repertoire  to  an  extent  which  varies  between  species 
(reviewed  by  Chen  et  al.,  1996).  Hence  a  primer  was  designed  from  alignment  of  the 
sequences  of  DQ52  segments  from  humans  and  other  species  (Figure  2.13).  About  30 
PCR  reactions  were  performed  with  this  DQ52  primer  and  JH6,  JH9  and  JH8R.  Only 
PCR  with  JH6  yielded  distinct  products  but  sequencing  of  amplicons  of  1200  and  1900 
bp  showed  that  they  were  irrelevant  DNA.  Later  work  described  below  showed  that 
though  a  bovine  DQ52  segment  exists,  it  differs  significantly  from  the  consensus  which 
was  used  in  primer  design,  explaining  the  failure  of  this  approach. 
Using  VH1A  primer 
The  primer  VHIA  binds  to  bovine  VH  segments,  about  80  bp  downstream  to  the 
leader  sequence.  We  reasoned  that  PCR  with  this  primer  and  a  primer  to  the  JH  locus 
primers  might  amplify  the  rearranged  V,  D  and  J  segment  from  lymphoid  genomic 
DNA,  enabling  identification  of  the  rearranged  JH  segment.  Four  clones  bearing  VH1A- 
JH6  amplicons  of  550,650,800  and  1500  bp  and  one  clone  possessing  a  1.2  kb  VH1A- 
JH8R  amplicon  were  sequenced  but  all  were  irrelevant  DNA  fragments.  Genomic  DNA 
prepared  from  a  lymph  node  and  liver  were  used  as  templates  in  these  experiments. 
Control  reactions  confirmed  that  under  the  experimental  conditions  employed,  all 
primers  would  extend  successfully  from  their  binding  sites.  This  experiment  assumed 
that  the  template  would  contain  sufficient  rearranged  DNA  from  B  cells  to  prime  the 
intended  reaction.  In  reality,  the  sample  would  have  contained  DNA  from  many  cells  in 
which  rearrangement  of  the  heavy  chain  locus  had  not  taken  place  (connective  tissue, 
dendritic  cells  and  other  leukocytes,  T  lymphocytes,  for  example).  Hybridisation  / 
extension  of  primers  to  DNA  from  these  sources  might  therefore  have  depleted  the 
concentration  available  to  prime  amplification  from  the  B  cell  DNA  in  the  pool. 
Significantly,  other  experiments  described  below  used  genomic  DNA  from  purified  B 
cells  to  a  similar  objective;  these  experiments  were  successful. 
47 Lambda  genomic  libraries 
Work  by  other  students  in  the  laboratory  isolated  a  clone  from  a  lambda  library  of 
bovine  liver  DNA  which  hybridised  with  a  JH  probe.  It  was  considered  possible  that 
the  clone  might  carry  upstream  flanking  sequences  and  perhaps  JH  segments  not 
recovered  by  the  PCR  strategy.  Using  PCR,  three  parts  of  the  locus  characterised  thus 
far  were  recovered  from  the  lambda  clone  for  sequencing,  spanning  about  1850  bp 
between  the  first  and  the  sixth  JH  segments.  In  addition,  sequences  representing  short 
interspersed  nucleotide  elements  (SINE)  were  detected  around  the  JH8R  binding  site. 
Amplicons  from  a  3.6  kb  SmaI  fragment  and  DraI  fragments  of  3.9,4.3  and  5  kb  were 
sequenced  but  all  were  irrelevant  sequences,  mainly  with  homology  to  alpha  globin.  It 
therefore  seems  likely  that  the  lambda  clone  carries  a  fragment  of  the  JH  locus  that  has 
been  translocated  to  a  different  chromosome.  Similar  translocations  have  been 
described  from  the  human  heavy  chain  locus  (Cook  and  Tomlinson,  1995). 
From  published  studies  (Knight  et  al.,  1988),  there  were  better  grounds  to  suppose 
that  a  lambda  clone  obtained  from  Prof  K.  Knight  (clone  15)  would  carry  the  upstream 
flanking  sequences  which  would  complete  the  characterisation  of  the  JH locus  and 
perhaps  identify  that  segment  which  most  frequently  forms  the  sequence  of  framework 
4.  Having  established  the  orientation  of  the  insert,  PCR  recovered  about  500  bp  of 
upstream  flanking  sequence.  Although  the  amplicon  carried  the  bovine  DQ52  segment 
at  the  5'  terminus,  it  did  not  contain  any  JH  segments. 
2.4.3  Organisation  of  the  bovine  J11  locus 
The  locus  can  be  divided  into  three  parts:  the  DQ52  segment,  the  J11  segments  and 
the  downstream  flanking  region.  Each  are  discussed  in  turn  below. 
The  DQ52  segment 
DQ52  forms  the  3'  terminus  of  the  D  locus,  separated  from  the  first  JH  segment  by  a 
short  distance  which  varies  between  species.  In  the  mouse,  it  lies  696  bp  upstream  of 
JH1  (Sakano  et  al.,  1981)  and  is  located  within  the  J  region  in  humans  (Ravetch  et  al., 
1981).  In  rabbits  it  is  localised  about  800  bp  upstream  of  Jill  (Chen  et  al.,  1996).  The 
segment  makes  a  similarly  variable  contribution  to  the  heavy  chain  repertoire.  In 
humans,  DQ52  is  used  preferentially  during  rearrangement  in  the  foetal  liver 
48 (Schroeder  and  Wang,  1990)  but  it  is  rarely  expressed  in  peripheral  B  lymphocytes  of 
the  adult  (Yamada  et  al.,  1991).  In  mice,  DQ52  is  preferentially  expressed  in  the  foetal 
liver  and  in  neonatal  B  cells  (Bangs  et  al.,  1991),  but  its  rearrangement  can  also  be 
detected  in  thymocytes  of  foetal,  newborn  and  young  mice  (Born  et  al.,  1988).  In 
contrast,  DQ52  in  the  rabbit  is  expressed  very  infrequently  during  foetal  development 
(Chen  et  al.,  1996).  Our  study  has  revealed  that  in  cattle,  DQ52  is  located  448  bp 
upstream  of  the  first  JH  segment.  The  segment  possesses  a  14  bp  coding  region  that  is 
longer  than  those  reported  from  other  animals  (Figure  2.13)  and  also  deviates  from 
them  in  sequence.  One  unresolved  issue  concerning  the  formation  of  bovine  Ig  heavy 
chains  is  what  underlies  the  exceptional  length  of  the  third  CDR  (Aitken  et  al.  1999). 
Perhaps  the  length  of  DQ52  indicates  that  other  D  segments  will  be  atypically  long, 
explaining  this  property.  By  comparing  the  sequence  of  DQ52  with  other  data  (Berens 
et  al.,  1997;  Sinclair  et  al.,  1997;  Saini  et  al,.  1997),  there  is  no  evidence  to  show  that 
DQ52  is  used  in  DJ  rearrangements  in  cattle  during  foetal  development  or  in  the  adult 
Ig  repertoire.  This  may  be  due  to  loss  of  recombination  competence.  The  5'  heptamer 
and  nonamer  RSS  match  those  of  the  mouse  except  for  the  eighth  base  in  the  nonamer. 
Similarly,  the  3'  heptamer  matches  that  from  humans,  mice  and  rats,  but  the  3'  nonamer 
differs  in  three  bases  (CACAAAA  versus  CACAGTG).  It  has  been  shown  that  when 
RSS  deviate  from  the  consensus  sequence  in  the  heptamer,  spacer  and  nonamer  regions, 
this  can  drastically  diminish  the  recombination  frequency  (Hesse  et  al.,  1989, 
Akamatsu  et  al.,  1994).  Although  CAC  at  the  first  three  positions  are  the  most  essential 
nucleotides,  it  has  shown  that  the  substitution  of  the  5th  or  7th  or  both  with  A 
diminishes  the  recombination  rate  to  87%,  74%  and  26%  respectively  (Hesse  et  al., 
1989). 
The  JH  segments 
The  cattle  JH  locus  appears  broadly  similar  to  that  of  the  sheep  (Dufour  and  Nau, 
1997)  with  only  three  significant  insertion  /  deletions  between  the  species.  Comparison 
of  the  loci  by  pairwise  BLAST,  excluding  these  three  stretches,  reveals  89%  homology. 
The  bovine  JH  locus  contains  6  JH-like  segments  as  in  sheep  (Dufour  and  Nau,  1997), 
rabbits  (Becker  et  al.,  1989;  Friedman  et  al.,  1994;  Tunyaplin  and  Knight,  1995)  and 
mice  (Sakano  et  al.,  1980),  whereas  the  chicken  possesses  a  single  JH  segment 
(Reynaud  et  al.,  1989),  and  there  are  nine  segments  at  the  human  JFj  locus  (Ravetch  et 
al.,  1981).  In  these  species,  two  hi  segments  are  functional  in  sheep,  5  in  rabbits,  4  in 
49 mice,  1  in  chickens  and  6  in  humans.  Comparison  between  the  bovine  and  ovine  JH 
segments  sequences  revealed  the  homology  of  the  equivalent  segments  is  76.5%, 
94.1%,  82.2%,  64.4%,  66%  and  84.3%  for  the  first  to  sixth  segments  respectively. 
It  is  of  obvious  importance  to  assess  which  segments  at  the  locus  retain  or  have  lost 
the  ability  to  undergo  rearrangement  and  thus  contribute  to  the  formation  of  Ig.  The 
significance  of  sequence  in  RSS  spacer  regions  has  been  addressed  by  Fanning  et  al., 
(1996).  In  their  work,  mutation  of  the  conserved  fifth  nucleotide  of  two  12  and  23-base 
spacers  resulted  in  a  relative  reduction  in  the  rate  of  recombination.  Other  articles 
suggest  that  mutation  of  50%  or  even  100%  of  AT  nucleotides  in  spacer  regions  to  GC 
did  not  significantly  reduce  the  level  of  recombination  (Akira  et  al.,  1987;  Wei  and 
Lieber,  1993).  Against  this  background,  it  is  very  difficult  to  assess  the  significance  of 
anything  other  than  nonamer,  heptamer  and  RNA  splice  signals  where  well-defined 
consensus  sequences  exist.  With  regard  to  the  first  JH  segment,  the  heptamer  motif 
matches  the  consensus  CACTGTG  but  the  nonamer  departs  from  consensus  and  the  3' 
RNA  splice  site  is  non-functional.  It  is  therefore  likely  that  as  in  the  sheep,  this  segment 
is  non-functional.  The  second  bovine  JH  segment  is  likely  to  be  a  pseudogene  for 
similar  reasons.  The  third  JH  segment  possesses  RNA  splice  sites  but  the  RSS  departs 
from  consensus  sequences.  Inspection  suggests  the  fifth  J}1  segment  of  cattle  is  a 
pseudogene  because  of  non-functional  heptamer  and  RNA  splice  sites  and  a  spacer  of 
just  20  bases. 
In  sheep  the  fourth  and  sixth  segments  are  functional.  At  the  bovine  locus,  all  RSS 
motifs  in  segments  four  and  six  are  identical  to  the  consensus  except  that  the  nonamer 
of  the  fourth  segment  has  aT  to  G  substitution  at  the  third  base.  In  sheep  the  fourth  JH 
segment  (JH1)  is  used  in  more  than  90%  of  Ig  cDNAs  and  the  6th  segment  (JH2) 
contributes  to  the  structure  of  the  remainder  (Dufour  and  Nau,  1997).  In  cattle,  a  similar 
bias  operates  with  a  single  sequence  appearing  in  framework  four  very  commonly  in 
heavy  chain  cDNA  (Armour  et  al.,  1994;  Sinclair  and  Aitken,  1995;  Berens  et  al., 
1997;  Saini  et  al.,  1997;  Sinclair  et  al.,  1997)  and  evidence  of  low-frequency 
rearrangement  of  an  alternative  JH  segment  (Berens  et  al.,  1997).  It  is  on  this  topic  that 
the  real  significance  of  this  characterisation  of  the  bovine  J11  locus  emerges.  Of  the  6 
segments  detected,  the  sequence  of  the  3'-terminal  segment  (the  6th  segment),  matches 
precisely  that  of  the  less  frequently  detected  framework  sequence.  Despite  partial 
homology  between  the  sequences  of  the  remaining  five  segments  and  most  commonly 
observed  sequence  in  framework  four,  no  segment  matches  exactly.  A  major  challenge 
50 was  therefore  to  identify  which  JH  segment  undergoes  frequent  rearrangement  in  cattle 
and  to  explain  what  processes  might  modify  the  germline  sequence  to  create  that 
observed  in  Ig  cDNA. 
The  downstream  flanking  region 
Sequence  of  the  region  downstream  of  the  JH  locus  has  close  homology  to  that  of  the 
sheep.  There  are  regions  of  disparity  ranging  from  1  to  24  nucleotides  but  is  difficult  to 
establish  if  these  represents  insertions  or  deletions.  The  most  notable  of  these  features  is 
a  deletion  of  24  nucleotides  from  the  sequence  present  in  sheep,  corresponding  to 
nucleotides  2592-2613  of  the  bovine  sequence.  Intriguingly,  the  ovine  sequence 
possesses  internal  complementarity  suggesting  that  it  might  form  a  short  stem-loop 
structure  when  transcribed  from  upstream  promoters  (the  so-called  "sterile  transcripts" 
or  "germline  transcripts"  [Hesslein  and  Schatz,  2001]).  The  3'  terminus  of  the 
characterised  regions  carries  about  300  bp  of  the  5'  intronic  heavy  chain  enhancer  with 
94%  similarity  to  the  ovine  sequence. 
2.4.4  Identification  of  the  rearranging  segment 
At  the  outset  of  this  work,  it  was  expected  that  characterisation  of  the  bovine  JH 
locus  would  lead  to  identification  of  two  segments  matching  precisely  the  major  and 
minor  framework  four  sequences  observed  in  Ig  cDNA.  Given  that  a  high  level  of 
similarity  was  detected  between  the  bovine  and  ovine  loci  and  that  this  outcome 
emerged  from  studies  of  the  sheep  (Dufour  and  Nau,  1997),  it  therefore  came  as  a 
considerable  surprise  to  find  that  a  JH  segment  corresponding  to  the  major  framework 
four  sequence  could  not  be  identified.  To  resolve  this  issue,  PCR  was  applied  to 
genomic  DNA  from  purified  peripheral  B  cells,  using  primers  against  the  VH  segment 
and  regions  of  the  JH  locus.  Sequencing  of  VHF-JH4  amplicons  clearly  implicated  the 
fourth  JH  segment  but  showed  a  series  of  substitutions  had  altered  its  germline  sequence 
to  that  typically  observed  in  Ig  cDNA.  Specifically,  these  modifications  altered  codons 
105,107-109  through  6  or  7  substitutions.  Downstream  of  the  segment,  the  number  of 
substitutions  to  the  germline  sequence  becomes  more  pronounced.  This  would  be 
expected  since  the  B  cells  were  isolated  from  the  peripheral  circulation  of  an  adult 
animal  and  therefore  are  likely  to  have  encountered  antigen  and  undergone  affinity 
maturation  through  somatic  hypermutation.  This  process  is  known  to  modify  the 
transcriptional  unit,  rather  than  the  coding  sequence  (Hesslein  and  Schatz,  2001). 
51 The  most  attractive  explanation  of  these  results  is  that  at  some  stage  during  B  cell 
development,  the  fourth  JH  segment  or  the  rearranged  sequence  encoding  framework 
four  undergoes  modification.  However,  the  following  explanations  were  also 
considered. 
Variation  exists  in  the  sequence  of  the  fourth  JH  segment 
By  chance,  these  studies  may  have  isolated  variants  of  the  fourth  JH  segment  that 
carry  an  atypical  sequence.  This  is  unlikely.  At  least  two  independent  preparations  of 
genomic  DNA  from  different  animals  returned  the  same  sequence  for  the  fourth  JH 
segment,  a  sequence  which  was  identical  to  that  from  independent  clones  from  different 
lambda  libraries  of  bovine  genomic  DNA.  Also,  the  sequence  of  the  fourth  segment 
was  determined  for  a  single  animal  from  leukocytic  (typical  germline  sequence)  and 
peripheral  B  cell  genomic  DNA  (typical  Ig  cDNA  sequence).  This  reduces  to  a  very 
low  level  the  likelihood  that  allotypes  or  other  variants  of  the  fourth  JH  segment  exist, 
one  rearranged  to  form  framework  region  four  and  another  (or  others)  that  fails  to 
undergo  rearrangement  /  expression  in  cDNA.  These  considerations  and  the  frequency 
with  which  a  single  framework  four  sequence  has  been  described  in  cDNA  isolated  in 
independent  studies  (Armour  et  al.,  1994;  Sinclair  and  Aitken,  1995;  Berens  et  al., 
1997;  Saini  et  al.,  1997;  Sinclair  et  al.,  1997)  rules  out  the  possibility  of  allelic 
variations  to  segment  4  in  the  bovine  population  generally. 
The  germline  sequence  of  the  fourth  JH  segment  arises  from  a  PCR  artefact 
The  recovery  of  "cross-over"  products  when  using  PCR  on  templates  with 
homologous  sequences  is  well  known  (Sinkora  et  al.,  2000).  This  would  tend  to 
introduce  a  false  impression  of  diversity  which  is  not  a  feature  of  the  data  presented 
here.  Also,  the  chance  of  artefacts  arising  from  PCR  from  single  clones  of  lambda  DNA 
is  significantly  reduced.  The  fact  that  a  consistent  germline  sequence  emerged  from  the 
studies  irrespective  of  the  source  of  template  argues  that  the  result  -  the  sequence  of  the 
fourth  (rearranging)  JH  segment  fails  to  match  the  sequence  of  framework  4-  is  not  an 
experimental  artefact. 
The  sequence  recovered  comes  from  a  non-functional  duplication  of  the  J1,  locus 
This  possibility  is  more  difficult  to  reject.  It  is  known  that  the  bovine  genome 
carries  at  least  one  translocated  copy  of  sequence  from  chromosome  21  to  9  which 
52 includes  IgM  constant  regions  (Tobin  Janzen  and  Womack,  1992;  Mousavi  et  al., 
1998).  The  distance  between  the  JH  locus  and  the  first  C  [t  exon  is  about  6  kb  and 
therefore  this  translocation  could  also  include  some  or  all  of  the  JH locus.  If  the 
segments  on  this  or  other  translocated  fragments  of  the  heavy  chain  locus  carried 
sequences  different  to  that  on  chromosome  21,  the  study  could  have  inadvertently 
characterised  these  non-functional  duplications.  Against  this,  lambda  clone  15  carries 
sequence  from  the  DQ52  segment  through  the  JH  locus  to  beyond  the  IgM  constant 
region  (Knight  et  al.,  1988).  This  has  all  the  characteristics  of  a  genomic  fragment  of 
about  18  kb  derived  from  the  heavy  chain  locus  on  chromosome  21,  yet  the  sequence  of 
the  fourth  JH  segment  is  consistent  with  data  gathered  by  PCR.  The  lambda  clone 
independently  isolated  in  our  laboratory  also  carries  this  sequence  but  the  presence  of  a 
SINE  element  strongly  suggests  that  this  genomic  fragment  is  from  a  non-functional 
duplication  of  the  locus.  It  therefore  seems  likely  that  both  functional  and  non- 
functional  copies  of  the  JH  locus  carry  the  sequence  reported  for  the  critical  fourth 
segment  and  there  are  no  grounds  to  suppose  that  the  sequence  characterised  as  the  JH 
locus  has  been  recovered  from  a  non-functional  translocation  of  this  region  of  the 
genome. 
2.4.5  Possible  mechanisms  of  modification 
Working  from  the  conclusion  that  the  fourth  JH  segment  undergoes  rearrangement 
and  modification  in  the  formation  of  bovine  antibodies,  what  processes  might  be 
responsible  for  altering  its  sequence? 
Templated  versus  non-templated  modification 
Somatic  hypermutation  is  known  to  diversify  the  sheep  antibody  repertoire 
(Reynaud  et  al.,  1995)  and  it  has  been  speculated  that  the  process  might  also  operate  in 
cattle  to  achieve  the  same  outcome  (Sinclair  and  Aitken,  1995;  Berens  et  al.,  1997; 
Saini  et  al.,  1997;  Sinclair  et  aL,  1997;  Aitken  et  al.,  1999).  This  process  has  biases  in 
the  bases  which  are  modified  and  the  locations  of  the  changes  which  are  introduced 
(Wagner  and  Neuberger,  1996).  Comparison  of  the  germline  and  rearranged  sequence 
of  the  fourth  JH  segment  does  not  suggest  that  this  process  is  responsible.  The 
consistency  with  which  substitutions  to  a  limited  number  of  nucleotides  occur  are  more 
typical  of  a  templated  process.  Notably,  the  mutation  of  the  (I/T),  Q  and  N  (isoleucine, 
glutamine  and  asparagine)  codons  (A[T/C]C  CAA  AAC)  to  the  leucine,  leucine  and 
53 valine  codons  (CTC  CTG  GTC)  is  striking  since  multiple  other  substitutions  could  have 
achieved  the  same  protein  sequence.  These  features  are  more  typical  of  a  templated 
process  (e.  g.  homologous  recombination  or  gene  conversion).  The  conserved  sequence 
of  the  insertion  present  on  the  upstream  flank  of  the  fifth  segment,  and  consistent 
substitutions  in  the  sixth  segment  are  consistent  with  this  mechanism. 
Linkage  with  B  cell  development  and  diversification  post-rearrangement 
Since  rather  little  data  is  presently  available,  it  is  difficult  to  assess  the  timing  of  the 
modification  process  relative  to  rearrangement,  B  cell  development  and  the 
diversification  of  the  antibody  repertoire.  One  statement  which  can  be  made  with  some 
certainty  is  that  modification  of  the  germline  sequence  takes  place  during  foetal 
development  before  significant  diversification  of  the  immunoglobulin  repertoire.  This 
can  be  seen  in  data  from  Berens  et  al.  (1997).  Here,  the  authors  aligned  antibody  cDNA 
sequences  from  foetal  tissue.  It  is  clear  from  this  that  the  sequence  of  framework  four 
has  achieved  that  typically  seen  in  adult  animals,  yet  there  is  very  little  diversity  in  the 
CDRs.  Turning  to  the  potential  timing  of  modification  in  B  cell  development,  the 
pathways  of  B  cell  development  are  poorly  established  in  cattle.  In  human  prenatal 
development,  the  foetal  liver  transiently  plays  the  major  role  in  the  production  of  cells 
for  the  B  lymphocyte  lineage.  Around  12  weeks  into  gestation,  the  production  of  B 
cells  shifts  to  the  bone  marrow.  Thereafter  in  mice  and  humans,  the  B  cell  repertoire  is 
generated  throughout  life  by  continual  rearrangement  of  Ig  genes  in  each  newly  formed 
B  cell  in  the  bone  marrow.  B  cell  development  in  the  bone  marrow  requires  successful 
rearrangement  at  the  heavy  and  light  Ig  loci  and  the  surface  expression  of  Ig,  the  B  cell 
antigen  receptor  (BCR)  (Retch,  1995).  The  first  rearrangements,  D-J  and  V-DJ,  are 
seen  in  "early  pro-B  cells"  and  "late  pro-B  cells"  respectively  but  rearrangement  of  the 
light  chain  occurs  at  a  later  stage  in  "small  pre-B  cells"  (Melchers  et  al.,  1995).  When 
pre-B  cells  undergo  successful  light  chain  rearrangement,  they  develop  into  immature  B 
cells  and  express  the  mature  BCR  (Li  et  al.,  1993).  Immature  B  cells  produced  in  the 
bone  marrow  migrate  into  the  periphery  to  complete  the  maturation  process  (O'Rourke 
et  al.,  1997).  Expression  of  the  pre-BCR  and  BCR  affords  the  possibility  that  the 
primary  B  cells  repertoire  is  shaped  and  directed  by  continuous  clonal  selection 
beginning  at  the  pre  B  cell  stage  of  differentiation  (Schwartz  and  Stollar,  1994).  It  is 
perhaps  during  this  phase  in  cattle  that  modification  takes  place  but  one  challenge  for 
the  future  will  be  to  derive  a  comparable  understanding  of  B  cell  development  in  cattle. 
54 For  the  present,  the  tissues  in  which  the  foundations  of  humoral  immunity  are  laid 
remain  uncertain  (Lucier  et  al.,  1998). 
Cis  and  trans-chromsomal  rearrangement 
Close  inspection  of  the  sequence of  the  bovine  JH  locus  failed  to  identify  any 
candidates  for  templated  modification  (e.  g.  the  non-functional  segments  present  at  the 
locus  or  remnants  of  JH  segments  in  the  intergenic  regions).  The  possibility  therefore 
arises  that  the  donated  sequence  may  come  from  interlocus  or  trans  rearrangement,  in 
which  the  rearranged  segments  are  from  different  loci  (Baer  et  al.,  1985;  Denny  et  al., 
1986;  Kobayashi  et  al.,  1991).  The  participating  loci  can  be  situated  on  two  chromatids, 
on  two  homologous  chromosomes  or  even  on  non-homologous  chromosomes.  Knight 
et  al.,  (1974;  1995)  showed  that  VH  and  Ca  allotypes  used  in  rabbit  IgA  heavy  chains 
were  encoded  by  VH  and  Ca  genes  in  trans  (from  different  parental  chromosomes), 
whereas  the  V11  and  JH  genes  used  in  V(D)J  rearrangements  were  from  the  same 
chromosome,  indicating  that  the  VH,  D  and  JH  gene  rearrangements  occurred  in  cis. 
They  suggested  that  the  trans-association  between  VDJ  and  Ca  did  not  occur  during 
VDJ  rearrangement  but  during  isotype  switching.  This  idea  supported  previous  studies 
performed  on  the  VH  and  CH  genes  (Kipps  and  Herzenberg,  1986;  Gerstein  et  al., 
1990). 
Although  interchromosomal  VJ  junctions  have  been  detected  in  the  TCR,  they  are 
rare,  estimated  to  occur  in  only  about  1  of  every  105  thymocytes  (Aster  and  Sklar, 
1992).  Interchromosomal  recombination  between  the  murine  Ig  x  and  ?  loci  has  been 
detected  in  Abelson  virus  transformed  pre-B  cells  at  a  frequency  which  is  about  1000- 
fold  lower  than  rearrangements  in  cis  (Baily  and  Rosenberg,  1997).  It  has  been  shown 
that  the  12-  and  23-RSSs  can  synapse  and  undergo  coupled  cleavage  in  vitro  (Hiom  and 
Gellert,  1998).  In  another  experiment  it  was  shown  that  12-  and  23-RSSs  on  separate 
transiently  transfected  plasmids  could  mediate  relatively  sufficient  synapsis,  coupled 
cleavage,  and  signal  joint  formation.  This  study  reported  a  dramatic  defect  in  coding 
joint  formation  if  the  two  RSSs  were  in  trans,  which  led  to  the  proposal  that 
mechanisms  exist  to  selectively  disfavour  or  inhibit  coding  joint  formation  in  trans 
(Han  et  al.,  1999).  In  contrast,  Tevelev  and  Schatz  (2000)  found  that  both  coding  and 
signal  joint  formation  can  occur  relatively  efficiently  in  trans.  Inefficient  as  these 
processes  might  appear,  it  should  be  recalled  that  in  humans,  some  55  billion  B  cells 
55 per  day  are  lost  in  the  bone  marrow  because  they  fail  to  make  a  functional 
immunoglobulin,  or  enter  apoptosis  because  they  are  specific  to  self-antigens. 
Given  these  finding,  a  hypothesis  worth  future  investigations  is  that  changes  to  the 
fourth  JH  segment  during  B  cell  development  occurs  through  a  gene  conversion  process 
which  operates  post-rearrangement  and  utilises  a  donor  sequence  lying  outwith  the 
3200  bp  which  has  been  sequenced  in  this  study.  One  objective  of  this  investigation 
would  be  to  establish  if  modification  is  driven  by  processes  operating  in  cis  or  in  trans. 
In  either  case,  this  appears  to  be  another  highly  unusual  feature  of  the  immunology  of 
cattle  as  a  group  of  vertebrates.  These  issues  could  be  tackled  by  first  identifying  the 
genomic  origins  of  the  donor  JH  segment  by  screening  a  genomic  library  for  the  inserted 
sequence  introduced  through  rearrangement.  In  itself,  this  would  assess  the  likelihood 
of  a  cis  versus  a  trans-mediated  process.  Following  from  this,  one  would  expect  the 
distance  between  flanking  marking  to  shorten  in  B  cells  if  rearrangement  were  the 
driving  force  for  introduction  of  the  JH  segment.  This  parameter  would  remain 
unchanged  and  the  sequence  of  the  donating  segment  would  not  alter  at  the  donating 
locus  if  gene  conversion  were  at  work. 
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Construction  of  a  library  of  recombinant  bovine  Fabs 
against  Mannlieimia  haemolytica 3.1  Introduction 
3.1.1  Overview  of  antibody  phage  display  libraries 
The  processes  of  gene  rearrangement,  diversification  and  chain  pairing  creates 
sufficient  antibody  diversity  to  protect  animals  against  most  forms  of  challenge  with 
antigen.  This  natural  diversity  can  be  captured  by  PCR  and  through  phage  display, 
antibodies  against  individual  antigens  can  be  conveniently  isolated.  Antibodies  can  be 
expressed  as  single  chain  Fvs  (scFvs)  or  Fab  fragments. 
scFv  libraries  are  generally  constructed  through  the  in  vitro  combination  of  VL  and 
VH  repertoires  each  recovered  by  PCR  (Marks  et  al.,  1991;  Cai  et  al.,  1995;  Vaughan  et 
al.,  1996;  Muller  et  al.,  1997;  de  Haard  et  al.,  1998;  Mousli  et  al.,  1999;  Lorenzen  et 
a1.,  2000).  The  VH  and  VL  repertoires  can  also  be  linked  into  scFvs  by  recombination 
processes  in  vitro  (Hogrefe  et  al.,  1993)  or  in  vivo  (Waterhouse  et  al.,  1993;  Griffiths  et 
al.,  1994).  In  some  cases  VH  and  VL  gene  fragments  are  separately  and  sequentially 
cloned  into  the  phage  display  vector;  these  fragments  may  be  either  PCR  products  that 
are  cloned  directly,  or  released  from  an  intermediate  vector  (Kipriyanov  et  al.,  1996a). 
For  construction  of  Fab  libraries  the  VH  (-CHI)  and  VL  (-CL)  fragments  are  cloned 
independently  into  the  display  vector.  The  fragments  can  be  either  PCR  products 
digested  with  appropriate  restriction  endonucleases  (direct  cloning)  (Barbas  et  al.,  1991; 
Ward  et  al.,  1996;  Siegel  et  al.,  1997)  or  restriction  fragments  released  from  an 
intermediate  vector  (Yau  et  al.,  1998;  de  Haard  et  al.,  1999).  The  phagemids  used  for 
Fab  library  construction  may  possess  CL  or  CH  sequences;  naturally,  this  will  affect  the 
strategies  for  designing  primers  for  amplification  of  VH  (-CH  1)  and  VL  (-CL)  fragments. 
Unlike  humans  and  mice,  the  primary  antibody  repertoire  of  domesticated  species 
often  lacks  great  combinatorial  diversity.  Despite  the  apparent  complexity  of  many 
light  and  heavy  chain  loci,  the  expressed  repertoire  may  be  founded  on  single  families 
of  V  genes  (e.  g.  cattle)  or  the  rearrangement,  diversification  and  expression  of  single  V 
segment  (e.  g.  chickens).  Therefore,  far  fewer  primers  are  required  to  recover  the  Ig 
repertoire  by  PCR  from  many  livestock  animals. 
3.1.2  Phage  display  antibodies  from  animals 
Hybridoma  techniques  have  generally  made  little  impact  in  the  generation  of 
monoclonal  antibodies  from  livestock  animals.  In  contrast,  there  are  fewer  constraints 
on  the  use  of  phage  display  and  recombinant  methods  with  these  species  and  there  are 
numerous  potential  benefits: 
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therapies  for  species  of  veterinary  and  economic  importance  and  could  provide, 
through  transgenesis  (Sola  et  al.,  1998),  or  other  novel  methods  of  immunoprophylaxis 
(Lorenzen  et  al.,  2000)  enhanced  protection  against  disease.  Other  applications  include 
passive  immunomodulation  of  a  range  of  physiological  process  and  Ig-targeted  drug  or 
vaccine  delivery  (Wang  et  al.,  2000).  By  using  antibodies  of  native  sequence,  anti- 
species  immune  responses  would  be  avoided. 
Antibody  production  from  different  species  like  chickens  may  be  a  useful  way  of 
producing  antibodies  recognising  conserved  epitopes  on  mammalian  molecules  which, 
because  of  self-tolerance,  are  not  obtained  by  immunisation. 
To  take  livestock  as  an  example,  phage-display  technology  will  obviate  the 
modelling  of  viral,  bacterial  or  parasitic  infections  in  rodent  systems  simply  to  obtain 
antibodies.  This  should  eliminate  potential  artefacts  arising  from  the  limited  ability  of 
many  veterinary  pathogens  to  colonise  laboratory  animals  or  differences  in  antigenic 
recognition  between  natural  and  laboratory  hosts. 
In  several  important  cases,  human  pathogens  fail  to  establish  in  rodents,  but  relevant 
infection  models  are  available  in  other  animal  species  (e.  g.  HIV  [Locher  et  al.,  2001]). 
Similarly,  there  are  many  human  diseases  with  close  parallels  in  veterinary  medicine. 
The  availability  of  antibodies  from  a  wider  range  of  species  should  increase  the  appeal 
of  animals  other  than  rodents  for  the  study  of  human  disease.  The  outbred 
characteristics  of  many  of  these  mammals  increase  their  value  as  models  for  human 
disease. 
Although  the  majority  of  research  in  phage  antibody  techniques  has  been  conducted 
using  libraries  of  human  origin,  phage  libraries  have  been  produced  from  several 
livestock  species. 
Rabbits 
Rabbits  have  been  used  for  decades  to  produce  polyclonal  antibodies  as  diagnostic 
research  tools;  however,  monoclonal  antibodies  from  this  species  have  not  been 
produced  via  routine  methods  such  as  immortalisation  of  B  cells.  Monoclonal 
antibodies  derived  by  phage  display  have  been  generated  from  rabbits  in  several  cases 
(Ridder  et  al.,  1995;  Lang  et  al.,  1996;  Foti  et  al.,  1998;  Li  et  al.,  2000;  Steinberger  et 
al.,  2000).  These  antibodies  have  been  produced  in  Fab  or  scFv  formats  expressed  in 
E.  coli  or  Pichia  pastoris  and  are  derived  from  rabbits  specifically  immunised  with 
58 antigens  of  interest  (detailed  in  Table  3.1). 
Chickens 
Although  fusion  partners  for  the  production  of  chicken  monoclonal  antibodies  have 
been  described  (Nishinaka  et  al.,  1991),  hybridoma  technology  is  not  widely  used.  In 
the  chicken,  single  functional  Ig  and  joining  gene  segments  at  the  heavy  and  light  chain 
loci  undergo  V(D)J  rearrangement.  Diversity  is  subsequently  introduced  by  gene 
conversion  with  upstream  V  region  pseudogenes  in  such  a  way  that  practically  all  V 
regions  have  identical  termini.  This  greatly  simplifies  the  representative  amplification 
of  V  region  genes.  Furthermore,  the  entire  nafve  repertoire  of  the  adult  chicken  is 
produced  in  the  bursa  of  Fabricius  of  young  birds.  These  properties  have  been  exploited 
in  procedures  to  produce  large  phage  display  libraries  of  diverse  chicken  Ig  genes. 
Most  of  the  phage  antibody  libraries  made  from  the  chicken  repertoire  are  from 
immunised  individuals  (Davies  et  al.,  1995;  Yamanaka  et  al.,  1996;  Andris-Widhopf  et 
al.,  2000)  although  a  naive  phage  library  has  also  been  constructed  and  screened 
against  a  number  of  proteins  (Cary  et  al.,  2000).  The  properties  of  these  libraries  are 
shown  in  Table  3.1. 
Sheep 
Genetic  studies  have  shown  that  B  cells  of  sheep  express  ten  germline  genes  from 
a  single  VH  gene  family,  a  homologue  of  the  human  VH4  gene  family  (Dufour  et  al., 
1996)  and  that  the  germline  carries  a  minimum  of  ten  V,,  genes,  classified  into  four 
families  (Hein  and  Dudler,  1999).  The  diversity  of  the  sheep  Ig  repertoire  is  generated 
by  hypermutation  of  mature  rearranged  V  genes,  that  is  via  postrearrangement 
diversification  (Reynaud  et  al.,  1995;  Reynaud  et  al.,  1997).  Sheep  polyclonal 
antibodies  have  been  used  as  specific  high  affinity  immunologic  probes  in  a  variety  of 
immunochemical  approaches  for  analytical  and  clinical  uses.  In  contrast,  ovine 
monoclonal  antibody  technology  is  poorly  developed.  Antibody  phage  display 
technology  has  allowed  the  generation  of  monoclonal  antibody  fragments  from  sheep. 
Libraries  constructed  via  this  manner  are  from  immunised  animal  and  express  antibody 
fragments  in  scFv  form  (Charlton  et  al.,  2000;  Li  et  al.,  2000). 
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The  camelidae  is  the  only  taxonomic  family  known  to  produce  an  important  fraction 
of  their  functional  Ig  as  homodimers  of  only  heavy  chains,  devoid  of  light  chains 
(Hamers-Casterman  et  al.,  1993).  Sequence  analysis  has  shown  that  the  VH  part  of 
these  heavy  chain  antibodies  is  very  similar  to  human  and  mouse  VH.  This  opened  the 
possibility  of  generation  of  single-domain  antibody  fragments  from  cloning  of  the  VH 
genes.  An  antibody  phage  library  from  camels  has  been  constructed  to  select 
antibodies  specific  for  tetanus  toxoid  (Arbabi  et  al.,  1997).  Peripheral  blood 
lymphocytes  were  used  as  source  of  mRNA  for  cDNA  synthesis.  The  V}iH  genes  were 
amplified  using  two  specific  primers  and  amplicons  then  were  cloned  into  pHEN4 
(modified  pHENI  vector  optimised  for  camel  VHH  gene  cloning).  E.  coli  XL  1  and  XL2 
were  used  for  transformation  of  ligated  materials  and  library  generation.  After  selection 
of  positive  clones,  antibody  fragments  were  expressed  as  single  domain  monomeric 
VHH  by  using  WK6  cells. 
Cattle 
A  single  gene  family  comprising  3  subfamilies  dominates  the  bovine  VL  repertoire. 
The  bovine  VH  repertoire  is  also  dominated  by  a  single  gene  family  consisting  of  about 
15  members,  although  there  is  evidence  of  other  gene  families  at  both  the  heavy  and 
light  chain  loci.  A  Fab  phage  display  library,  comprising  more  than  2x  l07clones,  has 
been  constructed  (O'Brien  et  al.,  1999).  In  this  case,  the  lymph  node  of  a  calf 
vaccinated  against  glutathione  S-transferase  (GST)  was  used  as  the  source  of  the  Ig 
repertoire.  After  total  RNA  isolation  and  cDNA  synthesis,  the  light  chain  and  heavy 
chain  repertoires  were  recovered  by  using  one  pair  of  primers  for  each.  The  amplicons 
were  cloned  into  phagemid  pComBov  and  the  ligated  materials  were  transformed  to  E. 
coli  XL1-Blue  cells.  pComBov  is  a  derivative  of  pComb3H  vector  that  has  been 
modified  for  bovine  Fab  phage  library  construction  and  expression.  The  characteristics 
of  pComBov,  the  phagemid  used  in  this  phase  of  the  project,  have  been  discussed  in  the 
end  of  this  section  (subheading  3.1.4). 
3.1.3  Complexity  of  antibody  gene  libraries 
Theoretically,  it  is  sufficient  to  produce  an  antibody  gene  library  only  once.  This 
library  should  approximate  to  the  complexity  of  the  immune  repertoire  in  which  nearly 
every  potential  antibody  is  presented.  For  several  reasons,  however,  this  has  proved 
60 difficult.  First,  it  is  unlikely  that  all  components  of  the  starting  material  will  amplify 
with  equal  efficiency  in  the  PCR  and  successfully  ligate  with  the  chosen  display  vector. 
Next,  the  efficiency  with  which  these  recombinant  molecules  can  be  transformed  is 
limited  and  this  affects  the  complexity  of  resulting  library.  Once  the  display  library  is 
established,  the  selection  system  may  be  pushed  to  its  limit  in  isolating  rare 
components.  Added  to  this,  production  and  cultivation  of  very  large  libraries  requires 
enormous  effort,  leading  to  logistical  limitations. 
According  to  the  intended  application  and  the  affinity  required  for  a  particular 
antibody,  libraries  of  different  complexities  (size)  are  necessary,  ranging  from  just  a 
few  clones  up  to  1010  different  sequences.  For  some  applications,  a  pre-existing 
hybridoma  line  can  deliver  the  antibody  gene  desired.  If  this  source  is  not  available,  an 
antibody  gene  library  must  be  produced,  from  which  the  desired  antibody  can  be 
selected.  Often  for  this  purpose,  a  source  of  B  lymphocytes  (e.  g.  blood)  from  an 
immunised  donor  is  used.  This  preselects  for  antigen-specific  genes  and  hence  libraries 
of  several  million  independent  clones  are  usually  sufficient  to  achieve  the  desired 
recombinant  antibody  fragment.  From  immune  libraries,  antibodies  can  be  obtained 
mainly  against  the  set  of  antigens  to  which  an  immune  response  was  provoked.  In  some 
instances  (e.  g.  when  high  affinity  is  required  or  when  antibodies  are  sought  for  multiple 
antigens),  it  is  necessary  to  generate  large  ("single-pot")  libraries.  Since  the  natural 
primary  antibody  repertoire  within  B  cells  contains  a  large  array  of  IgM  antibodies  that 
recognise  a  variety  of  antigens,  they  can  be  used  for  large  naive  library  construction. 
From  naive  libraries,  antibodies  to  any  chosen  antigens  including  autoantigens,  non- 
immunogenic  and  toxic  substances  are  selected.  On  the  other  hand,  the  diversity 
present  in  the  IgM  repertoire  is  potentially  limited  by  unequal  expression  of  the 
different  V  gene  families  or  segments,  and  the  unknown  immune  history  of  the  B  cell 
donor.  These  factors  can  influence  the  content  and  the  quality  of  the  library.  The 
affinity  of  antibodies  selected  from  a  naive  library  depends  upon  the  size  of  that  library; 
low  affinity  antibodies  are  usually  selected  from  smaller-size  libraries,  but  when  large 
repertoires  (101)  are  available,  high  affinity  antibodies  are  isolated  directly.  Many 
nave  libraries  have  been  generated  in  both  Fab  (de  Haard  et  al.,  1999)  and  scFv 
(Vaughan  et  al.,  1996;  Sheets  et  al.,  1998;  Little  et  al.,  1999;  Sblaterro  and  Bradbury, 
2000)  formats,  using  different  sources  of  IgM  mRNA  including  peripheral  blood 
lymphocytes  (Sheets  et  al.,  1998;  Little  et  al.,  1999;  Sblaterro  and  Bradbury,  2000), 
spleen  (Sheets  et  al.,  1998;  de  Haard  et  al.,  1999),  bone  marrow  and  tonsil  (Vaughan  et 
61 al.,  1996). 
In  the  other  kind  of  single-pot  libraries  -  synthetic  antibody  libraries  -  antibodies  are 
generated  by  in  vitro  assembly  of  V-gene  segments  and  D/J  segments.  Most  of  an 
antibody's  binding  strength  resides  in  the  six  CDRs  and  most  natural  structural  and 
sequence  diversity  is  found  in  the  loop  most  central  to  the  CDR3  of  heavy  chain 
(Chothia  et  al.,  1989).  This  has  been  exploited  to  create  antibodies  entirely  outside  their 
natural  host.  To  construct  a  synthetic  antibody  library,  V-genes  are  assembled  by 
introducing  a  predetermined  level  of  randomisation  to  the  CDRs  (possibly  also  the 
bordering  framework  region)  of  germline  V-gene  segments  (Hoogenboom  and  Winter, 
1992;  Griffiths  et  al.,  1994;  Nissim  et  al.,  1994;  de  Kruif  et  al.,  1995)  or  rearranged  V- 
genes  (Barbas  et  al.,  1992a).  One  of  the  main  advantages  of  synthetic  repertoires  over 
naive  repertoires  is  that  the  contents,  local  variability  and  overall  diversity  of  the  library 
may  be  controlled  and  defined. 
Given  the  importance  of  library  size,  more  efficient  techniques  such  Cre-lox 
recombination  have  been  developed  for  the  construction  of  large  antibody  libraries 
(Waterhouse  et  al.,  1993).  In  this  process,  termed  also  combinatorial  infection,  the 
heavy  and  light  chain  repertoires  are  combined  on  the  same  replicon  within  the 
bacterium  by  Cre  catalysed  recombination  at  IoxP  sites,  generating  a  large  number  of 
combinations,  potentially  as  large  as  the  number  of  bacteria  that  have  been  infected. 
Libraries  with  large  numbers  of  synthetic  Fabs  (close  to  6.5  x  10'°;  Griffiths  et 
aL,  1994)  scFvs  (3  x  1011;  Sblaterro  and  Bradbury,  2000)  have  been  constructed  by 
using  Cre-lox  recombination  and  antibodies  specific  for  many  different  proteins  and 
other  antigens  have  been  isolated  from  them. 
3.1.4  pComBov:  a  system  for  the  production  of  recombinant  bovine  antibodies 
The  pComBov  phagemid  has  been  designed  and  optimised  for  the  construction  of 
combinatorial  libraries  of  bovine  Fab  fragments  (O'Brien  et  al.,  1999).  The  vector  is  a 
modified  form  of  pComb3H,  in  turn,  a  modified  version  of  the  pComb3  vector  (Barbas 
et  al.,  1991). 
3.1.4.1  Composition  and  properties  of  phagemids  pComb3,  pCom3H  and 
pComBov 
The  phagemid  vector  pComb3  is  derived  from  the  phagemid  pBluescript 
(Stratagene)  (Barbas  et  al.,  1991).  It  contains  both  the  origin  of  replication  of  the 
62 multicopy  plasmid  ColEI  and  the  origin  of  replication  of  the  filamentous 
bacteriophage  fl.  pComb3  contains  two  lac  promoters,  one  for  the  transcription  of  the 
heavy  chain  fusion  to  gIIIp  and  one  for  the  transcription  of  the  light  chain.  In  this 
phagemid,  two  pe1B  leader  peptides  direct  independent  transport  of  each  antibody 
fragment  into  the  periplasm  where  natural  assembly  forms  the  Fab  fragment.  The 
carboxyl-terminal  methionine  of  the  pe1B  leader  is  fused  to  sequences  encoding 
AQVKL  and  AE  which  proceed  the  sites  of  heavy  and  light  chain  insertion 
respectively.  Furthermore,  pComb3  contains  the  gene  for  the  enzyme  beta-lactamase 
that  confers  ampicillin  (carbenicillin)  resistance  to  bacteria  that  harbour  pComb3. 
Since  the  vector  contains  the  origin  for  replication  of  phage  fl  but  lacks  the  genes 
required  for  replication  and  assembly  of  phage  particles,  superinfection  with  helper 
phage  is  necessary  for  replication,  assembly  and  display  of  the  cloned  Fab  at  the  viral 
surface  with  native  gIIIp.  Removal  of  the  sequence  encoding  gIIIp  from  pComb3  can 
be  achieved  by  cleavage  with  SpeI  and  NheI  restriction  enzymes.  Induction  of  the  lac 
promoters  then  drives  expression  and  export  of  the  Fab  sequence  alone  into  the 
bacterial  periplasm. 
The  pComb3H  vector  was  designed  to  provide  a  human  consensus  sequence  at  the 
amino  terminus  of  the  heavy  chain,  replacing  sequences  encoding  QVKLLE  with 
EVQLLE.  Furthermore,  the  duplicated  sequences  in  pComb3  were  removed.  This 
includes  one  of  the  lac  promoters,  creating  instead  a  dicistronic  operon  comprising 
light  and  heavy  chain  inserts.  The  pe1B  leader  linked  to  the  light  chain  was  replaced  by 
an  ompA  signal  sequence.  Typically,  the  vector  is  provided  as  pComb3HSS  designating 
that  the  vector  carries  stuffier  fragments  between  cloning  sites  for  the  immunoglobulin 
inserts.  The  heavy  chain  stuffer  is  300  bp  and  the  light  chain  stuffer  is  1200  bp  in 
length.  Like  pComb3,  a  NheI  /  SpeI  digest  allows  for  the  expression  of  soluble  Fab. 
In  the  pComBov  phagemid,  some  changes  were  introduced  to  pComb3H  to  modify 
it  for  bovine  Fab  library  construction.  DNA  downstream  of  the  unique  NruI  site 
located  in  the  bacterial  leader,  was  replaced,  retaining  the  ompA  reading  frame  and 
adding  codons  for  QAVLTQPSS,  the  native  amino  terminus  of  the  bovine  X  light 
chain,  downstream  of  the  predicted  cleavage  point  of  signal  peptidase.  Introduction  of 
Sacl  and  BstEII  restriction  sites  enabled  the  insertion  of  VL  as  SacI  /  BsIEII  fragments. 
The  remainder  of  the  X  constant  domain  (CO  was  amplified  from  bovine  cDNA  and 
inserted  downstream  of  the  light  chain  cloning  site. 
63 Sequences  encoding  the  amino  terminal  residues  of  the  heavy  chain  were  replaced  to 
provide  the  native  bovine  sequence  QVQLRESGPS  (Jackson  et  al.,  1992;  Berens  et  al., 
1997;  Saini  et  al.,  1997;  Sinclair  et  al.,  1997).  An  RsrII  restriction  site  was  embedded 
in  the  last  three  codons  allowing  insertion  of  VH-CH1  amplicons  as  RsrII  /  Spel 
fragments.  As  with  pComb3H,  digestion  with  Spel  and  NheI  removes  the  gill 
sequence,  allowing  for  expression  of  soluble  Fab  (O'Brien  et  al.,  1999). 
Expression  cassettes  of  pComb3,  pComb3H  and  pComBov  are  shown  in  Figure  3.1. 
3.1.5  Objectives 
The  objectives  of  this  aspect  of  the  study  were  to  improve  upon  existing  methods  for 
the  construction  of  bovine  Fab  libraries  in  pComBov  and  to  apply  these  techniques  to 
construction  and  screening  of  a  library  from  calves  immunised  against  Mannheimia 
haemolytica.  We  envisaged  that  recombinant  antibodies  of  defined  specificity  could  be 
used  to  elucidate  the  contribution  of  individual  factors  to  the  pathogenic  process 
through  in  vitro  assay,  organ  culture  or  direct  challenge  studies. 
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LZ 3.2  Materials  and  methods 
3.2.1  RNA  isolation 
Total  RNA  was  prepared  by  using  the  SV  total  RNA  isolation  kit  (Promega)  from 
seven  lymph  nodes  of  calves  vaccinated  against  Mannheimia  haemolytica.  Tissue  was 
packed  in  dry  ice  at  slaughter  for  transport  and  immediately  transferred  to  long-term 
storage  at  -70°C.  The  lymph  nodes  were  provided  by  Dr  W.  Donachie,  Moredun 
Research  Institute,  Edinburgh.  Gloves  were  worn  throughout  the  preparation  of  RNA  to 
reduce  the  chance  of  RNase  contamination.  Pieces  of  lymph  nodes  were  ground  on  dry 
ice  by  mortar  and  pestle  and  the  powder  was  divided  into  40  mg  samples  in  eppendorf 
tubes.  About  200  µl  of  lysis  buffer  containing  0.97%  (3ME  was  added  to  each  sample 
and  mixed  thoroughly  by  inversion.  On  occasions,  the  lysate  was  too  viscous  to  be 
pipetted  so  it  was  repeatedly  passed  through  a  narrow  gauge  needle.  350  µl  of  SV 
dilution  buffer  was  added  to  each  tube  and  after  mixing  by  inverting,  the  samples  were 
incubated  at  70°C  for  3  min  and  centrifuged  at  13000  xg  for  10  min  to  remove  the 
cellular  debris  and  proteins.  For  purification  of  the  RNA,  200  Al  of  95%  ethanol  was 
added  to  each  cleared  lysate  and  mixed  by  pipeting  3-4  times.  The  mixture  was  loaded  to 
a  spin  column  and  was  centrifuged  at  13000  xg  for  1  min.  The  bound  RNA  was  then 
washed  by  adding  600  µ1  of  washing  solution  and  centrifuging  at  13000  xg  for  1  min. 
To  eliminate  contaminating  DNA,  each  column  was  treated  with  50  µ1  of  DNase 
solution  and  incubated  at  room  temperature  (20-25°C)  for  15  min  before  addition  of  200 
. tl  of  DNase  stop  solution  to  each  column  membrane.  Columns  were  centrifuged  at 
13000  xg  for  1  min  and  again  were  washed  twice  by  addition  of  600µ1,  then  250  p1  of 
washing  solution  and  centrifugation  at  13000  xg  for  1  and  2  min  respectively.  The 
bound  RNA  was  eluted  by  adding  100  t1  of  nuclease-free  water  to  the  membrane  of  each 
column  and  then  centrifuging  at  13000  xg  for  2  min. 
The  concentration  of  RNA  was  determined  by  spectrophotometry  at  230,260  and  280 
nm  and  the  ratios  260/230  and  260/280  were  calculated  as  indices  of  guanidine  and 
protein  contamination  respectively. 
Concentration  of  RNA 
To  concentrate  the  RNA,  NaCI  was  added  to  a  final  concentration  of  0.1  M  and  after 
adding  2.5  volumes  of  cold  absolute  ethanol,  the  mixture  was  incubated  at  -  20°C  for  30 
min.  It  was  then  centrifuged  at  10000  xg  for  15  min  at  4°C.  The  RNA  pellet  was 
65 resuspended  in  nuclease-free  water. 
3.2.2  cDNA  synthesis 
Single  and  double  strand  cDNAs  were  prepared  from  RNA  and  were  used  as  template 
to  recover  the  light  chain  and  heavy  chain  repertoires  at  different  stages  of  the 
experiments  described  below. 
Double  strand  cDNA  synthesis 
Double  strand  cDNA  was  synthesised  using  the  Universal  Riboclone  cDNA  Synthesis 
system  kit  (Promega).  In  all  reactions,  nuclease-free  water  was  used  to  prevent 
degradation  of  the  RNA  or  DNA.  First  strand  synthesis  was  driven  by  avian 
myeloblastosis  virus  (AMV)  reverse  transcriptase  using  random  hexamer  and  oligo(dT) 
primers  in  two  separate  reactions.  In  each  reaction  of  15  µl,  2  µl  of  primer  (500  µg  /  ml) 
was  added  to  about  20  gg  of  RNA  (estimated  to  contain  about  2  Itg  mRNA).  The 
mixtures  were  heated  to  70  °C  for  10  min  and  then  chilled  on  ice  for  5  min.  First  strand 
cDNA  synthesis  was  carried  out  in  a  25  µl  reaction  containing  15  µl  sample,  30  units  of 
AMV  reverse  transcriptase,  40  units  of  RNasin  ribonuclease  inhibitor,  4  mM  sodium 
pyrophosphate  and  5  µl  of  first  strand  5x  buffer  that  provided  50mM  Tris-HCI  (pH  8.3), 
50  mM  KCI,  10  mM  MgC12,10  mM  DTT,  0.5  mM  spermidine  and  1mM  of  each  dNTP. 
Reactions  were  incubated  for  60  min  at  37°C  and  42°C  for  random  hexameric  primers 
and  oligo(dT)  primer  respectively. 
After  incubation, 20  µ1  of  each  reaction  was  used  in  a  second  strand  synthesis  reaction 
of  100  µl.  The  reaction  contained  23  units  DNA  polymerase  I,  0.8  units  RNase  H  and  40 
µl  of  the  second  strand  2.5x  buffer.  The  buffer  provided  40  mM  Tris-HCI  (pH  7.2),  90 
mM  KC1,3  mM  MgC12,3  mM  DTT  and  0.5  mg  /  ml  bovine  serum  albumin.  Reactions 
were  incubated  at  14  °C  for  2  hrs  and  then  were  heated  at  70°C  to  inactivate  the  enzymes. 
After  centrifugation  and  incubation  on  ice  for  5  min,  4  units  of  T4  DNA  polymerase  was 
added  and  the  reaction  temperature  was  raised  to  37°C  for  10  min.  Ten  µl  of  200  mM 
EDTA  was  added  to  each  sample  to  stop  the  reactions.  cDNA  was  then  isolated.  An 
equal  volume  of  TE-saturated  phenol-chloroform-isoamyl  alcohol  was  added  to  each 
reaction  and  mixed  by  inversion.  To  separate  the  aqueous  phase,  the  tubes  were 
centrifuged  at  room  temperature  for  2  min.  cDNA  was  precipitated  by  using  0.1  volume 
2.5  M  sodium  acetate  and  2.5  volumes  cold  absolute  ethanol.  Mixtures  were  incubated  at 
66 -70°C  for  30  min.  The  tubes  were  then  centrifuged  at  high  speed  for  5  min.  The  pellets 
were  washed  with  0.5  ml  cold  70%  ethanol  and  were  centrifuged  again  for  2  min.  The 
supernatants  were  removed  and  the  pellets  were  resuspended  in  15  µ1  of  TE  buffer. 
Single  strand  cDNA  synthesis 
Single  strand  cDNA  was  prepared  by  using  the  SuperScript  II  RNase  H  reverse 
transcriptase  (Life  Technologies).  The  general  procedure  was  as  described  above  for  first 
strand  cDNA  synthesis  with  differences  detailed  as  follows.  One  tl  (500  p.  g  /  ml)  of  each 
oligo(dT)  and  random  hexameric  primers  was  used  in  separated  12  µl  reactions,  each 
containing  4  µg  RNA  and  lµl  of  10mM  dNTPs.  Each  mixture  was  incubated  at  65  °C  for 
5  min  and  then  on  ice  for  2  min.  Four  µl  of  5x  first  strand  reaction  buffer,  2  µ.  l  of  100 
mM  DTT,  1  µl  of  RNasin  ribonuclease  inhibitor  (40  units)  were  added  to  each  reaction 
and  after  incubation  at  42  °C  for  2  min  (reactions  primed  with  random  hexamers  were 
held  at  25  °C  for  4  min  before  incubation  at  42  °C),  1  µl  of  SuperScript  II  reverse 
transcriptase  containing  (200  units)  was  added  to  drive  first  strand  synthesis.  The  5x  first 
strand  buffer  provided  final  concentrations  of  50  mM  Tris-HC1  pH  8.3,75  mM  KC1  and 
3  mM  MgCl2.  The  reactions  were  incubated  at  42  °C  for  50  min  with  a  preincubation  of 
hexameric-primed  reaction  at  25  °C  for  10  min.  . 
Reactions  then  were  inactivated  at  70 
°C  for  15  min.  To  remove  any  remaining  RNA,  2  units  of  RNase  H  was  added,  and 
reactions  were  incubated  at  37  °C  for  20  min. 
3.23  Recovery  of  heavy  (H)  and  light  (L)  chain  repertoires 
In  different  stages  of  this  study,  repertoires  of  the  light  chain  variable  region  (VL)  and 
the  heavy  chain  -  the  variable  domain  and  most  of  the  first  constant  region  -  were  each 
amplified  from  cDNA  prepared  with  oligo(dT)  and  random  hexameric  primers.  PCR 
reactions  were  carried  out  with  different  polymerases  including  Taq  DNA  polymerase 
(Promega)  and  Pfu  DNA  polymerase  (Promega).  As  discussed  before,  pComBov,  the 
phagemid  used  for  Fab  library  construction,  contains  a  CL  gene  and  so  only  the  VL 
repertoire  needs  to  be  cloned.  The  vector  also  carries  a  stuffer  fragment  between  cloning 
sites  for  the  heavy  chain  inserts.  In  common  with  many  domesticated  animals,  cattle  use 
a  limited  range  of  VL  and  VH  segments  to  establish  the  antibody  repertoire.  Thus  few 
primers  are  required  for  amplification  and  recovery  of  the  immunoglobulin  repertoire. 
Primer  sequences  are  shown  in  Table  3.9.  The  general  conditions  for  PCR  amplification 
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indicated. 
Repertoire  recovery  with  Taq  DNA  polymerase 
PCR  reactions  were  performed  with  0.5-1  µl  cDNA  in  a  reaction  volume  of  50  µl 
with  final  concentrations  of  500  µ.  M  dNTPs  (Promega),  400  nM  of  each  primer  and  2-4 
mM  MgC12.  In  addition,  the  reaction  buffer  provided  50  mM  KCI,  10  mM  Tris-HCI  (pH 
9.0)  and  0.1%  TritonýX-100.  Five  units  of  Taq  DNA  polymerase  (Promega)  were  used 
for  amplification  with  the  following  cycling  conditions.  The  reactions  were  heated  to 
94°C  for  5  min  and  were  then  incubated  for  35  cycles  of  94  °C  for  I  min,  55-57  °C  for  1 
min  and  72  °C  for  3  min,  with  a  final  incubation  of  72  °C  for  5  min. 
Repertoire  recovery  with  Pfu  DNA  polymerase 
The  VL  and  heavy  chain  repertoires  were  amplified  using  Pfu  polymerase  with  the 
following  conditions.  The  PCR  reactions,  mostly  with  a  volume  of  50  µl,  contained  1.5 
units  Pfu,  final  concentrations  of  300  µM  dNTPs,  400  nM  of  each  primer,  1.5  µl  cDNA, 
20  mM  Tris-HCl  (pH  8.8),  10  mM  KCI,  10mM  (NH4)2SO4,2  mM  MgSO4,0.1  mg/ml 
BSA,  0.1%  Trition®X-100.  The  reactions  were  kept  on  ice  prior  to  thermal  cycling. 
Thermal  cycling  consisted  of  one  cycle  of  2-4  min  at  94  °C  for  initial  denaturing,  35 
cycles  of  94  °C  for  1  min,  56  °C  for  I  min,  and  72  °C  for  2.5  min,  followed  by  final 
extension  at  72  °C  for  5  min. 
3.2.4  Direct  cloning  of  light  chain  segment 
Firstly,  direct  cloning  was  chosen  as  strategy  for  cloning  of  light  chain  and  heavy 
chain  amplicons.  Phagemid  pComBov  (O'Brien  et  al.,  1999)  was  used  as  vector  for  Fab 
library  construction. 
Initially,  efforts  were  made  to  clone  the  VL  segments.  In  total,  five  attempts  were 
made  to  achieve  this  aim.  In  each  attempt,  potentially  significant  changes  in  protocol 
were  introduced;  these  modifications  are  highlighted  in  the  text  which  follows.  In  these 
attempts,  the  VL  repertoires  were  amplified  from  cDNA  by  using  Taq  DNA  polymerase 
and  primers  VL1  and  VL2.  These  primers  were  based  on  the  known  sequences  of  bovine 
light  chains  and  contain  recognition  sites  for  SstI  and  BstEII  respectively  (O'Brien  et  al, 
1999).  After  digestion  with  these  enzymes,  the  amplicons  could  be  cloned  into 
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Procedures  used  in  the  first  experiment  are  described  in  detail.  For  other  experiments, 
only  variations  to  this  basic  method  are  described.  About  800ng  of  amplicons  of  the  VL 
repertoire  and  the  pComBov  vector  were  digested  by  30  units  of  SstI  and  BstEII  (Life 
Technologies).  Digestion  was  done  concurrently  in  buffer  number  2  provided  by 
manufacturer,  incubating  the  reactions  for  1.5  hrs  at  37  °C  and  then  1.5  hrs  at  60  °C.  This 
should  release  the  short  sequence  separating  the  light  chain  cloning  sites  in  pComBov 
and  also  digest  the  termini  of  the  VL  amplicons.  After  heat  inactivation  of  the  enzymes  at 
75  °C  for  15  min,  samples  were  run  on  agarose  gels  and  pComBov  and  VL  DNA 
extracted  from  gel  slices  using  extraction  columns  (Life  Technologies)  or  QIAEXII  resin 
(QIAGEN).  They  were  then  mixed  and  ligated. 
In  addition,  pComBov  DNA  carrying  a  bovine  light  chain  (pComBov-L)  was  digested 
with  the  same  enzymes  to  provide  control  material.  After  digestion,  a  sample  of  the 
reaction  was  run  on  a  gel  to  confirm  that  the  pComBov-L  had  been  digested  successfully 
with  each  enzyme.  The  vector  and  light  chain  fragments  were  then  isolated.  Purified 
fragments  and  the  pComBov-L  digestion  products  prior  to  gel-purification  were  mixed  in 
ligation  reactions  according  to  Table  3.2.  Ligation  was  performed  in  10-20  µl  reactions 
with  an  insert/vector  ratio  of  2/1  ligations,  150  ng  of  vector  DNA  and  4  units  of  T4  DNA 
ligase  (Life  Technologies).  Reactions  were  incubated  at  16  °C  for  16-20  hrs.  Ligation 
reactions  then  were  transformed  into  Epicurian  Coli  Solopack  Gold  supercompetent  cells 
(Stratagene)  using  heat  shock  at  54  °C  for  60  sec.  After  1  hr  incubation  with  shaking,  20 
pl  of  each  transformation  reaction  was  plated  onto  LA  containing  100  Itg/ml 
carbenicillin,  12  µg/ml  tetracycline  and  1%  glucose.  Results  showed  that  reaction  C  had 
significantly  higher  transformation  efficiency  than  the  other  two  reactions.  Assessment 
for  insert  frequency  was  done  by  restriction  analysis  of  plasmid  DNA  from  10  colonies 
from  each  transformation.  Plasmids  were  isolated  by  QlAprep  spin  miniprep  kit 
(QIAGEN)  and  were  then  cut  by  EcoRI  (Promega).  Digestion  products  were  run  on 
agarose  gels  and  their  sizes  were  compared  with  linearised  pComBov  and  pComBov-L 
DNA.  Insert  frequency  was  also  determined  by  PCR  using  Taq  DNA  polymerase  and 
primers  VL1  and  VL2.  Isolated  PCR  products  from  different  clones  were  digested  by 
EcoRII  (Promega)  to  determine  sequence  diversity. 
Colonies  chosen  from  reaction  A  did  not  possess  any  inserts  perhaps  due  to  the 
incomplete  digestion  of  pComBov  and  its  subsequent  religation.  All  colonies  chosen 
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chain  fragments  from  two  sources.  +  indicates  the  digest  added  to  each  ligation 
reaction. 
A  B  C 
pComBov  + 
VL  amplicons  +  +  + 
pComBov 
released  from  pComBov-L) 
+  + 
Light  chain  fragment 
released  from  pComBov-L) 
+ from  reaction  C  possessed  insert  and  the  EcoRII  digestion  profile  indicated  that  90%  of 
them  were  identical,  meaning  that  the  majority  of  inserts  were  those  released  from 
pComBov-L,  not  the  VL  amplicons  prepared  from  lymph  node  cDNA.  These  data 
suggested  a  significant  difference  between  the  efficiency  of  restriction  digestion  between 
VL  amplicons  and  VL  fragments  released  from  pComBov-L. 
Dephosphorylation  of  vector 
Since  the  first  attempt  to  clone  VL  amplicons  into  pComBov  suggested  vector 
religation  was  a  complicating  factor,  we  evaluated  the  effect  of  dephosphorylating 
pComBov  after  digestion  with  SstI  and  BstEII.  Vector  DNA  was  isolated  from  gel  slices 
using  the  ConcertTM  gel  extraction  columns  (Life  Technologies).  Dephosphorylation  was 
performed  in  a  100  tl  reaction  using  1  tl  of  calf  intestinal  alkaline  phosphatase  (CIAP; 
Life  Technologies)  and  incubation  at  37  °C  for  30  min.  The  reactions  were  stopped  by 
addition  of  EDTA  to  a  final  concentration  of  5  mM  and  heating  to  56  °C  for  30  min  to 
inactivate  the  enzyme.  DNA  was  extracted  with  phenol-chloroform  and  recovered  in 
distilled  water  after  ethanol  precipitation.  Ligation  were  set  up  with  an  insert/vector 
ratio  of  3/1  using  12  units  of  T4  ligase  (Life  Technologies)  for  16  hrs  at  16  T.  Solopack 
Gold  supercompetent  cells  (Stratagene)  were  used  for  transformation.  These  reactions 
failed  to  yield  any  transformants. 
Variation  to  insert/vector  ratio 
In  the  next  attempt,  a  range  of  insert/vector  ratios  -  1/1,2/1,3/1  and  4/1  -  were  tested. 
Twenty  tl  ligation  reactions  containing  9  units  T4  ligase  (Promega),  150  ng  of 
pComBov  (without  any  dephosphorylation  treatment)  were  set  up  with  digested  VL 
amplicons  at  the  indicated  ratios.  Reactions  were  incubated  at  16  °C  for  18  hrs  and  then 
transformed  into  NovaBlue  competent  cells  (Novagen).  Again,  these  reactions  failed  to 
yield  any  transformants.. 
Study  of  the  efficiency  of  restriction  digestion  of  VL  arnplicons 
Following  from  the  experiments  described,  we  studied  the  efficiency  with  which  VL 
amplicons  were  digested. 
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In  this  attempt,  light  chain  fragments  released  from  a  clone  of  pComBov-L  were  used 
for  cloning.  After  digestion  of  pComBov  and  pComBov-L  with  Sstl  and  BstEII,  VL 
fragments  and  vector  fragments  from  each  source  were  extracted  separately  using  the 
Concert  gel  extraction  system  columns.  Two  series  of  reactions  were  set  up  for 
ligation  of  VL  fragments  with  each  pComBov  fragment  using  insert/vector  ratios  of  1/1, 
1/2  and  5/1.  In  each  series,  an  additional  ligation  reaction  lacking  the  insert  evaluated 
background  due  to  the  presence  of  vector  cut  at  just  one  site.  Transformation  was  carried 
out  using  NovaBlue  competent  cells  (Novagen).  This  experiment  revealed  that  the 
cloning  problem  could  not  be  attributed  to  the  pComBov  vector. 
-  Elevated  concentration  of  restriction  enzymes 
Finally,  pComBov  and  1µg  of  VL  amplicons  produced  with  Pfu  were  digested  with 
150  units  of  Sstl  and  BstEII.  The  digested  DNA  was  run  on  an  agarose  gel  and  then 
isolated  using  QIAEXII  resin.  Insert  and  vector  were  added  to  10  91  ligation  reactions  at 
ratios  of  3/1  and  5/1.  After  overnight  incubation  at  16  °C,  2.5  µl  of  each  ligation  reaction 
was  transformed  into  XL1  electrocompetent  cells.  The  very  low  numbers  of 
transformants  isolated  showed  that  the  persistent  resistance  of  VL  amplicons  to  digestion, 
perhaps  due  to  the  proximity  of  the  restriction  sites  to  the  termini. 
The  difficulties  encountered  in  cloning  the  VL  repertoire  directly  led  us  to  change  the 
strategy  and  to  construct  intermediate  libraries  of  VL  and  heavy  chain  fragments.  In  this 
way,  release  of  the  fragments  after  digestion  guarantees  their  suitability  for  recloning 
into  the  phage  display  vector. 
3.2.5  Construction  of  intermediate  library 
Dephosphorylated  Smal-cut  pUC18  (Pharmacia)  was  chosen  as  the  intermediate 
vector  for  the  construction  of  libraries.  Two  separate  PUC-VL  and  pUC-H  libraries  were 
generated  as  described  in  the  following  protocols. 
3.2.5.1  Intermediate  VL  library 
Amplification  of  the  VL  repertoire 
VL  repertoire  was  amplified  from  lymph  node  cDNA  using  Pfu  DNA  polymerase  as 
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amplification  of  the  repertoire  using  cDNA  prepared  with  oligo(dT)  and  random 
hexameric  primers.  The  PCR  products  were  mixed  and  run  on  a  1%  agarose  gel.  The 
band  was  excised  and  amplicons  were  extracted  using  columns  from  Concert  gel 
extraction  kits  (Life  Technologies).  DNA  was  eluted  in  400  tl  of  TE  and  its 
concentration  was  measured  by  spectrophotometry  at  260  nm. 
Phosphorylation  and  polishing  reactions 
The  VL  repertoire  was  amplified  with  primers  without  5'  phosphate  groups,  and 
although  Pfu  polymerase  should  create  blunt  termini,  it  was  judged  wise  to  polish  the 
amplicons.  Phosphorylation  and  polishing  were  performed  concurrently  according  to 
protocol  described  insubheading  2.2.2.2.  with  one  variation:  desalting  of  the  final 
products  was  carried  out  with  QIAEXII  resin  instead  of  ethanol  precipitation. 
Ligation 
In  total,  six  attempts  were  made  to  clone  VL  amplicons  into  pUC18,  each  consisting 
of  several  ligation  reactions  of  10-20  µl,  different  ratios  of  insert/vector  (5-50/1)  and 
vector  concentration  of  20-50  ng/reaction.  Since  blunt  end  ligation  requires  about  50 
times  more  T4  ligase  than  cohesive  ligation,  1  µl  of  a  high  concentration  product 
containing  400  units/µl  (New  England  BioLabs)  was  used  in  each  reaction.  Ligation 
buffer  provided  final  concentrations  of  50  mM  Tris-HC1  (pH  7.5),  10  mM  MgC12i  10 
mM  DTT,  25  jig/ml  BSA  and  50  µM  ATP.  Following  the  supplier's  recommendation, 
the  concentration  of  ATP  was  reduced  from  ImM  to  50  µM  to  enhance  ligation 
efficiency.  Reactions  were  incubated  at  15-16  °C  for  18-24  hrs. 
Transformation 
For  transformation  of  the  ligated  DNA,  E.  co1i  XL1-Blue  electrocompetent  cells  were 
used.  The  cells  were  prepared  according  to  a  method  described  by  Prof  W.  Barnes 
(http:  //bamesl.  wustl.  edu/wayne/electrocompetent.  html).  A  few  colonies  of  E.  coif  from 
an  LA  plate  were  picked  into  30  ml  of  LB  and  media  was  incubated  at  37  °C  overnight 
with  shaking.  The  following  day,  10  ml  of  culture  was  inoculated  in  1  litre  2xTY 
medium  in  a2  litre  flask  and  shaken  at  37  °C  until  the  optical  density  at  550  nm  reached 
between  0.4  and  0.5.  The  culture  then  was  chilled  on  ice  to  prevent  further  growth,  it  was 
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supernatant  was  poured  off  and  the  pellets  were  resuspended  in  1/3  initial  culture  volume 
of  cold  10  %  glycerol  in  Millipore  water  with  minimal  force.  The  mixture  was  again 
spun  and  washed  3  more  times  with  successively  smaller  volumes  of  cold  10  %  glycerol 
until  the  volume  of  suspension  was  twice  the  cell  pellet  volume.  All  washing  steps  and 
centrifugation  were  carried  out  on  ice  and  at  4  °C  respectively.  Cells  were  divided  into 
100  µl  aliquots  and  were  transferred  into  liquid  nitrogen  for  storage  at  -80  °C. 
For  transformation  by  electroporation,  the  prepared  competent  cells  (l00µ1)  were 
gently  thawed  on  ice.  1-4  µl  of  ligation  reaction  was  added  to  the  cells  and  after  mixing, 
the  suspension  was  added  to  the  bottom  of  a  cold,  1  mm  electroporation  cuvette 
(Filtron).  The  cuvette  was  placed  in  the  electroporator  (BioRad)  and  pulsed  once  at  25 
µF,  1.7  kV  and  200  92.  Nine  hundred  µl  SOC  medium  was  immediately  added  to  the 
cuvette.  After  mixing,  cells  were  transferred  to  a  1.5  ml  eppendorf  tube,  and  incubated  at 
37  °C  with  shaking  for  1  hr.  From  1  ml  of  culture,  10-20  µl  was  plated  on  LA  containing 
100  µg/ml  ampicillin,  40  µl  of  4%  (w/v)  X-gal  and  40  µl  of  25  mM  IPTG  and  incubated 
at  37  °C  overnight.  The  size  of  the  library  was  measured  according  the  number  of  white 
colonies  recovered  from  each  transformation. 
Assessment  of  intermediate  pUC-VL  library 
To  assess  the  insert  frequency  in  the  PUC-VL  library,  plasmids  from  20  white 
colonies  were  isolated  as  described  in  Appendix  2.  DNA  was  digested  with  EcoRI 
(Promega)  and  run  on  1%  agarose  gels.  The  size  of  the  plasmids  was  compared  with  the 
size  of  cut  pUC  18  and  control  pUC-VL  plasmids  known  to  contain  inserts.  In  addition, 
insert  frequency  was  determined  by  PCR  using  M13/pUC  forward  and  reverse  flanking 
primers  (sequences  shown  in  Table  2.1).  PCR  was  performed  with  Taq  DNA  polymerase 
under  the  conditions  described  in  subheading  3.2.3  with  a  final  concentration  of  3.5  mM 
MgC12  and  an  annealing  temperature  of  56  °C.  The  PCR  products  were  run  on  1.2% 
agarose  gels  to  check  the  size  of  inserts. 
The  diversity  of  inserts  carried  in  the  pUC-VL  was  determined  by  EcoRII  digestion 
of  Taq  amplicons  from  clones  picked  at  random.  DNA  profiles  were  analysed  on  3% 
agarose  gel  for  comparison. 
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For  construction  of  the  pUC-H  library,  PCR  conditions,  phosphorylation  and 
polishing,  ligation,  transformation,  were  identical  to  those  described  for  the  PUC-VL 
library.  Primers  VHI  and  VH2  were  used  for  amplification  of  heavy  chain  repertoire. 
These  carry  recognition  sequences  for  RsrII  and  Spel  respectively.  To  characterise  the 
library,  40  colonies  were  analysed. 
3.2.6  Recloning  of  VL  and  H  fragment  repertoire  into  pComBov 
After  construction  of  pUC-VL  and  pUC-H  intermediate  libraries,  we  planned  to 
release  the  VL  and  heavy  chain  repertoires  for  recloning  into  pComBov. 
3.2.6.1  Recloning  of  the  VL  repertoire 
Growth  of  the  pUC-VL  library 
Transformation  mixtures  containing  the  pUC-VL  library  were  mixed  together  and  the 
volume  adjusted  to  200  ml  with  2xTY  media  containing  150  pg/ml  ampicillin  and  1% 
glucose.  The  culture  was  incubated  at  37  °C  with  shaking  for  2  hrs.  Ten  ml  of  the  culture 
was  taken  and  after  adding  5  ml  of  50%  sterile  glycerol,  it  was  stored  at  -80  °C  as  a 
stock  library.  The  remaining  culture  was  centrifuged  at  6000  rpm  for  10  min,  the 
supernatant  was  discarded  and  the  pellet  was  resuspended  in  200  ml  of  2xTY  containing 
200  tg/ml  of  ampicillin  and  1%  glucose.  Culture  was  incubated  overnight  at  37  °C  with 
shaking. 
Preparation  of  the  VL  repertoire  and  pComBov  DNA  for  ligation 
The  following  day,  plasmid  DNA  was  isolated  using  a  Midiprep  plasmid  purification 
system  (Life  Technologies).  A  sample  of  the  isolated  DNA  was  run  on  an  agarose  gel  to 
check  its  concentration.  Since  some  smearing  was  evident,  2  ml  of  DNA  was  loaded  to  a 
large  preparative  gel  and  the  band  corresponding  to  pUC-VL  was  extracted  with 
QIAQuick®  Gel  extraction  kit  (QIAGEN).  The  concentration  of  the  prepared  DNA  was 
measured  by  spectrophotometry. 
Restriction  digestion 
Plasmid  DNA  from  the  pUC-VL  library  and  pComBov  were  digested  with  SstI  and 
BstEII  to  obtain  the  VL  fragment  and  the  cut  phagemid.  Firstly,  about  7  tg  of  PUC-VL 
74 plasmid  was  digested  with  70  units  BstEII  (Life  Technologies)  in  a  volume  of  380  µl.  In 
a  separate  reaction  of  300  µl,  70  units  of  BstEII  was  used  to  cut  about  7.5  pg  of 
pComBov.  Buffering  was  according  to  the  manufacturer's  recommendation.  Reactions 
were  incubated  at  60  °C  for  3.5  hrs.  BstEII  and  SstI  (Life  Technologies)  work  in  the  same 
buffer.  Therefore,  200  units  of  Sst1  and  10  µl  of  reaction  buffer  were  added  to  the  pUC- 
VL  reaction  and  volume  was  increased  to  485  µl  with  distilled  water.  Similarly,  100  units 
of  Sal,  10  µl  reaction  buffer  and  85  µl  distilled  water  were  added  to  the  pComBov 
reaction.  Reactions  were  incubated  at  37  °C  for  another  3.5  hrs.  After  inactivation  at  70 
°C,  the  digested  samples  were  run  on  0.7%  agarose  gels  and  the  bands  (released  VL  350 
bp,  pComBov  4  kb)  extracted  using  QIAQuick®  Gel  extraction  kit.  The  concentrations  of 
extracted  DNA  were  estimated  by  running  3  µl  of  each  sample  on  an  agarose  gel. 
Cloning  of  the  VL  repertoire  into  pComBov 
To  clone  the  VL  repertoire  into  BstEII  /  SstI  cut  pComBov,  two  series  of  ligation 
reactions  were  set  up.  The  first  series  consisted  of  two  ligation  reactions  as  controls  for 
religation  of  the  vector  with  different  amounts  of  T4  DNA  ligase.  T4  DNA  ligase  was 
used  at  concentrations  of  6  units/reaction  (Promega)  and  400  units/reaction  (New 
England  BioLabs).  In  the  second  set,  4  and  6  reactions  were  allocated  to  the  cloning  of 
VL  fragments  into  pComBov,  with  T4  DNA  ligase  at  6  units/reaction  and  400 
units/reaction  respectively.  About  150  ng  of  cut  pComBov  was  used  in  all  reactions  with 
about  50  ng  of  VL  fragment  to  provide  an  insert/vector  ratio  of  about  5/1.  (Table  3.3). 
Reactions  were  incubated  at  16  °C  for  18  hrs. 
Transformation  of  ligated  materials 
E.  coll  XL1-Blue  electrocompetent  cells  were  prepared  and  transformed  by 
electroporation  as  described  in  subheading  3.2.5.1.  Two  µl  of  each  ligation  reaction  was 
transformed  into  100  µl  of  competent  cells  and  after  adding  900  µl  SOC  medium,  20  µl 
was  plated  on  LA  containing  50  gg/ml  carbenicillin  and  15  µg/ml  tetracycline.  Plates 
were  left  at  37  °C  overnight  and  next  day  the  colonies  were  counted.  There  was  a  marked 
difference  between  cloning  transformations  and  controls  for  vector  self-ligation  (Table 
3.14).  Hence,  further  cloning  transformation  were  performed. 
75 Table  3.3  Composition  and  volume  of  reagents  (µl)  used  for  cloning  VL  fragments  into  pComBov 
to  construct  pComBov-VL  library.  Each  series  of  ligation  reactions  were  performed  at  two 
concentrations  of  T4  DNA  ligase. 
Self  ligation  control  VL/  pComBov  ligation 
T4  DNA  ligase  3U/  µl  2  2  - 
T4  DNA  ligase  400  U/  µl  -  1  -  I 
Appropriate  10  x  reaction  buffer  1  1  1.6  1.5 
V,  fragment  -6-7  ng/µl  -  -  9  9 
pComBov  -40-50  ng/µl  3.5  3.5  3.5  3.5 
Insert/  Vector  ratio  -  -  511  511 
Distilled  water  3.5  3.5  -  - 
Number  of  ligation  reactions  1  1  4  6 Characterisation  of  the  pComBov-VL  library 
Fifteen  colonies  from  the  pComBov-VL  library  were  picked  to  determine  insert 
frequency.  They  were  inoculated  into  5  ml  LB  and  incubated  at  37  °C  overnight  with 
shaking.  Next  day,  plasmid  DNA  was  isolated  using  the  QlAprep  spin  miniprep  kit  as 
described  in  Appendix  2.  Seven  µl  of  each  plasmid  was  digested  with  EcoRI  at  37  °C  for 
1.5  hrs.  Insert  frequency  was  determined  by  running  the  digested  DNA  on  a  0.7% 
agarose  gel  with  linearised  plasmid  from  a  confirmed  pComBov-VL  clone  as  control.  In 
addition  to  this,  all  isolated  plasmids  and  the  control  pComBov-VL  sample  were 
subjected  to  PCR  using  VL1  and  VL2  primers,  using  an  annealing  temperature  of  56  T. 
3.2.6.2  Recloning  of  H  fragment  into  pComBov-VL  library 
Having  recloned  the  VL  repertoire  into  pComBov,  the  last  stage  of  Fab  library 
construction  required  release  of  the  heavy  chain  repertoire  from  the  pUC-H  library  and 
recloning  into  the  pComBov-VL  library.  Several  attempts  were  made  to  achieve  this 
objective:  protocols  for  preparing  DNA,  digestion,  ligation  conditions  and 
transformation  are  described  in  detail  in  the  following  sections.  Variations  to  these 
conditions  then  follow. 
Growth  of  the  p  UC-H  and  pComBov-VL  libraries 
Transformation  mixtures  of  the  pUC-H  and  pComBov-VL  libraries  were  mixed,  and 
their  volumes  adjusted  to  265  ml  and  250  ml  respectively  with  2xTY  and  glucose  to  a 
final  concentration  of  1%.  Ampicillin  and  carbenicillin  were  added  to  the  pUC-H  and 
pComBov-VL  cultures  respectively  to  a  final  concentration  of  75  ng/ml.  Cultures  were 
incubated  at  37  °C  for  2  hrs  with  shaking.  From  each  library,  10  ml  was  sampled  and  5 
ml  of  50%  sterile  glycerol  was  added  to  each  before  storage  at  -80  °C  as  stocks.  The 
remaining  cultures  were  centrifuged  at  6000  rpm  for  10  min,  supernatants  were 
discarded  and  the  pellets  were  resuspended  in  200  ml  2xTY  containing  100  ng/ml 
carbenicillin  and  1%  glucose.  They  were  then  incubated  at  37  °C  overnight  with  shaking. 
Stock  libraries  were  resampled  for  subsequent  plasmid  isolations. 
Preparation  ofpUC-H  and  pComBov-VL  DNA  for  ligation 
Plasmid  DNA  from  the  pUC-H  and  pComBov-VL  libraries  was  isolated  using 
QlAprep  spin  miniprep,  Miniprep  and  Midiprep  plasmid  reagents.  To  improve  the 
thoroughness  of  the  purification  and  to  concentrate  the  isolated  material,  DNA  was  run 
76 on  0.7%  agarose  gels,  the  relevant  bands  were  excised  and  DNA  was  extracted  using 
Concert  gel  extraction  system  columns.  The  concentration  of  DNA  was  estimated  by 
running  5  µl  samples  on  a  0.7%  agarose  gel. 
Restriction  digestion 
In  separate  reactions,  about  13  gg  of  pUC-H  and  6  µg  of  pComBov-VL  DNA  were 
digested  concurrently  with  RsrII  and  SpeI  (Life  Technologies).  For  digestion  of  pUC-H 
and  pComBov-VL,  120  units  and  100  units  of  RsrII  and  80  units  and  70  units  of  SpeI 
were  used  respectively.  Reaction  conditions  were  controlled  with  buffer  5  with  a  final 
concentration  of  1  mM  dithiothreitol  (DU)  (Table  3.4).  According  to  the  manufacturer's 
information,  SpeI  cuts  DNA  with  75%  efficiency  under  these  conditions.  The  reactions 
were  incubated  at  37  °C  and  after  4.5  hrs,  samples  were  assessed  on  an  agarose  gel  to 
verify  that  the  DNA  had  cut  as  expected.  Since  the  heavy  stuffer  in  pComBov  carries  an 
RsrIf  site,  digestion  of  pComBov-VL  was  expected  to  release  fragments  of  100  and  250 
bp  after  digestion  with  RsrII  and  Spel.  pUC-H  should  release  a  heavy  chain  fragment  of 
about  660  bp  with  these  enzymes.  After  confirmation,  each  entire  reaction  was  run  on  a 
0.7  %  agarose  gel  and  the  bands  of  interested  -  the  fragment  corresponding  to  the  heavy 
chain  repertoire  and  the  prepared  pComBov-VL  vector  -  were  isolated  using  Concert  gel 
extraction  reagents.  The  concentration  of  each  DNA  was  estimated  by  running  of  2  µ1  of 
eluted  DNA  on  an  agarose  gel  before  setting  up  ligation  reactions. 
Ligation 
Two  sets  of  ligations,  with  low  and  high  concentrations  of  T4  ligase,  were  set  up  for 
cloning  the  heavy  chain  fragments  into  the  pComBOV-VL  library  (Table  3.5).  In  the  first 
set,  6  units  of  T4  ligase  (Promega)  was  used  to  ligate  160  ng  of  pComBov-VL  and  about 
100  ng  of  the  heavy  chain  repertoire  in  3  reactions  of  16  µl.  The  second  set  comprised  7 
reactions  of  15  gl  containing  the  same  amounts  of  vector  and  insert  but  with  100  units  of 
T4  ligase  (New  England  BioLabs).  Each  set  of  reactions  also  included  a  control  reaction 
containing  cut  vector  but  no  insert  to  check  for  vector  religation.  Ligation  reactions  were 
incubated  at  16  °C  for  18  hrs. 
77 Table  3.4  Composition  and  volumes  (µI)  of  reagents  used  in  restriction  digests  required  for  recloning  of 
H  fragment  into  pComBov-VL  library. 
pUC-H  library  pComBov-VL 
DNA  360  200 
RsrII  20  U/µl  6  5 
Spe!  10  U/µl  8  7 
Reaction  buffer  No  5  46  27 
DTT  10  mM  46  27 
Reaction  volume  466  266 
Table  3.5  Composition  and  volume  of  reagents  (µl)  used  for  cloning  heavy  chain  fragments  into 
pComBov-VL  library.  Each  series  of  ligation  reactions  were  performed  at  two 
concentrations  of  T4  DNA  ligase. 
Self-  ligation  control  II/  pComBov-VL  ligation 
T4  ligase  3  U/µl  2  -  2  - 
T4  ligase  400  U/µl 
-  1  -  1 
Appropriate  10x  reaction  buffer  1.6  1.5  1.6  1.5 
Heavy  chain  fragment  15  ng/µl  6.4  6.4 
pComBov-VL  25  ng/µl  6.6  6.6  6.6  6.6 
Insert/  vector  ratio  -  -  4/1  4/1 
Distilled  water  6.4  6  -  0.5 
Reaction  volume  16.6  15.1  16.6  16 
Number  of  ligation  reactions  1  1  3  7 Transformation 
E.  coil  XL1-Blue  supercompetent  cells  (Stratagene)  were  used  for  transformation. 
After  thawing  the  cells  on  ice  from  -80  °C,  0.85  111  of  1.42  M  of  ß-mercaptoethanol 
provided  with  the  cells  was  added  to  each  50µ1  of  cells  giving  a  final  concentration  of  25 
mM.  Cells  were  kept  on  ice  before  adding  2.5  µl  of  each  ligation  reaction.  They  were 
then  incubated  on  ice  for  a  further  30  min.  Transformation  with  0.1  ng  of  circular  pUC18 
plasmid  (provided  with  the  cells)  was  used  to  estimate  transformation  efficiency.  After 
30  min  incubation  on  ice,  the  cells  were  heat  shocked  by  transfer  to  a  water  bath  at  42  °C 
for  45  sec,  then  return  to  ice  for  2  min  before  addition  of  950  µl  SOC  medium.  The 
cultures  were  incubated  in  37  °C  with  shaking  for  1  hr  and  then  20  µl  of  each  was  plated 
on  LA  containing  50  µg/ml  carbenicillin,  12  µg/ml  tetracycline  and  1%  glucose.  Plates 
were  incubated  at  37  °C  overnight  and  then  checked  for  the  appearance  of  colonies. 
Analysis  of  ligation  reactions  by  gel  electrophoresis 
Aside  from  transformation,  samples  from  some  ligations  were  run  on  an  agarose  gel 
in  an  attempt  to  identify  a  link  between  the  migration  of  DNA  and  transformation 
efficiency. 
As  mentioned  above,  several  attempts  were  made  to  clone  the  heavy  chain  fragment. 
In  each  attempt,  one  or  more  reaction  parameters  were  changed  as  described  in  the 
following  sections. 
Variation  in  the  source  of  restriction  enzymes 
Since  the  first  attempts  at  cloning  were  unsuccessful,  RsrIl  and  Spel  from  New 
England  Biolabs  were  used  to  digest  the  DNA.  The  experiments  assessed  the  impact  of 
the  source  of  enzymes  on  digestion  efficiency.  The  protocols  for  preparation  of  DNA, 
purification,  digestion  conditions,  ligation  and  transformation  were  as  described  above 
except  that  the  ratio  of  insert/vector  was  3/1. 
Variation  in  competent  cells 
In  this  experiment,  E.  coli  XL1-Blue  supercompetent  cells  (advertised  transformation 
efficiency  of  >I  x  109  cfu/µg  of  pUC  18  DNA)  were  replaced  by  Epicurian  Coli  Solopack 
Gold  supercompetent  cells  (Stratagene).  One  µl  of  ß-mercaptoethanol  was  added  to  50 
78 µ1  of  cells  and  the  cells  were  heat  shocked  at  54  °C  for  60  sec.  The  restriction  enzymes 
RsrII  and  SpeI  were  from  Life  Technologies  and  at  ligation,  the  ratio  of  insert/vector  was 
3/1.  Ligation  was  performed  using  100  and  6  units  (from  New  England  Biolabs  and 
Promega  respectively)  of  T4  DNA  ligase  in  separate  reactions.  Reactions  were  incubated 
at  16  °C  for  19  hrs.  The  ligation  reactions  also  were  run  on  an  agarose  gel  to  analyse  the 
profile  of  ligation  products. 
In  experiments  performed  up  to  this  stage,  cloning  attempts  were  unsuccessful. 
Analysis  of  the  profile  of  ligation  products  showed  the  presence  of  bands  of  higher 
molecular  weight  than  linearised  pComBov-VL,  a  band  corresponding  to  a  dimer  of  the 
heavy  chain  fragment  (about  1300  bp),  but  no  evidence  of  circular  DNA  which  might  be 
pComBov-VL  containing  a  heavy  chain  insert.  An  experiment  was  set  up  to  characterise 
the  1.3  kb  band.  Two  ligation  reactions  were  separately  digested  with  RsrII  or  SpeI  (Life 
Technologies).  Each  10  Itl  reaction  contained  6  µ1  of  ligation  mix,  the  reaction  buffer 
provided  by  Life  Technologies,  and  10  and  20  units  of  RsrII  and  SpeI  respectively.  The 
digests  were  incubated  at  37  °C  for  2.5  hrs  and  the  reactions  were  then  run  on  an  agarose 
gel  for  analysis.  Results  indicated  that  the  dimer  was  cut  by  Spel  but  not  by  RsrII. 
Variation  to  inserdvector  ratio 
Since  gel  analysis  showed  the  tendency  for  heavy  chain  dimer  formation,  further 
ligations  were  set  up  with  an  insert/vector  ration  of  1.5/1,  as  opposed  to  the  ratios  of  5/1 
and  3/1  used  in  previous  attempts.  In  addition,  a  control  ligation  reaction  was  prepared. 
This  contained  DNA  linearised  by  digestion  with  EcoRI.  The  DNA  was  isolated  from  a 
clone  known  to  carry  a  pComBov  construct  with  both  VL  and  heavy  chain  inserts.  XL1- 
Blue  supercompetent  cells  were  used  for  transformation.  Although  gel  analysis  revealed 
the  disappearance  of  the  heavy  chain  dimer  and  evidence  of  re-circularisation  of  control 
DNA,  only  a  single  colony  was  obtained  and  this  was  from  the  re-circularisation 
reaction. 
The  effect  of  pComBov  derivatives  on  survival  of  bacterial  cells 
After  observing  very  low  transformation  efficiencies  with  ligation  of  linearised 
pComBov  carrying  VL  and  heavy  chain  inserts  (pComBov-VLH),  a  control  experiment 
was  arranged  to  assess  if  these  constructs  had  an  adverse  effect  on  cell  growth.  About  50 
79 ng  of  the  pComBov-VL  library  and  a  pComBov-VLH  clone  were  transformed  into  50  µl 
of  XL1-Blue  supercompetent  cells.  The  high  level  transformation  efficiency  confirmed 
that  pComBov  derivatives  containing  the  bovine  light  chain  or  both  light  and  heavy 
chains  do  not  affect  cell  survival. 
The  effect  of  gel  extraction  methods 
The  tendency  of  heavy  chain  fragments  to  form  dimers  only  at  the  Spel-cut  termini, 
and  the  low  ligation  efficiency  of  linearised  pComBov-VLH  suggested  a  basic  problem 
of  ligation  between  vector  and  insert.  One  potential  explanation  was  degradation  of  the 
termini  during  fragment  isolation.  Hence  different  gel  extraction  methods  were  studied 
with  control  DNA.  In  two  separate  digestion  reactions  of  130  µl,  about  2.5  µg  of 
pComBov  DNA  was  cut  with  EcoRI  (Promega)  or  PvuII  (Life  Technologies)  in  reaction 
buffers  supplied  by  the  manufacturer.  These  digests  produced  protruding  and  blunt- 
ended  fragments  respectively.  After  inactivation  at  65  °C  for  20  min,  each  reaction  was 
divided  to  3  parts.  The  first  sample  from  each  reaction  was  precipitated  with  sodium 
acetate  and  ethanol,  the  second  sample  was  extracted  using  QIAEXII  resin  and  the  third 
sample  was  run  on  an  0.7%  agarose  gel  before  reisolating  with  extraction  columns  (Life 
Technologies).  DNA  was  eluted  in  water  of  30,35  and  40  µl  respectively.  Four  µl  of 
each  purified  sample  was  run  on  an  agarose  gel  to  determine  the  concentration  of  DNA. 
About  200  ng  of  the  three  samples  prepared  from  EcoRI-cut  DNA  were  religated  using 
6  units  of  T4  ligase  (Promega).  The  same  amounts  of  PvuII-cut  DNA  were  religated  with 
6  units  (Promega)  and  400  units  (New  England  BioLabs)  T4  ligase  in  separate  reactions 
(Table  3.6).  Seven  and  half  µl  of  each  ligation  reaction  was  run  on  an  agarose  gel  to 
analyse  the  changes  arising  from  ligation.  Two  µl  of  each  of  the  EcoRI-cut  samples  was 
transformed  to  XL1-Blue  cells.  Since  digestion  of  pComBov  with  PvuII  yielded  five 
fragments,  these  reactions  were  not  transformed.  The  profile  of  ligation  products  from 
these  reactions  revealed  differences  between  the  religation  of  column  extracted  DNA  and 
other  isolation  methods  in  both  low  and  high  concentrations  of  T4  ligase.  Similarly,  there 
were  marked  differences  in  the  numbers  of  colonies  arising  from  ligation  of  column- 
extracted  DNA  and  the  other  two  methods  (details  are  discussed  in  Results  section). 
Following  from  this  experiment,  another  attempt  was  made  to  clone  the  heavy  chain 
repertoire  into  the  pComBov-VL  library.  Plasmid  DNA  from  pUC-H  and  pComBov-VL 
libraries  was  digested  with  RsrII  and  SpeI  (Life  Technologies)  using  conditions 
80 Table  3.6  Volume  and  composition  of  reactions  to  religate  EcoRI  and  Pvull-cut  pComBov. 
Religation  ofEcoRl  and  Pvull 
cut  DNA 
Religation  ofPvull 
cut  DNA 
T4  ligase  3  U/µl  2  - 
T4  ligase  400  U/µI  -  1 
Related  reaction  buffer  1.5  1 
pComBov  -35  ng/µI  6  6 
Distilled  water  5.5  2 
Reaction  volume  15  10 described  above.  DNA  fragments  for  this  experiment  were  extracted  from  gel  slices 
using  QIAEXII  resin.  Ligation  reactions  were  set  up  with  an  insert/vector  ratio  of  3/1 
and  high  and  low  concentrations  of  T4  ligase.  Ligation  products  were  transformed  into 
XL1-Blue  supercompetent  cells.  The  experiment  again  failed  to  yield  transformants. 
Gel  composition  and  extraction  methods 
In  this  experiment,  multiple  purpose  agarose  was  replaced  with  low  melting  point 
(LMP)  agarose  to  ease  the  dispersal  of  gel  containing  the  desired  DNA  fragments. 
Linearised  DNA  was  prepared  by  digesting  pComBov-VL  with  SstI  (Life  Technologies). 
Digestion  products  were  run  on  a  0.7%  LMP  agarose  gel.  Gel  slices  were  divided  to  two 
parts:  one  was  extracted  with  QIAEXII  resin;  to  the  second,  two  volumes  of  TE  buffer 
were  added  and  after  heating  to  50  °C,  the  solution  was  extracted  with  phenol- 
chloroform  extraction  and  finally  precipitated  with  ethanol.  Two  high  and  low 
concentrations  of  T4  ligase  were  used  to  religate  the  linearised  DNA.  After 
transformation  into  XL1-Blue  supercompetent  cells,  no  significance  difference  between 
the  two  extraction  methods  could  be  observed. 
Although  the  numbers  of  colonies  recovered  in  this  experiment  was  much  lower  than 
expected,  another  attempt  was  made  to  clone  the  heavy  chain  repertoire  into  pComBov- 
VL  library,  using  electrophoresis  through  LMP  agarose,  phenol-chloroform  extraction 
and  ethanol  precipitation  to  isolated  DNA  fragments  for  ligation.  Analysis  of  the  ligation 
reactions  showed  a  strong  dimer  band  and  no  evidence  of  successful  insertion  of  the 
heavy  chain  fragment  into  pComBov-VL.  Restriction  analysis  of  the  dimer  again 
revealed  it  was  cut  into  two  fragments  of  about  650  bp  by  SpeI  but  not  by  RsrII. 
Temperature-cycle  ligation 
It  has  been  reported  that  temperature-cycle  ligation  (TCL)  can  achieve  higher  ligation 
efficiency  than  constant  temperature  reactions  by  balancing  the  different  requirements 
for  high  enzyme  activity  and  DNA  annealing  (Lund  et  al.,  1996).  This  was  evaluated  by 
seeking  religation  of  DNA  from  known  pComBov-VL  after  digestion  with  EcoRI 
(Promega).  The  linearised  DNA  was  divided  into  three  fractions.  Two  samples  were 
extracted  with  QIAEXII  resin  or  ethanol  precipitation.  The  third  samples  was  run  on  an 
LMP  agarose  gel  and  then  isolated  with  Wizard  reagents  (Promega).  About  130  ng  of 
each  extracted  DNA  was  religated  using  6  units  of  T4  ligase  (Promega)  and  overnight 
temperature  cycling  of  30  sec  at  10  °C,  1  min  at  13  °C  and  16  °C  and  30  sec  at  19  °C,  20 
81 °C  and  22  T.  After  overnight  thermal  cycling,  the  ligation  reactions  were  run  on  an 
agarose  gel  to  evaluate  the  profile  of  DNA  fragments  and  also  transformed  into  XL-1 
Blue  supercompetent  cells.  Gel  electrophoresis  showed  evidence  of  circular  DNA  and 
the  number  of  colonies  from  transformation  showed  that  high  religation  efficiency  had 
been  achieved  in  each  of  the  three  methods. 
Given  these  results  with  the  religation  of  linearised  pComBov-VL,  it  was  decided  to 
use  this  method  in  another  attempt  to  clone  the  heavy  chain  repertoire  into  the 
pComBov-VL  library.  DNA  from  pUC-H  and  pComBov-VL  libraries  was  digested  by 
RsrII  and  Spel  (Life  Technologies),  the  samples  were  run  on  an  LMP  agarose  gel  and 
bands  were  extracted  using  Wizard  reagents.  Ligation  was  carried  out  at  insert/vector 
ratios  of  3/1  and  4/1,  with  100  ng  and  150  ng  of  vector  in  each  reaction  and  6  units  of  T4 
ligase  (Promega).  Thermal  cycling  was  carried  out  overnight,  each  cycle  comprising  20 
sec  at  10  °C,  1  min  at  13  °C  and  16  °C  and  30  sec  at  19  °C,  22  °C  and  25  T.  Ligation 
reactions  were  run  on  an  agarose  gel.  Since  the  DNA  profile  showed  the  presence  of 
heavy  chain  dimer  but  no  evidence  of  circularised  pComBov-VLH,  transformation  was 
not  carried  out. 
During  these  experiments,  it  was  noted  that  digestion  of  DNA  from  the  pUC-H 
library  with  RsrII  and  SpeI  yielded  a  band  corresponding  to  the  heavy  chain  fragment 
and  a  second  of  about  100  bp.  Restriction  analysis  revealed  that  a  high  number  of  clones 
in  the  pUC-H  library  carried  inserts  with  SpeI  sites  at  each  terminus  and  an  RsrII  site  in 
the  middle  of  the  insert.  Although  this  would  not  affect  release  of  the  RsrII  /  SpeI  heavy 
chain  fragment,  3  clones  from  the  pUC-H  library  were  sequenced.  The  data  showed 
complete  identity  between  the  3  inserts.  This  led  us  to  conclude  that  certain  clone(s) 
dominated  the  pUC-H  library  perhaps  due  a  marginally  shorter  generation  time  during 
repeated  amplification  of  the  library  in  preparing  DNA  for  the  experiments  described 
above. 
This  factor,  coupled  with  the  failure  to  construct  a  pComBov-VGH  library  via  a  AUC- 
H  intermediate  step,  led  us  to  a  re-evalutation  of  the  direct  cloning  strategy. 
3.2.7  Direct  cloning  of  the  heavy  chain  repertoire  into  the  pComBov-VL  library 
As  described  at  the  beginning  of  this  chapter,  attempts  to  clone  the  bovine  VL 
repertoire  directly  into  pComBov  were  not  successful.  It  was  concluded  that  the  close 
proximity  of  SstI  and  BstEII  sites  to  the  termini  of  the  VL  amplicons  (7  and  10  bp 
82 respectively)  probably  reduced  substantially  the  efficiency  of  digestion.  However, 
attempts  to  clone  the  heavy  chain  repertoire  from  an  intermediate  pUC-H  library  into  the 
pComBov-VL  library  failed.  Therefore,  a  new  approach  to  the  direct  cloning  of  heavy 
chain  amplicons  was  adopted  with  the  aim  of  increasing  the  digestion  efficiency  of  RsrII 
and  Spel.  Two  new  heavy  chain  primers  (VH1A  and  VH2A)  were  designed,  extending 
the  5'  ends  of  VHI  and  VH2  respectively.  The  efficiency  of  action  of  RsrII  and  Spel  on 
heavy  chain  amplicons  was  evaluated  before  starting  further  cloning. 
Efficiency  of  restriction  digestion  of  VHIA  /  VII2A  amplicons 
RNA  isolation  and  single  strand  cDNA  preparation  were  performed  as  described  in 
subheadings  3.2.1  and  3.2.2  respectively.  cDNA  and  a  single  pComBov-VLH  clone 
carrying  light  and  heavy  chain  fragments  were  used  as  templates  for  Taq  DNA 
polymerase  amplification  using  different  pairs  of  primers  VHI,  VH1A,  VH2,  VH2A  and 
gllt.  PCR  products  were  desalted  and  concentrated  by  running  on  an  agarose  gel  and 
then  extracted  using  Concert  gel  extraction  columns.  Recovered  DNA  samples  were 
digested  with  RsrII  and  Spel  separately  or  concurrently  (Table  3.7)  and  were  run  on  a 
3%  agarose  gel  with  10  bp  ladder  DNA  markers  (Life  Technologies). 
Cloning  of  heavy  chain  repertoire  amplicons 
Since  the  termini  heavy  chain  amplicons  recovered  with  primers  VH1A  and  VH2A 
were  digested  successfully  by  RsrII  and  Spel,  these  Taq  amplicons  were  used  to 
construct  the  pComBov-VLH  library.  DNA  from  the  pComBov-VL  library  was  prepared 
as  described  above.  The  heavy  chain  amplicons  and  pComBov-VL  DNA  were  cut  with 
SpeI  and  RsrII  sequentially.  First  6  µg  of  each  DNA  was  digested  with  50  units  of  Spel 
(Life  Technologies)  for  2  hrs  at  37  °C  and  1  hr  at  50  °C.  The  digested  DNA  was  run  on  a 
1%  LMP  agarose  gel  and  the  desired  bands  were  extracted  using  Concert  gel  extraction 
columns.  The  extracted  DNA  was  then  cut  with  80  units  RsrII  (Life  Technologies),  run 
on  a  1.5%  LMP  agarose  gel  and  extracted  again.  The  efficiency  of  each  digestion  was 
assessed  by  electrophoresis.  In  addition,  DNA  from  a  single  clone  of  pComBov-VL  was 
cut  with  EcoRI  to  use  as  a  control  for  ligation  efficiency.  Ligation  reactions  contained 
about  150  ng  of  vector  with  an  insert/vector  ratio  of  3/1,100  units  T4  ligase  (New 
England  BioLabs)  and  lx  reaction  buffer.  An  additional  control  ligation  was  performed 
under  the  same  conditions  but  without  the  insert.  After  38  hrs  incubation  at  15  °C,  4  µl  of 
83 Table  3.7  Digestion  of  heavy  chain  amplicons  recovered  with  different  primers 
combinations.  +  shows  successful  digestion  was  carried  out  with  the  restriction 
enzyme  indicated;  a  blank  cell  indicates  that  the  digest  was  not  performed. 
Restriction  enzyme 
Amplicon  RsrII  Spel  RAI-Spei 
VH1-VH2  +  +  + 
cDNA  VH1A-VH2  +  +  + 
VHIA-VH2A  + 
Template  VH1-VH2  +  +  + 
pComBOVVL  VH1A-VH2  +  +  + 
H 
VH1A-VH2A  + 
VIII-gill  + each  reaction  was  run  on  a  1%  agarose  gel  to  evaluate  the  DNA  profile  and  4  µl  of  each 
mixture  was  transformed  into  XL1-Blue  supercompetent  cells.  Although  the  number  of 
colonies  recovered  from  cloning  the  heavy  chain  repertoire  was  significantly  less  than 
that  from  religation  of  linearised  control  DNA,  8  colonies  were  characterised  to  assess 
the  insert  frequency.  This  was  done  by  digesting  plasmid  DNA  with  EcoRl.  Since  non  of 
the  clones  contained  insert  and  the  efficiency  of  ligation  was  low,  conditions  were 
modified  as  described  below. 
Heavy  chain  inserts  from  plasmid  DNA  as  controls 
A  comparison  was  made  between  the  efficiency  of  cloning  heavy  chain  repertoire 
amplicons  and  a  heavy  chain  fragment  released  from  a  circular  vector.  Concurrent 
digestion  with  RsrII  and  Spel  (Life  Technologies)  was  used  to  release  the  heavy  chain 
fragment  from  a  single  clone  of  pComBov-VLH,  to  prepare  DNA  from  the  pComBov-VL 
library  and  to  cut  amplicons  of  the  heavy  chain  repertoire.  Digestion  products  were  run 
on  an  agarose  gel  and  the  desired  bands  were  extracted  using  ConcertTM  gel  extraction 
columns.  These  bands  included  the  amplicons  of  the  heavy  chain  repertoire,  vector 
fragment  from  the  pComBov-VL  library,  the  vector  fragment  from  the  single  pComBov- 
VLH  clone,  and  its  released  heavy  chain  fragment.  To  guarantee  that  the  vectors  were 
successfully  digested,  they  were  run  on  a  second  gel  and  extracted  again.  Ten  Al  ligation 
reactions  were  set  up  with  two  low  (Promega)  and  high  (New  England  BioLabs) 
concentrations  of  T4  ligase.  Each  reaction  contained  120  ng  of  vector  and  60  ng  of  insert 
to  provide  an  insert/vector  ratio  of  3/1.  Details  are  shown  in  Table  3.8.  The  ligation 
reactions  were  incubated  at  16  °C  for  23  hrs  before  transformation  into  XL1-Blue 
supercompetent  cells. 
Variation  to  restriction  enzymes,  extraction  methods  and  competent  cells 
The  failure  to  recover  transformants  in  the  previous  experiment  despite  high 
transformation  efficiencies  with  control  pUC  18  DNA  showed  an  obstacle  to  ligation 
existed.  In  an  attempt  to  define  this  problem,  amplicons  of  the  heavy  chain  repertoire  and 
pComBov-VL  library  DNA  were  cut  concurrently  with  RsrII  and  SpeI  (New  England 
BioLabs)  in  buffer  number  2  provided  by  the  manufacturer.  After  inactivation  at  65  °C, 
DNA  samples  were  run  on  a  1.3%  LMP  agarose  gel  and  the  desired  bands  were 
extracted  using  QIAEXII  resin.  Ligations  were  set  up  in  two  20  and  185  tl  reactions 
84 Table  3.8  Content  of  ligation  reactions  for  comparison  of  cloning  efficiency  of  heavy  chain 
fragments  from  two  different  sources. 
Control 
ligation 
Heavy  chain  repertoire 
amplicons 
Heavy  chain  fragment  released 
from  pComBov-VLH  clone 
T4  DNA  ligase  3U/  µl  -  -  1  -  1 
T4  DNA  ligase  400  U/  p1  1  1  -  1  - 
Appropriate  10  x  reaction 
buffer 
1  1  1  1.2  1.2 
Insert  -  4  4  6  6 
pComBov-VL  -30ng/µ1  4  4  4  4  4 
Insert/  Vector  ratio  -  3/1  3/1  311  311 
Distilled  water  4  -  -  -  - 
Number  of  ligation  reactions  1  4  4  4  4 with  400  and  800  units  T4  ligase  (New  Engand  BioLabs),  225  and  2400  ng  of  vector 
respectively  and  an  insert/vector  ratio  of  3/1.  After  18  hrs  incubation  at  16  °C,  DNA 
from  the  larger  volume  reaction  was  extracted  with  phenol-chloroform  and  precipitated 
with  ethanol.  Epicurian  coli  SURE2  supercompetent  cells  (Stratagene)  were  used  for 
transformation.  One  µl  of  ß-mercaptoethanol  provided  by  the  manufacturer  was  added  to 
each  50  µl  aliquot  of  thawed  cells  and  after  10  min,  ligation  products  from  all  reactions 
were  added.  After  30  min  incubation  on  ice,  the  cells  were  heat  shocked  at  42  °C  for  30 
sec,  incubated  on  ice  and  recovered  in  950  µl  of  SOC  medium.  After  2  hrs  shaking  at  37 
°C,  30  µl  from  each  transformation  reaction  was  plated  on  two  LA  media,  one  containing 
120  µg  ampicillin,  12  µg  tetracycline  and  1%  glucose  and  the  second  containing  120  µg 
ampicillin,  and  1%  glucose.  Since  no  colonies  were  recovered  after  overnight  incubation, 
the  entire  transformation  reactions  were  then  plated  onto  single  plates. 
85 Table  3.9  Sequences  of  primers  used  for  amplification  of  bovine  VL  and  heavy  chain 
fragment  repertoires  and  restriction  sites  on  them. 
VL1:  TAGAGCT*CCGTGTCCGTSWMYCTGGG 
7-8  -ti 
VL2:  GTAGAGGTAG*GTCACCGAAGGTGGGGACTTGGG 
Bat  EII 
VH1:  ATATATACG'GACCGAGCCTGGTGAAGCCCTCACAGA 
RsrII 
VH1A:  AGTACTATAGTATACG*GACCGAGCCTGGTGAAGCCCTCACAGACC 
RerII 
VH2:  TGGGCAA*CTAGTAACAGCCTTGTCCACCTTGGTGC 
spei 
VH2A:  TGATGGTCTGCATGTA*CTAGTAACAGCCTTGTCCACCTTGGTGC 
Spel 
gIII:  TCGGCATTTTTCGGTCATTAGC 
*  All  primers  are  shown  5'  to  3' 3.3  Results 
33.1  RNA  isolation 
Total  RNA  was  prepared  from  the  lymph  nodes  of  an  immunised  calf  using  the 
Promega  SV  total  RNA  isolation  kit.  The  recoveries  of  RNA  were  measured  by 
spectrophotometery  at  260  nM.  In  Table  3.10,  the  concentrations  of  RNA  from  different 
samples  are  expressed  in  µg/100  µl  of  recovered  solution  and  the  ratios  of  absorbances  at 
230,260  and  280  nm  (A260/A230  and  A260/A280)  are  shown  as  indicators  of  the 
quality  of  the  RNA.  The  amount  of  total  RNA  recovered  from  two  samples  of  bovine 
liver  -  controls  for  the  efficiency  of  the  isolation  method  -  are  also  shown  in  the  table. 
The  manual  for  the  isolation  kit  does  not  indicate  the  average  yield  of  RNA  from  lymph 
nodes.  However,  in  Table  3.11  average  recoveries  in  this  study  are  compared  with 
typical  data  presented  in  the  manual  for  a  selection  of  mouse  tissues.  Recoveries  of  RNA 
from  30-40  mg  of  bovine  lymph  node  tissue  compared  reasonably  well  with  results 
considered  typical  by  the  kit  manufacturer.  This  weight  of  tissue  perhaps  undergoes 
more  complete  cell  destruction  in  the  lysis  solution  than  larger  amounts.  Similarly,  losses 
may  have  less  impact  on  final  yield  than  when  smaller  starting  amounts  of  tissue  are 
used. 
The  quality  of  RNA  isolated  was  monitored  by  A260/A230  and  A260/A280  ratios. 
Samples  prepared  with  higher  amounts  of  bovine  lymph  node  were  of  better  quality  by 
these  criteria  than  from  smaller  amounts  of  starting  material.  The  expected  ranges  of 
A260/A230  and  A260/A280  are  1.8-2.2  and  1.7-2.1  -  lower  values  may  indicate 
guanidine  or  protein  contamination  respectively.  However  it  should  be  noted  that  the 
variation  between  starting  materials  and  procedures  from  day  to  day  can  impact 
significantly  (Table  3.10).  Overall,  the  A260/A230  and  A260/A280  ratios  obtained  for 
the  bovine  RNA  isolation  were  considered  acceptable  and  samples  of  higher 
concentration  and  quality  were  chosen  for  cDNA  synthesis. 
3.3.2  cDNA  synthesis 
For  the  synthesis  of  cDNA,  oligo(dT)  and  random  hexameric  primers  were  used  in 
separate  reactions  of  15-20  µl  fmal  volume.  Each  batch  was  assessed  separately  by  PCR 
using  heavy  chain  and  light  chain  primers.  The  successful  recovery  of  PCR  products  was 
taken  as  the  criterion  of  the  presence  of  cDNA  from  each  synthesis  reaction.  Virtually  all 
preparations  of  cDNA  met  this  measure. 
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Z  N  1'1  f  h  V  r  as  A  O  M  y  f  h  V  r  Y  P Table  3.11  Summary  of  yields  of  bovine  RNA  and  comparison  with  reported  yields  from  mouse  tissues. 
Amount  of 
tissue  mg 
Average  yield 
µg/100  µl  prep 
Average  yield 
µg/mg  tissue 
Average 
A260/A230 
Average 
A260/A280 
5-10  14.5  1.93  1.53  1.87 
Bovine  Lymph  node  30-40  45.5  1.30  1.83  2.25 
40-50  24  053  1.82  2.12 
Liver  6-10  38.8  4.85  2  1.97 
Liver  30  131  4.4  2.4  1.9 
Mouse  Kidney  20  44  2.2  2.1  1.9 
(data  Spleen  15  79  5.3  23  1.9 
fro  m 
Prome  a) 
Brain  60  39  0.65  2.1  2.1 
g 
muscle  30  22  0.73  1.8  2.1 3.3.3  Recovery  of  heavy  (H)  and  light  (L)  chain  repertoires 
Recovery  using  Taq  DNA  polymerase 
In  order  to  amplify  the  bovine  VL  and  heavy  chain  repertoires  from  lymph  node 
cDNA  with  Taq  DNA  polymerase,  magnesium  concentrations  were  titrated  and 
annealing  temperatures  for  the  reactions  were  optimised.  PCR  products  were  achieved 
with  MgC12  concentrations  ranging  between  2  and  4  mM  and  annealing  temperatures  of 
55-57  °C  (Figures  3.2  and  3.3).  Amplification  of  the  VL  and  heavy  chain  repertoires  was 
accomplished  from  both  oligo(dT)  and  random  hexamer-primed  cDNA  synthesis. 
Although  the  design  of  primers  for  these  reactions  underwent  some  changes  during  the 
course  of  the  study,  all  appropriate  combinations  resulted  successfully  in  amplicons.  To 
achieve  a  greater  level  of  purification,  PCR  products  were  routinely  run  on  agarose  gels 
and  the  desired  bands  were  extracted  from  gel  slices. 
Recovery  using  Pfu  DNA  polymerase 
PCR  products  of  the  VL  and  heavy  chain  repertoires  were  also  amplified  with  Pfu 
DNA  polymerase.  Amplicons  were  obtained  with  ease  with  primers  VL  1/  VL2  and 
VH1  /  VH2  from  both  oligo(dT)  and  random  hexamer-primed  cDNA  synthesis. 
Attempts  to  amplify  the  heavy  chain  repertoire  with  VHlA  /  VH2A  did  not  yield  the 
desired  amplicons.  Despite  extensive  attempts  to  optimise  the  concentration  of  MgC12, 
amplicons  could  not  be  obtained  by  PCR  from  cDNA  or  control  plasmid  DNA  from  a 
pComBov-VLH  clone  known  to  carry  a  heavy  chain  VHCHI  fragment. 
3.3.4  Direct  cloning  of  light  chain  amplicons 
Direct  cloning  of  the  bovine  antibody  repertoire  into  pComBov  was  initially  chosen 
as  our  strategy  for  construction  of  a  bovine  Fab  phage  display  library.  To  achieve  this 
objective,  amplicons  of  the  VL  repertoire  were  digested  with  Sstl  and  BstEII  and  attempts 
made  to  ligate  them  into  pComBov  cut  with  the  same  enzymes  (ligation  A).  As  controls, 
two  further  ligations  were  set  up:  a  reaction  containing  pComBov  and  a  mixture  of  equal 
amount  of  VL  fragment  released  from  a  single  clone  of  pComBov-L  and  digested  VL 
amplicons  (ligation  C);  the  vector  fragment  released  from  pComBov-L  and  digested  VL 
amplicons  (ligation  B)  (Table  3.2).  The  results  of  this  cloning  are  shown  in  Table  3.12. 
Despite  the  high  number  of  transformants  obtained  from  ligation  A,  non  of  the  10 
colonies  screened  for  the  presence  of  insert  carried  the  desired  fragment.  This  might  be 
87 ikb 
500  hp 
Figure  3.2  PCR  recovery  of  the  bovine  heavy  chain  repertoire. 
a:  Amp!  icons  from  control  pComBov-VLI  I  template 
b:  Amplicons  from  cDNA  template  (random  hexamer-primed  synthesis) 
c-e:  Replicated  reactions  from  cDNA  template  (oligo(d'I  )-primed  synthesis) 
M:  I  kb  ladder  (Promq-,,  a).  The  migration  ofmarkers  of  I  kb  and  500  bp  is 
indicated 
500  hp  - 
344  hp  -- 
Figure  3.3  PCR  recovery  of  the  ho%ine  Vi.  repertoire. 
a-c:  Replicated  reactions  from  cl)NA  template  (oli,,  o(d'l')-primed  synthesis) 
d-f:  Replicated  reactions  frone  cl)NA  template  (random  hexanter-primed 
synthesis) 
M:  1  kb  ladder  (Life  f  echnologies).  The  migration  of  markers  of  500  hp  and  344  bp 
is  indicated 
NI  .1hcdc 
%I  ahc  (I  cf Table  3.12  Results  of  initial  attempts  to  clone  the  VL  repertoire  and  an  isolated  VL  fragment  into 
pComBov.  The  table  shows  the  number  of  colonies  recovered  after  plating  of  20  111  samples 
from  150  µl  transformation  reactions  onto  selective  agar  medium. 
Composition  of  ligation  Number  of  colonies 
reaction 
Transformation  control  Circular  pUC18  >  2000 
Ligation  A  pComBov  vector  and  >  2000 
amplicons  of  the  VL  repertoire 
pComBov  vector  isolated  after 
Ligation  B 
digestion  of  pComBov-L  and 
2 
amplicons  of  the  VL  repertoire 
pComBov  vector  isolated  after 
digestion  of  pComBov-L  and  a 
Ligation  C 
mixture  of  an  isolated  VL  850 
fragment  and  amplicons  of  the 
V  repertoire  r due  to  the  incomplete  digestion  of  pComBov  and  so  the  presence  in  the  ligation  reaction 
of  vector  cut  by  just  one  restriction  enzyme.  In  contrast,  ten  colonies  selected  from 
ligation  C  and  analysed  by  restriction  analysis  with  EcoRJ  all  carried  insert.  This 
outcome  was  confirmed  by  PCR  on  the  plasmids  using  primers  VL  1  and  VL2.  Plasmid 
DNA  from  transformants  with  ligation  C  were  analysed  by  digestion  with  EcoRII,  a 
restriction  enzyme  which  cuts  immunoglobulin  sequences  with  high  frequency.  This 
revealed  that  9  of  the  10  clones  were  identical  (Figure  3.4)  showing  that  most  of  the 
inserts  were  those  released  from  the  pComBov-L  clone,  not  VL  amplicons.  Results  of 
ligations  B  and  C  showed  the  difference  in  efficiency  of  ligation  of  VL  amplicons  and  a 
VL  fragment  released  from  pComBov-L  back  into  the  vector.  This  difference  in  ligation 
efficiency  was  evaluated  in  the  next  series  of  experiments. 
Dephosphorylation  of  vector 
All  ten  colonies  sampled  from  cells  transformed  with  ligation  A-  the  reaction 
containing  pComBov  and  amplicons  from  the  VL  repertoire  amplicons  -  did  not  carry  an 
insert.  Dephosphorylation  of  the  digested  vector  was  therefore  used  to  prevent  the 
religation  of  pComBov  cut  with  a  single  enzyme.  The  ligation  reaction  contained  800  ng 
of  dephosphorylated  pComBov  with  an  insert/vector  ratio  of  of  3/1.  About  100  ng  of 
ligated  DNA  was  then  transformed  into  Solopack  Gold  supercompetent  cells.  The 
transformation  efficiency  achieved  with  control  DNA  -  closed  circular  pUC18  -  was 
high  (1.35  x  108  cfu/µg)  but  no  colonies  were  obtained  with  the  test  transformation. 
Variation  to  insert/vector  ratio 
To  evaluate  the  effect  of  insert/vector  ratios  on  ligation  efficiency,  pComBov  and  VL 
amplicons  were  digested  with  SstI  and  BstEII  and  four  20  µl  ligation  reactions  set  up 
with  insert/vector  ratios  of  1/1,2/1,3/1  and  4/1.  Again,  transformation  efficiencies  with 
control  pUC18  DNA  were  high  (1.8x108  cfu/µg)  but  no  colonies  grew  after  plating  20  µl 
samples  from  300  µl  transformation  cultures. 
Study  of  the  efficiency  of  restriction  digestion  of  VL  amplicons 
Since  experiments  to  this  point  failed  to  yield  recombinant  transformants,  attempts 
focused  on  the  efficiency  with  which  VL  amplicons  were  digested. 
88 500  bp  - 
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Figure  3.4  EcoRII  restriction  analysis  of  VI,  inserts  in  pComBov. 
The  figure  shows  digests  of  10  amplicons  of  which  only  one  (a)  differs  from  the 
remainder.  Markers  (M)  were  a  25  bp  ladder  (Life  Technologies).  The  migration  of 
markers  of  500  hp  and  125  bp  is  indicated. 
Ma  M -  Cloning  of  a  light  chain  fragment  released  from  circularised  vector 
In  this  experiment,  a  VL  fragment  was  released  from  a  characterised  clone  of 
pComBov-L  by  digestion  with  SstI  and  BstEII.  Attempts  were  then  made  to  clone  the 
isolated  fragment  into  the  pComBov  vector  also  isolated  in  this  procedure  and  a  second 
sample  prepared  by  digestion  with  SstI  and  BstEII.  Insert  and  vector  fragments  were 
mixed  in  different  ratios  for  ligation  and  the  products  were  transformed  into  NovaBlue 
competent  cells.  The  recovery  of  colonies  from  40  of  the  300  µl  transformation  mixture 
is  shown  in  Table  3.13.  Transformation  efficiency  with  closed  circular  pUC18  DNA  was 
relatively  high  (5.2  x  107  cfu/µg)  and  in  comparison  with  ligations  containing  both 
vector  and  insert,  background  religation  of  the  vector  alone  was  infrequent. 
Approximately  10-fold  higher  numbers  of  transformants  were  recovered  from  ligations 
of  the  isolated  VL  fragment  into  digested  pComBov  versus  religation  with  the  vector 
fragment  prepared  from  pComBov-L.  In  both  cases,  the  optimal  insert/vector  ratio  was 
2/1.  The  success  of  this  experiment  supported  the  idea  that  inefficient  digestion  of  the 
termini  of  VL  amplicons  with  SstI  and  BstEII  was  preventing  ligation  of  the  light  chain 
repertoire  into  pComBov. 
-  Using  high  concentration  of  restriction  enzymes 
In  general,  the  amount  of  a  restriction  enzyme  required  for  digestion  at  a  site  close  to 
the  terminus  of  a  piece  of  DNA  is  several  times  more  than  that  required  to  cut  at  an 
internal  site.  This  amount  varies  for  different  enzymes,  some  endonucleases  being 
relatively  efficient  in  this  application.  Although  the  amounts  of  SstI  and  BstEII  used  in 
experiments  performed  to  this  stage  was  higher  (40  units/µg  DNA)  than  those  required 
for  digestion  of  closed  circular  DNA,  concentrations  were  increased  further,  up  to  150 
U/µg  amplicon.  After  digestion  and  isolation  from  an  agarose  gel,  the  desired  bands 
were  extracted  by  QIAEXII  resin  to  minimise  potential  degradation  of  the  DNA  termini. 
The  isolated  fragments  were  ligated  with  digested  pComBov  using  10  and  100  units  of 
T4  ligase.  Although  the  transformation  efficiency  for  control  pUC  18  DNA  was  4.7  x  108 
cfu/µg,  only  two  transformants  were  recovered  with  the  test  ligations. 
3.3.5  Construction  of  intermediate  library 
Since  attempts  to  clone  directly  amplicons  comprising  the  VL  repertoire  into 
pComBov  failed,  the  cloning  strategy  was  modified  to  achieve  this  aim.  Firstly,  it  was 
89 Table  3.13  Optimisation  of  ligation  ratio  for  cloning  VL  fragments  into  pComBov.  The  table  shows 
the  number  of  colonies  recovered  after  plating  of  40  µl  samples  (5  µl  from  the  pUC18  control) 
from  300  µl  transformation  reactions  onto  selective  agar  medium. 
Composition  of  ligation  Insert/vector  Amount  of  vector  Number  of  Cfu/µg  DNA 
reaction  ratio  used  in  colonies 
transformation  (ng)  recovered 
Circular  pUC18  -  0.1  87  5.2  x  107 
1/1  88  922  7.9  x  10° 
Isolated 
2/1  88  1264  1.1  x  105 
VL  fragment  and  digested 
5/1  88  630  5.4  x  10° 
pComBov  vector 
Vector  alone  88  34  2.9  x  103 
Isolated  1/1  127.5  115  6.8  x  103 
VL  fragment  and  2/1  127.5  129  7.6  x  10; 
pComBov  vector  5/1  127.5  67  3.9  x  103 
released  from  pComBov-L  Vector  alone  127.5  28  3  1.6  x  103 
clone planned  to  clone  the  amplicons  into  an  intermediate  vector.  By  digesting  the  plasmid 
DNA  with  Sstl  and  BstEII,  it  was  envisaged  that  the  desired  fragments  would  be  excised 
efficiently  and  their  release  would  be  a  reliable  indication  of  their  suitability  for  cloning. 
For  construction  of  intermediate  libraries  of  the  VL  and  heavy  chain  repertoires, 
dephosphorylated  pUC  18  cut  with  Smal  was  chosen  as  vector. 
3.3.5.1  Intermediate  VL  library 
VL  repertoire  amplification,  phosphorylation  and  polishing  of  the  amplicons 
The  bovine  VL  repertoire  was  recovered  from  lymph  node  cDNA  by  amplification 
with  Pfu  DNA  polymerase.  After  running  the  reactions  on  an  agarose  gel,  products  were 
isolation  using  extraction  columns.  In  total  about  260  gl  of  solution  was  recovered  with  a 
DNA  concentration  of  60  ng/µl.  The  termini  of  the  VL  amplicons  were  polished  with 
Klenow  for  thoroughness  and  phosphorylated  using  polynucleotide  kinase.  After 
phosphorylation  of  about  2.34  jig  of  PCR  product,  the  DNA  was  extracted  into  TE 
buffer  using  QIAEXII  resin.  Measurement  of  the  DNA  concentration  by 
spectrophotometry  showed  recovery  of  about  2.24  µg  of  DNA. 
Ligation  and  transformation 
In  total,  6  ligations  were  performed  to  clone  the  350  bp  VL  amplicon  into  pUC18 
(detailed  in  subheading  3.2.5.1).  Forty  transformations  were  carried  out  to  generate  the 
PUC-VL  library.  Ligation  products  were  electroporated  into  competent  cells  prepared  in 
the  laboratory.  The  size  of  the  final  pUC-VL  library  was  calculated  from  the  number  of 
colonies  obtained  from  plating  samples  from  each  transformation.  In  total,  3.3  x  105 
colonies  were  generated  with  an  average  of  8250  colonies  per  transformation.  The 
transformation  efficiency  of  different  batches  of  electrocompetent  cells  using  control 
circular  pUC18  DNA  was  variable,  ranging  between  4.6  x  107  and  1.1  x  109  cfu/µg. 
With  one  of  the  best  batches  of  cells,  27700  transformants  were  obtained  from  ligation  of 
phosphorylated  VL  DNA  into  pUC18. 
Assessment  of  the  intermediate  pUC-VL  library 
Plasmids  of  twenty  white  colonies  from  the  PUC-VL  library  were  digested  with  EcoRI 
to  determine  the  insert  frequency.  The  size  of  the  linearised  DNA  was  compared  with 
pUC  18  and  a  known  control  PUC-VL  plasmids.  Nineteen  from  20  plasmids  were  the 
90 same  size  as  the  control  pUC-VL  construct.  The  plasmids  including  the  PUC-VL  control 
were  further  analysed  by  PCR  with  flanking  pUC18/  M13  forward  and  reverse  primers 
to  confirm  the  presence  of  inserts.  Gel  analysis  of  the  amplicons  revealed  that  18  of  the 
19  candidates  possessed  inserts  of  the  expected  size.  The  amplicons  were  then  digested 
with  EcoRII  to  assess  their  diversity.  Fourteen  of  the  18  inserts  (-  77%)  showed  unique 
patterns  of  fragments  when  run  on  a  3%  agarose  gel  (Figure  3.5). 
3.3.5.2  Intermediate  H  fragment  library 
Heavy  chain  repertoire  amplification,  phosphorylation  and  polishing  of  the  amplicons 
The  bovine  heavy  chain  repertoire  was  recovered  from  lymph  node  cDNA  by  PCR 
with  Pfu  DNA  polymerase.  After  running  the  reactions  on  an  agarose  gel,  the  desired 
bands  were  excised  and  the  DNA  extracted  with  QIAEXII  resin.  Following  procedures 
developed  in  the  cloning  of  VL  amplicons,  the  heavy  chain  products  were  polished  and 
phosphorylated  for  cloning  into  pUC18.  About  7.8  µg  of  isolated  amplicon  was  obtained 
from  seven  50  gl  PCR  reactions  and  of  this,  3-3.2  µg  of  phosphorylated  DNA  was 
obtained  from  each  of  2  phosphorylation  reactions. 
Ligation  and  transformation 
Seven  ligations  were  performed  to  clone  the  660  bp  heavy  chain  amplicon  into 
pUC18.  The  ligation  conditions  were  essentially  the  same  for  all  reactions.  Sixty 
transformations  were  carried  out  to  generate  the  pUC-H  library.  Again,  electroporation 
was  used  for  transformation  of  the  ligated  DNA  into  competent  cells  prepared  in  the 
laboratory.  A  library  with  1.1  x  106  members  was  achieved  with  an  average  of  18333 
colonies  per  transformation.  Transformation  efficiency  for  control  pUC  DNA  was 
variable  (1.9  x  107  to  1.32  x  109  cfu/µg)  and  the  maximum  yield  for  a  single 
transformation  of  ligation  products  was  71500  colonies. 
Assessment  of  the  intermediate  pUC-H  library 
Forty  white  colonies  from  the  pUC-H  library  were  picked  to  determine  the  insert 
frequency.  Their  plasmids  were  cut  with  EcoRl  and  the  size  of  the  digested  DNA  was 
compared  with  pUC18  and  a  known  control  pUC-H  plasmid.  Thirty  from  40  plasmids 
were  larger  than  the  control  pUC  plasmid.  Inserts  were  recovered  from  all  plasmids 
including  the  pUC-H  control  by  PCR  with  flanking  pUC18/  M13  forward  and  reverse 
91 Figure  3.  -5  EcoRll  restriction  analysis  to  determine  the  diversity  of  the  pUC-Vi,  library. 
Samples  were  run  on  two  separate  gels  (left  and  right  panels).  Fourteen  ot'the  18  samples 
analysed  showed  unique  digestion  patterns. 
M:  25  bp  DNA  marker  (Life  Technologies) 
Ni  M primers.  Gel  analysis  of  the  amplicons  on  a  1.2%  agarose  gel  revealed  that  24  of  the  30 
candidate  clones  possessed  inserts  of  the  expected  size.  The  amplicons  then  were 
digested  by  EcoRII  to  determine  their  diversity.  Ninteen  of  twenty  seven  inserts  (70%) 
showed  unique  digestion  patterns  when  analysed  on  a  3%  agarose  gel. 
3.3.6  Recloning  of  VL  and  H  repertoires  into  pComBov 
After  construction  of  the  intermediate  pUC-VL  and  pUC-H  libraries,  the  intention  was 
to  isolate  the  repertoires  from  each  library  and  clone  them  separately  into  pComBov. 
Firstly,  the  VL  repertoire  was  released  for  construction  of  the  pComBov-VL  library. 
3.3.6.1  Recloning  of  the  VL  repertoire 
Preparation  of  the  VL  repertoire 
DNA  was  isolated  from  an  overnight  culture  of  the  PUC-VL  library  using  a  Midiprep 
plasmid  purification  system.  Since  gel  electrophoresis  of  a  sample  of  the  isolated  DNA 
showed  some  smearing,  a2  ml  sample  was  run  on  a  0.7%  agarose  gel  and  the  required 
band  was  extracted  by  QIAQuick  gel  extraction  kit.  DNA  was  eluted  in  600  µl  of  elution 
buffer  at  a  concentration  estimated  as  40  ng/µ1. 
Restriction  digestion 
pUC-VL  and  pComBov  DNA  samples  were  cut  with  SstI  and  BstEII  sequentially  and 
were  then  run  on  a  0.7%  agarose  gel.  The  VL  fragment  (350  bp)  and  pComBov  vector 
(about  4  kb)  were  isolated  using  the  QIAQuick  gel  extraction  kit.  Seven  hundred  ng  of 
VL  fragment  and  about  7  tg  of  pComBov  were  harvested  from  digestion  of  7  and  7.5  µg 
of  PUC-VL  library  and  pComBov  DNA  respectively. 
Cloning  and  transformation 
For  ligation  of  the  VL  fragments  into  pComBov,  two  concentrations  of  T4  ligase  were 
used  for  control  and  cloning  reactions.  Control  reactions  contained  ligase  and  vector 
without  insert  evaluated  the  background  due  to  the  presence  of  undigested  or  single  cut 
vector.  For  transformation,  commercial  XLI-Blue  supercompetent  cells  and 
electrocompetent  cells  prepared  in  the  laboratory  were  used.  The  results  of 
transformation  are  shown  in  Table  3.14.  The  size  of  the  pComBov-VL  library  was 
estimated  to  be  4.6  x  105  transformants.  This  was  achieved  through  21  transformations. 
92 Table  3.14  Results  of  transformations  to  construct  the  pComBov-VL  library.  Transformations  were 
carried  out  with  samples  of  ligation  reactions  estimated  to  contain  20  ng  of  vector  DNA 
Transformation 
Amount  of  Number  of  colonies  per 
sum  total  of 
etliciencyof  ligated  DNA  Number  of 
T4  li  ase  g  transformation  colonies  from 
(cfu/µg)  colonies  from 
all 
Average  Maximum  Average  Maximum  control 
transforma- 
reactions 
tions 
(vector  alone) 
XL1-Blue 
electrocompetent 
6U  10217  21583  102170  5.1  x  10'  1x  10`  0 
cells  prepared  in 
the  laboratory  "  400  U  18532  26220  148261  9.3  x  10'  1.3  x  10`  55 
Commercial 
6U  10150  14600  20300  5110-1  73  x  10' 
XL1-Blue 
electrocompetent  400  U  49025  56000  196100  2.5  x  10`  2.8  x  10` 
cells  **  _ 
Competence  calculated  by  electroporation  with  pUC18  DNA:  *  2.45  x  10'  and  4.2  x  10`  cfu/µg;  **  1.98  x  10'  cfu/µg 
Blanks:  No  control  reaction  was  est Transformation  with  DNA  from  the  control  ligation  reaction  yielded  only  small  numbers 
of  colonies  indicating  a  low  level  of  vector  religation. 
Characterisation  of  the  pComBov-  VL  library 
Fifteen  colonies  from  the  pComBov-VL  library  were  evaluated  to  establish  the  insert 
frequency.  This  was  performed  by  digestion  of  plasmid  DNA  with  EcoRI  and  also  by 
PCR  with  primers  VL  1  and  VL2.  Gel  electrophoresis  of  digestion  products  and  PCR 
showed  that  all  colonies  possessed  an  insert  of  the  expected  size  (350  bp). 
3.3.6.2  Recloning  of  H  fragment  into  pComBov-VL  library 
The  final  phase  of  construction  of  the  pComBov-VLH  library  entailed  release  of  the 
heavy  chain  repertoire  from  pUC-H  and  cloning  into  the  pComBov-VL  library. 
Preparation  of  DNA 
Plasmids  from  the  pUC-H  and  pComBov-VL  libraries  were  isolated  from  overnight 
cultures  separately.  The  harvested  DNA  was  purified  and  concentrated  by  running  in  an 
agarose  gel  and  extraction  with  the  QIAQuick  gel  extraction  kit.  In  all,  650  and  500  µl  of 
pUC-H  and  pComBov-VL  at  concentrations  of  30  ng  /  µl  were  obtained.  Ten  µg  and  6 
Itg  samples  of  pUC-H  and  pComBov-VL  were  digested  by  SpeI  and  RsrII  concurrently. 
After  electrophoresis  on  an  agarose  gel  and  verification  that  the  desired  fragments  had 
been  released,  DNA  was  extracted  with  the  QIAQuick  gel  extraction  kit.  pUC-H  DNA 
released  two  fragments,  the  pUC  vector  and  the  660  bp  heavy  chain  insert.  pComBov-VL 
released  fragments  of  100  and  250  bp  from  the  heavy  chain  stuffer  and  the  vector  (about 
4  kb). 
Ligation  and  transformation 
Ligation  of  the  heavy  chain  repertoire  into  pComBov-VL  was  performed  at  two 
concentrations  of  T4  ligase.  In  each  set,  an  additional  control  reaction  contained  digested 
vector  without  the  intended  insert  fragment.  Transformation  of  ligated  DNA  into  XL1- 
Blue  supercompetent  cells  did  not  result  in  colony  formation.  The  transformation 
efficiency  for  control  circular  pUC18  was  2.6  x  108  cfu/µg. 
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Since  no  colonies  were  recovered  from  ligation  of  the  heavy  chain  repertoire  into 
pComBov-VL  library,  the  ligation  reactions  were  run  on  an  agarose  gel  to  assess  the 
profile  of  DNA  fragments.  There  was  no  evidence  of  circular  pComBov-VLH  DNA  but  a 
band  of  about  1.3  kb  was  present  in  reactions  set  up  with  different  concentration  of  T4 
ligase.  The  size  suggests  that  this  fragment  results  from  ligation  of  heavy  chain 
fragments  to  each  other. 
Since  the  desired  result  was  not  achieved  at  the  first  attempt,  efforts  were  made  to 
find  the  reason  for  failure  and  to  solve  it. 
Variation  in  the  source  of  restriction  enzymes 
In  this  experiment,  the  endonucleases  RsrII  and  SpeI  from  Life  Technologies  were 
replaced  by  enzymes  from  New  England  BioLabs  to  check  if  variation  in  quality  was 
responsible  for  the  initial  failure  to  complete  library  construction.  Two  concentrations  of 
T4  DNA  ligase  (6  units  and  100  units  per  reaction)  were  again  employed.  Although  the 
transformation  efficiency  with  pUC18  DNA  was  again  high  (4  x  108  cfu/µg),  neither 
ligation  produced  transformants. 
Variation  to  competent  cells 
XL1-Blue  supercompetent  cells  were  replaced  with  Solopack  Gold  supercompetent 
cells  to  rule  out  the  possible  effect  of  host  genotype  on  plasmid  stability.  In  this 
experiment,  enzymes  from  Life  Technologies  were  used  to  prepare  DNA  fragments 
which  were  again  ligated  with  two  concentrations  of  T4  ligase.  Gel  analysis  of  the 
ligation  products  showed  a  band  corresponding  to  a  heavy  chain  dimer  (1.3  kb)  in 
reactions  each  concentration  of  T4  ligase.  No  band  which  might  represent  circular 
pComBov-VGH  could  be  observed.  Transformation  efficiency  for  pUC18  in  this 
experiment  was  5.2  x  108  cfu/pg.  No  colonies  were  recovered  from  experimental 
ligations. 
Characterisation  of  the  1.3  kb  ligation  product 
The  common  presence  of  a  1.3  kb  band  in  previous  ligations,  was  investigated  by 
restriction  digestion  to  establish  its  origin.  The  band  was  excised  from  agarose  gels  and 
94 was  digested  separately  with  RsrII  and  Spel.  The  results  showed  that  the  band  was  cut  by 
SpeI,  dividing  it  into  fragments  corresponding  to  the  size  of  heavy  chain.  It  was  resistant 
to  digestion  to  RsrII,  indicating  that  the  1.3  kb  band  was  dimer  of  heavy  chains  ligated 
via  their  Spel  cut  ends  (Figure  3.6). 
Variation  to  the  insert/vector  ratio 
In  order  to  check  the  effect  of  the  insert/vector  ratio  on  the  cloning  results,  a  ligation 
reaction  was  performed  at  a  lower  ratio  (1.5/1  in  comparison  to  previous  attempts  at 
ratios  of  3/1  and  5/1).  Transformation  of  these  ligations  into  XL1-Blue  supercompetent 
cells  yielded  no  colonies  although  gel  analysis  of  the  ligation  reaction  revealed  that  the 
heavy  chain  dimer  had  disappeared.  As  a  control,  60  ng  of  a  known  pComBov-VGH 
construct,  linearised  by  digestion  with  EcoRJ,  was  ligated  and  transformed.  This  yielded 
only  50  colonies,  a  recovery  lower  than  expected  and  a  result  which  suggested  that  some 
degradation  of  DNA  termini  might  be  taking  place  during  fragment  isolation  or  other 
processing  steps.  Alternatively,  we  speculated  that  the  construct  might  be  toxic  to 
bacteria  in  spite  of  attempts  to  suppress  expression  by  inclusion  of  glucose  in  the 
selective  media. 
Checking  the  effect  ofpComBov  derivatives  on  cell  survival 
For  this  experiment,  50  ng  of  each  closed  circular  DNA  from  the  pComBov-VL 
library  and  a  known  pComBov-VLH  clone  were  transformed  into  XL1-Blue 
supercompetent  cells.  About  1x  105  and  2.25  x  105  colonies  were  obtained  from 
pComBov-VL  and  pComBov-VLH  respectively.  Transformation  efficiency  for  control 
pUC  18  was  1  x109  cfu/gg.  The  difference  in  size  between  the  pComBov  constructs  and 
the  pUC  control  may  explain  to  some  extent  the  difference  in  transformation  rates. 
However,  the  experiment  eliminated  the  possibility  of  a  significant  toxicity  effect 
between  pComBov-VL  and  pComBov-VLH  constructs. 
The  effect  of  gel  extraction  methods 
To  study  the  effect  of  fragment  isolation  using  extraction  columns,  a  series  of 
religation  reactions  were  set  up.  pComBov  DNA  was  linearised  by  EcoRI  and  PvuII  and 
reisolated  by  three  methods:  QIAEXII  resin,  ethanol  precipitation,  and  extraction  from 
gel  slices  with  QIAQuick  gel  extraction  columns.  The  three  batches  of  EcoRI  fragments 
were  religated  with  6  units  of  T4  ligase;  blunt  ended  PvuII  fragments  were  religated  with 
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Figure  3.6  Restriction  analysis  of  the  1.3  kb  DNA  fragment  observed  in 
ligation  reactions  during  cloning  of  heavy  chain  fragments  into 
the  pComBov-Vi,  library. 
a:  Ligation  products  before  digestion 
b:  Ligation  products  after  digestion  with  Spel 
c:  Ligation  products  after  digestion  with  R.  srll 
M:  I  kb  markers  (Life  Technologies).  The  migration  of  markers  of 
1.6  kb.  I  kb  and  500  bp  is  indicated. 
M11  It  bc 6  units  or  100  units  of  enzyme  (Table  3.6).  The  profile  of  DNA  fragments  was  studied 
by  gel  electrophoresis  revealing  differences  between  column-extracted  DNA  and 
samples  isolated  by  the  other  two  methods  (Figure  3.7).  Ligation  reactions  with  the 
EcoRI-treated  DNA  were  transformed  into  XL1-Blue  supercompetent  cells. 
Transformation  of  25  ng  DNA  from  ligations  of  resin-processed  ethanol  precipitated 
material  yielded  80000  and  85000  colonies  respectively.  Equivalent  amounts  of  DNA 
ligated  after  isolation  from  gel  slices  by  extraction  columns  only  yielded  250  colonies.  In 
comparison,  transformation  efficiency  for  pUC18  was  7.5  x  108  cfu/µg.  These  data 
showed  that  the  columns  used  for  extraction  of  DNA  from  gel  slices  might  have  a 
significant  effect  on  the  integrity  of  the  DNA  termini. 
Accordingly,  another  attempt  was  made  to  construct  the  pComBov-VLH  library. 
DNA  from  the  pUC-H  and  pComBov-VL  libraries  was  digested  with  Rsrll  and  SpeI  and 
run  on  an  agarose  gel.  The  desired  fragments  were  isolated  using  QIAEXII  resin. 
Attempts  to  transform  the  ligated  DNA  fragments  into  XL  1-Blue  supercompetent  cells 
failed  to  yield  any  colonies  whereas  the  transformation  efficiency  for  control  pUC18 
DNA  was  4.33  x  108  cfu/Itg.  Gel  analysis  of  the  ligation  reaction  showed  again  the 
presence  of  a  1.3  kb  heavy  chain  dimer  that  could  be  cut  with  SpeI  but  not  with  RsrII. 
Variation  in  gel  composition  and  alternative  extraction  methods 
Further  experiments  were  set  up  to  optimise  the  extraction  of  DNA  fragments.  To 
achieve  this,  pComBov-VL  DNA  was  cut  with  SstI.  The  linearised  DNA  then  was 
divided  into  two  parts,  and  each  was  run  on  an  LMP  agarose  gel.  The  two  samples  were 
then  extracted  by  different  methods:  one  was  extracted  with  QIAEXII  resin,  TE  buffer 
was  added  to  the  second,  and  after  dispersing  the  gel  at  50  °C,  DNA  was  isolated  by 
phenol-chloroform  extraction  and  ethanol  precipitation.  The  two  samples  were  then 
ligated  using  low  (6  units)  and  high  (400  units)  concentrations  of  T4  ligase  and  samples 
corresponding  to  70  ng  of  DNA  were  transformed  into  XLI-Blue  supercompetent  cells. 
Results  are  shown  in  Table  3.15.  The  transformation  efficiency  obtained  with  ligation 
products  was  low  but  sufficiently  encouraging  to  prompt  another  attempt  at  pComBov- 
VLH  library  construction.  pUC-H  and  pComBov-VL  libraries  DNA  were  digested  by 
RsrII  and  Spe!,  the  digestion  products  were  run  on  an  LMP  agarose  gel  and  slices 
containing  the  fragments  of  interest  were  processed  as  above  (phenol-chloroform). 
Ligation  was  done  at  two  concentrations  of  T4  ligase.  Transformation  of  about  70  ng  of 
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isolated  from  LMP  agarose  gel. 
DNA  and  extraction  method  Number  of  colonies  Transformation 
per  reaction 
efficiency  cfu/gg 
pUC18  3.75  x  103 
Resin  extracted  6U  T4ligase  1150  1.65  x  10° 
pComBov-VL  400  U  T4  ligase  6450  9.2  x  104 
Phenol-chloroform 
6U  ligase  2750  3.9  x  104 
t  t  d  d  h  l  ex  rac  an  et  ano  e 
precipitated 
400  U  ligase  5350  7.64  x  104 
pComBov-VL EcoRI  /11,1111 
4  kb 
6U  T-I  Lioase 
f 
.: 
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6U  T4  Iiuase  100  U  T4  Haase 
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Figure  3.7  Gel  analysis  of  pComBov  after  digestion  with  EcoRl  or  Prrill  and  religation. 
The  Figure  is  in  three  sections  showing  plasmid  digested  with  EcoRl  (left)  and  Pvull 
(right),  and  religation  with  6U  (left  and  centre)  and  100  U  of  ligase  (right).  Digested 
DNA  was  isolated  for  ligation  by 
a:  spin  columns 
b:  ethanol  precipitation  from  the  restriction  digest 
C:  QIAEXII  resin 
M:  I  kb  ladder  (Life  Technologies).  The  migration  of  the  4  kb  marker  is 
indicated. ligation  products  resulted  in  only  50  (6  units  ligase)  and  150  (400  units  ligase)  colonies. 
The  transformation  efficiency  of  pUC18  DNA  in  this  experiment  was  1x  109  cfu/µg. 
Temperature-cycle  ligation 
Temperature  cycling  was  studied  in  an  attempt  to  employ  more  efficient  ligation 
conditions.  A  mixture  of  DNA  from  known  pComBov-VL  clones  was  cut  with  EcoRI 
and  divided  into  3  parts.  DNA  was  then  isolated  using  QIAEXII  resin,  ethanol 
precipitation  and  extraction  from  slices  from  a  LMP  agarose  gel.  Religation  used  6  units 
of  T4  ligase  and  thermal  cycling.  About  80  ng  of  ligated  DNA  was  then  transformed 
into  XL1-Blue  supercompetent  cells.  Results  (Table  3.16)  showed  that  the  isolation  of 
linearised  DNA  from  LMP  agarose  gels  using  a  Wizard  extraction  kit  did  not  affect  the 
efficiency  of  religation  in  comparison  to  direct  reisolation  methods.  Gel  electrophoresis 
of  the  ligated  mixtures  also  showed  the  presence  of  circular  DNA  (Figure  3.8). 
These  results  prompted  another  attempt  at  construction  of  the  pComBov-VLH  library. 
Digested  DNA  from  the  pUC-H  and  pComBov-VL  libraries  was  run  in  an  LMP  agarose 
gel  and  then  extracted  by  Wizard  extraction  kit.  Thermal  cycling  was  used  for  ligation 
and  the  products  were  evaluated  by  gel  electrophoresis.  As  there  was  no  evidence  of 
circular  DNA,  transformation  was  not  carried  out. 
Overall,  the  project  failed  to  establish  the  conditions  required  for  cloning  the  bovine 
heavy  chain  repertoire  from  an  intermediate  library  into  the  pComBov-VL  library.  In 
addition,  sequencing  of  3  colonies  from  the  pUC-H  library  showed  them  to  be 
completely  identical,  throwing  into  doubt  the  diversity  of  the  intermediate  library. 
Therefore,  the  strategy  for  cloning  the  heavy  chain  repertoire  into  pComBov-VL  shifted 
again  to  direct  cloning  approaches. 
3.3.7  Direct  cloning  of  the  heavy  chain  repertoire  into  the  pComBov-VL  library 
First  attempts  at  direct  cloning  of  the  VL  repertoire  into  pComBov  were  not 
successful,  perhaps  due  to  the  inefficiency  of  restriction  endonucleases  to  act  close  to  the 
termini  of  the  amplicons.  Therefore,  for  direct  cloning  of  the  heavy  chain  repertoire  into 
the  pComBov-VL  library,  new  primers  -  VH1A  and  VH2A  -  were  designed,  carrying 
extensions  at  the  5'  termini  of  primers  VH1  and  VH2.  Definitive  data  on  the  properties 
of  Rsrll  are  not  available  but  it  was  reasoned  that  this  modification  should  assist  the 
action  of  the  restriction  enzyme. 
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Extraction  method  Number  of  colonies  Transformation  efficiency 
cfu/µg 
per  reaction 
pUC  18  control  3.6  x  103 
Resin  extraction  80000  1.14  x  106 
Ethanol  precipitation  32000  4.6  x  107 
Wizard  column  extraction  80000  1.14  x  106 
from  LMP  agarose 4  kb 
2  kb 
1  kb 
Figure  3.8  Cel  analysis  of  pComBov  after  digestion  with  Lco1ZI,  extraction  by 
different  methods  and  religalion. 
a:  pComBov  digested  with  LcoRl  (no  relipation) 
b:  DNA  extracted  by  ethanol  precipitation  and  relipated 
c:  DNA  extracted  by  QIAI:  XII  resin  and  relig,  tted 
d:  DNA  isolated  from  LMP  agarose  using  Wizard  columns  and  religated. 
Circular  DNA  are  indicated  by  arrow. 
M:  I  kb  ladder  (Life  "technologies).  The  migration  of  markers  of  I  kb,  2  kb 
and  4  kb  is  indicated. Efficiency  of  digestion  of  VH1A  /  VH2A  amplicons 
To  assess  the  ability  of  restriction  enzymes  to  digest  the  termini  of  PCR  products 
produced  with  VHIA  and  VH2A,  reactions  were  set  up  with  different  pairs  of  primers 
from  the  following  pool:  VH1,  VH1A,  VH2,  VH2A  and  gIII.  Bovine  lymphoid  cDNA 
and  plasmid  DNA  from  a  known  pComBov-VLH  clone  were  used  as  template.  The 
amplicons  were  digested  with  RsrII,  SpeI  or  both  enzymes  and  were  analysed  on  3% 
agarose  gels.  Gel  analysis  showed  that  the  termini  of  amplicons  amplified  by  VH1A  and 
VH2A  were  cut  by  RsrII  and  SpeI,  but  that  these  enzymes  did  not  cut  PCR  products 
amplified  with  VH  1  and  VH2.  To  confirm  the  action  of  Spel  in  these  experiments,  a 
PCR  product  amplified  with  VH1A  and  gIII  was  successfully  digested  (Figure  3.9). 
Cloning  of  heavy  chain  repertoire  amplicons 
Plasmid  DNA  from  the  pComBov-VL  library  and  heavy  chain  amplicons  produced 
with  VHIA  and  VH2A  were  digested  with  SpeI  and  RsrII  (Life  Technologies) 
sequentially.  After  electrophoresis  in  LMP  agarose,  bands  were  excised  and  DNA  was 
extracted  with  the  Concert  gel  extraction  system.  Ligation  was  performed  using  400 
units  of  T4  ligase  at  16  °C.  Two  control  reactions  were  set  up:  the  first  contained  the 
digested  vector  without  insert;  the  second  contained  pComBov-VL  DNA  linearised  by 
digestion  with  EcoRI  to  monitor  the  efficiency  of  the  ligation  reaction.  Ligated  materials 
were  transformed  into  XL1-Blue  supercompetent  cells.  Thirty  µl  of  each  transformation 
reaction  was  plated  to  select  for  transformants.  Religation  of  linearised  pComBov-VL 
DNA  yielded  >2000  colonies,  while  95  were  obtained  from  ligation  of  double-digested 
vector  in  the  absence  of  insert.  Two  ligation  reactions  containing  vector  and  insert 
produced  71  and  126  colonies  respectively.  Restriction  analysis  of  plasmid  DNA  isolated 
from  8  colonies  picked  at  random  from  the  cloning  reactions  showed  that  none  contained 
a  heavy  chain  insert.  The  results  again  revealed  a  fundamental  problem  in  ligation  of  the 
bovine  heavy  chain  repertoire  into  pComBov-VL.  They  also  prompted  further 
consideration  of  how  best  to  separate  vector  cut  with  RsrII  and  Spel  from  incompletely 
digested  DNA  in  order  to  suppress  the  appearance  of  false  positive  colonies. 
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Figure  3.9  Restriction  digestion  of  bovine  heavy  chain  amplicons. 
PCR  products  were  generated  with  V  112  and  VI  II  or  VIIIA  (Ictt  panel,  lanes  to  left 
of  markers  [MI),  or  VI  IIA  and  gill  or  VI  12  or  VI  12A  (left  panel,  lanes  to  rii.  ht  of 
markers  IM]:  right  panel).  The  products  were  then  digested  with  R.  srII  and  /  or  . ti'/,,,  l. 
Primer  combinations  are  specified  on  the  first  and  third  lines  above  the  Figure. 
Restriction  enzymes  used  liar  the  analysis  are  specified  on  the  second  line.  Upper  and 
lower  panels  show  the  same  gel  with  (lit  ti  rent  exposure  conditions  to  demonstrate 
fragments  released  from  the  ampticuns,  as  indicated  by  *.  pCumRRuv-11  I  was  used  as 
template  for  all  I CR  reactions  except  where  indicated  by  li:  in  this  case  cDNA  was 
used. 
M:  25  bp  ladder  ([,  ite  Technologies).  The  migration  ofthe  25  hp  starker  is  indicated. Using  heavy  chain  fragments  released  from  circularised  vector  as  controls 
In  this  experiment,  the  heavy  chain  fragment  was  released  from  a  single,  confirmed 
clone  of  pComBov-VGH  for  use  as  a  control  in  cloning  the  heavy  chain  repertoire  into 
the  pComBov-VL  library.  DNA  from  the  pComBov-VGH  clone,  the  pComBov-VL 
library  and  heavy  chain  amplicons  were  cut  with  RsrII  and  SpeI  (Life  Technologies) 
concurrently.  The  heavy  chain  fragments  and  vector  from  pComBov-VL  library  were 
isolated  from  agarose  gels  using  the  Concert  gel  extraction  system  columns.  The  vector 
was  used  in  two  ligation  reactions  with  heavy  chain  fragments  from  the  two  sources. 
Ligation  was  performed  using  two  concentration  of  ligase  and  the  material  was 
transformed  into  XL  1-Blue  supercompetent  cells.  Irrespective  of  the  source  of  the  heavy 
chain  insert,  no  colonies  were  obtained.  The  transformation  efficiency  for  the  reaction 
was  checked  with  pUC  18  DNA  and  was  2.6  x  108  cfu/µg. 
Variations  to  restriction  enzymes,  extraction  methods  and  competent  cells 
In  this  final  attempt  at  construction  of  a  pComBov-VGH  library,  most  of  the  factors 
involved  in  digestion,  extraction,  ligation  and  transformation  were  changed  in  an  attempt 
to  identify  the  problem.  Heavy  chain  amplicons  and  pComBov-VL  DNA  were  cut  with 
RsrIl  and  SpeI  concurrently  with  enzymes  from  New  England  BioLabs.  The  products 
were  then  were  run  in  an  LMP  agarose  gel  and  the  bands  of  interest  were  extracted  with 
QIAEXII  resin.  The  amount  of  vector  DNA  was  increased  to  225  and  2400  ng  in  two 
reactions  of  20  and  185  µl  volume.  Four  hundred  and  800  units  of  T4  ligase  were  used 
for  20  and  185  µl  reactions  respectinely.  After  incubation  at  16  °C  for  18  hrs,  DNA  from 
the  185  . tl  reaction  was  concentrated  using  phenol-chloroform  extraction  and  ethanol 
precipitation.  Epicurian  coli  SURE2  supercompetent  cells  were  used  for  transformation 
of  samples  from  all  of  the  ligation  reactions.  Samples  from  the  transformation  mixtures 
were  plated  onto  LA  containing  ampicillin  and  glucose,  with  or  without  tetracycline.  No 
colonies  were  recovered  from  any  of  the  plates,  even  when  the  entire  remaining 
transformation  mixture  was  spread  to  the  selective  medium. 
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The  central  goal  of  the  experiments  described  in  this  chapter  was  to  construct  a 
library  of  recombinant  bovine  Fab  antibodies  from  animals  immunised  against 
Mannheimia  haemolytica.  The  intention  was  to  screen  this  library  for  antibodies 
against  outer  membrane  proteins  from  the  pathogen.  Antibodies  isolated  in  this  way 
would  be  more  useful  than  antibodies  generated  in  other  species  (e.  g.  conventional 
murine  monoclonals)  for  immunological  or  pathological  investigations  of  bovine 
pasteurellosis. 
To  achieve  this  aim,  cDNA  was  prepared  from  an  immunised  animal  and  used  to 
amplify  the  antibody  light  and  heavy  chain  repertoires.  This  was  achieved  successfully 
with  Taq  and  Pfu  polymerases,  confirming  that  this  aspect  of  the  work  was  feasible. 
Aside  from  work  in  cattle  (O'Brien  et  al.,  1999),  investigators  have  recovered  the  Ig 
repertoire  from  a  range  of  different  livestock  species  using  PCR  for  further 
characterisation  (rabbits,  chickens,  sheep  and  camels;  see  Introduction  to  this  chapter). 
Oligonucleotide  primer  sets  to  achieve  this  objective  have  been  recently  compiled 
(O'Brien  and  Aitken,  2002). 
Attempts  to  clone  the  VL  repertoire  directly  to  phagemid  pComBov  failed  although 
this  is  a  strategy  frequently  employed  in  the  construction  of  phage  display  libraries 
(Clark,  2002).  Several  variations  were  made  to  protocols  to  resolve  the  problem 
including  variation  to  ratio  of  insert/vector  fragments,  dephosphorylation  of  vector 
ends,  varying  concentrations  of  restriction  enzymes  (SstI  and  BstEII),  but  the  situation 
could  not  be  resolved.  By  releasing  a  VL  fragment  from  closed  circular  plasmid  DNA 
-a  pComBov  construct  previously  characterised  -  with  these  enzymes  and  using  it  as 
a  control  for  ligation  efficiency,  it  was  established  that  the  problem  related  to  low 
efficiency  digestion  of  the  termini  of  amplicons  with  Sstl  and  BstEll.  It  is  known  that 
restriction  enzymes  cleave  DNA  with  a  wide  range  of  efficiencies  when  their 
recognition  sequences  are  located  near  the  termini  of  the  duplex.  A  tabulation  of  the 
characteristics  of  several  restriction  enzymes  is  available  from  New  England  Biolabs 
as  an  appendix  to  the  company  catalogue.  The  data  was  gathered  from  two 
experimental  approaches:  the  cleavage  of  short  synthetic  duplexes  in  which  the 
restriction  site  is  flanked  by  progressively  longer  stretches  of  random  sequence;  the 
cleavage  of  plasmid  DNA  linearised  by  digestion  with  other  enzymes  at  sites 
progressively  further  from  the  site  of  interest.  Both  sets  of  data  are  useful,  but  neither 
is  entirely  comparable  to  cleavage  close  to  the  termini  of  a  PCR  product  of  several 
100 hundred  bases.  Published  data  on  this  issue  is  limited  (Popa  et  al.,  1995).  From  New 
England  Biolabs  data,  it  is  known  that  the  efficiency  with  which  BsIEII  cleaves  a 
recognition  sequence  placed  2  bases  from  the  terminus  of  the  duplex  is  only  10%  after 
20  hrs  digestion.  Amplification  of  the  VL  repertoire  with  primer  VL1  placed  the  BsiEII 
site  10  bases  from  the  terminus.  On  this  basis,  it  seemed  reasonable  to  expect 
considerably  higher  efficiency  digestion  to  occur.  There  is  no  equivalent  data  for  Sstl 
but  given  that  this  strategy  was  used  successfully  by  O'Brien  et  al.  in  the  construction 
of  a  bovine  phage  display  library  (O'Brien  et  al.,  1999),  direct  cloning  was  a  valid 
starting  point  for  this  phase  of  the  project. 
The  problems  encountered  in  direct  cloning  led  us  to  the  alternative  strategy 
described  in  this  chapter,  the  cloning  of  amplicons  into  an  intermediate  vector.  It  was 
reasoned  that  this  would  increase  the  efficiency  of  restriction  enzyme  action  and  also 
would  facilitate  monitoring  through  gel  electrophoresis  the  release  of  fragments  for 
isolation  and  cloning  into  pComBov.  This  strategy  has  been  adopted  in  the 
construction  of  Fab  and  scFv  libraries  by  some  investigators.  In  each  case,  the 
intention  was  to  enhance  the  limited  efficiency  of  direct  cloning  rather  than  to 
overcome  a  fundamental  obstacle  such  as  was  encountered  here.  Sheets  et  al.  (1998) 
constructed  a  large  non-immune  scFv  phage  library  comprising  6.7  x  109  clones  via 
the  cloning  of  VL  and  VH  repertoires  into  independent,  intermediate  plasmids.  Inserts 
were  released  by  restriction  digestion,  fused  to  create  scFvs  and  recloned  into  pHENI 
to  create  the  final  phage  display  library.  The  intermediate  VL  and  VH  libraries  in  this 
work  were  3x  107  and  2.3  x  108  respectively.  de  Haard  et  al.  (1999)  also  used  this 
strategy  in  the  construction  of  a  large  non-immune  Fab  libraries.  The  main  library  of 
4.3  x  1010  (3.7  x  106  clones  with  full-length  Fab  inserts)  was  assembled  from 
intermediate  H,  VX  and  Vic  libraries  of  1.75  x  108,5.2  x  107  and  9.4  x  107  members 
respectively. 
In  our  experiments,  intermediate  libraries  of  the  light  and  heavy  chain  repertoires 
were  constructed  by  cloning  amplicons  into  pUC  18  as  blunt  ended  fragments.  The  VL 
repertoire  was  then  released  for  cloning  to  pComBov  by  digestion  with  Sstl  and 
BstEII.  The  ease  with  which  this  was  achieved  confirmed  the  suspicion  that  direct 
approaches  failed  because  of  inefficient  digestion  of  the  termini  with  these  restriction 
enzymes. 
In  contrast,  an  intermediate  library  of  heavy  chain  fragments  was  constructed  but 
difficulties  were  encountered  in  recloning  RsrII  /  Spel  fragments  into  pComBov-VL.  It 
101 was  confirmed  that  a  fragment  of  about  660  bp  could  be  release  from  the  intermediate 
heavy  chain  library;  the  obstacle  arose  at  ligation.  A  thorough  investigation  of 
experimental  conditions  attempted  to  find  a  solution  but  without  success.  These 
experiments  covered  the  insert  /  vector  ratio  for  ligation,  temperature-cycle  ligation 
(Lund  et  al.,  1996),  the  source  of  restriction  enzymes,  the  host  genotype,  and  the 
toxicity  of  the  expressed  products.  In  studying  the  effect  of  different  DNA  extraction 
methods,  QIAEXII  resin  showed  some  advantage  over  spin-columns,  at  least  for  the 
religation  of  linearised  DNA,  but  application  of  this  method  to  the  cloning  of  the 
heavy  chain  repertoire  into  pComBov  again  failed.  The  use  of  LMP  agarose  gels  and 
extraction  with  phenol-chloroform  yielded  some  recombinant  colonies  but  the 
efficiency  was  far  too  low  for  use  in  library  construction.  Other  authors  have  reported 
that  the  termini  of  DNA  fragments  can  be  damaged  by  some  isolation  methods  with 
detrimental  effects  on  cloning  efficiency  (Fransen  et  al.,  1998).  Whether  this  effect  is 
more  pronounced  with  the  3  base  extensions  produced  by  enzymes  such  as  RsrIl  than 
the  4  base  extensions  typically  produced  by  restriction  endonucleases  is  not  known. 
After  the  failure  of  indirect  cloning  of  the  heavy  chain  repertoire  into  a  pComBov- 
VL  library,  attention  returned  to  a  direct  cloning  strategy.  Using  revised  primers,  the 
distance  between  the  restriction  sites  and  the  termini  of  heavy  chain  amplicons  was 
increased.  Restriction  analysis  showed  that  the  termini  of  amplicons  were  efficiently 
digested  by  RsrII  and  Spel.  Attempts  to  clone  the  digestion  products  were 
unsuccessful,  reiterating  previous  findings.  It  was  also  significant  that  when  a  heavy 
chain  insert  was  released  from  a  pComBov  construct  carrying  a  bovine  Fab  insert,  this 
could  not  be  religated  into  the  releasing  vector.  This  is  in  marked  contrast  to 
comparable  control  experiments  with  the  VL  fragment.  This  finding  clearly  points  to  a 
failure  of  some  aspect  of  the  ligation.  During  the  study,  dimers  of  the  heavy  chain 
fragment  could  be  identified  which  were  ligated  via  their  Spei-digested  termini.  This 
implicates  a  failure  of  the  RsrII  termini  to  undergo  ligation. 
In  principle,  there  is  no  reason  why  DNA  fragments  prepared  with  RsrII  should  not 
undergo  ligation  although  Life  Technologies  report  a  religation  efficiency  about  one- 
third  of  that  of  more  commonly-used  restriction  enzymes.  In  the  literature,  several 
investigators  report  the  use  of  this  enzyme  in  cloning  (Ye  and  Huang,  1993;  Pfleiderer 
et  al.,  1995)  and  bovine  Fab  libraries  in  pComBov  were  successfully  prepared  using 
RsrII  by  O'Brien  et  al.  (1999).  RsrII  is  a  orthodox  type  II  restriction  enzyme  that 
recognises  and  cleaves  the  heptanucleotide  palindromic  sequence  5'  CGG(A/T)CCG 
102 3'  (O'Connor  et  al.,  1984;  O'Connor  et  al.,  1987).  Orthodox  type  II  restriction 
endonucleases  are  typically  homodimers  comprising  30  kDa  monomers,  which 
recognise  defined  palindromic  sequences  4  to  8  bp  in  length.  In  the  presence  of  Mgt+, 
the  endonuclease  cleaves  the  two  strands  of  the  target  DNA  sequence  within  or 
adjacent  to  the  recognition  site,  generating  termini  which  bear  5'  phosphate  and  3' 
hydroxyl  groups.  Many  type  II  restriction  endonucleases  do  not  conform  to  this 
narrow  definition,  making  it  necessary  to  define  subdivisions  (Pingoud  and  Jeltesch, 
2001).  As  the  recognition  sequence  of  RsrIl  can  possess  degeneracy  in  its  middle  base 
(A  or  T)  it  was  of  obvious  importance  to  ensure  that  fragments  prepared  with  this 
enzyme  possessed  the  same  base  at  the  central  position  to  enable  religation  to  take 
place.  In  this  study,  the  RsrII  recognition  sites  on  both  the  primer  VH1A  and 
pComBov  were  designed  with  A  in  this  position.  With  regard  to  other  factors,  it  is 
known  that  adenine  methylation  can  reduce  the  efficiency  of  cohesive  ligation  (Levin 
and  Boeke,  1990).  Digestion  with  RsrII  can  be  inhibited  if  DNA  has  undergone 
methylation  in  vitro  (Sambrook  and  Russell,  2001)  but  as  the  enzyme's  recognition 
sequence  does  not  contain  the  motifs  targeted  by  the  E.  cola  Dam  (5'  GATC  3')  or 
Dcm  (5'  CCAGG  3'  or  5'  CCTGG  3')  methylation  systems,  this  seems  an  unlikely 
explanation  for  the  findings  reported  in  this  chapter.  It  seems  equally  unlikely  that  the 
results  can  be  attributed  to  local  DNA  structure  (Merenkova  et  al.,  1993;  Dolinnaya  et 
al.,  1994),  or  sequence  dependent  effects  (Merenkova  et  al.,  1992)  since  O'Brien  et  al. 
(1999)  successfully  constructed  Fab  libraries  by  ligating  heavy  chain  amplicons  into 
pComBov  as  RsrIl  /  SpeI  fragments.  In  spite  of  attempts  in  this  study  to  replicate  as 
carefully  as  possible  O'Brien's  methods  -  extraction  techniques,  competent  cells, 
source  and  concentration  of  enzymes  -  it  therefore  seems  most  likely  that  a  minor 
difference  had  a  substantial  impact  upon  the  ligation  of  fragments  prepared  by 
digestion  with  RsrII. 
One  factor  which  could  be  investigated  in  future  studies  concerns  the  buffering 
conditions  for  the  ligation  step.  The  assumption  was  made  in  this  chapter  that  standard 
buffers  would  suffice  for  the  ligation  of  DNA  prepared  with  RsrII  since  the  enzyme 
generates  DNA  fragments  with  5'  overhanging  termini.  It  may  be  significant  that  the 
overhang  is  3  nucleotides  in  length,  compared  with  4  from  many  other  restriction 
enzymes.  Perhaps  under  standard  conditions  this  difference  results  in  less  stable 
association  between  fragments  prior  to  the  ligation  reaction.  To  test  this  hypothesis, 
the  addition  of  condensing  agents  such  as  polymeric  polyethylene  glycol  as  frequently 
103 used  in  blunt  ligation  could  be  attempted  (Sambrook  and  Russell,  2001).  Also,  it  is 
known  that  the  efficiency  of  T4  DNA  ligase  is  dependent  to  some  extent  on  the  ionic 
strength  of  the  buffer  (Sambrook  and  russell,  2001).  There  are  minor  differences 
between  the  composition  of  ligation  buffers  from  New  England  Biolabs,  Promega  and 
Life  Technologies.  Reagents  from  Promega  were  used  for  the  repeated  attempts  to 
ligate  heavy  chain  fragments  into  pComBov-VL.  It  is  not  known  whether  the  buffers 
used  for  ligation  in  this  study  differed  in  their  composition  from  those  used  by  O'Brien 
but  this  could  potentially  have  influenced  the  results  and  may  merit  further 
investigation  in  the  future. 
Clearly,  this  issue  needs  to  be  resolved  if  the  pComBov  vector  system  is  to  be  used 
for  the  routine  isolation  and  expression  of  recombinant  bovine  antibodies.  The  RsrII 
restriction  site  was  chosen  to  maintain  the  native  protein  sequence  in  framework 
region  1  (5'  (TC)C  GGA  CCG  3';  codons  encoding  the  sequence  SGP).  In  view  of  the 
difficulties  encountered  here,  the  BspEI  site  also  encoded  in  this  sequence  might  be 
utilised  (5'  TCC  GGA  3')  since  the  enzyme  produces  a4  nucleotide  5'  extension. 
Although  BspEI  is  blocked  by  overlapping  Dam  methlylation,  the  two  bases  following 
the  restriction  site  are  CC  which  fails  to  complete  the  GATC  motif  recognised  by  the 
Dam  methlyase  (Sambrook  and  Russell,  2001).  Alternatively,  it  might  be  argued  that 
the  RsrII  site  should  be  replaced  completely  with  one  recognised  by  a  more 
conventional  restriction  enzyme,  sacrificing  the  native  sequence  of  framework  1.  It 
would  be  wise  to  assess  the  impact  of  amino  acid  substitution  either  by  modelling  on 
the  known  crystal  structure  of  the  heavy  chain  variable  domain  (Padlan  et  al.,  1989)  or 
by  direct  investigation  before  undertaking  lengthy  studies.  To  take  one  example 
however,  pComBov  presently  contains  a  single  BamHl  site.  If  this  were  eliminated  by 
site-directed  mutagenesis,  the  recognition  sequence  could  be  reintroduced  using  a 
synthetic  duplex  (O'Brien  et  al.,  1999)  to  replace  the  RsrII  site.  This  would  change  5' 
(TC)C  GGA  CCG  3'  (encoding  SGP)  with  5'  (TC)G  GAT  CC(G)  3'  (encoding  SDP). 
BamHI  fragments  are  easily  ligated  and  it  is  known  that  the  enzyme  can  cut  close  to 
the  terminus  of  a  DNA  duplex  (data  from  New  England  Biolabs),  which  is  an  added 
advantage. 
In  summary,  these  attempts  to  generate  a  phage  display  library  of  bovine  Fab 
fragments  failed  and  it  was  not  possible  to  progress  to  screen  for  recombinant 
antibodies  against  the  outer  membrane  proteins  of  Mannheimia  haemolytica.  In  the 
104 following  chapter,  this  objective  is  addressed  by  an  alternative  strategy,  the  use  of  a 
large,  semi-synthetic  phage  display  library  obtained  from  other  investigators. 
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Screening  of  Griffin.  1  scFv  library  against 
outer  membrane  proteins  of 
Mannheimia  haemolytica 4.1  Introduction 
4.1.1  Application  of  phage  display  antibodies  to  studies  of  infectious  diseases 
The  phage  display  system  provides  a  means  to  identify  monoclonal  binding  ligands 
to  pathogen  antigens  and  virulence  factors.  Most  studies  of  pathogenesis  have  tended  to 
use  conventional  hybridoma  methods  to  generate  antibodies.  In  comparison,  phage 
display  offers  several  significant  advantages.  To  begin  with,  phage  antibody  libraries  are 
typically  much  larger  than  the  number  of  hybridoma  clones  that  could  be  easily 
propagated  and  screened  and  therefore  they  offer  a  much  larger  repertoire  of  antibodies 
from  which  useful  ligands  can  be  selected.  Secondly,  the  flexibility  of  phage  display 
enables  selection  'strategies  to  be  designed  which  preferentially  isolate  antibodies  likely 
to  be  of  relevance  to  the  end  use.  For  example,  immobilisation  of  target  molecules  at  an 
inert  surface  for  panning  directly  leads  to  the  isolation  of  antibodies  with  an  affinity  for 
these  targets.  Finally,  the  ligands  isolated,  scFv  or  Fab  fragments,  are  readily  produced 
in  vitro  for  application  as  biological  probes,  affinity  reagents,  diagnostic  tools  or 
therapeutic  agents.  A  selection  of  examples  in  which  phage  display  has  been  used  in  the 
study  of  infectious  disease  are  discussed  briefly  in  the  following  sections. 
4.1.1.1  Parasites,  fungi  and  moulds 
Haemonchus  contortus 
A  scFv  library  was  constructed  from  the  abomasal  lymph  node  of  an  immune  sheep 
after  challenge  with  the  gastrointestinal  nematode  parasite  Haemonchus  contortus 
(White  et  al.,  2001).  scFv  were  selected  by  panning  the  library  against  a  purified  outer 
membrane  protein  but  only  low  affinity  antibodies  were  isolated  from  nearly  960  clones 
processed  by  screening.  The  authors  attributed  this  outcome  to  limitations  in  their 
selection  strategy.  Given  the  success  of  other  investigators  in  generating  ovine  phage 
display  libraries  and  isolating  high  affinity  scFvs  (Charlton  et  al.,  2000),  this  seems  the 
most  likely  explanation  of  the  findings  of  White  et  al.  (2001). 
Plasmodium  falciparun: 
Phage  antibodies  were  isolated  from  a  phage  library  binding  to  the  merozoite  surface 
protein  1  (MSPI),  a  major  candidate  for  blood-stage  malaria  vaccine.  An  antibody 
library  was  constructed  from  the  blood  lymphocytes  from  10  patients  with  clinical 
malaria  (Sowa  et  al.,  2001).  After  isolation  of  pliage  antibodies  against  MSPI,  the 
authors  concluded  that  the  strategy  was  useful  for  both  the  characterisation  of  the 
106 antigenic  composition  of  the  parasite  and  the  nature  of  the  human  response  to  malaria 
infection. 
Candida  albicans 
Haidaris  et  al.  (2001)  selected  two  scFv  clones  from  an  antibody  phage  library,  which 
detected  Candida  albicans  antigens  by  indirect  immunofluorescence  assay,  ELISA  and 
Western  blotting.  The  phage  library  was  prepared  from  peripheral  blood  lymphocytes  of 
about  100  donors.  Antibodies  such  as  these  can  be  used  to  either  purify  native  antigen 
for  biochemical  characterisation,  or  evaluation  as  protective  antigens.  They  can  also  be 
used  to  derive  peptide  mimetics.  In  this  context,  a  scFv  was  first  generated  as  a  mimetic 
of  the  yeast  killer  toxin  of  Pichia  anomala.  Two  recombinant  strains  of  Streptococcus 
gordonii  were  then  generated  which  either  secreted  the  scFv  or  displayed  it  at  the 
bacterial  surface.  These  strains  stably  colonised  the  vagina  of  experimental  rats  and  were 
evaluated  as  treatments  against  Candida  albicans  infection  Three  weeks  after  challenge, 
75%  and  35%  of  the  rats  treated  with  the  secreting  and  displaying  bacteria,  respectively, 
were  cured  of  the  infection  in  comparison  to  animals  treated  with  a  bacterial  strain 
expressing  an  irrelevant  scFv  (Beninati  et  al.,  2000). 
Aflatoxin 
Phage  antibodies  specific  for  Aflatoxin-B  1  were  isolated  by  panning  of  two  phage 
antibody  libraries,  a  human  lymphocyte  library  and  a  semi-synthetic  library,  on  a  BSA- 
toxin  conjugate  (Moghaddam  et  al.,  2001).  This  experiment  is  amongst  the  few  to  report 
isolation  of  a  scFv  against  a  low  molecular  weight  hapten  from  a  naive  phage  antibody 
library.  Work  by  Porter's  group  in  Aberdeen  has  also  tackled  this  objective  for  small 
microbial  toxins  (McElhiney  et  al.,  2000).  A  wide  range  of  polyclonal  and  monoclonal 
antibodies  to  Aflatoxins  have  been  prepared  for  routine  screening  for  these  products 
destined  for  animal  and  human  consumption.  Potentially,  recombinant  antibodies  have 
greater  sensitivity  for  these  purposes. 
4.1.1.2  Viruses 
There  are  numerous  reports  in  the  literature  of  the  generation  of  recombinant 
antibodies  against  viruses  using  phage  display  presumably  because  of  the  pressing  need 
for  novel  antiviral  therapies.  The  antiviral  activity  of  antibodies  have  been  recently 
reviewed  (Parren  et  al.,  2001).  A  selection  of  examples  of  recombinant  antiviral 
107 antibodies  is  presented  below. 
Bluetongue  virus 
A  scFv  antibody  specific  to  VP7  of  bluetongue  virus  (BTV)  was  constructed  through 
the  cloning  of  VL  and  VII  fragments  of  an  anti-BTV  myeloma  antibody  in  a  phage  vector 
(Nagesha  et  al.,  2001).  This  scFv  showed  similar  binding  specificity  to  the  parental 
antibody  when  tested  against  VP7. 
HIV-1 
By  application  of  combinatorial  library  technology,  scFv  antibodies  were  constructed 
against  the  major  capsid  protein  p24  of  HIV-1.  A  library  of  scFvs  was  made  using  B 
cells  taken  from  the  spleen  of  mice  immunised  with  a  viral  lysate.  These  scFv  antibodies 
may  form  the  basis  for  a  sensitive  assay  for  p24  as  a  measure  of  viral  load  (de  Haard  et 
al.,  1998). 
Respiratory  syncytial  virus 
A  human  Fab  recombinant  antibody  was  constructed  against  respiratory  syncytial 
virus  (RSV).  The  antibody  bound  to  the  viral  F  glycoprotein  and  neutralised  the 
infectivity  of  virus.  Anti-viral  protection  could  be  demonstrated  by  delivering  the  Fab 
directly  into  the  lungs  of  RSV-infected  mice  (Barbas  et  al.,  1992b;  Crow  et  al.,  1994). 
Nguyen  et  al.  (2000)  reported  a  combined  effort  of  applying  hu-PBL-SCID  mice  and 
scFv  phage  display  library  to  boost  human  immune  responses  against  RSV,  and  to  clone 
a  panel  of  RSV  neutralising  scFvs,  respectively.  The  resulting  scFvs  were  shown  to  be 
derived  from  different  human  V}1  families  with  mutated  CDRI  nucleotide  sequences  and 
some  of  them  exhibited  high  RSV-F  binding  affinity  associated  with  RSV  neutralising 
activity  in  vitro.  These  data  suggest  that  the  generated  scFv  have  clinical  potential  to 
treat  severe  RSV  infection  and  that  the  combined  approach  may  be  widely  applicable  for 
cloning  high  antigen-specific  and  neutralising  human  monoclonal  antibodies. 
Rabies  virus 
Phage  display  technology  was  used  to  produce  a  scFv  antibody  from  a  hybridoma 
secreting  an  anti-glycoprotein  antibody.  The  scFv  was  found  to  be  identical  in 
specificity  and  neutralising  capacity  to  the  full-length  monoclonal  from  which  it  was 
derived.  This  antibody  could  be  used  in  a  cocktail  of  multivalent  or  multispecific 
108 neutralising  antibodies  for  passive  therapy  (Muller  et  al.,  1997). 
4.1.1.3  Bacteria 
Considering  the  range  of  bacterial  pathogens  of  importance  to  human  and  animal 
health,  the  detailed  understanding  of  the  process  of  pathogenesis  and  the  rapid 
accumulation  of  genomic  data  on  these  organisms,  it  is  surprising  that  phage  display 
technology  has  yet  to  make  substantial  impact  in  this  area.  The  following  examples 
illustrate  the  scope  of  what  has  been  accomplished  and  the  potential  in  this  area. 
Bordetella  pertussis 
A  scFv  phage  library  was  derived  from  the  peripheral  blood  lymphocyte  of  two 
patients  recently  recovered  from  pertussis  infection.  The  library  was  screened  on 
pertussis  toxin,  an  important  virulence  factor,  but  by  no  means  the  only  one  produced 
by  this  pathogen  (Locht  et  al.,  2001).  Six  of  the  isolated  scFvs  bound  to  pertussis  toxin 
and  3  were  able  to  neutralise  the  toxin  as  determined  by  its  effects  on  cells  in  tissue 
culture  (Williamson  and  Matthews,  1999). 
Bacillus  antkracis 
In  this  example,  the  starting  resource  was  a  naive  scFv  phage  library  (Sheets  et  al., 
1998).  The  protein  chosen  for  screening  was  PA83,  the  protective  antigen  from  the  toxin 
of  Bacillus  anthracis.  Several  unique  clones  were  isolated  with  high  affinity  for  different 
epitopes  of  PA83  of  which  one  could  inhibit  receptor-mediated  binding  of  PA  to  target 
cells.  Aside  from  its  potential  as  a  therapeutic,  the  authors  proposed  another  use  for 
these  scFvs  might  be  as  recognition  elements  for  a  biosensor  (Cirino  et  al.,  1999). 
Clostridium  botulinum 
Botulinum  toxin  is  widely  regarded  as  the  most  potent  natural  toxin  known.  Several 
groups  have  attempted  to  use  phage  display  as  an  alternative  to  conventional  hybridoma 
methods  (Pless  et  al.,  2001)  to  understand  better  its  function  and  to  develop  potential 
immunotherapeutics  (Amersdorfer  et  al.,  1997;  Chen  et  al.,  1997).  In  one  recent 
example,  three  single  chain  Fv  antibodies  specific  to  the  heavy  chain  binding  domain  of 
botulinum  neurotoxin  serotype  A  (BoNT/A  lie)  were  selected  from  phage  libraries.  The 
libraries  were  constructed  from  mice  immunised  with  BoNT/A  He  or  humans 
immunised  with  pentavalent  botulinum  toxoid.  These  antibodies  were  coated  onto  a 
109 solid  phase  and  phage  libraries  were  panned  against  them  in  order  to  map  cpitopes  of 
functional  importance  in  toxin  action  (Mullaney  et  at.,  2001). 
Pseudomonas  aeruginosa 
A  Fab  recombinant  antibody  was  constructed  from  a  conventional  monoclonal 
antibody  against  the  0  antigen  of  Pseudomonas  aeruginosa.  The  parent  antibody  bound 
to  the  0  antigen  of  organisms  of  serotype  06,  the  serotype  of  most  clinical  relevance. 
Immunotherapy  with  antibodies  against  the  LPS  of  Pseudomonas  aeruginosa  might 
form  an  alternative  to  LPS-based  vaccines  and  antibiotics.  The  recombinant  Fab 
antibody  was  shown  to  be  specific  for  the  LPS  of  most  serotype  06  isolates  (Tout  and 
Lam,  1997). 
Streptococcus  suis 
Our  own  efforts  to  extract  anti-bacterial  scFvs  from  the  Griffin.!  synthetic  library  are 
described  later  in  the  chapter.  This  library  has  also  been  used  to  select  recombinant 
antibodies  directed  against  surface  components  and  the  extracellular  factor  (EF)  of  a 
pathogenic  strain  of  Streptococcus  Buis  serotype  2.  Whole  cells  and  purified  EF  were 
used  for  panning  of  the  library.  Three  clones  were  identified  in  each  panning  which 
bound  to  the  antigens  of  interest  (de  Greeff  et  al.,  2000). 
Moraxella  catarrhalis 
Boel  et  al.  have  described  the  isolation  of  scFvs  which  recognised  the  high  molecular 
weight  outer  membrane  protein  (HMW-OMP)  of  complement-resistant  strains  of 
Moraxella  catarrhalis  (Boel  et  al.,  1998),  using  a  synthetic  phage  library  as  a  starting 
point  (de  Kruif  et  al.,  1995).  HMW-OMP  is  not  found  on  complement-sensitive  strains, 
a  property  which  was  exploited  in  the  selection  procedure  to  deplete  the  library  of  scFvs 
against  surface  components  common  to  complement-sensitive  and  complement-resistant 
strains 
4.1.2  Selection  of  scFv  antibodies  against  Mannlrein:  ia  1laemolylica  from  Griffin.  1 
library 
Since  experiments  performed  in  the  previous  chapter  to  construct  a  phage  display 
library  from  cattle  immunised  against  Mannheimia  haemolytica  failed,  our  attempts 
turned  to  use  of  the  Griffin.  l  library  in  order  to  select  antibodies  against  outer  membrane 
110 proteins  (OMPs)  of  this  pathogen.  Pasteurella  haemolytica  biotype  1  has  been  recently 
recategorised  into  the  Mannheimia  (Angen  et  al.,  1999). 
The  Griffin.  1  library  is  a  human  synthetic  scFv  library  with  highly  diversified  VE1  and 
VL  repertoires.  It  was  developed  at  the  Medical  Research  Council  Centre  for  Protein 
Engineering,  at  the  University  of  Cambridge.  The  repertoires  were  prepared  from  the  lox 
library  constructed  by  Griffiths  et  al.,  1994  and  cloned  into  the  phagemid  pHEN2.  The 
original  Griffiths  library  expressed  Fab  fragments  derived  from  commonly  expressed 
human  VH  and  VL  families.  In  the  Griffin.!  library,  these  repertoires  were  recloned  as 
scFvs  with  fusion  of  the  VL  gene  to  gIII  allowing  for  expression  of  scFv  on  rescued 
phage.  An  amber  codon  between  the  antibody  gene  and  gill  allows  expression  of  soluble 
scFv  fragments  on  induction  with  IPTG  in  a  non-suppressor  E.  coli  strain  such  IIB2151. 
In  amber  suppressing  strains  such  TG1,  induction  with  IPTG  causes  production  of  a 
scFv-pIII  complex,  which  embeds  into  the  bacterial  inner  membrane  before  capping  of 
the  emerging  phage  particle  (Figure  4.1). 
4.1.3  The  genus  Pasteurella 
Species  of  Pasteurella  are  small  gram-negative,  non-motile,  non-spore-forming, 
facultative  anaerobic  rods  or  coccobacilli.  These  organisms  have  adapted  to  parasitic  life 
on  the  oral  and  upper  respiratory  epithelia  of  apparently  healthy  animals  and 
occasionally  humans.  Most  strains  have  marked  host  species  specificity,  being 
associated  almost  exclusively  with  one  or  two  specific  hosts.  Infection  is  more  common 
than  disease,  which  usually  occurs  as  consequence  of  stress  such  as  overcrowding, 
chilling,  transportation  or  concurrent  infection.  Nevertheless,  the  "pasteurelloses",  as 
these  diseases  are  called,  are  of  major  pathologic  and  economic  significance  in 
veterinary  medicine.  Principal  hosts  of  some  Pasteurella  species  are  shown  in  Table  4.1. 
The  pathogenicity  characteristics  of  Mannheimia  kacmolytica  are  described  below 
using  its  previous  designation  as  Pasteurella  haemolytica. 
4.1.4  Pasteurella  haemolytica 
P.  haemolytica  is  a  commensal  of  the  nasopharynx,  and  confined  almost  exclusively 
to  ruminants  such  as  cattle,  sheep  and  goats.  Serotypcs  are  classified  on  the  basis  of 
immunological  recognition  (e.  g.  using  passive  haemagglutination  or  rapid  plate 6xHis-tag 
Plac  peiB  leader 
Amber  colon 
m)  c-lag 
111 
VII  cloning  VL  cloning 
6t.  ßc1. 
Figure  4.1  Structure  of'  phagenlid  piIEN-2. 
'1'hc  man  features  of  Ihr  vector  are  indicated.  'Iranscrihliun  takes  place  limn  a  Im. 
promoter  (shaded  arrow)  and  in  a  suppressor  strain  of  E.  roh,  the  translated  product 
Comprises  a  PeII3  leader,  the  single-chain  antibody  created  by  insertion  of  V￿  and  V, 
sequences  at  the  sites  indicated  separated  by  a  linker  (shad(-(I  hox),  peptide  lags,  and 
the  phage  p111  protein.  'I'hr  hinding  sites  oI  primers  and  their  poly  itirs  are  indicated  by 
arrows. Species  Host(s) 
P.  multocida  Cattle,  Sheep,  Rabbits,  Poultry,  Pigs 
P.  haemolytica  Cattle,  Sheep 
P.  pneumotropica  Rodents,  Dogs,  Cats 
P.  urea  (Actinobacillus  urea)  Human 
P.  gallinarum  Poultry 
P.  aerogenes  Pigs 
P.  canis  Dogs 
P.  dagmatis  Dogs,  Cats 
P.  avium  Chickens 
P.  stomatis  Dogs,  Cats 
P.  caballi  Horses 
P.  anatipestifer  Ducks,  Chickens,  Turkeys,  Pheasants 
P.  volantium  Chickens 
P.  anatis  Ducks 
P.  granulomatis  Cattle 
P.  langaa  Chickens 
P.  testudinis  Turtles,  Tortoises 
Table  4.1.  Principal  hosts  of  the  Pasteurella  species. agglutination  tests)  of  soluble  or  extractable  surface  antigens. 
There  are  two  distinct  biotypes,  A  and  T,  a  distinction  based  on  fermentation  of 
arabinose  and  trehalose  respectively.  The  classification  has  biological  significance  since 
biotype  A  strains  are  associated  with  ruminant  pneumonia,  septicaemia  in  young  lambs, 
and  ovine  mastitis,  while  biotype  T  strains  are  usually  associated  with  septicaemic 
infection  in  older  lambs  and  sheep.  Both  biotypes  and  all  serotypes  are  found  on  the 
nasal  and  oral  epithelia  of  clinically  normal  ruminants.  Pneumonia  of  cattle  and  sheep 
are,  economically,  the  most  important  P.  haemolytica  infections  and  the  economic 
losses  result  both  from  acute  fatalities  and  poor  productivity  of  chronically  affected 
animals. 
4.1.4.1  Pathogenesis  of  Pasteurella  haen:  olytica 
The  pathogenicity  of  M.  haemolytica  is incompletely  understood  but  several  of  the 
most  important  virulence  factors  are  described  below. 
Lipopolysaccharide  (LPS) 
As  in  other  gram-negative  bacteria,  the  cell  wall  of  P.  hacnzolytica  contains 
lipopolysaccharide  (LPS)  or  endotoxin.  Intravenous  injection  of  purified  LPS  in  calves 
triggers  the  release  of  thromboxan  A2,  prostaglandins,  serotonin,  cyclic  adenosine 
monophosphate  (cAMP)  and  cyclic  guanosine  monophosphate  (cGMP)  (Emau  et  al., 
1987).  All  or  some  of  these  mediators  may  be  responsible  for  the  clinical  signs 
associated  with  endotoxic  shock. 
Leukotoxin  (LKT) 
All  established  serotypes  of  P.  haemolytica  produce  a  soluble,  heat-labile  leukotoxin 
with  specificity  for  leukocytes  of  ruminants.  At  low  concentrations,  this  toxin  impairs 
phagocytosis  and  lymphocyte  proliferation;  higher  concentrations  result  in  cell  death 
due  to  lysis.  Lysis  results  from  formation  of  0.9-1.2  nm  transmembrane  pores  in  the 
membrane  of  alveolar  macrophages  and  other  target  cells.  Both  the  enzymes  released 
following  cytolysis  and  the  LKT  itself  are  chemotactic  for  other  leukocytes  and  augment 
lung  damage  by  increasing  cell  recruitment  into  the  inflammatory  focus.  This  toxin  is 
also  lytic  for  ruminant  platelets,  lysis  of  which  may  induce  the  pulmonary  vascular 
thrombosis  and  fibrin  exudation  typically  associated  with  shipping  fever  pneumonia. 
112 Polysaccharide  capsule  (CPS) 
Each  serotype  produces  a  characteristic  polysaccharide  capsule  that  is  anti- 
phagocytic  and  may  mediate  adhesion  to  respiratory  epithelium.  Anaphylaxis  and  an  IgE 
response  following  vaccination  with  purified  CPS  have  suggested  that  this  antigen  has 
the  potential  to  exacerbate  pneumonia  through  induction  of  pulmonary  hypersensitivity 
on  subsequent  exposure  to  live  organisms  (Conlon  and  Shewen,  1993). 
Outer  membrane  proteins 
The  major  outer  membrane  proteins  (OMPs)  of  gram  negative  bacteria  serve  a  range 
of  structural  and,  functional  roles  (e.  g  many  are  porins  and  function  to  regulate  the 
permeability  of  the  outer  membrane)  but  are  also  often  targets  for  the  host  antibody 
response.  In  addition,  OMPs  isolated  from  Pasteurella  haemolytica  induce  alterations 
to  the  biological  activity  of  bovine  polymorphonuclear  leukocytes.  A  dose-dependent 
reduction  of  the  capacity  of  adherence  to  nylon  wool  in  vitro  has  been  observed.  OMPs 
also  act  as  chemotaxins  (Iovane  et  al.,  1998).  Several  of  the  OMPs  expressed  by  P. 
haemolytica  are  regulated  by  conditions  experienced  in  vivo  (e.  g.  iron  concentration) 
and  have  proved  important  antigens  for  the  development  of  protective  immune 
responses  in  cattle.  OMPs  with  surface  exposed  domains  may  be  targets  for  antibodies 
that  function  in  bovine  host  defence  mechanisms  such  as  complement-mediated  killing 
(MacDonald  et  al.,  1983)  and  phagocytosis  and  killing  by  neutrophils  or  macrophages 
(Czuprynski  et  al.,  1987;  Chae  et  al.,  1990). 
Outer  membrane  proteins  involved  in  iron-acquisition 
The  ability  to  acquire  iron  in  the  host  is  necessary  for  most  pathogens  to  successfully 
establish  an  infection.  A  number  of  different  iron  acquisition  systems  have  evolved, 
including  the  production  of  siderophores  and  the  presence  of  specific  receptors  for  iron- 
containing  glycoproteins  such  as  lactoferrin  and  transferrin.  P.  haemolytica  Al  produces 
several  novel  outer-membrane  proteins  in  the  absence  of  iron,  and  two  of  these  (TbpA 
and  TbpB)  have  been  shown  to  bind  bovine  transferrin  and  mediate  acquisition  of  iron 
from  this  source  (Ogunnariwo  et  al.,  1997). 
4.1.5  Objectives 
As  described  in  the  previous  chapter,  our  attempts  to  construct  a  phage  display  library 
from  cattle  immunised  against  Mannheimia  haemolytica  were  unsuccessful.  One  might 
113 expect  that  a  Fab  library  from  immunised  cattle  would  be  enriched  in  antibodies  of 
relevance  to  this  goal  but  the  size  and  diversity  of  some  phage  display  libraries  is  such 
that  they  contain  antibodies  against  many  natural  or  synthetic  chemical  targets.  The  aim 
of  work  presented  in  this  chapter  was  therefore  to  select  antibodies  against  outer 
membrane  proteins  (OMPs)  of  Mannheimia  haemolytica  from  the  Gritfn.  1  library,  a 
large  synthetic  scFv  library  based  upon  commonly  expressed  human  VF{  and  VL  gene 
families. 
114 4.2  Materials  and  methods 
4.2.1  Manneheimia  haemolytica  strain 
Manneheimia  haemolytica  isolate  30  was  obtained  from  Dr  R.  L.  Davies,  University 
of  Glasgow.  The  organism  was  propagated  on  blood  agar  plates,  grown  at  37  °C.  After 
overnight  growth,  the  colonies  were  surrounded  by  haemolytic  zone. 
4.2.2  Preparation  of  outer  membrane  proteins  (OMP)  using  Sarkosyl 
The  following  method  was  performed  essentially  as  described  by  Davies  et  al.  (1991) 
except  that  EDTA  was  not  incorporated  in  the  Tris  buffer.  It  exploits  the  differential 
solubility  of  the  cytoplasmic  and  outer  membranes  in  the  detergent  sodium  N- 
lauroylsarcosine  (Sarkosyl).  Ten  ml  of  Brain  Heart  Infusion  broth  (BHIB)  was 
inoculated  with  M.  haemolytica,  and  incubated  overnight  on  the  shaker  at  37°C  with 
loosened  cap  to  ensure  an  aerobic  environment.  Four  hundred  Al  of  this  overnight  culture 
was  added  to  400  ml  of  pre-warmed  BHIB  in  a  two  litre  non-dimpled  flask  and 
incubated  on  an  orbital  shaker  (120  rpm)  at  37°C  for  six  hrs.  Bacteria  were  harvested  in 
250  ml  centrifuge  bottles  by  centrifugation  at  10000  rpm  for  20  min  at  4°C.  The  pellet 
was  resuspended  in  20  mM  Tris-HCl  (pH  7.2)  to  a  total  volume  of  50  ml  and  was  kept 
on  ice  overnight.  The  next  morning,  the  bacteria  were  washed  by  collecting  the  cells 
after  centrifugation  at  10000  rpm  for  30  min  at  4°C,  and  resuspending  them  in  7  ml  of 
ice-cold  20  mM  Tris-HC1.  The  cells  were  then  sonicated  on  ice  for  5-8  min  in  a 
sonication  vial  at  a  setting  of  12  microns  amplitude.  To  avoid  frothing,  the  probe  was 
immersed  into  the  suspension  to  a  depth  of  1-1.5  cm.  The  sonicated  sample  was  placed 
on  ice  for  10  min  and  then  centrifuged  at  10000  rpm  for  30  min  to  remove  unbroken 
cells.  The  supernatant  was  carefully  removed  and  transferred  to  a  10  ml  ultracentrifuge 
tube  and  centrifuged  at  35000  rpm  at  4°C  for  1  hr  to  pellet  the  cell  membranes.  The 
supernatant  was  discarded  and  the  gelatinous  pellet  was  resuspended  in  7  ml  of  0.5  % 
sodium  N-lauroylsarcosine  (Sarkosyl)  and  left  at  room  temperature  for  20  min  to 
solubilise  the  cytoplasmic  membranes.  The  sample'was  centrifuged  again  at  35000  rpm 
at  4°C  for  1  hr  to  pellet  the  outer  membrane.  The  gelatinous  pellet  was  resuspended  in 
ice-cold  20  mM  Tris-HCI  (pH  7.2)  and  was  centrifuged  again  at  35000  rpm  at  4°C  for  1 
hr.  The  final  pellet  was  resuspended  in  1  ml  of  20  mM  Tris-l  ICI  (p117.2).  The  prepared 
OMP  was  kept  at  -  80°C.  Protein  concentration  was  assayed  and  samples  of  the  OMP 
were  analysed  by  SDS-polyacrylamide  gel  electrophoresis  (SDS-PAGE)  to  determine 
115 their  composition  before  use  as  a  target  for  screening  the  phage  display  library. 
4.2.2.1  Protein  assay  of  OMPs 
The  concentration  of  protein  in  the  OMP  was  measured  using  the  BCA  Protein  Assay 
Kit  (Pierce).  Serial  dilutions  of  a  standard  protein  (BSA)  were  prepared  and  0.1  ml  of 
each  dilution  and  the  OMP  were  added  to  2  ml  of  working  reagent,  before  incubation  at 
37°C  for  30  min.  The  absorbance  of  each  sample  was  then  measured  at  562  nm  and 
standard  curve  prepared.  From  this,  the  protein  concentration  of  the  OMP  was 
determined. 
4.2.2.2  SDS-PAGE  analysis  of  OMPs 
Polyacrylamide  gel  electrophoresis  was  carried  out  to  standard  protocols  (Laemmli, 
1970).  Briefly,  25  µ1  of  OMP  was  boiled  in  sample  buffer  containing  ßME  for  two  min 
and  then  was  loaded  to  one  lane  of  a  12.5%  SDS-polyacrylamide  gel.  Samples  were  run 
at  110  V  and  30-40  mA  current.  The  gel  was  stained  with  Coomassie  Brilliant  Blue  stain 
for  about  5  min  and  then  destained  until  the  bands  became  visible. 
4.2.3  Selection  of  anti-OMP  antibodies  from  Griffin.  1  scFv  pliage  library 
4.2.3.1  Growth  of  library  and  preparation  of  VCS-M13  helper  phage 
Aliquots  of  the  library  and  VCS-M13  helper  phage  were  provided  by  Dr.  P.  Ogston, 
University  of  Glasgow.  The  library  was  originally  supplied  by  the  Medical  Research 
Council  Centre  for  Protein  Engineering,  University  of  Cambridge.  Aliquots  of  library 
and  helper  phage  were  amplified  according  to  the  protocols  provided  by  staff  at  the 
Centre  (http:  //www.  mrc-cpe.  cam.  ac.  uk/phagelglmtaf.  html). 
4.2.3.2  Panning  the  library  against  Manneheimia  haetnolylica  OMP 
First  round  of  selection  in  inmuinotubes 
One  immunotube  (NUNC)  was  coated  by  rotation  overnight  at  room  temperature  with 
4  ml  of  OMP  at  a  protein  concentration  of  50  Ftg/ml  in  PBS.  Next  day,  the  tube  was 
washed  5  times  with  PBS  to  remove  unbound  proteins.  Blocking  was  performed  with  4 
ml  of  2%  skimmed  milk  in  PBS  (MPBS)  at  37°C  for  2  hrs.  The  tube  was  then  washed  5 
times  with  PBS. 
From  the  Griffin.!  scFv  library,  phage  were  added  to  the  coated  tube  in  a  volume  of  4 
116 ml  of  2%  MPBS  and  the  tube  was  incubated  for  30  min  at  room  temperature,  rotating 
continuously,  and  then  stood  for  a  further  90  min.  The  supernatant  was  discarded  and  the 
tube  was  washed  10  times  with  PBS  containing  0.1  %  Tween  20,  and  then  10  times  with 
PBS  to  remove  unbound  phage  antibodies.  To  elute  the  bound  phage,  1  ml  of  100  mM 
triethylamine  (TEA)  in  water  was  added  to  tube  and  tube  was  left  rotating  for  10  min  at 
room  temperature.  The  eluted  phage  were  mixed  with  0.5  ml  of  1M  Tris-HC1(pH  7.4) 
and  stored  at  4°C.  After  elution,  a  further  200  µl  of  1M  Tris-HCl  (pH  7.4)  was  added  to 
the  immunotube  to  neutralise  the  remaining  TEA  and  the  tube  was  kept  at  4°C  to  be  used 
in  the  next  step. 
Infecting  E  coli  with  eluted  phage  antibodies 
To  provide  exponentially  growing  E.  coli  cells  ready  for  infection  with  phage,  50  µl 
of  an  overnight  culture  of  E.  coil  TG1  in  2x  TY  was  inoculated  to  50  ml  of  2x  TY  and 
the  culture  was  incubated  at  37°C  with  shaking  until  the  absorbance  reached  0.5  at  600 
nm.  From  1.5  ml  of  phage  eluted  from  the  first  round  of  selection,  0.75  ml  was  added  to 
9.25  ml  of  exponentially  growing  bacteria.  Also,  3.8  ml  of  bacterial  culture  was  added 
directly  to  the  immunotube  containing  200  µl  of  buffer.  To  determine  the  number  of 
input  phage,  1  ml  of  the  culture  of  TG1  was  infected  with  2  µl  of  a  1/500  dilution  (in 
PBS)  of  phage  stock.  The  three  cultures  were  incubated  in  a  water  bath  at  37°C  without 
shaking  for  30  min  to  allow  infection  to  take  place.  After  incubation,  the  10  and  4  ml 
samples  of  infected  TG1  cells  were  pooled  as  output  and  five,  100-fold  serial  dilutions 
(in  2xTY)  were  prepared.  The  same  dilutions  of  TG1  infected  with  input  phage  were  also 
prepared.  Titration  of  input  and  output  phage  was  performed  by  plating  100  t1  of  each 
dilution  on  TYE  plates  containing  100  µg/ml  ampicillin  and  1%  glucose,  and  incubating 
the  plates  at  30°C  overnight. 
The  remaining  14  ml  of  infected  TG1  cells  were  centrifuged  at  3300  g  for  10  min  and 
the  bacterial  pellet  was  resuspended  in  I  ml  of  2x  TY.  This  was  then  divided  between 
two  20  x  20  cm  plates  of  TYE  containing  100  pg/ml  ampicillin  and  1%  glucose,  and 
spread  to  dryness.  Plates  were  incubated  at  30°C  overnight.  The  next  day,  96  single 
colonies  were  picked  from  the  large  plates  and  inoculated  into  wells  in  a  96  well  U 
bottom  Nunc  cell  culture  plate,  each  well  containing  120  ltl  of  2x  TY.  After  ihrs 
incubation  at  37°C  with  shaking,  60  tl  of  sterile  50  %  glycerol  was  added  and  plate  was 
kept  at  -80°C. 
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The  colonies  which  appeared  on  the  two  large  selection  plates  were  washed  into  40 
ml  of  2xYT.  Seventy  tl  of  this  culture  was  added  to  100  ml  of  2x  TY  containing  100 
gl/ml  ampicillin  and  1%  glucose.  The  culture  was  incubated  at  37°C  with  shaking  until 
the  absorbance  at  600  nm  reached  0.57.  To  rescue  the  phage  antibodies,  about  4.4  x  1011 
t.  u.  of  helper  phage  (VCS-M13)  were  added  to  10  ml  of  the  culture.  Cells  were  left  at  37 
°C  for  30  min  without  shaking  and  the  culture  then  was  centrifuged  at  3300g  for  10  min 
to  recover  the  infected  bacteria.  The  pellet  was  resuspended  in  50  ml  of  2x  TY 
containing  120  µg/ml  ampicillin  and  30  µg/ml  kanamycin  and  was  incubated  at  30°C 
with  shaking  overnight.  Forty-five  ml  of  overnight  culture  was  centrifuged  at  3300  g  for 
30  min  to  remove  the  bacteria.  To  harvest  the  rescued  phage  antibodies,  9  ml  of 
PEG/NaCI  was  added  to  the  supernatant  and  the  mixture  was  left  at  4°C  for  1  hr.  The 
suspension  was  then  centrifuged  at  5300  g  for  30  min  to  precipitate  the  aggregated 
phage.  The  supernatant  was  discarded  and  the  pellet  was  resuspended  in  2  ml  of  PBS  and 
then  centrifuged  again  at  11600  g  for  10  min  to  remove  the  remaining  bacterial  debris. 
The  supernatant  containing  the  rescued  phage  was  kept  at  4  °C  before  titration  and  use  in 
the  second  round  of  selection. 
Titration  of  pliage  rescued  front  the  first  round  of  selection 
Titration  was  performed  by  infecting  aliquots  of  an  exponentially  growing  culture  of 
E.  coli  TG1  with  10-fold  serial  dilutions  of  rescued  phage  as  described  for  titration  of 
the  input  phage. 
Second  round  of  selection 
In  the  second  round  of  selection,  two  immunotubes  were  coated  with  4  ml  of  12 
µg/ml  or  120  µg/ml  of  OMP  in  PBS,  overnight.  Selection  at  the  lower  concentration  was 
to  be  eluted  with  TEA,  aiming  to  preferentially  select  for  pliage  antibodies  with  a  high 
affinity  for  OMP.  Phage  binding  in  the  second  tube  (120  µg/ml)  were  to  be  eluted  by 
addition  of  a  hyperimmune  anti-OMP  serum  as  a  competitive  ligand.  Washing  and 
incubation  conditions  were  as  described  for  the  first  round  of  selection.  Ix  1014  PEG 
precipitated  phage  from  the  first  round  of  selection  were  added  to  each  tube  in  3% 
MPBS.  After  incubation  and  washing  to  remove  the  unbound  pliage,  TEA  was  used  to 
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anti-OMP  antiserum  (provided  by  Dr.  It  L.  Davies)  was  added  and  the  tube  was 
incubated  at  37  °C  with  rotation  for  1.5  hrs.  After  incubation,  the  contents  of  the  tube 
were  added  to  10  ml  of  an  exponentially  growing  culture  of  E.  cols  TG  1.  Four  ml  of 
bacterial  culture  was  also  added  directly  to  the  tube  to  recover  by  infection  any 
remainder  phage.  Remaining  procedures  including  isolation  of  infected  bacteria, 
superinfection  with  helper  phage,  recovery  of  phage  using  PEG  precipitation  and 
titration  were  as  described  for  round  one. 
Third  round  of  selection 
For  the  third  round  of  selection,  two  immunotubes  were  again  coated  with  OMP  for 
elution  with  TEA  and  anti-OMP  antiserum.  Concentrations  of  OMP  were  reduced  10- 
fold  for  each  tube,  giving  concentrations  of  1.2  and  12  pg/m1  for  TEA  and  antiserum 
elution  reactions  respectively.  Ix  1013  PEG  precipitated  phage  from  the  second  round  of 
selection  were  added  to  each  tube.  Procedures  were  as  described  for  previous  rounds  of 
selection. 
4.2.4  Screening  phage  antibodies  by  ELISA  (monoclonal  phage  ELISA) 
After  each  round  of  selection,  96  transfected  colonies  were  picked  at  random  into  the 
wells  of  microtitre  plates  (see  above).  From  these  bacterial  lines,  phage  were  prepared 
and  screened  for  binding  to  the  Manneheimia  haemolytica  OMP  antigens  using  ELISA. 
Since  each  preparation  of  phage  is  derived  from  a  single  infected  bacterial  colony,  this  is 
termed  "monoclonal  phage  ELISA". 
Preparation  of  p/iage  antibodies  for  ELISA 
From  each  well  of  the  stock  microtitre  plates,  15  tl  of  bacterial  suspension  was 
transfered  to  a  second  96  well  plate  containing  in  each  well  70  Etl  of  2x  TY  with  100 
tg/ml  ampicillin  and  1%  glucose.  The  second  plate  was  incubated  with  shaking  for  3-4 
hrs  at  37  °C.  Five  µl  from  each  well  was  transferred  to  a  third  microtitre  plate  containing 
in  each  well  150  µl  of  2x  TY  with  100  µg/ml  ampicillin  and  1%  glucose.  Growth 
continued  with  shaking  for  2  hrs  at  37  °C  before  addition  to  each  well  of  Ix  1010  tu 
VCS-M13  helper  phage  in  20  µl  of  the  same  media.  T7hc  plate  was  left  standing  in  an 
incubator  at  37  °C  to  allow  the  helper  phage  to  infect  the  E.  coli  cells,  and  then  it  was 
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antibodies,  the  plate  was  centrifuged  at  1800  g  on  a  specialist  plate  carrier,  the 
supernatant  was  aspirated  and  the  pellet  in  each  well  was  resuspended  in  220  µl  of  2x 
TY  containing  100  tg/ml  ampicillin  and  50  tg/ml  kanamycin.  The  plate  was  incubated 
overnight  at  30  °C  with  shaking.  The  next  day,  the  plate  was  again  centrifuged  at  1800  g 
and  the  supernatant  containing  phage  antibodies  was  recovered. 
Coating  of  antigen 
The  wells  of  ELISA  plates  were  coated  with  100  tl  of  OMP  in  PBS  at  a  protein 
concentration  of  50  pg/ml.  Since  milk  had  been  use  during  phage  selection,  a  second 
series  of  plates  were  coated  with  100  tl  of  2%  MPBS  to  control  for  the  specificity  of  the 
selected  scFvs.  Plates  were  left  at  room  temperature  overnight  to  allow  protein  binding. 
Blocking 
The  following  day,  plates  were  flipped  to  discard  excess  liquid  and  washed  3  times 
with  PBS  to  remove  any  unbound  antigens.  Remaining  binding  sites  on  the  plastic  were 
blocked  by  adding  200  µl  of  3%  bovine  serum  albumin  in  PBS  (BSA-PBS)  to  each  well 
and  then  incubating  at  room  temperature  for  2  hrs. 
Adding  the  single  ph  age  antibodies 
After  washing  the  plates  3  times  with  PBS,  100  tl  of  each  phage  antibody  under  test 
was  added  to  wells  of  the  test  (OMP  coating)  and  control  plates  (MPBS  coating).  Plates 
were  incubated  for  2  hrs  at  room  temperature  to  allow  binding. 
Detection  of  bound  phage  antibodies 
After  incubation,  plates  were  washed  3  times  with  0.05%  Twcen  20  in  PBS  and  ten  3 
times  with  PBS  to  remove  unbound  phage  antibodies.  One  hundred  1tl  of  a  1000-fold 
dilution  of  HRP-conjugated  anti-M13  antibody  (Amersham  Pliarmacia  Biotech)  in  3% 
BSA-PBS  was  added  to  each  well.  This  antibody  recognises  pVIlI,  the  dominant 
component  of  the  coat  of  filamentous  phage.  Plates  were  incubated  at  room  temperature 
for  1.5  hrs. 
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After  washing  the  plates  3  times  with  0.05%  Tween  20  in  PBS  and  3  times  with  PBS 
to  remove  unbound  anti-M13  antibodies,  100  tl  of  developer  was  added  to  each  well. 
This  solution  comprised  0.1  M  citric  buffer  containing  1  mg  /  ml  o-phenylenediamine 
(OPD;  Sigma)  and  0.4  µl  /  ml  30%  hydrogen  peroxide.  The  colorimetric  reaction  was 
stopped  by  addition  of  100  µl  IM  sulphuric  acid.  Absorbance  was  read  at  450  nm  on  an 
ELISA  reader  (Rosys). 
For  each  round  of  selection,  the  OD  measurement  for  a  given  phage  clone  on  the 
OMP-coated  plate  was  corrected  by  subtraction  of  the  OD  measured  on  plates  coated 
with  milk.  Values  were  then  ranked.  From  those  clones  with  strongest  signals,  15  were 
chosen  form  the  first  round  of  selection,  15  each  from  TEA  and  anti-OMP  elution  at 
round  two,  and  24  and  15  from  the  final  round  after  elution  with  TEA  and  anti-OMP 
antiserum  respectively.  These  clones  were  then  characterised  further. 
4.2.5  Optimisation  of  ELISA 
Before  starting  the  phage  ELISA  and  during  subsequent  analysis,  the  following 
experiments  were  performed  to  check  and  optimise  the  reaction  conditions.  Aside  from 
the  variations  highlighted  in  the  sections  which  follow,  all  conditions  (volumes, 
temperature  and  duration  of  incubations,  washing  steps  and  development)  were  as 
described  in  the  previous  section  for  the  monoclonal  phage  ELISA. 
Binding  of  OMP  to  ELISA  plates 
To  check  the  ability  of  ELISA  plates  to  adsorb  the  OMP  antigens,  2  sets  of  4  wells  of 
an  ELISA  plate  (Iwaki)  were  coated  with  50  and  25  tg  /  ml  OMP.  After  overnight 
incubation  at  room  temperature,  the  plate  was  blocked  with  3%  BSA-PBS  and  then 
dilutions  of  1/100,1/500,1/1000  and  1/2000  of  a  rabbit  anti-OMP  antiserum  (donated  to 
the  study  by  Dr  R.  L.  Davies)  were  added  to  each  row.  An  IMP  anti-rabbit  conjugate 
(Sigma)  was  used  at  a  dilution  of  1/2000  as  a  secondary  antibody  and  reactions  were 
developed  using  OPD.  To  refine  this  experimental  set-up  and  define  factors  contributing 
to  background  reactions,  further  assays  omitted  the  OMP  coating  layer,  coated  wells 
with  the  rabbit  anti-OMP  antiserum,  and  defined  levels  of  binding  of  the  detecting 
antibodies  to  wells  coated  only  with  the  BSA  blocking  protein  (Table  4.2). 
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Coating  material 
Primary 
antibody 
Secondary  antibody 
A  ODMP  anti-ONIP  IIRP  anti  rabbit 
B  PBS  anti-O;  ý1P  IIRP  anti  rabbit 
C 
1  Anti-OMP  ZIRP  anti  rabbit 
2 
antiserum 
-  - 
I  anti-OSIP  IIRP  anti  rabbit 
D  2  BSA  -  IIRP  anti  rabbit 
3  -  - 
3%  BSA  in  PBS  was  used  for  blocking. Optimal  dilution  of  anti-M13  phage  antibody 
Four  rows  of  4  wells  were  coated  with  10  fold  serial  dilutions  of  VCS-M13  helper 
phage  from  a  starting  concentration  of  2x  109  phage  particles  per  well.  After  incubation 
and  blocking,  HRP-conjugated  anti-M13  antibody  was  added  in  2  fold  serial  dilutions 
from  1/500  across  the  plate  to  create  a  matrix  defining  the  optimal  concentration  of 
antibody  to  detect  phage  bound  to  the  wells.  An  additional  row  of  4  wells  was  coated 
with  BSA  and  then  equivalent  concentrations  of  the  HRP-conjugated  anti-M13  antibody 
were  added  (1/500,1/1000,1/2000  and  1/4000).  The  OD  of  these  reactions  showed  the 
level  of  background  attributable  to  binding  of  anti-M13  antibodies  to  the  blocked  plastic. 
Comparison  between  BSA  and  milk 
-  Helper  phage  coated  wells 
A  series  of  experiments  compared  the  qualities  of  BSA  and  milk  as  blocking  or 
diluent  agents.  Two  sets  of  wells,  each  consisting  of  four  rows  of  4  wells,  were  coated 
with  VCS-M13  helper  phage.  The  first  row  of  each  set  was  coated  with  2x  1012  phage 
particles  per  well  with  succeeding  rows  receiving  10-fold  serial  dilutions.  The  first  set 
was  blocked  with  3%  BSA-PBS,  the  second  with  2%  MPBS.  HRP  anti-M13  antibody  in 
3%  BSA-PBS  was  then  added  at  concentrations  of  1/500,1/1000,1/2000  and  1/4000  to 
each  row  of  the  first  set.  The  second  series  of  wells  were  tested  with  the  detecting 
antibody  diluted  in  2%  MPBS. 
-OMP  coated  ivells 
Three  rows  of  4  wells  were  set  up  with  different  combinations  of  MPBS  and  BSA- 
PBS  as  blocking  or  diluent  for  phage  ELISA  (Table  4.3).  All  wells  were  coated  with 
OMP  at  a  concentration  of  50  µg/ml.  In  two  columns,  remaining  binding  sites  on  the 
plastic  were  blocked  by  addition  of  2%  MPBS.  In  the  other  two  columns,  3%  BSA-PBS 
was  used  as  blocker.  Phage  antibodies  comprising  a  mixture  of  PEG  precipitated  phage 
from  7  clones  known  from  previous  experiments  to  be  reactive  with  OMP,  were  added  to 
the  first  row,  the  combined  supernatant  from  cultures  of  the  same  clones,  containing 
phage  antibodies  at  a  lower  concentration,  was  added  to  the  second  row,  and  finally  PEG 
precipitated  phage  antibody  from  a  clone  weich  failed  to  react  with  OMP  in  previous 
assays  was  added  to  the  third  row.  The  diluent  for  IIRP  anti-M13  antibody  was  varied; 
the  first  and  third  columns  received  the  conjugate  diluted  in  2%  MPBS  while  the  diluent 
from  columns  two  and  four  was  3%  BSA-PBS.  Since  the  titre  of  PEG  precipitated  phage 
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Code  for  reaction  MM  MB  BM  BB 
Blocking  Milk  Milk  BSA  BSA 
Phage  source  PEG  precipitated  PEG  precipitated  PEG  precipitated  PEG  precipitated 
Diluent  of  anti  M13  Milk  BSA  Milk  BSA 
Blocking  Milk  Milk  BSA  BSA 
Phage  source  Supernatant  Supernatant  Supernatant  Supernatant 
Diluent  of  anti  M13  Milk  BSA  Milk  BSA 
Blocking  Milk  Milk  BSA  BSA 
Phage  source  Negative  clone  Negative  clone  Negative  clone  Negative  clone 
Diluent  of  anti  M13  Milk  BSA  Milk  BSA antibodies  is  higher  than  those  in  the  supernatant  from  infected  cultures,  the  OD  values 
obtained  in  this  experiment  can  only  be  compared  for  like  treatments  to  judged  the  effect 
of  BSA  and  milk  on  the  assay.  However,  results  consistently  showed  that  milk 
particularly  when  used  as  a  blocking  agent,  affected  significantly  the  results  of  pliage 
ELISA  (Figure  4.14). 
Comparison  of  two  ELISA  plates 
This  experiment  compared  the  properties  of  ELISA  plates  supplied  by  Nunc  and 
Iwaki.  The  rows  of  a  plate  from  each  supplier  were  divided  into  two  parts.  One  was 
coated  with  OMP  at  50  µg/ml,  the  other  with  2%  MPBS.  Blocking  was  carried  out  with 
3%  BSA-PBS.  In  the  next  step,  100  µl  samples  of  supernatant  from  overnight  cultures  of 
12  positive  colonies,  selected  from  the  third  round  of  panning  by  elution  with  anti-OMP 
antiserum,  was  added  to  the  12  wells  of  the  first  row  of  each  section  on  each  plate.  Ten- 
fold  serial  dilutions  of  each  sample  were  then  made  into  the  next  3  wells  in  each  column. 
HRP  anti-M13  antibody  was  added  in  BSA-PBS  and  OPD  was  used  as  developer.  The 
results  revealed  that  the  Nunc  ELISA  plates  were  superior  for  phage  ELISA. 
4.2.6  Analytical  PCR  for  the  detection  of  full-length  scFvs 
Various  investigators,  ourselves  included,  have  observed  that  panning  can  isolate 
phage  from  antibody  libraries  which  are  reactive  with  the  target  antigen,  but  which  lack 
either  the  VF{  or  the  VL  components  of  the  scFv.  Presumably,  these  constructs  possess 
sufficient  affinity  for  the  target  to  emerge  from  selection.  To  assess  the  presence  of  Vif 
and  VL  in  clones  selected  on  OMP,  crude  bacterial  lysates  of  24  and  12  clones  selected 
from  the  last  rounds  of  selection,  eluted  by  TEA  and  anti-OMP  antiserum  respectively, 
were  analysed  by  PCR.  Amplification  was  performed  with  primers  LMB3  and 
FOR_LinkSeq,  or  LMB3  and  pHEN-SEQ  or  Fdseql  (Table  4.4).  Primers  LM133  and 
FOR_LinkSeq  amplify  across  the  cloning  sites  for  the  heavy  chain  fragment,  whereas 
LMB3  and  pHEN-SEQ  or  Fdsegl  should  recovers  both  light  and  heavy  chain  sequences 
(Figure  4.1).  The  approximate  expected  size  of  amplicons  produced  with  these  primer 
combinations  is  shown  in  Table  4.5  PCR  was  performed  in  a  reaction  volume  of  25  tI 
with  final  concentrations  of  500  µM  of  each  dNTPs  (Promega),  400  nM  of  each  primer 
and  3.5  mM  MgCl2.  The  reaction  buffer  provided  50  mM  KCI,  10  mM  Tris-IICI  (pll 
9.0)  and  0.1  %  Triton®X-  100.2.5  units  of  Taq  DNA  polymcrase  (Promega)  were  used  for 
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LMB3:  CAGGAAACAGCTATGAC 
Fd  segl:  GAATTTTCTGTATGAGG 
FOR  LinkSeq:  GCCACCTCCGCCTGAACC 
pHEN-SEQ:  CTATGCGGCCCCATTCA 
Sequences  are  present  5'  to  3' 
Table  4.5  Predicted  size  of  amplicons  from  PCR  analysis  of  pIIEN-2. 
Primers  Possible  scenarios  Approximate  expected  size  (bp) 
LAMB3  -  FOR  LinkSeq 
No  insert  present  190 
_ 
VH  insert  present  490 
No  insert  present  320 
LMB3  -  pIIEN-SEQ  VL  or  V0  insert  present  620 
Both  VL  and  V11  present  920 
No  insert  present  360 
LAMB3  -  Fdseq  I  VL  or  Vn  insert  present  660 
Both  VL  and  VII  present  960 amplification  with  the  following  conditions.  The  reaction  was  heated  to  94°C  for  5  min 
and  was  then  incubated  for  35  temperature  cycles  of  94  °C  for  50  sec,  56  °C  for  I  min 
and  72  °C  for  3  min.  There  was  a  final  extension  step  of  72  °C  for  7  min.  Products  were 
analysed  on  1%  agarose  gel.  The  results  showed  that  most  clones  possessed  only  VL 
inserts.  Two  clones,  one  with  both  VL  and  VII  and  another  with  only  a  light  chain,  were 
sequenced  using  primers  LMB3  and  pHEN-SEQ. 
4.2.7  Western  blotting 
The  OMP  preparation  from  Mannheimia  haemolytica  contained  a  wide  range  of 
proteins.  Western  blotting  was  therefore  used  to  determine  the  specificity  of  the  phage 
antibodies  selected  by  panning.  The  general  procedures  for  Western  blotting  are 
described  in  the  Appendix  of  General  Methods.  Variations  and  specific  features 
employed  in  this  phase  of  the  project  are  highlighted  in  the  following  sections. 
4.2.7.1  Western  blotting  using  phage  antibody  and  anti-M13  antibody 
About  160  Itg  of  Sarkosyl-prepared  OMP  was  mixed  with  sample  buffer  and  heated 
in  boiling  water  for  3  min.  The  sample  was  then  divided  between  8  wells  cast  in  a  12.5% 
SDS-polyacrylamide  gel.  Electrophoresis  was  done  using  100  volts  and  40  mA  until  the 
bromophenol  blue  dye  reached  the  end  of  the  gel.  The  proteins  were  transferred  to 
nitrocellulose  membrane  (Amersham  Pharmacia  Biotech).  Briefly,  a  nitrocellulose 
membrane  was  cut  to  the  same  size  as  the  gel  and  soaked  in  transfer  buffer.  It  was 
carefully  located  onto  the  gel  which  was  then  sandwiched  between  4  layers  of  filter 
paper  and  fibre  pads  of  the  same  size.  The  assembly  was  put  into  the  blotting  cassette 
and  loaded  to  the  electrophoresis  tank,  placing  the  gel  in  the  anode  (-)  side  and  the 
membrane  in  the  cathode  (+)  side.  After  1.5  hrs  of  transfer  at  100  volts,  40  mA  current, 
the  membrane  was  peeled  off  the  gel  and  stained  with  Ponceau  red  dye  to  confirm  that 
the  proteins  had  been  transferred.  Ponceau  binds  to  proteins  temporarily  and  is  easily 
removed  by  washing  with  distilled  water.  After  confirming  protein  transfer  had  taken 
place,  the  membrane  was  blocked  with  3%  milk  in  Tris-NaCI  (pII  7.4)  overnight.  The 
membrane  was  then  washed  with  Tris-NaCI  and  was  cut  vertically  into  eight  strips  each 
carrying  the  separated  OMP  proteins.  Each  strip  was  incubated  with  supernatant  from  a 
single  phage  antibody  clone  isolated  from  the  third  round  of  selection.  Incubation  was 
performed  in  individual  sealed  pockets  of  polythene  for  1  hr  at  37  °C  with  shaking.  After 
incubation  and  washing,  the  strips  were  incubated  with  IIRP  anti-M13  antibody  for  1  hr 
124 at  37  °C  with  shaking.  The  strips  were  washed  and  developed  with  4-chloro-l-naphtol. 
This  general  procedure  failed  to  detect  binding  by  any  of  the  phage  antibodies  under  test. 
The  experiment  was  repeated  with  clones  isolated  in  different  rounds  of  selection,  with 
PEG  precipitated  phage,  with  extended  incubation  times  and  variations  to  the 
temperature  of  incubation,  and  with  more  sensitive  light-emitting  enzymes  substrates. 
No  variation  was  identified  which  would  produce  a  signal  from  Western  blotting. 
4.2.7.2  Western  blotting  using  scFv  and  anti-pIII  antibody 
Since  the  use  of  phage  antibodies  for  Western  blotting  with  OMP  antigens  did  not 
succeed,  we  considered  using  scFvs.  In  this  method,  scFvs  were  expressed  as  a  fusions  to 
pIII  by  inducing  with  IPTG.  Conventionally,  scFvs  are  expressed  as  soluble  proteins  in 
amber  non-suppressing  strains  of  E.  cola  such  as  HB2151,  exploiting  the  presence  of  the 
amber  stop  codon  between  the  scFv  insert  and  the  gill  sequence  in  vectors  such  as 
pHEN2  (McCafferty  et  al.,  1990).  By  inducing  expression  in  E.  coli  TG  I,  the  scFv-pIII 
fusion  protein  accumulates  in  the  cytoplasmic  membrane  from  which  it  can  be  released 
with  detergents  and  detected  with  anti-pIII  antibodies  (Tesar  et  al.,  1995;  Mersman  et  al., 
1998)  (Figure  4.2).  Before  using  this  system  in  Western  blotting,  it  was  necessary  to 
verify  that  scFv-pIII  proteins  were  successfully  expressed  and  that  they  could  be  detected 
with  an  anti-pI1I  monoclonal  antibody.  This  was  assessed  through  dot  blotting  and 
ELISA. 
Dot  blotting 
The  procedures  leading  to  the  preparation  of  a  bacterial  cell  lysate  are  shown  in 
Figure  4.3.  Two  clones  were  chosen  from  the  third  round  of  selection  showing  the 
highest  signal  in  anti-OMP  phage  ELISA.  Fifteen  tl  of  a  suspension  of  each  clone  were 
added  to  5  ml  of  LB  containing  100  pg/ml  ampicillin  and  1%  glucose  and  the  cultures 
were  incubated  at  37  °C  with  shaking,  overnight.  Next  day,  100  tl  from  each  culture  was 
added  to  10  ml  of  LB  containing  100  pg/ml  ampicillin  and  1%  glucose.  The  cultures 
were  incubated  at  37  °C  with  shaking  until  the  OD  at  600  nm  reached  to  0.55  to  0.6. 
Each  culture  was  then  divided  to  5  ml  aliquots  and  centrifuged  at  5100  rpm.  One  pellet 
from  each  clone  was  resuspended  in  5  ml  of  LB  containing  100  Ftg/ml  ampicillin  and  I 
mM  IPTG  and  the  another  pellet  from  each  clone  was  resuspended  in  the  sane  media 
containing  0.1  mM  IPTG  (Kipriyanov  et  al.,  1997).  Cultures  were  left  shaking  at  30  °C 
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Figure  4.2  Two  methods  for  detection  of  anti-OAMP  antibodies. 
A:  Phage  carrying  an  anti-OMP  scFv  recognises  the  antigen  coated  to  a  solid  phase.  Anti-M13 
antibodies  conjugated  to  horseradish  peroxidase  (HRP)  binds  to  the  phage  coat,  most  likely  to 
pVIlI,  the  most  abundant  component  of  the  capsid. 
B:  pIII-scFv  expressed  by  bacteria  binds  to  the  OMP-coated  surface.  It  is  then  'detected  by  a 
monoclonal  anti-pIII  antibody  and  HRP-conjugatcd  anti-mouse  reagents. Clones  selected  for  analysis 
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Figure  43  Procedure  for  the  preparation  of  scFv-pIII  used  in  dot  blotting  and  ELISA. overnight  to  allow  expression  of  the  scFv-pIII  fusion.  The  following  day,  each  5  ml 
culture  was  divided  into  two  parts  for  lysis  with  different  detergents.  After 
centrifugation,  one  pellet  from  each  2.5  ml  aliquot  was  resuspended  in  200  tl  of  LB 
containing  110  µl  of  0.05%  Tween  20;  the  other  was  resuspended  in  200  tl  of  LB 
containing  110  µl  of  Bugbuster  solution  (Novagen).  The  lysis  reactions  were  incubated 
with  shaking  at  30  °C  for  4.5  hrs  and  were  then  centrifuged  at  7000  g  for  10  min. 
Supernatants  predicted  to  contain  scFv-pIII  were  collected  and  the  pellets  were  treated 
with  50  µl  of  P1  and  P2  solutions  (resuspension  and  lysis  solutions)  from  QIAprep  spin 
miniprep  kit  to  assess  the  efficacy  of  lysis. 
A  nitrocellulose  membrane  was  used  to  spot  out  the  lysates  in  a  pattern  shown  in 
Figure  4.16.  Two  p1  of  the  lysates  prepared  from  each  clone,  after  induction  with  1  and 
0.1  mM  IPTG  were  spotted  onto  the  membrane  and  left  at  room  temperature  until  dry. 
Two  µl  of  a  PEG  precipitated  phage  preparation  was  spotted  as  a  positive  control,  and  as 
negative  controls,  aliquots  of  Bugbuster  and  Tween  20  detergents  were  added.  The 
membrane  was  blocked  with  3%  BSA-PBS  for  2.5  hrs  and  it  was  then  washed  3  times 
with  PBS.  The  membrane  was  then  incubated  with  a  1/1000  dilution  of  a  mouse  anti-pIIl 
monoclonal  antibody  (Mo  Bi  Tee)  diluted  in  3%  BSA-PBS.  Incubation  was  for  1.5  hrs 
and  after  washing,  a  1/1000  dilution  of  an  HRP-conjugated  anti-mouse  antibody  was 
added  for  a  further  1.5  hrs.  After  the  last  round  of  washing,  the  dot  blot  was  developed 
with  4-chloro-l-naphtol  substrate.  The  result  showed  that  the  anti-pIIl  antibody 
recognised  a  ligand  (pIII)  on  the  blot  (Figure  4.16). 
ELISA 
The  efficacy  with  which  anti-pIII  could  detect  scFv-pIII  fusions  was  checked  by 
ELISA.  Two  rows  of  4  wells  were  coated  with  100  µl  of  50  pg/ml  OMP  and  two  rows 
were  coated  with  2%  MPBS  as  a  control.  After  overnight  coating  at  room  temperature 
and  blocking  with  3%  BSA  at  37  °C  for  2  hrs,  wells  from  each  coating  were  allocated  for 
lysates  produced  from  the  clone  analysed  by  dot  blotting  after  induction  with  IPTG  at  I 
mM  and  0.1  mM.  One  hundred  µl  samples  of  lysates  produced  with  Twcen  20  and 
Bugbuster  and  the  Qiaprep  lysates  from  each  set  of  cell  pellets  were  added  to  designated 
wells.  After  incubating  the  plate  at  room  temperature  for  21us  and  washing,  100  µ1  of  a 
1/1000  dilution  of  mouse  anti-pIII  (Mo  Bi  Tech)  was  added  to  all  wells  for  incubation  at 
room  temperature  for  1.5  hrs.  The  plate  was  then  washed  and  100  Id  of  a  1/1000  dilution 
126 of  HRP  anti-mouse  antibody  was  added  to  each  well  and  plate  was  incubated  for  1.5  hrs 
incubation  at  room  temperature.  After  final  washing,  OPD  substrate  was  added  and  the 
OD  was  recorded  at  450  nM.  The  results  demonstrated  the  expression  of  scFv-pIII  and 
recognition  by  the  anti-pIII  antibody. 
Western  blotting 
After  confirmation  that  scFv-pIII  fusion  was  produced  by  the  selected  clones  and  that 
it  could  be  detected  by  immunochemistry,  further  Western  blotting  experiments  were  set 
up  to  define  the  specificity  of  selected  phage  antibodies.  All  procedures  were  performed 
as  described  before.  The  nitrocellulose  membrane  carrying  separated  OMP  proteins  was 
cut  into  10  strips  and  each  was  incubated  with  a  scFv-pIII  prepared  by  Bugbuster  lysis 
from  10  clones  from  the  third  round  of  selection.  The  anti-pIII  and  anti-mouse  antibodies 
were  diluted  to  1/1000  and  4-chloro-1-naphthol  substrate  was  used.  This  experiment 
resulted  in  faint  signals.  Repeating  the  experiment  with  a  mixture  of  lysate  of  12  clones 
again  resulted  in  a  stronger  signal  at  the  same  location. 
4.2.8  Identification  of  major  protein  reacting  with  antibodies 
To  identify  the  component  of  the  OMP  preparation  which  was  reactive  with  selected 
recombinant  antibodies  in  Western  blotting,  the  relevant  band  was  sliced  from  a 
Coomassie  stained  acrylamide  gel.  The  molecular  weight  of  this  protein  was  about  40 
kDa.  Since  the  reactive  band  migrated  close  to  another  OMP  of  similar  molecular  weight, 
care  was  taken  to  avoid  contamination  from  this  species.  The  band  was  despatched  to  the 
Department  of  Molecular  and  Cell  Biology,  University  of  Aberdeen  where  it  was  digested 
with  trypsin  and  analysed  by  mass  spectrometry.  The  molecular  weights  of  the  tryptic 
fragments  were  screened  by  database  searches  to  identify  the  target  protein. 
4.2.9  Native  acrylamide  electrophoresis. 
We  reasoned  that  the  weak  reaction  of  scFvs  in  recognising  of  their  target  OMP 
proteins  on  Western  blots  (c.  f  efficient  detection  in  ELISA)  might  be  due  to 
conformational  changes  after  exposure  to  SDS  in  acrylamide  gel  clectrophoresis  or  the 
separation  of  multimeric  proteins  into  their  monomers.  To  address  this,  native 
acrylamide  gel  electrophoresis  was  chosen  as  an  alternative  separating  technique.  To 
achieve,  this  acrylamide  gels  were  prepared  with  the  same  composition  described  before 
but  without  SDS.  Two  sets  of  4  wells  were  prepared  for  samples  analysis.  In  one  well, 
127 the  OMP  sample  (25  µg)  was  loaded  intact  in  a  loading  buffer  without  mercaptoethanol 
or  heating.  In  other  wells,  1.5  µl  of  0.1%  solutions  of  the  following  detergents  were 
added;  CHAPS,  sodium  deoxycholate  and  Tween  20.  Electrophoresis  was  performed  at 
110  volts  and  30-40  mA  current  using  a  transfer  buffer  from  Western  blotting  of  pli  8.7. 
After  running,  one  set  of  samples  was  stained  to  determine  protein  migration.  Only 
proteins  prepared  with  addition  of  sodium  deoxycholate  and  Tween  20  had  undergone 
weak  migration.  The  second  set  of  samples  was  subjected  to  Western  blotting.  Protein 
transfer  was  performed  using  conventional  transfer  buffer  with  p11  8.1.  Blocking  was 
done  with  2%  skimmed  milk  in  Tris-NaCI  and  the  membrane  was  then  incubated  with 
the  scFv-pIII  fusions  from  two  ELISA  positive  clones,  prepared  as  Bugbuster  lysates. 
After  incubation  with  anti-pIII  and  anti-mouse  antibodies,  400  µl  of  the  sensitive  ECL 
substrate  was  used.  Signals  could  be  detected  from  samples  prepared  with  sodium 
deoxycholate  and  Tween  20. 
128 4.3  Results 
4.3.1  Protein  assay  of  Mannheimia  haemolytica  OMP  preparations 
Based  on  standard  curves,  the  concentrations  of  protein  in  different  batches  of  OMP 
were  determined  with  the  BCA  protein  assay  kit  to  be  between  1.4  and  2.4  mg/ml. 
4.3.2  SDS-PAGE  analysis  ofMannheimia  haemoly7ica  OMP  preparations 
The  protein  composition  of  isolated  OMPs  from  M.  haemolytica  was  analysed  by 
SDS-PAGE.  Three  major  bands  could  be  observed  along  with  numerous  less  abundant 
proteins  (Figure  4.4).  One  of  the  dominant  components  ran  with  an  estimated  molecular 
weight  of  about  31  kDa.  The  other  two  migrated  close  together  at  around  40  kDa.  The 
overall  appearance  of  these  gels  was  similar  to  those  described  by  others  (Morton  et  al., 
1996;  Brennan,  et  al.,  1997)  using  bacteria  of  the  A  biotype. 
4.3.3  Panning  the  Griffin.!  library  against  Mannheimia  Iraemolylica  OMPs 
Anti-OMP  antibodies  were  isolated  from  the  phage  antibody  library  using  two 
strategies.  The  first  was  conventional:  OMPs  were  bound  to  plastic  immunotubes  and 
phage  selected  by  successive  rounds  of  binding,  washing  and  elution  with  TEA.  In  the 
other  approach,  phage  recovered  from  the  first  round  of  conventional  selection  were 
applied  to  coated  immunotubes  but  then  eluted  by  adding  an  anti-OMP  scrum.  This 
competitive  elution  was  used  in  two  rounds  of  selection.  In  both  strategies,  the 
concentration  of  OMPs  applied  to  the  selecting  surface  was  reduced  round-on-round: 
from  120  µg/ml  (round  1),  to  12  µg/ml  (round  2),  to  1.2  µg/ml  (round  3)  for  elution  with 
TEA  and  from  120  µg/m1(rounds  1  and  2),  to  12  µg/ml  (round  3)  for  elution  with  anti- 
OMP  antiserum.  The  numbers  of  input  and  output  phage  at  each  of  round  of  selection 
for  the  two  methods  are  shown  in  Table  4.6 
. 
For  selections  in  which  TEA  was  used  as 
eluting  agent,  enrichment  was  not  observed  at  round  2  but  it  rose  sharply  to  52  for  the 
third  round  of  selection.  Similar  patterns  were  observed  when  anti-OMP  antiserum  was 
used  for  elution:  no  enrichment  was  detected  at  round  2  (value  0.03)  but  15-fold 
enrichment  occurred  at  round  3. 
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Elution 
agent 
Round  Input'  Output'  %  recovery 
x10'6 
Enrichment 
1  1x10"  9x10'  9x10'=  - 
TEA  2  1x10"  8.4x105  8.4x10-1  0.009 
3  1x10"  4.4x106  4.4x10''  52 
Anti- 
2d  1x10"  2.8  x  10'  2.8x10-3  0.03 
OMP  3  1  x10"  43x10'  43x10-2  15 
Input  and  output  phage  titres  determined  by  transduction  of  E.  coli  to 
ampicillin  resistance  using  serial  dilutions  of  samples 
b  Percent  recovery  determined  by  division  of  output  phage  titre  by  input 
titre  and  multiplication  by  100.  Data  expressed  after  further 
multiplication  by  1000 
Enrichment  calculated  by  division  of  percent  recovery  by  percent 
recovery  achieved  in  previous  round  of  selection 
d  Round  1  for  this  experiment  was  round  1  with  TEA  elution 4.3.4  Screening  recombinant  antibodies  by  monoclonal  phage  ELISA 
Ninety  six  colonies  were  picked  after  each  round  of  selection  and  analysed  by 
monoclonal  phage  ELISA  to  determine  which  showed  highest  reaction  with  the  OMP 
preparation.  Phage  clones  were  screened  on  OMP-coated  plates  and  on  plates  coated 
with  skimmed  milk,  the  blocking  agent  used  in  selection,  to  check  for  specificity.  The 
OD  measurement  achieved  for  a  given  phage  clone  on  the  OMP-coated  plate  was 
corrected  by  subtraction  of  the  OD  measured  on  plates  coated  with  milk  and  the  values 
were  then  ranked.  Results  of  these  phage  ELISAs  for  each  round  of  selection  are  shown 
in  Figures  4.5  to  4.9.  Monoclonal  phage  ELISA  was  then  repeated  to  compare  the  80 
clones  showing  strongest  reactivity  with  OMPs.  The  results  are  shown  in  Figure  4.10. 
The  data  shows  a  progressive  increase  in  reactivity  of  individual  clones  towards  OMPs 
with  the  selection  round  from  which  they  were  recovered.  This  supports  the  hypothesis 
that  progressive  reduction  in  the  concentration  of  the  OMPs  used  for  selection  should 
drive  the  recovery  of  clones  which  react  best  with  the  target. 
4.3.5  Optimisation  of  ELISA 
To  achieve  these  results,  substantial  efforts  were  made  to  optimise  the  ELISA 
methods. 
Binding  of  OMP  to  immunoplate 
To  determine  the  efficiency  with  which  OMPs  bound  to  the  plastic  surface,  an 
ELISA  experiment  was  set  up  with  OMP  antigens  and  anti-OMP  antiserum.  Controls 
also  checked  to  what  extent  background  readings  from  the  ELISA  could  be  attributed  to 
the  different  reagents  used  in  the  assay.  Results  of  this  experiment,  shown  in  Figure 
4.11,  confirmed  that  the  OMPs  prepared  with  Sarkosyl  could  bind  to  the  microtitre 
plates.  ELISA  results  with  different  coating  proteins  and  combinations  of  other  reagents 
confirmed  that  the  absorbance  values  were  specific  for  the  interaction  between  OMPs 
coated  to  the  plates  and  the  test  antiserum,  and  not  due  to  the  background. 
Optimal  dilution  of  anti-11113  phage  antibody 
Binding  of  anti-M13  antibody  to  phage  was  assessed  by  coating  serial  dilutions  of 
PEG-precipitated  phage  to  microtitre  plates  and  then  using  IIRP-conjugated  anti-M13 
antibody.  Results  of  this  experiment  are  shown  in  Figure  4.12.  revealed  that  the  anti- 
M13  conjugate  recognised  the  phage. 
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Figure  4.5  Phage  ELISA  of  clones  from  the  first  round  of  selection  and  eluted  with  TEA. 
(A):  ELISA  results  from  12  clones  ranked  by  difference  in  reactivity  in  OMP  versus  milk 
coated  wells.  Note  the  differential  reactivity  ranges  between  0.5  and  0.3.  (B):  ELISA  reactivity 
towards  OMPs  of  96  clones  picked  at  random  from  the  first  round  of  screening.  Results  for  12 
clones  with  the  strongest  reactivity  are  separated  from  the  rest. 
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Figure  4.6  Phage  ELISA  of  clones  from  the  second  round  of  selection  and  eluted  with  TEA. 
(A):  ELISA  results  from  12  clones  ranked  by  difference  in  reactivity  in  OMP  versus  milk  coated 
wells.  Note  the  differential  reactivity  ranges  between  1.5  and  0.5.  (B):  ELISA  reactivity  towards 
OMPs  of  96  clones  picked  at  random  from  the  second  round  of  screening.  Results  for  12  clones 
with  the  strongest  reactivity  are  separated  from  the  rest. B  2nd  rand  of  selection(anti-0MP) 
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Figure  4.7  Phage  ELISA  of  clones  from  the  second  round  of  selection  and  eluted  with  anti- 
OMP  serum. 
(A):  ELISA  results  from  12  clones  ranked  by  difference  in  reactivity  in  OMP  versus  milk  coated 
wells.  Note  the  differential  reactivity  ranges  between  2.6  and  0.9.  (B):  ELISA  reactivity  towards 
OMPs  of  96  clones  picked  at  random  from  the  second  round  of  screening.  Results  for  12  clones  with 
the  strongest  reactivity  are  separated  from  the  rest. B 
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Figure  4.8  Phage  ELISA  of  clones  from  the  third  round  of  selection  and  eluted  with 
TEA. 
(A):  ELISA  results  from  24  clones  ranked  by  difference  in  reactivity  in  OMP  versus  milk 
coated  wells.  Note  the  differential  reactivity  for  the  first  12  ranges  between  1.6  and  1.1. 
(B):  ELISA  reactivity  towards  OMPs  of  96  clones  picked  at  random  from  the  third  round  of 
screening.  Results  for  24  clones  with  the  strongest  reactivity  are  separated  from  the  rest. A  3rd  round  of  selection  (anti-OW) 
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Figure  4.9  Phage  ELISA  of  clones  from  the  third  round  of  selection  and  eluted  with 
anti-OMP  serum. 
(A):  ELISA  results  from  12  clones  ranked  by  difference  in  reactivity  in  OMP  versus  milk 
coated  wells.  Note  the  differential  reactivity  ranges  between  1.5  and  0.4. 
(B):  ELISA  reactivity  towards  OMPs  of  96  clones  picked  at  random  from  the 
second  round  of  screening.  Results  for  12  clones  with  the  strongest  reactivity  are 
separated  from  the  rest. OD  A/450 
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Figure  4.10  ELISA  to  compare  80  clones  isolated  from  different  rounds  of  selection. 
Fifteen  clones  which  reacted  best  in  initial  anti-OMP  ELISA  were  taken  from  each  round 
of  selection  as  indicated  (20  clones  for  the  third  round  of  selection  with  TEA  elution). 
Monoclonal  phage  ELISA  was  carried  out  for  each  clone  on  wells  coated  with  OMPs  and 
millk.  The  ELISA  results  (y  axis)  are  corrected  for  values  obtained  on  control  wells  coated 
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Figure  4.11  ELISA  to  confirm  the  binding  of  OMPs  to  ELISA  plates. 
Wells  were  coated  with  serial  dilutions  of  OMPs  (section  A;  two  rows  coated  with  dilution 
from  left  to  right),  PBS  (section  B;  two  rows),  serial  dilutions  of  an  anti-OMP  rabbit  serum 
(section  C;  dilutions  left  to  right)  or  BSA  (section  D).  Rabbit  anti-OMP  serum  was  then 
added  to  sections  A,  B,  and  DI,  followed  by  an  anti-rabbit  HRP  conjugate  (all  sections 
except  C2  and  D3).  The  reactions  were  then  developed  with  OPD  substrate. OD  A1450 
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Figure  4.12  ELISA  to  optimise  dilution  of  anti-M  13  antibody  for  the  detection  of  phage. 
Wells  were  coated  with  10-fold  serial  dilutions  of  helper  phage  and  with  BSA.  Sections  of  the 
plate  were  then  probed  with  different  dilutions  of  the  anti-M  13  antibody  (see  x  axis). 
A:  2x10e9  phage 
B:  2xI0e8  phage 
C:  2x10e7  phage 
D: 2xlOe6  phage Comparison  between  BSA  and  milk 
-  Helper  phage  coated  wells 
In  order  to  compare  the  relative  values  of  BSA  and  milk  blocking  agents  on 
microtitre  plates  or  as  components  of  the  diluents,  an  ELISA  plate  coated  with  VCS- 
M13  helper  phage  was  then  blocked  with  BSA-PBS  or  MPBS,  and  these  reagents  used 
for  dilution  of  the  anti-M13  antibody.  Results  presented  in  Figure  4.13  showed  that 
ELISA  readings  from  reactions  in  which  milk  had  been  used  were  decreased  markedly 
when  compared  to  the  use  of  BSA.  This  experiment  also  emphasised  the  importance  of 
achieving  appropriate  dilution  of  the  anti-M13  antibody.  Note  the  marked  fall  in  ELISA 
signal  upon  dilution  of  antibody  from  1/500  (last-most  column)  to  1/1000  (next  column 
to  right). 
-OMP  coated  wells 
A  further  experiment  was  performed  to  study  the  effect  of  BSA  and  milk  on  the 
ELISA  when  OMPs  instead  of  phage  were  coated  to  the  microtitre  plates.  Phage 
antibodies  prepared  in  different  ways  were  then  added  with  BSA-PBA  and  MPBS  as 
diluents.  The  results  again  showed  that  milk  had  a  negative  effect  on  the  assay 
particularly  when  used  as  blocking  reagent  (Figure  4.14).  Different  OD  values  were 
obtained  with  PEG-precipitated  phage  and  phage  antibody  prepared  from  bacterial 
culture  supernatant,  probably  reflecting  the  higher  numbers  of  virus  in  the  former 
sample.  The  assay  also  included  phage  which  were  reactive  and  unreactive  with  the 
OMPs.  Since  these  viruses  were  both  prepared  by  the  same  methods  (from  bacterial 
culture  supernatants),  their  results  in  the  assay  are  comparable  and  reaffirm  the 
specificity  of  the  resulting  signals. 
Comparison  of  immunoplates 
Microtitre  plates  from  two  Nunc  and  IWAKI  were  compared  in  ELISA.  Each  plate 
was  coated  with  OMPs  and  milk  as  a  control  negative  control  and  phage  from  overnight 
culture  supernatants  of  12  positive  clones  were  added.  The  successful  binding  of  phage 
was  then  detected  with  an  anti-M13-HRP  conjugate.  Results  presented  in  Figure  4.15 
showed  the  clear  superiority  of  the  Nunc  plate:  the  final  ODs  obtained  from  the  Nunc 
plate  coated  with  OMPs  were  higher  than  from  the  other  plate  and  the  background 
values  from  milk  coated  wells  were  lower. 
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Figure  4.13  ELISA  to  compare  BSA  and  milk  as  blocking  agents  for  the  detection 
of  phage. 
Wells  were  coated  with  phage  as  indicated  in  the  key  to  the  right  of  the  Figure 
and  blocked  with  either  BSA  or  milk,  as  indicated.  Dilutions  of  anti-M13 
antibody  were  then  made  in  BSA  or  milk  consistent  with  the  blocking  agent, 
and  applied  to  the  wells  to  detect  bound  phage.  Anti-M13  antibody  was  added 
in  dilutions  of  1/500,1/1000,1/2000  and  1/4000  from  left  to  right  in  each  row. 
A:  2xlOel2  phage 
B:  2xlOell  phage 
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Figure  4.14  ELISA  to  compare  BSA  and  milk  as  blocking  and  diluting  agents  for 
phage  recognition  of  OMPs. 
Wells  were  coated  with  OMPs  and  blocked  with  BSA  or  milk.  Phage  reactive  with  the 
OMPs  ("+"  in  the  key  to  right  of  the  Figure)  or  negative  control  phage  ("-"  in  the  key) 
were  added  (either  supernatants  from  infected  bacteria  or  phage  concentrated  by  PEG 
precipitation  -  see  key)  in  diluents  containing  BSA  or  milk,  and  their  binding  detected 
with  ant-M13  antibodies. 
MM:  milk  was  used  for  both  blocking  and  dilution 
MB:  milk  and  BSA  were  used  for  blocking  and  dilution  respectively 
BM:  BSA  and  milk  were  used  for  blocking  and  dilution  respectively 
BB:  BSA  was  used  in  both  steps. NUNC  EUSA  plate 
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Figure  4.15  ELISA  to  compare  NUNC  and  Iwaki  microtitre  plates. 
Wells  on  each  plate  were  coated  with  either  OMPs  or  milk  (see  key  to  right  of 
Figure),  blocked,  and  12  test  phage  (clustered  bars  across  the  Figure)  added  in 
serial  dilutions  (bars  within  each  cluster).  Binding  of  phage  was  detected  with 
anti-M13  antibodies.  The  test  phage  were  prepared  from  culture  supernatants  of 
clones  taken  from  the  third  round  of  panning  and  eluted  with  anti-OMP  serum. 
The  lower  section  of  each  bar  shows  the  ELISA  reaction  in  OMP-coated  wells. 
The  upper  (yellow)  section  shows  the  generally  weaker  reaction  in  wells  coated 
with  milk. Optimal  conditions  for  phage  ELISA 
Given  the  results  of  experiments  described  above  the  following  condition  were 
determined  as  optimal  for  phage  ELISA  to  detect  the  OMPs: 
-  dilution  of  1/500  of  anti-M13  antibody 
-  using  of  ELISA  plate  from  NUNC  instead  Iwaki 
-  using  of  3%  BSA-PBS  instead  2%  milk-PBS  as  blocking  agent  and  diluent 
4.3.6  Analytical  PCR  for  the  determination  of  scFv  length 
It  has  been  well  established  from  other  studies  that  scFvs  isolated  by  phage  display 
can  be  reactive  with  the  selecting  target  even  if  they  are  incomplete,  possessing  solely 
VH  or  VL  inserts.  To  determine  the  frequency  of  full  length  inserts  in  clones  selected 
from  the  library  with  OMPs,  crude  bacterial  lysates  were  used  in  analytical  PCR. 
Twenty-four  clones  selected  from  the  last  round  of  OMP  selection  and  eluted  with  TEA 
were  grown  with  12  clones  from  the  final  round  of  selection  and  eluted  with  anti-OMP 
antiserum.  PCR  was  performed  on  crude  lysates  using  primers  LMB3  and 
FOR_LinkSeq  or  LMB3  and  pHEN-SEQ  or  Fdseql.  Primers  LMB3  and  FOR  LinkSeq 
amplify  the  heavy  chain  fragment,  whereas  primers  LMB3  and  pHEN-SEQ  or  Fdseql 
amplify  the  sequences  of  both  light  and  heavy  chains.  By  comparing  the  size  of  the 
resulting  amplicons  with  that  predicted  for  full-length  scFvs,  the  phage  antibodies  could 
be  characterised.  Twelve  clones  from  anti-OMP  elution  were  ranked  according  to  the 
strength  of  their  reactivity  in  anti-OMP  ELISA.  Only  3  of  the  clones  possessed  full- 
length  scFv  inserts:  these  lay  at  the  bottom  of  the  ranking.  Twenty  four  clones  from 
TEA  elution  were  analysed  similarly.  Eight  possessed  both  light  and  heavy  chains 
(Table  4.7).  Although  some  of  these  phage  reacted  strongly  with  OMPs  in  ELISA,  5  are 
located  at  the  end  of  the  ranking.  These  results  revealed  that  the  clones  with  the 
strongest  reactivity  in  ELISA  with  OMPs  were  those  that  lacked  a  heavy  chain 
component  of  the  scFv. 
4.3.7  Western  blotting 
4.3.7.1  Western  blotting  using  phage  and  anti-M13  antibodies 
In  order  to  determine  the  specificity  of  each  clone  selected  from  scFv  library,  OMPs 
were  run  on  SDS-acrylamide  gels  and  then  blotted  to  nitrocellulose.  Phage  prepared  by 
PEG  precipitation  or  culture  supernatants  from  E.  coli  infected  with  individual  clones 
132 Table  4.7  Inserts  carried  by  clones  from  the  third  round  of  selection.  A:  clones  eluted 
with  anti-OMP  serum.  B:  clones  eluted  with  TEA.  Amplicons  of  the  sizes  (bp)  shown  in  the 
body  of  the  table  were  recovered  with  primers  LMB3  and  the  primers  indicated  of  the  top. 
Clones  are  ranked  in  order  of  decreasing  reactivity  in  anti-OMP  phage  ELISA. 
A 
clone  Fdseql  PHEN-SEQ  FOR_LinkS 
eq 
Insert  carried 
1  650  600  Small  VL 
2  650  600  Small  VL 
3  650  &  850  600  &  800  Small  &  300  VL  &  incomplete  Vff 
4  650  600  Small  VL 
5  500  450  ?  Incomplete  VL 
6  650  600  Small  VL 
7  650  &  800  600  &  750  Small  &  450  VL  &  incomplete  VII 
8  650  600  Small  VL 
9  650  600  Small  VL 
10  950  900  500  VL  &  VII 
11  950  900  500  VL  &  VH 
12  650  &  950  600  &  900  Small  &  500  VL  &  VII 
clone  Fdse  1  PHEN-SEQ  FOR  LinkSe  Insert  carried 
1  650  600  Small  VL 
2  650  600  Small  VL 
3  950  900  500  VL  &  VII 
4  650  600  Small  VL 
5  450  &  700  400  &  650  250  ? 
6  650  600  Small  VL 
7  650  600  Small  VL 
8  650  600  Small  VL 
9  650  600  Small  VL 
10  650  600  Small  VL 
11  650  600  Small  VL 
12  650  600  Small  VL 
13  650  600  Small  VL 
14  650  &  950  600  &  900  500  VL  &  VII 
15  650  600  Small  VL 
16  650  600  Small  VL 
17  650  &  950  600  &?  500  VL&VII 
18  650  600  Small  VL 
19  650  600  Small  VL 
20  650  &  950  600  500  VL  &  VII 
21  950  600  &  900  Small  &  500  VL  &  VII 
22  650  &  950  900  500  VL  &  VII 
23  650  &  950  600  Small  &  500  VL  &  VII 
24  950  600  &  900  Small  &  500  VL  &  VII 
B were  applied  to  the  blot  and  their  binding  detected  with  anti-M  13  reagents.  This  protocol 
failed  to  generate  signals  from  any  of  the  antigens  on  the  blot.  In  consequence,  a  revised 
method  using  scFv-pIII  fusion  proteins  was  developed. 
4.3.7.2  Western  blotting  using  scFv  and  anti-pIII  antibody 
This  method  differs  in  several  respects  from  conventional  approaches  to  the 
expression  of  scFvs  and  their  use  as  immunochemical  reagents  (Tesar  et  al.,  1995).  In 
pHEN2,  an  amber  codon  lies  between  to  coding  sequence  of  the  scFv  and  gIII. 
Conventionally,  phagemids  are  used  in  suppressor  strains  of  E.  coli  (e.  g  TG1)  for  the 
propagation  of  phage  bearing  scFvs  fused  to  pIII.  The  constructs  are  transferred  to  non- 
suppressor  strains  (e.  g.  HB2151)  for  expression  of  the  scFv  in  soluble  form.  Detection 
of  the  recombinant  antibody  then  depends  upon  use  of  peptide  tags  at  the  carboxy- 
terminus  of  the  scFv  (e.  g.  histidine  repeats  or  the  c-myc  epitope).  Expression  of 
phagemids  in  suppressor  strains  triggers  synthesis  of  the  scFv-pIII  fusion  which  in  the 
absence  of  superinfecting  helper  phage,  accumulates  in  the  bacterial  membrane.  If 
liberated  from  this  location  with  detergent,  the  attached  pill  sequence  provides  a  tag 
which  is  readily  detectable  with  anti-plll  reagents  (Mersman  et  al.,  1998).  Before 
applying  this  method  to  the  identification  of  OMP  targets  by  Western  blotting,  the 
system  was  tested  in  dot  blotting  and  ELISA. 
Dot  blotting 
E.  coif  carrying  phagemid  from  two  positive  phage  clones,  were  induced  with  I  and 
0.1  mM  IPTG  overnight.  Bacterial  extracts  were  prepared  with  Bugbuster  and  Tween  20 
and  the  cell  pellets  from  each  extraction  treated  with  alkaline  SDS  solution  from  a 
QlAprep  plasmid  kit.  PEG-precipitated  phage  of  each  clone,  the  bacterial  extracts, 
lysates  and  buffer  containing  just  the  detergents  as  negative  controls  were  spotted  to 
nitrocellulose.  After  blocking,  anti-pIII  antibodies  were  applied  in  a  typical  blotting 
protocol.  The  results  (Figure  4.16)  clearly  showed  that  the  anti-pIIl  antibody  could 
recognise  the  scFv-pIII  complex  in  the  lysates.  The  strongest  signals  were  obtained  from 
the  QlAprep  lysates  of  pellets  from  detergent-extracted  cells.  No  signals  could  be 
detected  from  the  media  and  detergents  used  in  preparation  of  the  extracts  ruling  out  the 
possibility  that  results  were  non-specific. 
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Figure  4.16  Dot  blotting  of  bacterial  I)  saIcs  lu  lest  fur  scl,  'ý  -pII1. 
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spotted  With  extracts  (specified  below)  and  [lie  presence  º,  I  SCI'V-I,  III  fusion  proteins 
detected  Willi  an  anti-pill  monoclonal  antihody. 
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Figure  4.17  ELISA  to  assess  the  induction  of  scFv-plll  fusion  proteins  and  their 
extraction  with  detergent  for  binding  to  OMPs. 
Bacteria  were  induced  to  express  a  scFv-pill  fusion  protein  by  culture  in  medium 
containing  IPTG  (see  key  to  right  of  Figure).  Detergent  extracts  were  prepared  from 
bacterial  pellets  and  applied  to  ELISA  wells  coated  with  OMPs  or  milk.  Binding  of 
the  fusion  protein  was  detected  with  an  anti-pill  monoclonal  antibody.  The  bars  show 
the  difference  in  ELISA  reactions  between  OMP  and  milk  coated  wells. 
A:  Tween  20  extract 
B:  QlAprep  lysate  of  Tween  20  extracted  bacteria 
C:  Bugbuster  extract 
D:  QlAprep  lysate  of  Bughuster  extracted  bacteria ELISA 
For  this  experiment,  a  microtitre  plate  was  coated  with  OMPs  and  the  lysates 
prepared  from  one  of  the  clones  described  above  were  used  as  a  source  of  scFv-plIl 
protein.  Again,  the  results  (Figure  4.17)  again  showed  that  the  scFv-pill  fusion  was 
detectable  by  anti-pIII  reagents.  The  experiment  further  demonstrated  that  the  scFv 
fusion  protein  possessed  specificity  for  components  of  the  OMP  preparation.  In  this 
experiment,  the  extract  prepared  with  Bugbuster  showed  the  highest  signals. 
Western  blotting 
Having  confirmed  that  scFv-pI1I  fusion  proteins  could  be  prepared,  that  they  could  be 
detected  specifically  with  anti-pIII  reagents  and  that  they  recognised  successfully 
components  of  the  OMP  preparation,  the  system  was  applied  in  Western  blots.  Samples 
of  OMPs  were  run  on  SDS-polyacrylamide  gels  and  the  proteins  were  transferred  to 
nitrocellulose  membranes.  scFv-pI11  proteins  were  applied  to  the  blot  as  Bugbuster 
extracts  and  their  binding  detected  with  anti-pIII  antibodies  and  anti-mouse-HRP 
conjugates.  Faint  recognition  could  be  detected  using  extracts  from  two  scFv  clones.  By 
pooling  extracts  from  12  clones  which  individually  gave  little  or  no  signal,  stronger 
recognition  of  an  OMP  protein  of  about  40  kDa  could  be  demonstrated  (Figure  4.18). 
4.3.8  Identification  of  the  OMP  component  recognised  by  scFv-pIII  fusion  proteins 
The  band  recognised  in  Western  blots  by  the  scFv-plli  proteins  was  carefully  excised 
from  an  SDS-poylacrylamide  gel  and  despatched  to  the  University  of  Aberdeen  for 
analysis  by  mass  spectrometry.  Once  the  quantity  of  protein  used  for  tryptic  digestion 
had  be  optimised,  MALDI-TOF  analysis  clearly  showed  the  protein  to  be  PomA  of 
Mannheimia  haemolytica  (molecular  mass  determined  to  be  40461  Da;  40%  coverage 
of  theoretical  tryptic  fragments  with  fragments  from  the  sample). 
4.3.9  Native  acrylamide  electrophoresis 
Since  phage  and  scFv-pIII  fusion  proteins  tended  to  react  weakly  with  OMPs  on 
Western  blots,  it  was  postulated  that  the  presence  of  SDS  in  gels  might  be  denaturing 
epitopes  recognised  by  the  recombinant  antibodies.  Hence,  native  electrophoresis  was 
chosen  as  an  alternative.  Electrophoresis  was  performed  with  acrylamide  gels  and 
running  buffers  without  SDS.  Samples  of  OMPs  were  either  loaded  directly  to  gels  in  a 
sample  buffer  lacking  SDS  and  mercaptoethanol  or  mixed  first  with  the  detergents 
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'I'hc  nti,  ratntn  of  neurkeis  of  45  kl)a  and  3l)  kohl  i,  indiralyd. CHAPS,  Tween  20  or  sodium  deoxycholate.  In  the  absence  of  detergent  or  when 
CHAPS  was  used,  protein  staining  revealed  very  little  migration  of  material  into  the  gel. 
This  might  indicate  that  the  complexity  of  the  OMP  preparation  was  too  high  in 
molecular  weight  to  enter  the  resolving  gel,  or  that  under  the  electrophoresis  conditions 
employed,  the  proteins  lacked  sufficient  charge  to  drive  their  migration.  With  Tween  20 
or  sodium  deoxycholate,  the  OMP  sample  did  enter  the  gel  slightly  as  shown  by  staining 
with  Coomassie  Blue,  but  there  was  no  effective  resolution  of  the  components  present. 
However,  when  these  samples  were  transferred  to  nitrocellulose  by  electroblotting, 
binding  of  scFv-pIII  could  be  detected  by  ECL  and  signal  strength  from  probing  was 
good.  However,  the  failure  of  this  method  to  differentiate  which  proteins  present  in  the 
OMP  preparation  reacted  with  individual  antibodies  was  a  fundamental  obstacle  to  the 
further  characterisation  of  the  panel  of  scFvs. 
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Phage  display  has  enabled  the  generation  of  large  repertoires  of  human  antibodies 
and  the  rapid  isolation  of  antibodies  against  numerous  targets.  If  sufficiently  large  and 
diverse,  naive  or  synthetic  libraries  can  be  used  to  generate  antibodies  to  any  antigen 
of  interest  providing  that  a  suitable  screening  method  can  be  devised  (O'Brien  and 
Aitken,  2002)  ).  The  potential  uses  of  these  antibodies  for  the  detection  and  treatment 
of  infectious  diseases  are  only  just  being  unlocked. 
Overall,  screening  the  Griffin.!  library  of  human  scFv  antibodies  against  the  OMPs 
of  Mannheimia  haemolytica  was  successful.  Phage  which  reacted  with  components  of 
the  OMP  preparation  were  readily  isolated  and  once  ELISA  methods  had  been 
optimised,  the  interaction  of  individual  scFvs  with  the  OMPs  could  be  measured. 
While  some  obstacles  were  encountered  in  defining  which  bacterial  proteins  in  the 
preparation  were  recognised  by  individual  recombinant  antibodies,  in  one  instance 
unambiguous  identification  was  possible. 
A  well-established  protocol  was  used  for  the  isolation  of  OMPs  from  Pasterella 
haemolytica  (Davies  et  at,  1991)  which  exploits  the  differential  solubility  of  the 
cytoplasmic  and  outer  membranes  of  Gram  negative  bacteria  in  Sarkosyl.  The  protein 
composition  of  isolated  OMPs  from  Mannheimia  haemolytica  was  analysed  by  SDS- 
PAGE.  Three  major  bands,  one  of  31  kDa  and  two  closely  migrating  proteins  around 
40  kDa  could  be  observed  along  with  numerous  less  abundant  proteins.  The  overall 
appearance  of  these  gels  was  similar  to  those  described  by  others  (Morton  et  al.,  1996; 
Brennan  et  al.,  1997)  using  bacteria  of  the  A  biotype.  Estimates  of  the  molecular 
masses  of  the  major  OMPs  vary  slightly  in  these  papers:  Morton  et  at,  (1996)  reported 
the  molecular  weights  to  be  30.5  and  43  kDa  using  gels  of  11-12  %  acrylamide; 
Brennan  et  al.,  (1997)  reached  similar  conclusions  (31  and  42  kDa  on  12  %  gels)  as 
did  Iovane  et  at  (1998)  (28,31  and  40  kDa).  The  differences  may  be  due  to  the 
differing  co-migration  of  OMPs  in  gels  containing  different  concentrations  of 
acrylamide  as  Mahasreshti  et  al.,  (1997)  reported  that  the  30  kDa  band  observed  on 
12%  gels  separated  into  two  proteins  of  32  and  35  KDa  on  18%  gels.  They  also 
reported  that  the  major  protein  of  the  outer  membrane,  PomA,  appeared  in  two  forms 
of  35  kDa  and  40  kDa  when  samples  were  incubated  at  37  °C  but  that  it  was  heat 
modifiable;  incubation  for  10  min  at  100  °C  resulted  in  a  single  band  of  40  kDa. 
The  Griffin.!  library  was  screened  against  OMPs  which  had  been  immobilised  on 
immunotubes.  The  bound  phage  antibodies  were  eluted  with  TEA  or  an  anti-OMP 
136 antiserum.  As  reported  by  other  investigators  (O'Brien  and  Aitken,  2002),  phage 
ELISA  indicated  increasing  strength  of  reactivity  towards  the  OMPs  in  this  assay, 
round-on-round,  perhaps  reflecting  the  selection  of  scFvs  of  increasing  affinity  as  the 
concentration  of  target  at  the  selecting  surface  was  progressively  reduced.  Valuable  as 
phage  ELISA  was  in  these  experiments,  it  would  be  unwise  to  draw  firm  conclusions 
from  the  absolute  values  obtained  at  the  end  of  each  assay.  One  observation  made 
during  the  course  of  these  experiments  was  that  an  individual  clone  could  vary  in  its 
reactivity  towards  the  OMPs  between  different  assays,  perhaps  reflecting  different 
phage  titres  obtained  from  one  experiment  to  the  next,  variable  proteolytic  breakdown 
of  scFv  displayed  at  the  phage  surface  or  inconsistencies  in  the  binding  of  the  target 
OMP  component  to  microtitre  plates.  It  is  therefore  the  pattern  of  results  from  these 
experiments  which  is  significant  rather  than  their  absolute  values. 
Analytical  PCR  revealed  that  antibodies  which  reacted  most  strongly  with  OMPs 
typically  possessed  only  a  VL  domain.  de  Bruin  et  al.,  (1999)  reported  similar 
observations  when  they  screened  the  Griffin.  1  library  for  antibodies  against  two  target 
proteins.  They  noted  that  all  phage  antibodies  recovered  from  the  final  panning 
performed  poorly  in  ELISA  and  Western  blot  analysis.  PCR  and  sequencing  revealed 
that  only  1  from  100  phage  antibodies  carried  a  complete  scFv  insert,  the  majority 
lacking  the  V11  component.  de  Bruin  et  al.  showed  that  increasing  the  stringency  of 
elution  from  the  protocol  recommended  by  the  team  that  constructed  the  Griffin.  1 
library  resulted  in  selection  of  phage  antibodies  with  full  length  inserts. 
Despite  the  strong  ELISA  signals  obtained  from  phage  isolated  in  our  study, 
attempts  to  define  their  specificity  using  Western  blotting  only  resulted  in  faint 
reactions.  Signal  strength  was  improved  when  a  mixture  of  antibodies  was  used.  This 
may  be  because  the  pooled  scFvs  act  rather  like  a  polyclonal  serum,  binding  to 
different  epitopes  on  the  same  target  protein.  Western  blotting  is  routinely  used  with 
recombinant  antibodies  selected  by  phage  display  and  nitrocellulose  or  polyvinylidene 
fluoride  membranes  have  been  used  to  immobilise  antigens  for  panning  (Liu  and 
Marks,  2000;  Nakamura  et  al.,  2001;  Foy  et  al.,  2002).  There  is  therefore  no  reason  in 
principle  for  the  method  to  yield  low  signals.  It  may  be  that  the  common  lack  of  a  Vii 
insert  in  ELISA  positive  phage  impaired  scFv  affinity  for  the  target.  Alternatively,  the 
use  of  SDS  and  mercaptoethanol  in  preparing  samples  for  clectrophoresis  might  have 
denatured  target  epitopes  sufficiently  to  reduce  the  binding  of  scFvs  to  blots.  As 
shown  in  this  study,  native  gel  electrophoresis  has  some  potential  to  overcome  these 
137 drawbacks  but  the  technique  as  implemented  lacks  the  resolution  required  to  separate 
the  different  proteins  from  the  OMP  preparation.  For  future  work  with  the  panel  of 
anti-OMP  scFvs,  immunoprecipitation  would  avoid  these  problems  but  the  yield  of 
target  protein  tends  to  be  low.  If  the  OMPs  could  be  labelled  in  vitro  prior  to 
interaction  with  scFvs,  this  would  improve  the  sensitivity  of  the  technique 
significantly.  For  example,  if  labelled  with  biotin,  the  precipitated  protein  could  be 
blotted  and  then  detected  by  reaction  with  streptavidin-HRP  conjugates.  At  present, 
the  diversity  of  the  panel  of  anti-OMP  scFvs  isolated  by  phage  display  remains 
uncertain.  While  this  could  be  assessed  through  identification  of  target  proteins  as 
suggested  above,  there  remains  the  possibility  that  multiple  clones  recognise  distinct 
epitopes  on  the  same  OMP.  Competition  ELISA  might  be  one  way  to  tackle  this, 
perhaps  testing  soluble  scFvs  against  scFv-pIII  fusion  proteins  to  avoid  the  need  to 
label  one  component  of  the  competing  antibody  mixture.  The  other  would  be  to  assess 
through  DNA  sequencing  the  diversity  of  clones  reactive  with  a  common  OMP.  As 
time  for  this  phase  of  the  project  was  limited,  little  sequence  data  was  gathered  from 
the  anti-OMP  scFv  clones  isolated  by  phage  display. 
Comparison  between  phage  antibodies  selected  through  the  two  different  methods  of 
elution  -  release  with  TEA  and  competitive  elution  with  anti-OMP  antibody  -  did  not 
reveal  marked  differences.  In  both  groups,  the  reactivity  of  individual  clones  increased 
progressively  during  the  rounds  of  selections,  ELISA  signals  from  clones  at  the  same 
round  of  selection  under  each  protocol  did  not  differ,  and  in  both  selection  methods,  the 
clones  with  the  highest  ELISA  signal  carried  only  the  VL  chain.  Finally,  clones  from 
each  selection  method  failed  to  recognise  OMPs  on  Western  blots  when  used 
individually. 
One  protein  band  from  the  OMP  preparation  was  detected  by  some  scFvs  or  by 
mixtures  of  them.  Analysis  using  mass  spectrometry  revealed  this  to  be  PomA  of 
Mannheimia  haemolytica.  The  amino-terminal  sequence  of  this  protein  is  homologous 
to  OmpA  from  Escherichia  coli  and  related  proteins  from  other  gram  negative  bacteria 
such  as  Haemophilus  it  fluenzae  and  Salmonella  typhimurilun  (Mahasreshti  el  at, 
1997).  As  a  porin,  OmpA  is  important  in  maintaining  the  integrity  of  the  E.  coli  outer 
membrane  (Sonntag  et  at,  1978)  and  by  virtue  of  its  surface  location,  it  stimulates  a 
strong  antibody  response  (Puohiniemi  el  al.,  1990).  In  Western  blotting,  PomA  of 
Pasteurella  haemolylica  is  recognised  by  antibodies  raised  against  OmpA  from 
Escherichia  coli  (Mahasreshti  et  at,  1997)  and  it  must  also  be  located  at  the  bacterial 
138 surface  since  it  is  accessible  to  treatment  with  chymotrypsin.  Antibodies  against 
OmpA  and  several  other  members  of  this  family  of  proteins  are  bactericidal,  opsonic 
or  protective  (Ichihara  et  al.,  1981;  Murphy  et  al.,  1986;  Mathews  and  Gilleland,  1987; 
Hughes  et  al.,  1992).  Vaccination  with  Pasteurella  haemolytica  Al  OMPs  confers 
protection  against  pneumonic  pasteurellosis  (Mosier  et  al.,  1989;  Morton  et  al.,  1995; 
Srinand  et  al.,  1995)  and  cattle  vaccinated  with  live  Pasteurella  haemolytica 
developed  a  significant  increase  in  serum  antibodies  to  partially  purified  PomA 
(Mahasreshti  et  al.,  1997).  Hence,  PomA  of  Mannheimia  haemolytica  has  potential  as 
a  vaccine  target.  It  would  be  interesting  to  see  if  the  scFvs  isolated  against  this  target 
could  mediate  bacteriocidal  activity  when  conjugated  to  a  heavy  chain  constant 
domain  (Wang  et  al.,  1999).  This  might  offer  a  novel  therapeutic  against 
pasteurellosis. 
As  regards  the  generation  of  antibodies  against  components  of  the  bacterial  surface, 
a  further  feature  of  these  results  is  significant.  No  attempt  was  made  to  quantify  levels 
of  lipopolysaccharide  (LPS)  in  the  OMP  preparations  but  its  presence  is  inevitable. 
Preliminary  experiments  attempted  to  determine  if  scFvs  against  LPS  were  commonly 
isolated  from  the  Griffin.  1  library.  OMPs  prepared  with  Sarkosyl  were  treated  with 
Proteinase  K  in  an  attempt  to  digest  the  proteins  present.  This  had  a  marginal  effect  on 
the  reaction  of  a  selection  of  phage  but  SDS-PAGE  indicated  that  traces  of  the  major 
protein  components  were  still  present.  In  contrast,  the  reaction  of  phage  with  OMPs 
prepared  with  the  detergent  n-dodecyl  ß-D-maltoside  (DDM)  was  significantly 
reduced  after  protease  digestion,  but  insufficient  material  remained  for  analysis  by 
SDS-PAGE.  The  results  (not  shown)  were  therefore  inconclusive.  This  issue  could  be 
investigated  more  thoroughly  by  treatment  of  larger  quantities  of  OMPs  with  protease 
before  assay  in  monoclonal  phage  ELISA  or  by  coating  microtitre  plates  with  purified 
LPS. 
With  the  rapid  advance  of  genomic  projects  for  major  bacterial  pathogens,  the 
approach  described  in  this  chapter  has  significant  potential  for  the  identification  of 
bacterial  proteins  with  therapeutic  or  vaccine  potential.  In  one  recent  investigation, 
Pizza  et  al.  (2000)  analysed  the  genomic  sequence  of  a  virulent  scrogroup  B  strain  of 
Neisseria  meningitfdis  for  vaccine  candidates.  A  total  of  350  candidate  antigens  were 
expressed  in  Escherichia  coli,  were  purified  and  sera  raised  against  each  protein  by 
immunising  mice.  The  sera  were  then  tested  for  bactericidal  activity.  Given  the 
success  with  which  scFvs  against  OMPs  were  isolated  in  this  project,  application  of 
139 phage  display  in  this  context  would  seem  attractive.  Selection  of  phage  can  be  done  in 
the  wells  of  a  microtitre  plate  (O'Brien  and  Aitken,  2002),  hence  antibodies  against 
350  proteins  could  be  isolated  on  only  4  ELISA  plates.  For  biological  evaluation  the 
Fc  portion  of  an  antibody  would  be  required  for  complement  activation.  Fab  or  scFv 
antibodies  selected  from  phage  display  libraries  could  either  be  fused  to  Fe  domains 
by  recloning  or  with  appropriate  immunochemical  reagents,  a  second  full-length 
antibody  directed  against  a  tag  (e.  g.  pill  as  used  in  this  chapter  with  scFv-pIII  fusion 
proteins  for  dot  blots,  ELISA  and  Western  blotting)  could  be  used  to  activate 
complement. 
This  chapter  thus  fulfils  the  aims  set  earlier  in  the  thesis:  to  use  phage  display 
technology  to  isolate  recombinant  antibodies  against  the  outer  membrane  proteins  of 
Mannheimia  haemolytica.  The  panel  of  scFvs  generated  need  to  be  characterised 
further,  but  the  reactivity  of  clones  towards  PomA  has  demonstrated  that  this  approach 
offers  significant  potential  as  a  tool  for  the  investigation  of  bacterial  infection. 
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Conclusion 5  Conclusion 
The  scope  of  this  study  has  been  broad.  It  has  examined  the  basic  immunology  of 
the  bovine  antibody  system  and  it  has  brought  new  techniques  of  molecular  biology  to 
the  applied  immunology  of  this  species.  It  both  areas,  the  project  has  attempted  to  help 
close  the  gap  between  present  understanding  of  the  biology  of  humans  and  laboratory 
animals,  and  that  of  cattle,  a  group  of  animals  of  huge  importance  to  industrial  and 
rural  economies  across  the  globe. 
At  the  start  of  the  project,  it  was  well  known  that  the  bovine  antibody  system 
showed  at  least  one  unique  feature.  Its  use  of  a  single  gene  family  in  the  formation  of 
the  heavy  chain  'repertoire  is  in  marked  contrast  to  humans  or  mice  (Cook  and 
Tomlinson,  1995)  but  is  a  feature  shared  with  other  veterinary  species  (e.  g  sheep 
(Dufour  et  al.,  1996),  chickens  (Reynaud  et  al.,  1994)  and  pigs  (Sun  et  al.,  1994). 
Rather,  it  is  the  length  of  CDR3H  that  sets  bovine  antibodies  apart  (Berens  et  al., 
1997;  Saini  et  al.,  1999).  In  seeking  to  characterise  the  bovine  J1;  locus,  it  was 
imagined  that  strong  similarities  would  emerge  with  the  equivalent  region  of  the  ovine 
heavy  chain  locus  i.  e.  that  6  segments  would  be  present  but  that  2  would  account 
without  ambiguity  for  the  sequences  of  FR4H  observed  in  bovine  Ig  cDNA.  Useful  as 
this  data  would  be,  it  was  envisaged  that  its  main  value  would  simply  be  to  provide  a 
fixed  point  of  reference  from  which  to  isolate  and  characterise  bovine  D  segments  and 
thereby  explain  why  CDR3H  is  atypically  long. 
The  result  of  these  studies  -  that  the  J11  segment  which  undergoes  rearrangement 
does  not  appear  to  originate  from  the  main  J11  locus  -  has  instead  revealed  another 
unique  aspect  of  the  bovine  Ig  system  and  set  another  set  of  puzzles  for  future 
investigations:  where  does  the  sequence  observed  in  rearranged  B-cells  come  from; 
when  is  it  accessed  during  B  cell  development;  what  process  brings  it  into  the  coding 
sequence  for  bovine  Igs.  Clearly  the  donor  sequence  lies  outwith  the  3200  bp  which 
has  been  sequenced  in  this  study;  whether  it  lies  on  the  same  chromosome  as  the 
heavy  chain  locus  (chromosome  21)  or  elsewhere  in  the  genome  remains  unknown.  In 
either  case,  this  appears  to  be  another  highly  unusual  property  of  the  immunology  of 
cattle  as  a  group  of  vertebrates.  The  availability  of  BACs  for  characterising  significant 
parts  of  the  Ig  locus  and  other  regions  of  the  genome  should  assist  the  location  of  these 
sequences  and  elucidation  of  how  they  are  introduced  (gene  conversion  or  perhaps 
trans-chromosomal  rearrangement). 
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fixed  point  of  reference  for  the  isolation  of  D  segments.  These  studies  have  already 
been  initiated  by  others  in  the  laboratory.  Three  potential  suggestions  have  been 
made  regarding  the  length  of  bovine  CDR3H  (Aitken  et  al.,  1999):  that  D  segments 
are  unusually  long;  that  D-D  fusions  emerge  frequently  from  the  process  of 
rearrangement;  that  terminal  transferase  introduces  significant  lengths  of  non- 
templated  sequence  during  rearrangement.  Since  the  DQ52  segment  described  in  this 
thesis  was  found  to  be  longer  than  equivalent  segments  from  other  species,  there  may 
already  be  an  indication  that  bovine  D  segments  will  emerge  as  unusually  long. 
A  further  puzzle  surrounding  the  formation  of  antibodies  in  cattle  is  the  process 
which  introduces  diversity,  post  rearrangement.  Leading  candidates  for  this  include 
gene  conversion  (Parng  et  al.,  1996)  and  somatic  hypermutation  (Berens  et  al., 
1997).  Distinguishing  between  these  processes  in  the  Ig  reading  frame  is  difficult. 
However,  it  might  be  predicted  that  gene  conversion  would  favour  the  introduction 
of  substitutions  within  the  protein  coding  sequence,  whereas  somatic  hypermutation 
(at  least  in  mice)  targets  the  transcriptional  unit  (Wagner  and  Neuberger,  1996).  The 
work  described  in  this  thesis  successfully  recovered  sequence  from  regions 
downstream  of  the  rearranged  JH  segment  using  genomic  DNA  from  B  cells.  During 
the  process  of  diversification,  perhaps  random  substitutions  would  appear  here  if 
somatic  hypermutation  was  active  whereas  little  substitution  would  occur  is  gene 
conversion  was  the  driving  force  for  diversification. 
Attempts  to  construct  a  bovine  Fab  library  were  time-consuming  and  ultimately 
unsuccessful  but  the  selection  of  scFvs  against  Mannheimia  haentolylica  from  the 
Griffin.  1  library  showed  the  potential  application  of  phage  antibody  technique 
investigations  of  infectious  diseases.  Clearly,  the  weak  signals  obtained  in  Western 
blotting  pose  a'  challenge  for  the  future  but  ways  in  which  this  could  be  tackled  have 
been  suggested.  A  wider  question  concerns  the  use  to  which  these  reagents  could  be 
put.  There  is  little  doubt  that  scFvs  selected  from  phage  antibody  libraries  could  be 
applied  to  the  diagnosis  of  livestock  infections.  To  take  one  aspect,  the  ability  to 
express  these  monoclonal  Igs  in  bacteria  offers  significant  opportunities  for  cost- 
saving.  Perhaps  this  could  be  utilised  in  designing  assays  to  be  nun  on  site  by 
personnel  with  little  specialist  training  (e.  g.  farm  staff).  This  might  enable  rapid 
142 isolation  of  animals  showing  signs  of  infection,  selection  of  animals  in  good  health 
for  transport  to  market,  or  monitoring  of  animals  for  selected  pathogens  before 
introduction  to  a  herd.  There  is  some  precedent  for  this  in  the  steady  rise  of  patient- 
run  assays  in  human  medicine  (e.  g.  pregnancy  tests  and  assays  for  blood  sugar 
levels). 
Recombinant  antibodies  are  having  an  increasing  impact  in  human  therapy;  it  is 
questionable  to  what  extent  the  economics  of  modern  livestock  farming  could  sustain 
this  area  of  application,  and  how  delivery  to  large  numbers  of  animals  would  actually 
be  carried  out.  In  selected,  high-value  animals  (e.  g.  horses  and  companion  species), 
there  may  be  the  opportunity  to  apply  the  techniques  described  in  this  thesis  to  the 
development  of  protein  therapeutics  against  infectious  diseases.  The  exposure  of 
PomA  at  the  surface  of  Mannheimia  haemolytica  and  the  availability  of  a  panel  of 
recombinant  monoclonal  antibodies  offers  the  opportunity  to  test  these  ideas.  The 
work  would  entail  linkage  of  the  scFvs  to  constant  region  domains  able  to  fix 
complement  and  expression  of  the  constructs  in  mammalian  cells  owing  to  their  size 
and  requirement  for  glycosylation.  Depending  upon  yield,  assays  of  bactericidal 
activity  in  vitro  might  progress  to  limited  testing  against  established  or  challenge 
infections  ofM.  haemolytica  in  vivo.  One  value  of  this  kind  of  study  aside  from  proof 
of  principle  would  be  that  more  informed  costing  could  be  made  for  production  of  a 
protein  therapeutic  against  bacterial  diseases  of  livestock  animals.  It  would  be 
interesting  to  also  investigate  the  delivery  of  recombinant  antibodies  via  DNA 
immunisation  methods  (Lorenzen  et  al.,  2000)  or  attenuated  bacterial  species  able  to 
colonise  the  tissue  to  be  protected  (Beninati  et  al.,  2000). 
One  area  where  phage  antibodies  are  certain  to  have  an  impact  is  in  basic  studies 
of  the  pathogenesis  of  bacterial  infection.  Reference  has  already  been  made  to  this 
topic  earlier  in  the  thesis  but  it  is  worth  repeating  that  as  genome  projects  provide 
increasing  volumes  of  data,  the  need  to  produce  antibodies  against  proteins 
implicated  in  the  pathogenic  process  will  similarly  escalate.  There  is  an  obvious 
value  for  these  reagents  in  evaluating  the  vaccine  potential  of  their  targets.  More 
speculatively,  the  use  of  antibody  arrays  (de  Wildt  et  al.,  2000;  1lolt  et  al.,  2000)  to 
monitor  the  expression  of  proteins  (c  f.  transcriptional  analysis)  would  offer  the 
chance  to  observe  expression  at  the  level  of  the  proteome  or  its  constituent  subsets 
(e.  g.  surface-located  proteins,  proteins  induced  exclusively  in  vivo). 
143 Appendices Appendix  1: 
Sequence  from  the  bovine  JH  locus.  Sequences  were  assembled  from  5  individual  sources 
indicated  with  different  colours  (see  below),  the  numbers  in  brackets  indicating  repeated 
sequencing  runs  from  the  same  clone.  From  these,  a  consensus  was  derived  (indicated  by 
"Cattle"  at  the  left  of  the  Figure).  Data  are  compared  with  the  sheep  JH  locus  (Dufour  and  Nau, 
1997)  using  bars  to  indicate  differences.  In  the  body  of  the  Figure,  dashes  indicate  identity  with 
the  consensus,  differences  are  shown  with  the  nucleotide  identified  at  that  position.  Arrows 
indicate  primer  binding  sites. 
Black  :  genomic  DNA  from  liver 
Red:  genomic  DNA  recovered  from  palate  tissue 
Blue:  peripheral  blood  genomic  DNA 
Purple:  a  lambda  clone  isolated  from  a  library  of  bovine  genomic  DNA 
Green:  clone  15,  a  lambda  clone  carrying  the  bovine  JH  locus  (Knight  et  al.,  1988) 
144 Cattle  AATTCC  CCGGATCTGT  GGGCAGGGTT 
.,,.  RR2  > 
Cattle  CCCAAGGGGG  TCGGTGGCCG  ACCCCCCTGG  CCCTTGCTCG  CCTGCGGCCA  GCCCTAAGGG 
C15.  OJ1R<  -.  G  ---------  N  ---C--T---  -CC  ---  T-.  -  -T--.  -----  ---C-  ''.  ' 
C15.  RR2  -N--  ------G  ---N--C--  NN---N-C-  -C--C.  -.  --  ti-  :; 
Cattle  TTTTGGCCAA  GCCAGAAACC  ACAGTGGAAC  TCGGTGGGGC 
C15.  OJ1R  ----------  G----A-N--  N--------  T  -G-  - 
C15RR'  N----N-A--  A------G--C  -C-------- 
Cattle  ACAAAAACCC  CTGAGCAAAG  TGGCCCCAGG  GAAGCCGGGG 
C15.  C.  'iR  T-A-C--N--  ----------  --- 
C15kRz  N-G-G-N--  G---------- 
Cattle  CCCTGTCAGC  GCACACGGGG  TCAGGTCAGC  CAGGAGCCTG 
C15...  JIR  --------G-  ----------  -C------G-  ---N-G-N-N 
C15.  N 
--  ---------C-  ----------  -N------N-  ---N-N-C-G 
Cattle  CCTGGGCTGA  CGGTGAAGGG  GCCTCCCAGG  CGGGCACGGA 
C15.  OJ1R  -N-G--C  --_  --  ------G-  -----A---- 
C15.  J1OR(1)  <  A- 
C15.  J1OR(2) 
C15.  RR2  -C-N--N---  ----G-----  --------N-  -----N---- 
CACAAAAATT  GACAACTTT. 
-A--A-----  -----T---T 
...  N--.  N_.  _.  _.  _.  -----C--.  _. 
GGGGTCTCAC  TTTGAGGGTT 
-----C-C--  ---N------ 
------T-N--  ---G------ 
AAGGCACTGG  AAAAGAGCCA 
------N---  ----  N--N--N 
-----C---  -----A-A---N 
GCCAGGCCCA  GCCCAGGCAA 
----------  ------ 
----------  ---------- 
<  -----  ---------- 
----------  N--------- 
Cattle  GGGGCCAGGT  CCCCAAGGCC  TGGGGTGCAG  GGAGTCCA"G  GGAATTGGGG  GTTGAGGTGG 
C15C,  J1R  -  ----  -----------  ----------- 
C15.  JlOR(1)  ----------  ---------N  ----------  ----------  ---N- 
C15.  JlOR(2)  -  -T--------  ---------  ----------  ---------. 
C15.  RR2  -------N--  ----------  -N--------  --------A-  ----------  ---------- 
C15.  J8R(1)  <  ----  ---N-----A 
Cattle 
C15.  JBR(1)  -N-N  ---  -A------  A  ---N-TC  -  -----  ---  --- 
C15.  OJ1R  -_.  ---  --- 
---------  ----------  -------  C15.  J10R(1)  -N---------  ----------  ---------- 
-----.  ----  ----------  ---------  C15.  J10R  (2)  -----------  -  --------  ---------- 
C15.  RR2  ---N----NT  --  --------A  --  -----  T-T--  --NN-T----  -----A--N-  --------- 
Cattle  AGCAG.  A.  CACT.  CAAATCCCAG  ACCAGGGGCC  TGAGGCAGAC  AGGTGCT 
C15.  l<(1)  A  ----C-C-C--_ 
C15.  OJ1R 
--------------  ----------  ----------  ----------  ------- 
---  -N--------  -------  C15.  J10R(1) 
.  -----.  ------- 
----.  -----  ------- 
C15.  RR2 
.  ---NN.  -.  ----T  N----T---A  -------N-T  NA-N-A-A-A  --T-.  -- 
Sheepl  TCGAGGGTGG  GGGGCAAGCG  TCTTCAGGAA  GACAGACTTA 
I 
CAGCTCCCGG  GGGCTTCCTG 
111111  IIIII 
Cattle 
III  I 
TGTCGGTTGG 
I 
GGGGCAAGTG  TCTTCAGGAA  GACAGACTTG  CAGC......  ..... 
TCCTG 
C1S  ..  T8R(  )  -  _------  r-  -N-  -  N--  --  G 
C15.  OJ1R  ----------  -  --  -T  -N-  _G  -- 
C15.  J1OR(1)  ----------  -------  'r  C  G 
C15.  J1OR(2)  ----------  --------'r-  C 
C15.  RR2  -N-T------  ------  > 
Sheep  61  GGGGCTTCCT  GGGGACCCTG  AGTGGGTTTC  CATGCCCCCC  AGCACAGGGC  CAGCCCACTG 
Cattle 
1 
GGGGCTCCCT  GGGGACCCTG  GGTGGGTTTC  CGTGCCTCCC  AGCACAGGGC  CAGCCCACTG 
C15.  JBR(1)  ------  --  G  r 
C15.  JBR(2)  AAC 
C15.  OJ1R  ------C---  ----------  G--------- 
C15.  J1OR(1)  ------C---  ----------  G---------  -G---T----  ----------  ---------- 
C15.  J1OR(2)  ------C---  ----------  G---------  -G---T----  ----------  ---------- 
145 Ovine  JE1R 
Ovine  JH1 
Sheep  121  TGACTATGCT  GACTTCCATC  TCTGGGACCA  GGGT.  G000TG  GTCACCGTCT  CCTCAGGAGA 
1  II  II  AC  GTCT  I 
Cattle  TGACTATGCA  GACTTCCATC  TCTGGAGCCA  GGCT.  G000TG  GGCTGCCCTG  CCTCAGGTGA 
2-4.  OJ1(2)  >  ---  -----AG---  --C-.  ------  -G-TG-CCTG  .  -------T-- 
2-4.  OJ1(3)  >  ---  -----AG---  --C-.  ------  -G-TG-CCTG  .  -------T-- 
2-4.  OJ1(1)  >  ---  ----  NAN---  --C--------  -G-TG-CCTG  .  -------T-- 
L.  JH2  >  CC-----  T-- 
L.  OJ1(1)  >  ---  -----AG---  -----------  -G--------  --------T-- 
L.  OJ1(2)  >  ---  -----AG---  A-C-T------  NG--------  N----  N-T-- 
L.  J8R(2)  <--N----T-  ----T-----  -T--AAG---  --T-.  ---T--  -G--------  --------T-- 
C15.  J8R(3)  <-  --T-.  N--T--  -G-N-G----  .  ---N---TN- 
C15.  J8R(1)  ---------A  ----------  -----AG---  --C-.  ------  -G--------  --------T-- 
C15.  J8R(2)  ---T---CAA  ACT-------  -T--AAG---  --T-.  ---T--  -G--------  -------.  -- 
C15.  J1OR(1)  ---------A  ----------  -----AG---  --C-.  ------  -G--------  C-------  T-- 
C15.  J1OR(2)  ---------A  ----------  -----AG---  --C--------  -G--------  --------T-- 
g 
Sheep  181  ATCTCGTGTC  CAGTGACCAA  ATCAGGGGAC  AATGGGACTT  GGGTGGACTG  GGGATGGGAG 
III  I 
Cattle  ATCTGGTGTC  TAGTGTCCAA  GTCAGGGGAC  AGCAGGACTT  GGGTGGACTT  GGGATGGGAG 
2-4.  OJ1(2)  ----G-----  T----T----  G---------  -GCA------  ---------T  ---------- 
2-4.  OJ1(3)  ----G-----  T----T----  G---------  -GCA------  ---------T  ---------- 
2-4.  OJ1(1)  ----G-----  T----T----  G---------  -GCA------  ---------T  ---------- 
L.  JH2  ----G-----  T----T----  G---------  -GCA------  ---------T  ---------- 
L.  OJ1(1)  ----G-----  T----T----  G---------  -GCCA-----  T  ---------T  ---------- 
L.  OJ1(2)  ----G-----  T----T----  G---A-----  -GCAC-----  ---------T  -N-----  N-- 
L.  JSR(2)  --T-G----T  T----T----  G---------  -GCA------  ---------T  -------A-- 
C15.  JBR(3)  --T-G-----  N----T----  G---------  -GCA------  -----A---T  ---------- 
C15.  J8R(1)  ----G-----  T----T----  G---------  -GCA------  ---------T  ---------- 
C15.  J8R(2)  --T-G--T-T  N----T----  G---------  -GCA---N--  ---------T  --N----  N-- 
C15.  J1OR(1)  ----G-----  T----T----  G---------  ------  < 
C15.  J1OR(2)  ----G----N  T----  < 
JH10R 
Sheep  241  TCAGGGCCAG  CAAGGAGGCA  GTG.  TGTGTTT  TTGTAGAAAA  GAAGCAGCAG  AATAGAAGCT 
Cattle  TCAGGGCCAG 
2-4.  OJ1(2)  ---------- 
2-4.  OJ1(3)  ---------- 
2-4.  OJ1(1)  ---------- 
L.  JH2  ---------- 
L.  OJ1(1)  ---------A 
L.  OJ1(2)  ---CN----A 
L.  J8R(2)  -----  ---- 
C15.  J8R(3)  ---------C 
C15.  J8R(1)  --G------- 
C15.  J8R(2)  --G------- 
Sheep  301  ACGCTGCTGG 
Cattle  ATGCTGCTGG 
2-4.  OJ1(2)  -T-------- 
2-4.  OJ1(3)  -T-------- 
2-4.  OJ1(1)  -T-------- 
L.  JH2  -T-------- 
L.  JBR(2)  -T-------- 
C15.  J8R(3)  -T-------- 
C15.  J8R(1)  -T-------- 
C15.  J8R(2)  -T----  N--- 
CAAGGAGGTA 
--------T- 
--------T- 
T- 
---N----  T- 
----N---T- 
----N---T- 
----A---T- 
GACTCGGGTC 
GACTTGGATC 
----T--A-- 
----T--A-- 
----T--A-- 
----T--A-- 
----TA-A-- 
----T--A-- 
----T--A-- 
----T--A-- 
GGG.  TGTGTTT  TTGTIGGAAAA  GAATTAACAG  AAGAGAAGCC 
-G  ---------  ----  G  -----  ---  TT-A---  --G  ------  C 
-G  ---------  ----  G  -----  ---  TT-A---  --G  ------  C 
-G  ---------  ----  G  -----  ---  TT-A---  --G  ------  C 
-G-.  --N  ----  ----  G  -----  ------  A---  --G  ------  c 
AG-G  -------  --  > 
TG-G  -------  --T-G  -----  ---  NCCN--A  --G  ------  > 
-G  ---------  ----  G  -----  ---  GC-A---  --G  ------  C 
-G  ---------  ----  G  -----  N  -----  A--N  --N  ------  C 
-G  ---------  ----  G  -----  N  -----  A---  --G  ------  C 
-G  ---------  ----  G  -----  N  -----  A---  --N  ------  C 
TCTGGGGCCA  GCGCACCCCG  GTCACCGTGT  CCTTGGGCAG 
TI 
TCTGGGGCCA  GCGCACCCCG  GTCACCGTGT  CCTTGGGGAG 
----------  ----------  ----  T  -----  -------  G-- 
----------  ----------  ----  T  -----  -------  G-- 
----------  ----------  -N--T  -----  -------  G-- 
----------  ----------  ----------  -------  G-- 
----------  ----------  ----------  -------  G-- 
----------  ----------  ----------  -------  G-- 
-N  --------  ----------  ----------  -------  G-- 
-N  --------  ----------  ----------  -------  G-- 
146 Sheep  361  TGTCTCCCTT  GCAGTGCTGC  CTGGGCCTCG  GGCAGTTCCC  TGGG.  TCTGTG  CAG.  CCCACCA 
II  AA  ......  ... 
Cattle  TGTCTCCCTT  GCAGCACTGC  CTGGGCCTCG  GGCAGTTCCC  TGGGGTCCGTG  CAGCCCCACCG 
2-4.  OJ1(2)  ----------  ----CA----  ----------  ----------  ----G--C---  ---C------G 
2-4.  OJ1(3)  ----------  ----CA----  ----------  -------N--  ----G-NC---  ---C------G 
2-4.  OJ1(1)  ----------T  ---NCA----  --------T-  -------N--  ----G--C--N  --NC--  > 
L.  JH2  ----------  ----CA----  AA--......  ...  -------  ----G--C---  ---C------G 
L.  J8R(2)  ----------  ----CA----  AA--...... 
...  -------  ----G--C---  ---C------G 
C15.  J8R(3)  ---N------  ----CA----  ----------  ----------  ----G--C---  ---C------G 
C15.  J8R(1)  C---------  ----CA----  ----------  ----------  ----G--C---  ---C------G 
C15.  J8R(2)  C---------  ----CA----  ----------  ----------  ----G------  ---C------G 
Sheep  421  TGCCCGGAGC  AAGGCAGGGT  CCT.  GGTCTAG  TGGGGTCCTG  CCCTTGGATC  TGCCAGAGCC 
I  II  1 
Cattle  TGCCCTGAGC  AAGGCAGGGT  CCT.  GGTCCAA  CGGGGTCGCG  CCCTTGGATC  TGCCGGAGCC 
2-4.  OJ1(2)  -----T----  ----------  ---.  ----C-A  C------GC-  ----------  ----  G----- 
2-4.  OJ1(3)  -----T----  ----------  ---.  ----C-A  C------GC-  ----------  -T--G----- 
L.  JH2  -----T----  ----------  ---.  ----C-A  C------GC-  ----------  ----  G----- 
L.  J8R(1)  <  ---  ----------  ---T----  C-A  C------GC-  ----------  ----  G----- 
L.  J8R(2)  -----T----  ----------  ---.  ----C-A  C------GC-  ----------  ----  G----- 
C15.  J8R(3)  -----T----  ----------  ---.  ----C-A  C------GC-  ----------  ----  G----- 
C15.  J8R(1)  -----T----  ----------  ---.  ----CNA  C----N-GC-  ----------  ----  G----- 
C15.  J8R(2)  -----T----  ----------  ---.  ----C-A  C------GC-  ----------  ----G----- 
JHBR 
,  if 
JH8 
Sheep  481  CCTGGAGGTG  AGGCAGCTGA.  GCCTGAGAGG  AGGACAGGAG  CTG.  CT.  000TG  GGAGGAAACG 
IIIIII 
Cattle  CCTGGAGATA  AGCCAGCTGAG  GCCTGAGGGG  CTGACT.  GGGCG  GGAGGAAAGG 
2-4.  OJ1(2)  -------A-A  --C-------.  -------G--  ----------  ---A------  C-  --------G- 
2-4.  OJ1(3)  -------A-A  --C-----  T-G  -------G--  ----------  ---A--T---CC  --------G- 
L.  JH2  -------A-G  --C-------  G  -------G--  ----------  ---A------  C-  -----  > 
L.  J8R(1)  ----A--A-G  --C-------G  -------G--  ---------  < 
L.  J8R(2)  -------A-G  --C-------  G  -------G--  ---------  < 
C15.  J8R(3)  -------A-A  .  -C-------  G  --N.  --NG  < 
C15.  J8R(1)  -------A-G  --C-------  G  -------G--  ---------  < 
C15.  J8R(2)  -------A-G  --C-------  G  -------G--  ---------  < 
Sheep  541 
v 
TGG.  CAGAGCC  CGACGGGTCA  GCGTCTGTGT  GGTGA.  000C.  A  GGGCAGGCCC  CTGGGCCTGA 
Cattle  TGGGCAGAGC.  TGACGGGGCA  GGGTCTGTGC.  AGTGA.  GGGC.  A  GGGGAGGCCC  CCGGGACTGG 
2-4.  OJ1(2)  ---G--A---.  T---C--G--  ---------CA  AN--------  A-  ---A--N---  -C---A---G 
2-4.  OJ1(3)  ---G--G---.  T---N-NG--  N-----N-NC.  A----  G------  ---N------  -C-N.  A---G 
2-4.  JH8  >  --G--  ---C-----C.  A----.  ----.  -  ----------  -C---A---G 
L.  JH8  >  C.  A----.  ----.  -  ----------  -C---A---G 
Pa1.  JH8  >  T---T--G--  G--------C.  A---------  T.  N  ----------  -C--A---G 
C15.  JH8  >  --  ---------C  A----.  ----.  A  ----------  -C---A---G 
BG.  JH8  >  ------G--  ---------C  A----.  ----.  -  ----------  -C---A---G 
Sheep  601  CCTCCCAAGG  GTTCATGTCT  TGGGGACAGC  CGGCACGGCG  TCCTTCATCA  TTGCTTTTGA 
Cattle  CCTCCCCAGG  GTTCATGTCT  TGGGGGCAGC.  CGGGACTGCG  TCCCTCAGCA  ATGCTTTTGA 
2-4.  OJ1(2)  ---N--C---  ---N--  > 
2-4.  OJ1(3)  ------C---  T--N--N-N-  -----  > 
2-4.  JH8  ------C---  ----------  -----  G-----  ------T---  ---C---G--  A--------- 
L.  JH8  ------C---  ----------  -----  G-----  ------T---  ---C---G--  A--------- 
Pa1.  JH8  ------C---  ----------  -----G---.  ------T---  ---C---G--  A--------- 
C15.  JH8  ------C---  ----------  -----  G----  C  ------T---  ---C---G--  A--------G 
BG.  JH8  ------C---  ----------  -----  G-----  ------T---  ---C---G--  A--------- 
IA7 Sheep  661  CTCCTGGGGC  CAGCGCGCCC  CGGTCACAGT  CTCCTCAGGT  GAGA,  CGG000  TCTGCCCGCT 
Cattle  CTCCTGGGGC  CAGCGCACCC  CCATCTCCGC  CTCCTCAGGT  GAGACGGCTC  TCTGCCCGCT 
2-4.  JH8  ----------  ------A---  -CA--T-C-C  ----------  --------T-  ---------- 
L.  JH8  ----------  ------A---  -CA--T-C-T  ----------  --N-----T-  -N-------- 
Pal.  JH8  ----------  ------A---  -CA--T-C-T  -----------  -------NT-  -N-------- 
C15.  JH8  ---  ------A---  -CA--T-CAT  ----------  -------T-  ----------- 
BG.  JH8  ----------  ------A---  -CA--T-CAT  ----------  --------T-  ---------- 
Sheep  721  CGGTCCTGGG  CTGGGAAAGA  AGTCTCCAGA  GGCCCCTCGG  TCTGTGGCAG  ACCCTCTGTG 
A  I 
Cattle  CCGTCCTGGG  CCGGGGAAGG  CGTCTCCAGG  GGCCCCTTGG  TCTGGGGCAG  ACCCTCCGTG 
2-4.  JH8  -C--------  -C---G---G  C--------G  -------T--  ----G-----  ------  C--- 
L.  JH8  -C--------  -C---G--NA  C--------G  -------T--  ----G----N  ------  C--- 
Pal.  JHB  -C--------  -C---G---A  C--------  G  -------T--  ----G-----  ------  C--- 
C15.  JH8  -C--------  -C---G---G  C--------G  -------T--  ----G----A  ------C--- 
BG.  JH8  -C--------  -C---G---G  C--------  G  -------T--  ----G-----  ------C--- 
Sheep  781  GCCCCTGGGG  GP,  TCTGCCTC  TGAGGCCGTT  TGCCTCTCTG  CCCTGTTGA.  G  GTGGTGCCTC 
IA 
Cattle  GTCCCTGGGG  GATCTGCGTC  TGAGGCCGTT  TGCCTCTCTG  CCCTGTTGA.  G  GTGGCGCCTC 
2-4.  JH8  -T--------  -------G--  ----------  ----------  ---------A-  ----CA---- 
2-4.  JH9  <--  -------N-A-  ----CA-N-- 
L.  JH8  -T--------  -------G-N  ----------  -------N--  -----------  -N--C----- 
Pal.  JH8  -T--------  -------G--  ----------  ----------  -----------  ----  C----- 
Pal.  JH9  <--N-- 
C15.  JH8  -T--------  -------G--  ----------  ----------  -----------  -N--C----- 
BG.  JH8  -T--------  -------G--  ----------  ----------  -----------  ----  C----- 
BG.  JH6  <  ----  A-.  -  ----C----- 
Sheep  841  TGCCTGTGGA  ATGTGGCCAG  GCAGA..  GTGGG  CTCTGTGGAC  CTGGGGGCCT  GGCTTTGCAT 
Cattle  TGCCTGTGGA  ACGCGGCCAG  GCAGA..  GTGGG  CTCTGTG..  C  CTGGGGGCCT  GGCTTTGTGT 
2-4.  JH8  ----------  -C-C------  ------------  ----------  ----------  -------TG- 
2-4.  JH9  ---N----A-  -C-C-C----  C--A-A.  -----  ----------  ---N------  -CT----  TG- 
L.  JH8  ----------  -C-C------  ---N--------  -----  N----  ----------  -------TG- 
Pa1.  JH8  ----------  -C-C------  ------------  ----------  -----------  -------  TG- 
Pal.  JH9  ---N------  -C-C-----  A  --CAANA-----  N------..  -  T---------  -------TG- 
C15.  JH8  -N--------  -C-C.  ----A  ---AA..  N----  ----N--..  C  ----------  ------TTG- 
BG.  JH8  ----------  -C-C------  ---G--------  -----------  ----------  -------TG- 
BG.  JH6  ---T------  -C-C----CA  --CANA.  -----  --T-T---..  -  ----------  -------TG- 
Sheep  901  GGGAGCAGA.  G  GCCGCCAAGC  CTTGGGTTTT  TGCAC.  AGC.  CC  TAACGGGGCC  CATGGCACTG 
Cattle  GGGGGCAGA.  G  GACGCCAGGC  CTTGGGGTTT  TGCAC.  AG000C  TAGCGGGGCC  CATGGCACTG 
2-4.  JH8  ---G-------  -A-----  G--  ------G---  -----A---C--  --G-------  ---------- 
2-4.  JH9  ---C.  --N-.  -  -A-----GC-  N-----  G---  -----.  ---C--  --G-------  ---------- 
L.  JH8  ---G---N-.  -  -A-----  G--  ------G--  -N-------  C--  --N-------  ---------- 
Pa1.  JH8  ---G-----.  -  -A-----  G--  ------G---  -----.  ---C--  --G-------  ---------- 
Pal.  JH9  ---G.  ----A-  AA-N---GC-  ------G---  -----.  ---C--  --G-------  ---------- 
C15.  JB8  ---G---A-.  A  -A-C---C--  ---T--GG  --  -----.  ---C--  --A------.  -----  N---- 
C15.  J6(1)  <  -----N---  -----.  ---C--  .  NAG------  ---------- 
BG.  JH8  ---G-------  -A-----  G--  ------G---  -----.  ---C--  --G-------  ---------- 
BG.  JH6  -----------  -A-----  G--  ------G---  -----.  ---C--  --G-------  ---------- 
Sheep  961  TGACTATATC  GACTACTGGG  GCCCAG.  GACT  CCTGGTCACC  GTCTCCTCAG  GTGA.  G000TC 
Cattle  TGACTAT.  TC  GACAACTGGG  GCCCAG.  GAAT 
IIII 
CCAAAACACC  GTCTCCTCAG 
I 
GTGA.  GTCCTC 
2-4.  JH8  ----------  ---A------  ------.  --AC  --AAAA----  ----------  ----A-T---N 
2-4.  JB9  ----------  ---AN-----  ------.  --AC  --AAAA----  ----------  ------  T---- 
L.  JH8  ---N---.  --  N--A------  ----CAN--A-  --AAAA----  --T------N  -N--.  -T---N> 
Pal.  JH8  -------  --  ---A------  ------.  --A-  --AAAA----  ----------  ------  T---- 
Pal.  JH9  ----------  ---A------  ------.  --A-  --AAAA----  ----------  ------  T---- 
C15.  JH8  -------  > 
C15.  JH6(l)  ---T------  ---A-T----  ------.  N-A-  --AAAA-N-G  ----------  --N-.  -T-N-- 
BG.  JH8  ----------  ---A------  ------.  --A-  --AAAA----  -------N--  ----.  -T---N 
BG.  JH6  ----------  ---A------  ------.  --A-  --AAAA----  ----------  ----.  -T---- 
148 Sheep  1021  ACC.  A000T.  TC  TCTCCTCACT  CT..  CT.  CTGAGT  TTTGGTGCAC 
.  TTT000GGAA  ATCGAGGGTG 
Cattle  AAC.  AG000.  TC  TCTCCTCACT  CTGTCT.  CA000T  TTTGGTGCAC  TTTGGGGAAA  ATCGAGGGTG 
2-4.  JHB  -A-A----  C.  --  --GT--.  -A-G--  ----------  .  -------A--  -------- 
2-4.  JH9  -A-.  ----C.  --  --GT--.  -A-G--  ----------  .  -------A--  ---------- 
Pal.  JH8  -A-A----  C.  -N 
. 
-N  --------  --GT--T-A-G--  ----------  .  -------A--  ---------- 
Pal.  JH9  -A-.  ----C.  --  T-T--------  --GTN-.  -A-G--  ----------  T-------  A--  ---N------ 
C15.  J6(1)  -A------  C.  -N  .  --------T-  T-GTT-.  NA-G--  ----------  .  ------NA--  ---------- 
BG.  JH8  -A-A----CC--  TN-GTT-NAANG--  ----------  ---T---G--  -----  A---- 
BG.  JH6  -A------  C.  --  ----------  --GT--.  -A-G--  ----------  -------A--  ---------- 
Sheep  1081  TCGGGTCTAG  AGGGCCTGGG  ACGGCCAGGG  GTCTGAGACG  GGGAAGGCCC  AGGGGCCCAG 
Cattle  TCGGGTCTAG  AGGGCCTGGG  GCGG.  CTGGG  ATCTGAGACA  CGGAGGACCC  AGGGGCCCAG 
2-4.  JH8  ----------  ----------  G---.  -T---  A--------A  C---G-A---  -A-------  N 
2-4.  JH9  ----------  ----------  .  ---.  -T---  A--------A  C---G-A---  ---------- 
Pa1.  JH8  ----------  -----  -----  G---.  -T---  A--------A  C---G-A---  -N-------- 
Pal.  JH9  ---------N  ----------  G---.  -T---  A-N------A  C---G-A---  ---------- 
C15.  JH6(1)  -----.  ---N  ----------  .  ---.  TT---  A-N-N----A  C---G-A---  ---------- 
BG.  JH8  ----------  -A--------  G---  > 
BG.  JH6  ----------  ----------  G---.  -T---  A--------A  C---G-A---  ---------- 
Sheep  1141  GCTTACAGCA  GCAAGGAGCA  GAGGCTCCAG  GCACCCTCTC  CTCCTGGGCT  CTGTAGCCAG 
Cattle  GCTTACAGCA  GCGAGGAGCA  GAGGCTCCAG  GCACCCTCTC  CTCCTGGGCT  CTGTAGCCAG 
2-4.  JH8  ----------  N-C-N-----  --N---T--N  -------T-T  --T--.  ----  -----A---N 
2-4.  JH9  ----------  --G-------  ------T---  ----------  ----------  ---------- 
Pal.  JH8  > 
Pal.  JH9  ----------  --G-------  -------  ---  --  ---  -----  ----------  ---------- 
C15J6(1)  ----------  --G-------  ----------  --------C-  ----------  ---------- 
BG.  JH6  ----------  --G-------  ----------  ----------  ---------- 
Sheep  1201  GGCCTTCTCT 
Cattle  GGCTTTCTCT 
2-4.  JH8  --NT----  N- 
2-4.  JH9  ---T----  C- 
Pa1.  JH9  ---T----  N- 
CI5JH6(2) 
C15J6(1)  ---T------ 
BG.  JH6  ---T----N- 
GAGGGCCTCA  GCCACCCTTG  GGCTCTGGAC  TCCCAAGGTC  CCAGCTGTGC 
I  III 
GGGGGCCTCA  GCCACCCTTG  GGCTCTGGAC  TCCCAAGGTC  CCAGCTG... 
TG---N--T-  AN--------  -CTNT-----  -T--------  ---  > 
-G--------  ----------  ----------  ----------  -------.. 
-G--------  ----------  ----------  ----------  ------- 
<--  N--NGGN---  NN  N----  N---------  ---NT--... 
-0--------------------------------------------- 
..  -G--------------------------------------------- 
Sheep  1261  TGGCCTCGTG  AGGCCACATG  TGAGGTAGTC  CGGAGGCCTC  AGCCGGCCAC  GAGCTCGTGC 
Cattle 
2-4.  JH9 
Pal.  JH9 
C15JH6(2) 
C15J6(1) 
BG.  JH6 
TG  TGAGGTGGTC  CGGAGGCCTC  AGCCGGCCAC  GAGCTCTTGC 
-?  ----G---  ----------  ----------  ------T--- 
--  G----G--  --------_.  -_  -----_.  _  T.  --_.. 
-A  ---G---  --N------  ---------  ---N---T-- 
-  -G----G---  ----------  ----------  ------T--- 
-G----G---  ----------  ----------  ------T--- 
JH7  10 
Sheep  1321  TTGGGGTCCC  AGCATCACTG  TCACAGTGTA  ACGACTGGCT 
Cattle  CTGGGGTCAC  AGCATCATTG  TCACTGTGTA  ACAACTGGCT  CAAGCACTGG  GGTCAGGAAG 
2-4.  JH9  C-------A-  -------T--  ----T-----  --A-------  ----------  --T----  A-G 
Pal.  JH9  C------A-  ----  T--  ----T--  ----  -A-  --  -T----A-G 
C15JH6  (2)  C----A-  -------  T---  ---  T-  -  --A----N  N  NN  C.  -N  --c-  < 
C15J6(1)  C-------A-  G------  T--  ----T-----  --A-------  -G----  < 
BG.  JH6  C-------A-  -------T--  ----T-----  --A-------  ----------  --T----A-G 
149 3B6 
44 
Sheep  1381  CCCGA.  CGCTG  TCTGCTCAGC  TGAGCCCTCC  CCACCCCACT  TC.  ACTGCACC  TGGGGAGGCC 
Cattle  CCTGGGCACTG  TCTGCTCAGC  TGAGCCCTCA  CCACCCCACT  CC.  ACTGCACC  TGGGGAGACC 
2-4.  JH9  --T-GG-A---  ----------  ---------A  ----------  C-.  --C  -----  -------A-- 
2-4.  J4(2)  <  ------T-  C-.  --------  ----A--A-- 
L.  JH4  <  ------  -------A-- 
Pal.  JH9  --T-GG-A---  ----------  ---------A  ------------  C--.  --------  -------A-- 
C15.  JH4  <  ------A  --------A-  TCC-T-----T  ----A--A-T 
BG.  JH6  --T-GG-A---  ----  < 
Sheep  1441  TGGGGTGTCA  GAGP,  TCCAGG  GGCATTCTGG  AGGTCAAGAA  AGGGAGCTGG  GGAGAGGGT 
Cattle  TGGAGCGTCA  GAGATCCAGA  GGCATTCTGG  AGGTCAAGAA  AGGGAGCTGG  GGAGAGGGT 
2-4.  JH9  ---A-C----  ---------A  ----------  ----------  ----------  --------- 
2-4.  J4(2)  ---A-C----  ---------A  ---------N  --------N-  ---A------  ---A----- 
L.  JH4  ---A-C----  ---------A  ---------  A  ----------  ---A------  --------- 
Pal.  JH9  ---A-C----  ---------A  ----------  ---------  ----------  --------- 
C15.  JH4  --AA-C----  N-------NA  ------N--A  -------N--  ---A------  -A-N----- 
Sheep 
Cattle  TCTGGTAAAC  AGGC.  AGAGCC  AGACCTC 
2-4.  JH9  -----------  ------- 
2-4.  J4(2)  -----------  ------- 
L.  JH4  -T--------  --CAN--..  --  ------- 
Pal.  JH9  -----------  ------- 
C15.  JH4  -N--------  -----A-N-CGG  ------- 
Sheep  1500  CC.  CG000CA.  AG  GACACTGCAA  TGTGGGTATG  AGGCGG.  CTCC  TCTGG.  CGGGT  CTGGCTGTCT 
Cattle  CC.  TG000CA.  AG  GACACCACGA  TGTGGGTACA  AGGCGG.  CTCC  TTCGG.  TGGGT  CTGGCTGCCT 
2-4.  J4(2)  -N.  T------.  --  N----CA-G-  --------CA  ------G----  -T---GT----  -------C-- 
2-4.  F(3)  --TT------  G--  -----CA-G-A  --------CA  ------.  ---N  -TA--.  T----  -N-----  C-- 
2-4.  JH9  --.  T------.  --  -----CA-G-  -------GCA  -----------  -T---.  T-.  --  -------CA-< 
L.  JH4  --.  T------.  --  -----CG-G-  --------CA  --N---.  ----  -T---.  T----  -------C-- 
Pal.  JH9  --.  T------.  --  -----CG-N-  N-------CA  -----------  -T---.  T----  -------  C-- 
C15.  JH4  -N.  T------.  --  -----CA-G-  --------CA  -----------  -TC--.  T----  -------C-- 
4 
JH9 
Sheep  1561  GAC.  TTGAGCA  GGACCGGGGG  CTTCCGTCGC  TGTCTGGGGC  AGGTG.  GCTGC  TCAAGGCTGG 
Cattle  CAC.  TTGAGCA  GGACCAGGGG  CTTCCGTCAC  TTTCTGGGGC  AGGCA.  GCTGC  TCGAGGCTGG 
2-4.  J4(2)  -----------  -----A----  --------A-  -?  --------  ---CA.  -----  --G------- 
2-4.  F(3)  ---N-------  -A---A----  --------A-  -T------.  -  ---CAA-----  --G------- 
L.  JH4  -----------  -----G----  --------A-  -T--------  ---CA.  -----  --G------- 
Pal.  JH9  < 
C15.  JH4  -----------  -----A----  --------A-  -T--------  ---CA.  -----  --G------- 
Sheep  1621  ACTTAGGTGT  CTGTGGGTCA  CGGTCAGCTG  GTCCAGGCAG  GCACTGGTCT  GGCCTCTGGG 
Cattle  ACTTAGGAGT  CTGTGGTTCA  TGGTCCGCCA  GCCCAGCCAG  GCAGTGGTCT  GGCCTCTGTG 
2-4.  J4(2)  -------A--  ------T---  T----C--CA  -C----  C---  ---G------  --------T- 
2-4.  F(3)  -------A--  ------T---  T----C--CA  -C----  C---  ---G------  --------T- 
L.  JH4  -------A-  ------T---  T----C--CA  -C----  C---  ---G------  --------  T- 
C15.  JH4  --------  A_  . ------  T---  T----C--CA  -C----  C---  ---G------  ---------T- 
150 Sheep  1681  GGCCAAAATG 
Cattle  GGCCAGAATG 
2-4.  J4(2)  -----  G---- 
2-4.  F(3)  -----  G---- 
2-4.  F(1)  <--N- 
L.  JH4  -----  G---- 
C15.  JH4  -----G---- 
GGACA.  TAGTG  TCTCTGGCAC 
. 
AGTCAGGTGG  GGCGGGGCCG  GCAGAGGGCC 
GGACA.  TAGTG  TCTCTGGCAC  AGTCAGGTGG  GGTGGGGCCA  GCAGAGGGTC 
-----------  ----------  ----------  --T------A  --------T- 
-----.  -----  ----------  A----------  --T------A  --------T- 
-----AN----  -N----  N---  A---N---NN-  --T---N--A  --------TA 
-----  -----  ---N------  .  ----------  --T------  A  --------T- 
----  ---  ------  -------  --T------A  -------T- 
Sheep  1741  ACAGGCAAGC  CACTTTGACC  AGCGGCTTCC  CTGTGGTGCC  TGGAGATGGG  GTGGGGGCCC 
Cattle  ACTGACAAGC  GACTTTGACC  AATGGTTTCC  CTGTGGCGCC  TGGAGATGGG  GTGGGGGCCC 
2-4.  J4(2)  --T-A-----  ----------  -AT--T----  ------C---  ----------  ---------- 
2-4.  F(3)  --T-A-----  ----------  -AT--T----  ------C---  --A-------  ---------- 
2-4.  F(1)  --T-A---A-  ----------  -AT--T----  ----  N-C---  --N----A--  --N------- 
L.  JH4  --T-A-----  ----------  -AT--T----  ------C---  ----------  ---------- 
C15.  JH4  --T-A-----  ----------  -AT--T----  ------C---  ----------  ---------- 
Sheep  1801  AGGTGCCTCG  AGCCTTGCCA  GGCTCCCGA.  G  GTTTTTGTTG  GGCGAGGCTG 
Cattle  AGGCGCCTCG  AGCCTCGTCA  GGCTCCCGA.  G  GTTTTTGTTG  GGCGAGGCTG  GAGATA.  TCA 
2-4.  J4(2)  ---C------  -----C-T--  -----------  ----------  ----------  ------.  --A 
2-4.  F(3)  ---C------  -----C-T--  -----------  ----------  ----------  ------.  --A 
2-4.  F(l)  --.  C------  -----C-T--  ---------A-  ----------  ----------  ------.  --A 
L.  JH4  ---C------  -  C-T-  ----------  ----------  ---------  A 
C15.  JH4  ---C------  C-T-  -------_  --  --  _--  --A 
JH2A 
10 
Sheep  1861  CCACTGTGAT  TACTACGGTG  TAGATGTCTG  GGGCCGAGGA  CTCCTGGTCA  CCGTCTCCTC 
Cattle  CCACTGTGTT  TACTATGGTA  TAGACGCCTG  GGGCCGAGGG  CTCAGGGTCA  CCGTCTCCTC 
2-4.  J4(2)  --------T-  -----T---A  ----  C-C---  ---------G  ---AG-----  ---------- 
2-4.  F(3)  --------T-  -----T---A  ----  C-C---  ---------G  ---AG-----  ---------- 
2-4.  F(1)  --------T-  -----T---A  ----  C-C---  ---------G  ---AG-----  ---------- 
2-4.  JH2A  >  --  -N--T----- 
L.  JH4  --------T-  -----T---A  --N-C-C---  ---------G  ---AG-----  ---------- 
C15.  JH4  --------T-  -----T---A  ----  C-C---  ---------G  ---AG----- 
C15.  JH'A  >  --CT-----  ---- 
Sheep  1921  AGGTAAGAGC  GGCC.  ATACAG  AGCCTTTGCT  TTCTCTCCTA  TTCGTGGGAT  TTTTCTGAGC 
Cattle  AGGTAAGAGC  AGCCCATCCAG 
2-4.  J4(2)  ----------  A---C--C--- 
2-4.  F(3)  ----------  A---C--C--- 
2-4.  F(l)  ----------  A---C--C--- 
2-4.  JH2A  --------N-  GN--C--C--- 
L.  JH4  --------N-  A---C--C--- 
C1'  J114  -A-  ,-  t'- 
-I',  7Ii7A  --  --  A  -..  C--- 
GGCCTTTGCT 
G--------- 
G--------- 
G----  NGGGG 
TTATCTCAT. 
--A----  A-- 
--A----  A-. 
GNA----  A-. 
--N----A-. 
--A----  A-. 
A  .  _A 
-A-----  A-. 
TTCGTGCGAT  TTTTCTGAGC 
------CA--  ---------< 
------CA--  ---------< 
------CA--  -------NN< 
---CNNC---  ----N----- 
------C---  ----  NT---< 
-  CA--  ------ý 
JH4 
Sheep  1981  ATCACTG....  GTC  CTCTGATGTG  TCCTTGTCCC  CTCCTCCCCG  GGGGGACTGG  GCAGACTGGC 
Cattle  ATCACTGTCTGGTC  CTCTGATGTG  TCCTTGTCCC  CTCCTCCCCG  GGGGAACTGG  GCAGACTGGC 
2-4.  JH2A  ---N----------  ---N------  ----------  ----------  ----A-----  ---------- 
,.:  15.  JH2A  ---  -  ----  A 
Sheep  2041  CAGGAGGG.  AC  CAGCTGCCCT  ATGCATTTCA  GAGTCTCT.  AT  CTTCTGATAG  CTTTAAAAAA 
Cattle  CAGGAGGGGAC  CAGCTGCCCT  ATGCATTTCA  GAGTCTCTTAT  TTTCCGATGC  CTTTAAAAAA 
2-4.  JH2A  --------G--  ----------  ----------  --------T--  T---C---GC  ---------- 
2-4.  ENR  <  ---------- 
C15.  JH2A  ---------G--  -G--------  ----------  --------  T--  T---C---GC  ---------- 
151 Sheep  2101  CCAGAATCTT  GCTGGCATTC  AGAGGGGGCT  TGGGCAGGAA  GGGCCACCAG  TGGG.  GGAGTC 
Cattle  TCAGAATCTT  GCTGGCATTC  AGAAGGGGCT  TGGGCGGGAA  TGGCCACCAG  TGGG.  GGAGTC 
2-4.  JH2A  T-------T-  ----------  -G-A------  -----G----  T---------  ----------- 
2-4.  EµR  T-------C-  ----------  -A-A------  -----G----  T---------  ----  G------ 
i_:  1`;.  "er.:  A  -__.  ..  -Tr  -----------  G-A------  --  --G----  T---------  -----  ------ 
Sheep  2161  CCAGGCCTCC  CTTGGCAGCA  G 
.........  ..........  ... 
GGCAACTTG  CTGTGGTCCT 
Cattle  CCAGGCCCCT  CTTGGCAGCA  GGGCAGCTTG  GGATGCGGTG  GAAGGCAACTTG  CTGCAGTCCT 
2-4.  JH2A  -------C-T  ----------  -GGCAGCTTG  GGATGCGGTG  GAA---------  ---CA----- 
2-4.  E_R  -------C-T  ----------  -GGCAGCTTG  GGATGCGGTG  GAA---------  ---CA----- 
C'_5  J  :  P_  --  -C-T  ---  GGCAGI:  TTG  GGATC;  i'ý;  G  :  'G  GAA---------  --CA----- 
Sheep  2201  AGCATCTGCG 
Cattle  AGCATCTGCG  GAGGAGCGTG 
2-4.  JH2A  ----------  ---------- 
2-4.  EµR  -------N--  ---------- 
-  'F; 
_'A  -------0-  - 
Sheep  2221  TCTGGATAAC  TTAGGGCCTC  AGGAGCGCCG  CCCGCAGTGG  G.  GCAGAGAAG  GCCCTCCTCG 
Cattle  TCTGGATAA.  TTAGGGCCTC  AGGAACGCTG  CCCGTGGCGG  GCGCAGAGAAC  GCCCCCCTCG 
2-4.  JH2A  -N-------.  ----------  ----A---T-  ----TG-C--  -C--------C  ----  C----- 
2-4.  EVR  ----------  ----------  ----A---T-  ----TG-C--  -C--------C  ----  C----- 
C15.  J}i2A  -c-------.  ------°---  ----A---T-  ----TG-C--  -C---N-N--C  ----C----- 
Sheep  2281  GGTGAGGTTG  GCTCTGCACT  AGACTGTGTT  TAAAATTCTT  TATTGGGCAG 
Cattle  CGTGAGGTGT  GTTCTGCACT  AGACTGTGTT  TAAAATTCTT  TATTGGGTAG  GAAGAGAATT 
2-4.  JH2A  C-------GT  -T--------  -N--------  ----------  -------T--  ---------- 
2-4.  ENR  C-------  GT  -T--------  ----------  ----------  -------T--  ---------- 
Cl', 
-'Ii-'A  --_.  i;  T  -----  -N-----  -----  ----  ----..  _T--  ---N  -N--- 
Sheep  2341  GTCTAGGTGA  GGAC.  GACACG  CAGTGTCCCG  ACCGCGGCAA  GAGAGGGGAG  GCTGGGGAGG 
Cattle  GTCTAGGTGA  GGACGGACATG  CAGTGTCCCG  ATCGTGGCGA  GAGAGGGGAG  CCCGGGGAGG 
2-4.  EµR  ----------  ----G----T-  ----------  -T--T---G-  ----------  C-C------- 
2-4.  JH2A  -------N--  --  > 
C1S..  if  ?:  'A  ----  T  --  ---  -C---CC  --A-GT-----  -T-AT--G-  N-N-A---  C-T-----_ 
Sheep  2401  TGACGGGCGC  TGGGCTTTGT  GAGGCCACTG  TAAGAGAAAG  AAAAGCTGTT  CGCCAGAGGA 
II  II  II 
Cattle  TGACGGGCGC  TGGGCTTTGT  GAGGCCAGTC  TAAGAGA..  G  AAAGGCCGTT  CGCCAGAGC.  A 
2-4.  EpR  ----------  ----------  -------G-C  ----------  ---G--C---  ---------- 
C15.  JH,  A  --T  A  --N-  .  -NC  CN  N-AA.  NArG.  AA 
Sheep  2461  GGTGTGCTTG  CGAATACCAA  GACAGGGCAT  CTTCAAAGCG  ACTCCTGATA  GTCTGGAAAA 
III 
Cattle  GGTGTGCTTG  CGAACACCAA  GACAGGGCAT  CTCTGAAGCG  ATTCCTGATA  GTCTGAAA)1A 
2-4.  EµR  ----------  ----C-----  ----------  --CTG-----  -T--------  -----A---- 
C1''  JH2A  ---  ---  - 
152 Sheep  2521  TTGAAACTTT  AAAAAGAGAG  ATGTTTAAAG  TATTTTAAAT  TTTTATCATT  TAATTAACAA 
II  1 
Cattle  TTGAAACTTT  AAAAA..  GAA  ATGTTTAAAG  TATTTTAAAT  TTTTATCATT  TAATTAACAA 
2-4.  EpR  ----------  -----..  --A  ----------  ----------  ----------  °°------ 
Sheep  2581  CTGCGAATCA  TGGCTTTGGA  GAGTTGAGTA  AG.....  AGT  TTGGCTGAAA  AGTACTAACT 
II  11111 
Cattle  CCGCAAATCG  TGGCTTTGGA  GAGTTGAGAC  AGGTACAAGT  TTGGCCGAAA  AGTACTAACT 
2-4.  EVR  -C--A----G  ----------  ----------  ----------  ----------  ---------- 
Sheep  2636  AGGTTCCATC  GGCCCTCGGC  CCCAATTCAG  GGCTGTTTTG  AGAATAATAA  ATTCAGCTTA 
Cattle  AGGTTCCATC  GGCCCTCGGC  CCCAATTCAG  GGCTGTTTTG  AGAATAATAA  ATTCAGCTTA 
2-4.  EpR  ----------  ----------  ----------  ----------  ----------  ---------- 
Sheep  2696  TTTTTTTAAT  GTAATTGGTG  GTGCCGAGTT  AGTCAAGATG  GCCACGGGCC  AGACTGACCA 
Cattle  TTTTTTTAAT  GTAATTGGTG  GTGCCGAGTT  AGTCAAGATG  GCCACGGGCA  GGACTGACCA 
2-4.  EpR  ----------  ----------  ----------  ----------  °°°---  A  G--------- 
Sheep  2756  CCTGCAGCA  2764 
Cattle  CCTGCAGCA 
2-4.  EpR  ---------  < 
153 Appendix  2:  General  Methods 
Plasmid  preparation  using  QIAGEN  reagents 
Samples  of  3-5  ml  from  an  overnight  bacterial  culture  were  spun  in  a  microfuge  to 
collect  the  cells.  Each  pellet  was  resuspended  in  250  µl  of  the  manufacturer's 
resuspension  solution  and  was  then  mixed  with  250  pl  of  lysis  buffer.  Once  the 
mixture  had  visibly  clarified,  350  pl  of  neutralisation  buffer  was  added  to  precipitate 
the  proteins  and  genomic  DNA.  The  mixture  was  centrifuged  at  high  speed  and  the 
supernatant  carefully  recovered.  This  was  poured  into  a  spin-column  preloaded  by  the 
manufacturer  with  ion-exchange  resin  to  absorb  the  DNA.  The  lysate  sample  was  spun 
through  using  a  microfuge  and  after  washing  with  solution  containing  80%  ethanol, 
and  further  centrifugation  to  remove  traces  of  wash  solution,  the  DNA  was  eluted  by 
adding  TE  or  distilled  water.  The  recovered  DNA  was  collected  by  transferring  the 
spin-column  to  a  fresh  microfuge  tube  and  recentrifuging. 
Typical  digestion  of  DNA  with  restriction  endonuclease 
Four  µl  of  DNA  was  digested  in  a  reaction  of  10  pl  containing  1  ttl  of  each 
restriction  enzyme,  a  lOx  reaction  buffer  selected  to  optimise  reaction  efficiency  (the 
composition  of  restriction  buffers  used  in  this  project  is  indicated  in  appendix  section), 
and  sterile  distilled  water.  The  reaction  was  incubated  a  temperature  appropriate  for  the 
enzymes  being  used  for  1.5-2  hrs. 
Agarose  gel  electrophoresis 
General  purpose  agarose  (electrophoresis  grade)  was  dissolved  in  TAE  buffer  to  a 
concentration  appropriate  for  resolution  of  DNA  fragments  of  interest  (Sambrook  and 
Russell,  2001)  using  a  microwave  oven.  Ethidium  bromide  was  added  from  a  stock  of 
10  mg/ml  in  water  to  achieve  a  final  concentration  1  pg/ml.  After  cooling,  the  gel  was 
poured  to  an  electrophoresis  tray  containing  a  comb  to  form  sample  wells  and  allowed 
to  set  at  room  temperature.  It  was  then  transferred  to  the  electrophoresis  tank  and 
samples  were  loaded  in  sample  buffer.  Powcrpacks  were  set  to  apply  a  voltage  equal  to 
8-10  volts  per  centimetre  of  gel. 
154 Extraction  of  DNA  from  gel  slices  using  QIAEXII  resin 
The  DNA  fragment  of  interest  was  excised  from  an  agarose  gel  with  a  sharp  blade 
and  transferred  to  a  sterile  microfuge  tube.  After  adding  three  volumes  of  dispersing 
buffer  supplied  by  Qiagen,  the  manufacturer  of  the  kit,  and  a  volume  of  QIAEXII  resin 
appropriate  to  the  quantity  of  DNA  to  be  recovered,  the  sample  was  incubated  at  50  °C 
for  10  min,  vortexing  every  2  min  to  keep  the  resin  in  suspension.  This  dispersed  the 
agarose  gel,  releasing  the  DNA  to  the  solution.  The  sample  was  then  centrifuged  at 
high  speed  in  a  microfuge  for  30  seconds  and  the  supernatant  was  removed.  The  pellet 
of  resin  was  washed  using  first  dispersing  buffer  and  then  buffer  containing  80% 
ethanol.  To  do  this,  buffer  was  added  to  the  tube,  the  sample  was  vortexed  to  resuspend 
the  resin,  the  tube  was  centrifuged  for  30  seconds  and  finally  the  supernatant  was 
discarded.  The  pellet  of  resin  was  air-dried  for  about  30  min  and  the  DNA  was 
recovered  by  adding  at  least  20  µl  of  distilled  water.  By  spinning  in  a  microfuge,  the 
supernatant  containing  the  eluted  DNA  was  isolated  for  further  manipulation.  This 
method  was  also  occasionally  used  to  extract  DNA  from  solutions  (eg  restriction 
digests). 
Extraction  of  DNA  from  gel  slices  using  QIAQuick®Gel  extraction  kit.  (QIAGEN) 
DNA  of  the  desired  size  was  excised  from  the  gel  and  dispersed  in  the 
manufacturer's  buffer  at  50  T.  The  solution  was  then  centrifuged  through  a  QIAQuick 
membrane,  washed  with  buffer  containing  80%  ethanol.  DNA  was  eluted  in  50  µl  of 
water. 
DNA  precipitation  with  ethanol 
One  tenth  volume  of  3M  sodium  acetate  (pH  5.2  or  7)  and  2.5  volumes  of  cold 
absolute  ethanol  were  added  to  the  sample.  The  mixture  was  incubate  at  -  20  °C  for  30 
min  and  then  was  spun  at  high  speed  (4  °C)  for  10-15  min.  The  supernatant  was  taken 
out  and  the  pellet  dried  by  air.  An  appropriate  volume  of  TE  or  distilled  water  was 
added  to  dissolve  the  pellet  and  recover  the  DNA. 
155 Preparation  of  electrocompetent  cells 
The  desired  strain  of  E.  coli  was  streaked  onto  a  TYE  plate  and  was  incubated  at  37 
T.  The  following  day  a  single  colony  was  picked  into  30  ml  of  2xTY  broth  and  was 
incubated  overnight  at  37  T.  Next  day,  one  litre  of  2xTY  was  inoculated  with  10  ml  of 
this  culture  and  was  incubated  at  37  °C  with  thorough  shaking.  The  OD  of  the  culture 
was  monitored  at  550  nm  and  the  culture  was  transferred  on  ice  when  it  reached  a 
value  of  between  0.3  and  0.5.  Cells  were  harvested  by  centrifugation  at  6000  rpm,  the 
supernatant  was  discarded  and  the  pellet  was  gently  resuspended  in  1/S  volume  sterile 
10%  glycerol,  90%  distilled  water.  Harvesting  was  repeated  3  times  with  successively 
smaller  volumes  of  cold  10%  glycerol  until  the  volume  of  the  resuspended  pellet  was 
twice  that  of  the  packed  cells.  Working  in  a  cold  room  at  4  °C,  the  suspension  was 
divided  into  200  pl  aliquots  in  microfuge  tubes.  These  were  finally  snap-frozen  with 
liquid  nitrogen  and  stored  at  -80  °C.  All  of  the  above  operations  were  done  on  ice  or  at 
4  °C  in  order  to  generate  cells  of  high  competence. 
Preparation  of  media  for  white-blue  screening 
Forty  µl  of  4%  (w/v)  X-gal  in  dimethylformamide  and  40  pl  of  25  mM  IPTG  were 
spread  onto  LB  plates  containing  antibiotics  required  for  selection.  The  plates  were 
incubated  at  37  °C  or  room  temperature  for  at  least  30  min  to  let  the  substances  diffuse 
into  the  agar.  An  appropriate  volume  of  the  bacterial  transformation  reaction  was 
spread  onto  each  plate  and  the  plate  was  incubated  at  37°C  overnight.  The  following 
day,  blue  (non-recombinant)  and  white  (recombinant)  colonies  were  visible  for  further 
analysis. 
Storing  bacterial  cultures  at  -80  °C 
Cultures  of  bacteria  grown  on  agar  plates  were  scraped  and  resuspended  in  0.5-1  ml 
of  LB  and  after  adding  0.5  volumes  of  sterile  50%  glycerol  in  water,  the  suspensions 
were  transferred  to  -80  °C  in  polypropylene  containers  suitable  for  low  temperature 
storage. 
Preparation  of  bacterial  lysates  as  templates  for  PCR 
A  single  bacterial  colony  was  inoculated  to  an  eppendorf  tube  containing  250  itl  of 
LB  with  an  appropriate  antibiotic  and  the  culture  was  incubated  at  an  appropriate 
156 temperature  overnight.  The  following  day,  the  tube  was  centrifuged  to  pellet  the  cells 
and  the  supernatant  was  discarded.  The  pellet  was  resuspended  in  30  Itl  of  distilled 
water  and  the  tube  was  heated  in  a  boiling  water  bath  for  10-15  min  to  lyse  the 
bacteria.  The  tube  then  was  centrifuged  to  pellet  the  debris.  Eight  µl  of  supernatant  was 
used  as  template  for  PCR  reactions  of  25  µl.  After  cycling,  7-8  tl  of  the  reaction  was 
run  on  an  agarose  gel. 
PCR  machines 
Unless  otherwise  indicated,  all  PCR  reactions  were  run  on  Perkin  Elmer  GeneAmp 
9700  and  2400  instruments  using  cycling  conditions  specified  in  the  relevant  section  of 
the  thesis. 
Western  blotting 
After  electrophoresis,  the  SDS  gel  was  equilibrated  in  cold  transfer  buffer  for  at  least 
30  min.  The  blotting  membrane  (typically  Hybond  C,  Amersham),  fibre  pads  and  filter 
paper  were  also  soaked  for  10-15  min.  The  gel  holder  was  submerged  in  transfer  buffer 
and  a  sandwich  comprising  the  gel,  the  blotting  membrane,  and  filter  papers,  top  and 
bottom,  was  packed  between  fibre  pads  and  assembled  into  the  holder.  Each  layer  was 
kept  moist,  avoiding  the  entry  of  air  bubbles.  The  cassette  was  transferred  to  the  blotting 
tank,  ensuring  that  the  blotting  membrane  was  nearest  the  positive  terminal.  Blotting 
was  performed  at  100  volts  for  1  hr  or  30  volts,  40  milliamps  overnight.  The  membrane 
then  was  blocked  using  50  ml  of  3%  skimmed  milk  in  Tris-NaCI  (TBS)  (pHH  7.4).  This 
was  done  with  constant  agitation  on  a  shaking  table  for  1  hr  or  overnight  at  room 
temperature.  The  membrane  was  transferred  to  3%  skimmed  milk  in  TBS  containing  an 
appropriate  dilution  of  the  primary  antibody  and  was  incubated  with  shaking  for  2-3  hrs 
at  37  °C  or  8  hrs  at  room  temperature.  Unbound  antibodies  were  removed  by  washing 
with  40  ml  aliquots  of  TBS.  Four  washes,  each  of  5  min  were  routinely  used.  The 
secondary  antibody-enzyme  conjugate  was  added,  typically  at  a  dilution  of  1/1000  in 
3%  skimmed  milk  TBS  for  incubation  at  37  °C  for  1  hr.  Washing  was  done  as 
described.  The  membrane  was  then  transferred  to  the  developer  solution,  allowing  the 
bands  to  develop.  Once  the  image  was  clear,  the  membrane  was  washed  with  distilled 
water  and  dried  on  filter  paper. 
157 Appendix  3:  Chemicals 
Acetic  acid  (Glacial):  BDH  Laboratory  Supplies,  England.  #  10001  CU 
30%  Acrylamide-Bis  solution  (19:  1):  BIO-RAD  Laboratories,  USA.  #  161-0154 
Agarose:  Roche  Diagnostic  GmbH,  Germany  #1  388  991 
Ammonium  persulfate  (APS):  SIGMA-Aldrich  Chemical  GmbH,  Germany  #  A-3670 
Blood  agar:  Oxoid  Ltd.,  England.  #  CM271 
Bovine  serum  albumin  (BSA):  Fraction  V,  SIGMA-Aldrich  Chemical  GmbH,  Germany  # 
A-2153 
Brain  heart  infusion:  Oxoid  Ltd.,  England.  #  CM225 
Coomassie  Brilliant  Blue:  SIGMA  Chemical,  USA.  #  B-0149 
Bromophenol  blue:  SIGMA  Chemical,  USA.  #  B-5525 
4-chloro-l-naphthol:  SIGMA-Aldrich  Chemical  GmbH,  Germany  #  C-8890 
Chloroform:  Fisher  Scientific,  UK.  #  C/4920/17 
Citric  acid:  Fisher  Scientific,  UK.  #  C/0200/53 
dNTPs:  Promega,  #U  1201,1211,1221,1231 
Diaminoethane  tetra-acetic  acid,  disodium  salt  (EDTA):  Fisher  Scientific,  UK.  #  D/0700/53 
di-Sodium  hydrogen  orthophosphate  (anhydrous):  BDI!  Laboratory  Supplies,  England.  # 
1024944  C 
di-Sodium  hydrogen  orthophosphate  (dihydrate):  Fisher  Scientific,  UK.  # 
S/4450/53 
Dithiothreitol  (DTT):  Melford  Laboratories  Ltd,  UK.  #  16286 
Glucose:  BDH  Laboratory  Supplies,  England.  #  10117 
Glycerol:  SIGMA-Aldrich,  Riedel-deHaen,  Germany,  #  15523 
Glycine:  Fisher  Scientific,  UK.  #  G/0800/60 
Hydrogen  peroxide,  30%  solution:  Sigma  Chemical,  USA  #  11-1009 
Isoamyl  alcohol:  Fisher  Scientific,  UK.  #  A/7080/08 
Isopropanol:  BDH  Laboratory  Supplies,  England.  #10224BQ 
Isopropyl-B-D-  thiogalactopyranoside  (IPTG):  Melford  Laboratories  Ltd,  UK.  #  16327 
Potassium  chloride  :  BDH  Laboratory  Supplies,  England.  #  101984L 
di-Potassium  hydrogen  orthophosphate:  BDH  Laboratory  Supplies,  England.  #  104363A 
Sodium  chloride:  SIGMA-Aldrich,  Riedel-deliaen,  Germany.  #  31434 
N-Lauroyl  sarcosine,  sodium  salt  (Sarkosyl):  SIGMA-Aldrich  Chemical  GmbII,  Germany.  # 
L-5125 
158 Lysozyme:  Promega. 
Methanol:  BDH  Laboratory  Supplies,  England.  #  10158  BG 
Micro  agar:  Duchefa,  Netherlands  #M  1002 
0-  phenylenediamine  tablets,  15  mg/tablet:  SIGMA-Aldrich  Chemical  GmbH, 
Germany  #  4664  SIGMA 
Phosphate  buffered  saline  tablets:  SIGMA-Aldrich  Chemical  GmbH,  Germany  #  P-4417 
Rainbow  molecular  weight  markers:  Amersham  Pharmacia  Biotech,  England.  #  RPN  756 
Skimmed  milk:  Marvel.  Premier  Brands.  UK. 
Sodium  bicarbonate:  SIGMA-Aldrich  Chemical  GmbH,  Germany  #  S-8875 
Sodium  carbonate  (anhydrous):  SIGMA-Aldrich  Chemical  GmbH,  Germany  # 
S-1641 
Sodium  di-hydrogen  orthphosphate:  BDH  Laboratory  Supplies,  England.  #  301324Q 
Sodium  hydroxide:  Fisher  Scientific,  UK  #  S/4920/53 
Tri-sodium  citrate:  Fisher  Scientific,  UK  #  S/3320/53 
Sodium  Dodecyl  Sulphate:  Fisher  Scientific,  UK.  #  S/P530/53 
Sucrose:  Fisher  Scientific,  UK  #  5/8600/63 
Sulphuric  acid  (1.84):  Fisher  Scientific,  UK.  #  S/9230/PB/7 
TAE  buffer:  Anachem  Ltd. 
TEMED:  SIGMA-Aldrich  Chemical  GmbH,  Germany  #  T-9281 
Tris-HCI:  TRIZMA:  SIGMA-Aldrich  Chemical  GmbH,  Germany  #  T-3253 
Tris:  Trizma  base:  SIGMA-Aldrich  Chemical  GmbH,  Germany  #  T-1503 
Tryptone:  Oxoid  Ltd.,  England.  #  L42 
Tween  20:  SIGMA-Aldrich  Chemical  GmbH, 
Germany  #  P-1379 
Yeast  extract:  Oxoid  Ltd.,  England.  #  L21 
Yeast  extract:  Dachefa,  Netherlands  #  T-1333 
Immunotubes:  Nagle  Nunc  International,  Denmark 
Hybond-C  Super:  Nitrocellulose  transfer  membrane  for  proteins.  Amersham  Pharmacia 
Biotech,  England. 
Hybond-N+:  Nylon  transfer  membrane  for  DNA:  Amersham  Pharmacia  Biotech,  England. 
Hybond-P:  PVDF  transfer  membrane  for  protein.  Amersham  Pharmacia  Biotech,  England. 
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HRP  anti-rabbit  antibody:  SIGMA-Aldrich  Chemical  GmbH,  Germany 
Mouse  anti-pllt:  Mo  Bi  Tec.  GmbH,  Germany.  #  PSKAN3 
HRP  anti-M13:  Amersham  Pharmacia  Biotech,  England.  #  27-9421-01 
HRP  anti-mouse:  SIGMA-Aldrich  Chemical  GmbH,  Germany  #  A-9309 
Media 
Luria  broth: 
Tryptone  log 
Yeast  extract  5g 
NaCl  "  log 
Distilled  water  up  to  I  litre 
2xTY 
Tryptone  16  g 
Yeast  extract  log 
NaCl  5g 
Distilled  water  up  to  1  litre 
TYE 
Tryptone  log 
Yeast  extract  5g 
NaCl  8g 
Agar  15  g 
Distilled  water  up  to  I  litre 
BHI 
Brain  Heart  Infusion  37  g 
Distilled  water  up  to  1  litre 
Soc 
Tryptone 
Yeast  extract 
NaCl 
Distilled  water 
The  medium  is  auto 
added  prior  to  use. 
Buffers 
20  g 
5g 
0.5  g 
up  to  1  litre 
;  laved  and  10  ml  of  1M  MgC12  and  10  nil  of  IM  of  MgSO4  is 
Citrate  buffer:  consists  of  53  %  of  0.1  M  trisodium  citrate  and  47  %  of  0.1  M  citric  acid 
monohydrate 
IIRP  Substrate  solution:  I  OPD  tablet  (15  mg)  and  6  µl  of  30%  hydrogen  peroxide  in  15 
ml  citrate  buffer 
160 DNA  sample  buffer  (agarose): 
Bromophenol  blue  0.25% 
Xylene  cyanol  0.25% 
Sucrose  40% 
SDS-Polyacrylamide  electrophoresis 
Stacking  gel  4% 
30%  Bis-acrylamide  487.5  pl 
0.5  M  Tris-HC1(pH  6.8)  1.25  ml 
10%  SDS  50  pl 
Distilled  water  3.26  ml 
TEMED  5  µl 
10%  APS  2.5  pl 
Resolving  gel  12%  10% 
30%  Bis-acrylamide  4  ml  3.3  ml 
1.5  M  Tris-HC1(pH  8.8)  2.5  ml  2.5  ml 
10%  SDS  0.1  ml  0.1  ml 
Distilled  water  3.3  ml  4  ml 
TEMED  5  µl  51tl 
10%APS  0.1  ml  0.1  ml 
5x  Running  gel  buffer 
Tris  base  9S 
Glycine  43.2  g 
SDS  3S 
Distilled  water  up  to  100  ml 
Destain: 
Methanol  450  ml 
Distilled  water  450  ml 
Glacial  acetic  acid  100  ml 
Gel  stain 
Methanol  450  ml 
Glacial  acetic  acid  100  ml 
Brilliant  Coomassie  Blue  0.125  g 
Distilled  water  450  ml 
Western  blotting 
Western  blotting  transfer  buffer 
Tris-base  3.03  g 
Glycine  14.4  g 
Methanol  200  ml 
Distilled  water  up  to  1  litre 
pH  8.1-8.4  (pH  not  adjucted) 
161 Tris-NaCI  (TBS) 
Tris-base  1.21  g 
NaCl  8.7  g 
Concentrated  HCl  0.8  ml 
Adjust  the  pH  to  7.4 
Developer  for  Horse  Radish  Peroxidase  (should  be  prepared  fresh:  maximum  30  min  prior  to 
use) 
4-chloro-1-naphthol  30  mg 
Methanol  10  ml 
Tris-NaCI  pH  7.4  50  ml 
30%H202  30  µl 
Restriction  enzyme  buffers:  (x  10) 
React  buffer  2  for  BstEII,  Sstl  and  EcoRV  (Life  Technologies): 
500  mM  Tris-HCI  (pH  8) 
100  mM  MgC12 
500  mM  NaCI 
React  buffer  5  for  RsrII  (Life  Technologies): 
100  mM  Tris-HCI  (pH  8.2) 
80  mM  MgC12 
React  buffer  4 
500  MM 
200  mM 
100mM 
10mM 
pH  7.9 
for  RsrH  (New  England  Biolabs): 
potassium  acetate 
Tris  acetate 
Magnesium  acetate 
DTT 
React  buffer  4  for  SpeI  (Life  Technologies): 
200  mM  Tris-HCI  (pH  7.4) 
50  mM  MgCI2 
React  buffer  B  for  Spel  (Promega): 
60  mM  Tris-HCI  (pH  7.5) 
500  mM  NaCl 
60  mM  MgC12 
10  mM  DTT 
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